data_2kwz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kwz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 20' ' ' ILE . 64.4 mt -61.76 -41.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.904 -0.498 . . . . 0.0 109.989 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.61 -42.61 88.58 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.2 m -62.35 -39.43 93.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 17' ' ' ILE . 68.0 mt -63.46 -43.35 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 m -58.91 -42.04 88.68 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -61.8 -47.28 85.85 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.89 -33.62 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 tp -56.06 -43.24 77.73 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.835 -0.541 . . . . 0.0 109.621 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.65 -30.62 68.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.732 -0.605 . . . . 0.0 110.12 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.19 -7.23 59.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.3 tt . . . . . 0 N--CA 1.502 2.162 0 O-C-N 121.433 -0.792 . . . . 0.0 111.562 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.3 tp . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.6 -42.19 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -45.12 86.19 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.098 -0.376 . . . . 0.0 110.445 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 m -57.77 -42.09 83.32 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.69 -42.88 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.782 -0.574 . . . . 0.0 109.586 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -60.26 -41.46 93.29 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.732 -0.605 . . . . 0.0 110.088 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -58.65 -38.04 77.27 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -85.5 -29.06 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.85 -46.77 81.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.669 -0.645 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.86 -27.68 68.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.475 -0.766 . . . . 0.0 110.486 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.73 -31.69 57.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.309 0.576 . . . . 0.0 109.677 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.0 mt . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.349 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.91 -35.63 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.417 ' O ' HG23 ' A' ' 21' ' ' THR . 16.9 m-85 -71.68 -33.41 68.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.79 -0.569 . . . . 0.0 110.164 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.7 m -73.28 -42.13 62.81 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.0 110.412 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -64.53 -44.69 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.827 -0.545 . . . . 0.0 110.982 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 18' ' ' PHE . 9.3 t -64.5 -30.48 71.51 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.242 -0.911 . . . . 0.0 110.746 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.297 -0.877 . . . . 0.0 109.315 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.4 mt -98.17 10.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.788 -0.57 . . . . 0.0 110.597 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.18 -42.7 86.61 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.753 -1.217 . . . . 0.0 110.941 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.5 7.68 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.457 -0.777 . . . . 0.0 110.702 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.54 14.87 11.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.627 -0.671 . . . . 0.0 109.769 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.497 1.921 0 O-C-N 121.554 -0.717 . . . . 0.0 109.443 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -61.16 -31.28 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -70.03 -45.39 67.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.698 -0.626 . . . . 0.0 109.966 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.8 m -70.17 -42.99 71.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.705 -0.622 . . . . 0.0 109.756 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.2 mm -65.82 -48.28 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 0.0 110.219 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 t -63.5 -30.22 71.37 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.313 0.96 . . . . 0.0 110.878 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -40.24 93.01 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.867 0.758 . . . . 0.0 109.223 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -31.52 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.09 -49.32 74.16 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.833 -0.542 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 pp -70.23 -11.32 60.81 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.575 -0.703 . . . . 0.0 111.927 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.28 -1.07 48.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.32 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 179.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.3 mt -72.41 -27.54 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.69 -39.61 70.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.953 . . . . 0.0 109.504 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.4 m -71.98 -39.2 69.47 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.72 -0.612 . . . . 0.0 110.252 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 17' ' ' ILE . 1.9 tp -60.32 -26.12 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.414 -0.803 . . . . 0.0 110.862 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -60.74 -41.69 95.89 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.492 -0.755 . . . . 0.0 109.339 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -63.61 -45.71 89.07 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 20' ' ' ILE . 6.2 mt -61.09 -40.73 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -61.45 -38.58 87.72 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 mt -76.96 -3.49 39.15 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.518 . . . . 0.0 111.365 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.28 -11.63 15.96 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.636 -0.665 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.612 -0.68 . . . . 0.0 109.568 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.06 -23.41 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.555 -0.715 . . . . 0.0 111.193 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -88.92 -42.69 11.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.963 -1.085 . . . . 0.0 108.748 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.8 m -64.81 -30.17 71.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.926 -0.484 . . . . 0.0 110.844 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 tp -55.08 -36.34 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.417 -0.802 . . . . 0.0 110.243 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -68.7 -41.55 78.99 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -42.57 99.36 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -62.24 -38.24 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -60.16 -40.74 90.98 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -4.18 46.63 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.731 -0.605 . . . . 0.0 110.876 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.42 5.1 14.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.451 -0.781 . . . . 0.0 111.036 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 27' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.47 -0.768 . . . . 0.0 110.4 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.14 -40.92 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.39 -23.43 62.6 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.013 -0.429 . . . . 0.0 111.056 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.0 m -100.48 -43.56 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.431 -0.793 . . . . 0.0 110.64 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.4 mm -73.42 -56.16 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.593 -0.692 . . . . 0.0 111.676 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -58.12 -35.42 71.45 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 119.203 0.911 . . . . 0.0 111.258 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -40.25 92.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.59 -0.694 . . . . 0.0 110.165 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.2 mt -81.0 -36.99 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -47.35 86.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.673 -0.642 . . . . 0.0 109.773 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -20.91 65.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.642 -0.661 . . . . 0.0 111.195 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.68 -17.94 39.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.686 -0.634 . . . . 0.0 111.492 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.499 1.978 0 O-C-N 121.768 -0.582 . . . . 0.0 109.778 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.1 -37.87 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.58 -34.49 72.78 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -69.26 -45.75 68.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.76 -41.05 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.872 -0.517 . . . . 0.0 109.607 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 p -64.91 -30.3 71.29 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -64.29 -42.18 96.52 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.5 -39.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -39.55 94.11 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.06 -28.08 66.22 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.779 -0.575 . . . . 0.0 110.5 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.8 -16.71 60.7 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.746 0.308 . . . . 0.0 111.608 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.3 mt . . . . . 0 N--CA 1.498 1.949 0 O-C-N 121.707 -0.621 . . . . 0.0 110.437 -179.849 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.3 tp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.5 -48.7 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.621 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -44.25 69.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.632 -0.668 . . . . 0.0 110.763 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -58.45 -41.53 85.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.449 -0.782 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.54 -51.31 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.66 -0.65 . . . . 0.0 110.266 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -65.28 -33.12 75.23 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.377 -0.827 . . . . 0.0 110.52 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -66.08 -46.09 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.46 -40.69 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -36.4 79.26 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.724 -0.61 . . . . 0.0 109.439 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.27 -4.04 58.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.751 -0.593 . . . . 0.0 110.991 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.62 14.26 24.63 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 110.257 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.1 mm . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.33 -0.856 . . . . 0.0 109.311 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 mm -61.23 -27.46 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -91.12 -36.06 14.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -76.67 -26.56 54.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.716 -0.615 . . . . 0.0 110.674 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.5 tp -52.17 -39.78 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.505 -0.747 . . . . 0.0 111.508 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.6 p -63.73 -44.22 94.2 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -66.82 -44.29 81.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.9 mm -62.87 -35.28 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.871 -0.518 . . . . 0.0 109.723 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.75 -42.93 84.97 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.696 -0.627 . . . . 0.0 110.119 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.97 -8.07 56.08 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.744 -0.598 . . . . 0.0 111.292 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.47 1.73 41.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.622 -0.673 . . . . 0.0 110.767 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.704 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.25 -29.22 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.43 -36.12 63.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.99 -0.444 . . . . 0.0 110.436 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.7 m -73.57 -48.78 30.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.1 mm -54.89 -49.78 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.787 -0.571 . . . . 0.0 111.402 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -62.91 -34.7 78.0 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.627 -0.67 . . . . 0.0 110.54 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -68.0 -41.29 82.5 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.628 -0.67 . . . . 0.0 109.837 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.96 -38.63 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.78 -41.31 95.31 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.63 -17.02 60.76 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.071 -0.393 . . . . 0.0 111.072 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.0 12.62 29.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.841 -0.537 . . . . 0.0 111.204 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.774 . . . . 0.0 109.491 179.832 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.459 ' HA ' HD13 ' A' ' 20' ' ' ILE . 17.1 mm -53.97 -41.79 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.983 -0.448 . . . . 0.0 110.395 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.72 -41.55 86.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.794 -0.566 . . . . 0.0 109.972 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.5 m -64.73 -43.84 92.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.78 -0.575 . . . . 0.0 109.578 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -58.41 -44.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.663 -0.648 . . . . 0.0 109.763 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.4 m -62.83 -42.83 99.89 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.739 -0.6 . . . . 0.0 109.802 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -44.14 97.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.836 -0.54 . . . . 0.0 110.007 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mm -62.1 -40.03 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.31 -43.21 88.06 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.3 -28.86 67.55 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.972 0.415 . . . . 0.0 110.171 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.34 60.77 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.484 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.5 mm -59.5 -38.12 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -65.89 -36.81 84.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.113 -0.367 . . . . 0.0 110.636 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.53 -25.49 54.18 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.358 -0.839 . . . . 0.0 111.546 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.2 mt -58.3 -48.88 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.417 -0.802 . . . . 0.0 109.705 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.3 p -65.32 -36.5 84.24 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.749 -0.594 . . . . 0.0 109.898 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -45.37 93.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 90.1 mt -62.58 -37.06 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.96 -42.14 97.71 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.697 -0.627 . . . . 0.0 110.538 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.71 5.42 51.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.648 . . . . 0.0 111.305 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 27' ' ' ILE . 80.1 mt . . . . . 0 N--CA 1.504 2.274 0 O-C-N 121.135 -0.978 . . . . 0.0 111.279 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.3 mt -59.11 -42.55 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.29 -39.13 85.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -61.27 -45.1 95.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.95 -0.469 . . . . 0.0 109.916 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.65 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.756 -0.59 . . . . 0.0 109.452 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.0 m -61.09 -40.53 94.08 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.592 -0.693 . . . . 0.0 109.41 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -63.21 -45.58 91.02 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.818 -0.551 . . . . 0.0 109.695 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.76 -39.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.4 -42.53 82.41 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.845 -0.535 . . . . 0.0 109.635 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 tt -67.45 -35.65 79.63 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.235 0.541 . . . . 0.0 110.011 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.43 -8.51 54.29 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.536 -0.728 . . . . 0.0 109.668 179.738 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tt . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.7 mm -60.16 -38.75 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.56 -32.15 73.53 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.697 -0.627 . . . . 0.0 110.678 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 m -85.4 -49.45 8.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.716 -0.615 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.99 -43.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -60.7 -39.05 87.05 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -44.62 88.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.698 -0.626 . . . . 0.0 109.58 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.93 -40.64 96.2 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.583 -0.698 . . . . 0.0 109.166 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.23 -22.56 64.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.838 -0.539 . . . . 0.0 110.496 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.02 -11.36 53.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.157 -0.339 . . . . 0.0 111.396 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.3 mt . . . . . 0 N--CA 1.501 2.11 0 O-C-N 121.572 -0.705 . . . . 0.0 110.051 179.801 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 tp . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mm -57.09 -35.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -87.01 -33.81 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -71.23 -40.23 71.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.474 -0.766 . . . . 0.0 109.832 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 18.7 mm -65.59 -44.97 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.747 -0.595 . . . . 0.0 109.922 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 p -63.7 -39.37 94.15 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.811 -0.556 . . . . 0.0 110.691 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -59.18 -47.06 86.7 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.715 -0.616 . . . . 0.0 109.63 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.92 -29.1 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -57.71 -47.75 81.52 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.22 -33.39 73.41 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.298 0.571 . . . . 0.0 110.377 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.6 62.42 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.594 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.8 mt . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.851 -0.531 . . . . 0.0 109.724 179.602 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 mt -62.03 -38.66 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -61.14 -28.52 69.17 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.819 -0.551 . . . . 0.0 110.686 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.3 m -88.98 -26.56 21.42 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.305 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.1 mt -60.48 -45.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.404 -0.81 . . . . 0.0 109.131 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -60.58 -33.54 72.86 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.805 -0.56 . . . . 0.0 109.812 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.69 -48.43 54.79 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.77 -34.18 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -40.28 78.13 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -12.28 59.97 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.973 -0.454 . . . . 0.0 111.276 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.01 8.63 28.42 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.784 -0.572 . . . . 0.0 110.942 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 0.0 109.75 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.502 ' HA ' HD13 ' A' ' 20' ' ' ILE . 42.4 mm -61.31 -39.18 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -45.42 93.1 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.808 -0.557 . . . . 0.0 110.223 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.8 m -60.81 -39.0 87.28 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.762 -0.586 . . . . 0.0 110.539 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.502 HD13 ' HA ' ' A' ' 17' ' ' ILE . 45.4 mt -65.35 -44.89 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.834 -0.541 . . . . 0.0 109.595 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.7 m -64.1 -39.11 93.35 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.717 -0.614 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -60.85 -45.66 93.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.721 -0.612 . . . . 0.0 109.429 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.19 -40.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -42.18 86.72 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.7 mt -78.53 -1.78 35.56 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.787 -0.571 . . . . 0.0 111.435 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.97 13.0 20.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.772 . . . . 0.0 110.3 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.4 mt . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.356 -0.84 . . . . 0.0 109.596 179.878 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 N--CA 1.501 2.075 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 mm -63.73 -39.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.22 -38.82 84.53 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -65.62 -43.07 90.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.81 -42.46 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -59.81 -41.65 91.71 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.706 -0.621 . . . . 0.0 109.75 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -43.89 94.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.793 -0.567 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.1 -38.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 tp -61.34 -40.5 94.49 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.41 -36.02 81.78 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.3 68.68 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.197 0.522 . . . . 0.0 110.772 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.501 2.081 0 O-C-N 122.051 -0.406 . . . . 0.0 110.367 179.632 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 N--CA 1.499 1.979 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.39 -41.2 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -60.58 -36.65 79.03 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.912 -0.492 . . . . 0.0 111.072 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -85.67 -44.35 12.65 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 110.555 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mt -60.06 -40.98 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.959 -0.463 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -65.52 -31.13 72.02 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 119.581 1.082 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.82 -36.38 59.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.39 -0.819 . . . . 0.0 109.612 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.441 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 46.2 mt -100.93 9.51 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 110.647 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 tp -58.16 -48.86 78.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.818 -1.176 . . . . 0.0 109.625 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -78.82 -14.03 59.48 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.907 -0.495 . . . . 0.0 110.906 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.55 21.96 15.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 111.571 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.198 0 O-C-N 121.307 -0.871 . . . . 0.0 111.305 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 ' HA ' HD11 ' A' ' 20' ' ' ILE . 63.1 mt -59.38 -37.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -65.26 -38.6 90.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.912 -0.493 . . . . 0.0 109.925 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.1 m -65.04 -43.12 93.4 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.75 -0.594 . . . . 0.0 109.503 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' A' ' 17' ' ' ILE . 14.4 mt -61.33 -41.94 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.957 -0.464 . . . . 0.0 109.749 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.6 m -65.08 -40.0 94.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.597 -0.689 . . . . 0.0 110.155 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -57.48 -45.02 85.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.962 -0.461 . . . . 0.0 109.89 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -38.19 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -49.6 77.23 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -17.03 62.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.82 -0.55 . . . . 0.0 111.31 179.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.03 2.18 56.51 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.807 -0.558 . . . . 0.0 111.184 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.4 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.449 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 37.1 mt -65.39 -38.65 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.67 -26.32 67.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.686 -0.634 . . . . 0.0 110.692 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -96.46 -41.96 8.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.689 -0.632 . . . . 0.0 109.963 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 tt -57.39 -33.37 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.717 -0.614 . . . . 0.0 111.254 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.8 p -63.49 -43.25 97.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.498 -0.751 . . . . 0.0 109.168 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -63.92 -35.68 81.47 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.3 mm -75.48 -40.9 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.59 -43.62 93.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.48 -32.99 74.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.797 -0.564 . . . . 0.0 110.44 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.84 -30.14 63.77 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.239 0.542 . . . . 0.0 110.533 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.7 mt . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.703 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mt -71.39 -36.36 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.6 -34.98 71.73 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.92 -0.488 . . . . 0.0 109.696 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.2 m -75.68 -41.13 54.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.4 mm -64.8 -40.31 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.995 -0.441 . . . . 0.0 110.271 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.8 p -64.73 -37.21 86.82 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.497 -0.752 . . . . 0.0 109.741 179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -45.02 93.99 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -65.13 -37.14 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.64 -40.85 89.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.205 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -68.26 -22.11 64.78 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.871 -0.518 . . . . 0.0 110.593 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.82 5.78 47.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.09 -0.382 . . . . 0.0 110.817 179.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm . . . . . 0 N--CA 1.499 2.017 0 O-C-N 121.496 -0.752 . . . . 0.0 109.902 -179.884 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 N--CA 1.5 2.069 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.83 -46.48 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -55.07 -38.24 67.8 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.834 -0.541 . . . . 0.0 111.009 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -78.57 -49.37 13.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.575 -0.703 . . . . 0.0 110.594 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.89 -45.63 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.733 -0.604 . . . . 0.0 110.005 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.7 m -59.55 -32.75 70.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.0 109.716 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.44 -35.64 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.038 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.97 -45.18 94.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -66.2 -29.54 69.83 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.919 -0.488 . . . . 0.0 110.943 179.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.81 -17.98 60.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.077 -0.39 . . . . 0.0 111.921 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.9 mt . . . . . 0 N--CA 1.499 1.99 0 O-C-N 121.823 -0.548 . . . . 0.0 110.593 -179.977 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mm -64.82 -42.29 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -60.3 -33.37 72.26 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.6 m -68.67 -43.25 76.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HA ' HD11 ' A' ' 23' ' ' ILE . 37.1 mm -66.58 -42.31 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.079 -0.388 . . . . 0.0 110.037 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.3 p -63.54 -37.94 89.25 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.455 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.42 -40.92 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.738 -0.601 . . . . 0.0 109.546 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 20' ' ' ILE . 14.8 mt -74.01 -43.57 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -44.71 89.05 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.86 -0.525 . . . . 0.0 109.795 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.22 -5.08 45.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.808 -0.558 . . . . 0.0 111.298 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.52 9.27 21.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.613 -0.679 . . . . 0.0 110.53 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 0.0 109.931 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 20' ' ' ILE . 46.6 mt -57.49 -44.54 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.351 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.94 -42.93 99.67 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.131 -0.356 . . . . 0.0 110.119 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.7 m -59.04 -40.91 86.53 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 17' ' ' ILE . 49.2 mt -65.17 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 m -60.36 -41.13 93.04 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.633 -0.667 . . . . 0.0 109.783 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -63.62 -41.34 98.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -77.66 -26.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -45.46 86.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.498 -0.751 . . . . 0.0 109.566 179.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -16.53 63.96 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.782 -0.574 . . . . 0.0 111.365 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.27 5.71 50.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.827 -0.545 . . . . 0.0 111.073 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 0.0 109.319 179.938 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.03 -45.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.648 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.94 82.21 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -62.98 -42.68 99.91 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.402 ' HA ' HD11 ' A' ' 20' ' ' ILE . 19.5 mm -60.62 -42.25 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -63.47 -38.81 92.58 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.712 -0.618 . . . . 0.0 109.646 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -60.08 -35.91 76.23 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.497 . . . . 0.0 109.851 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.47 -31.18 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.79 -45.68 93.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.651 -0.655 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.6 -13.07 61.94 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.925 179.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.26 -8.24 33.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.73 -0.606 . . . . 0.0 111.056 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.3 mm . . . . . 0 N--CA 1.499 2.0 0 O-C-N 121.569 -0.707 . . . . 0.0 109.367 179.898 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.502 ' HA ' HD11 ' A' ' 20' ' ' ILE . 32.4 mm -54.37 -41.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 122.053 -0.405 . . . . 0.0 110.388 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -63.69 -38.65 91.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.713 -0.617 . . . . 0.0 110.171 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -65.41 -39.17 91.82 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.751 -0.593 . . . . 0.0 109.739 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 17' ' ' ILE . 7.6 mt -66.98 -43.96 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.8 m -58.75 -41.38 86.39 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.812 -0.555 . . . . 0.0 109.889 179.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.18 -35.8 74.19 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.931 -0.481 . . . . 0.0 110.456 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.78 -20.14 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.736 -0.603 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tp -57.98 -45.36 86.89 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.47 -29.32 70.36 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.846 -0.533 . . . . 0.0 110.037 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.62 -36.17 29.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.26 0.552 . . . . 0.0 110.208 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.2 mm . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 121.438 0.637 . . . . 0.0 109.726 179.957 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.6 mm -60.79 -35.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.674 -0.642 . . . . 0.0 109.597 179.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -75.85 -44.07 42.62 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m -66.24 -33.33 75.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.767 -0.583 . . . . 0.0 110.809 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.86 -34.24 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.13 -0.981 . . . . 0.0 110.098 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -65.62 -43.85 88.31 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -65.33 -44.15 88.73 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -63.61 -36.91 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.69 -38.84 79.12 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.612 -0.68 . . . . 0.0 110.121 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.95 -11.24 60.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.616 -0.678 . . . . 0.0 111.13 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.44 7.81 45.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.75 -0.594 . . . . 0.0 110.531 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.592 -0.693 . . . . 0.0 109.648 179.882 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.5 mt -58.14 -40.22 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -41.67 96.05 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.854 -0.529 . . . . 0.0 109.916 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -61.94 -41.7 98.26 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 17' ' ' ILE . 17.8 mt -63.68 -42.28 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.8 m -61.98 -33.95 75.25 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.487 -0.758 . . . . 0.0 110.022 179.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -69.12 -37.38 78.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 25.4 mt -102.63 6.03 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.786 -0.571 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -54.42 -50.12 68.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.852 -1.155 . . . . 0.0 110.626 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.0 mt -68.32 -19.22 64.66 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.243 178.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.34 10.45 39.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.109 -0.369 . . . . 0.0 111.166 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 2.7 tt . . . . . 0 N--CA 1.501 2.09 0 O-C-N 121.249 -0.907 . . . . 0.0 111.905 -179.886 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.7 mt -65.02 -30.54 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.751 -0.593 . . . . 0.0 109.706 179.462 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -88.43 -25.95 22.39 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.426 -0.796 . . . . 0.0 109.863 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.7 m -88.93 -21.57 23.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 0.0 110.503 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 tt -53.49 -37.66 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 121.315 -0.865 . . . . 0.0 110.581 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -71.01 -39.7 72.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -61.58 -36.12 79.76 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.294 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.9 mt -74.3 -30.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.66 -0.65 . . . . 0.0 109.35 179.25 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 tp -60.0 -41.21 91.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.701 -0.624 . . . . 0.0 110.297 179.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.68 2.59 28.94 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.503 -0.748 . . . . 0.0 110.701 179.034 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.2 10.89 13.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.515 -0.74 . . . . 0.0 110.355 179.294 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.1 tt . . . . . 0 N--CA 1.499 1.977 0 O-C-N 121.605 -0.684 . . . . 0.0 109.987 179.848 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.484 ' HA ' HD13 ' A' ' 20' ' ' ILE . 71.7 mt -56.96 -45.03 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -44.56 94.63 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.736 -0.603 . . . . 0.0 109.601 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.457 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 2.4 m -61.23 -33.95 74.32 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.818 -0.551 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 17' ' ' ILE . 64.1 mt -60.43 -40.25 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.44 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -58.75 -39.49 81.1 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.251 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -64.89 -43.48 92.74 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.187 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.2 mm -71.31 -33.28 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.313 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tp -55.56 -41.49 73.35 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.867 -0.521 . . . . 0.0 109.834 179.411 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 2.71 22.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.733 -0.604 . . . . 0.0 111.302 179.3 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.65 6.53 11.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.481 -0.762 . . . . 0.0 110.903 179.374 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.1 mt . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 0.0 109.465 179.63 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mt -64.07 -38.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.46 -34.83 77.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.825 -0.547 . . . . 0.0 109.952 179.276 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.1 m -59.4 -42.62 92.19 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.788 -0.57 . . . . 0.0 109.912 179.637 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.44 -43.43 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.524 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.5 m -61.69 -39.78 92.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.682 -0.636 . . . . 0.0 109.85 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -60.52 -51.83 67.77 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.9 mt -63.48 -35.74 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.12 -41.18 92.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 179.341 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.35 -18.61 62.37 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.951 -0.468 . . . . 0.0 110.952 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.11 -1.63 57.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.861 -0.524 . . . . 0.0 111.522 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt . . . . . 0 N--CA 1.498 1.933 0 O-C-N 121.589 -0.695 . . . . 0.0 109.667 179.837 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.19 -32.54 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.801 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -87.8 -39.32 14.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.3 m -69.39 -22.95 63.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.752 -0.592 . . . . 0.0 110.87 179.641 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 tp -55.43 -36.0 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.044 0.838 . . . . 0.0 110.142 179.765 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.1 p -65.08 -42.91 93.67 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.081 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -67.54 -36.52 81.14 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 27' ' ' ILE . 71.1 mt -73.55 -36.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.56 -0.712 . . . . 0.0 109.827 179.605 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.6 tp -48.75 -49.8 36.7 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.619 -0.676 . . . . 0.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.49 -5.7 44.13 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.648 -0.658 . . . . 0.0 111.8 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -107.59 3.67 25.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.718 -0.614 . . . . 0.0 111.078 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 23' ' ' ILE . 22.6 mm . . . . . 0 N--CA 1.498 1.967 0 O-C-N 121.443 -0.786 . . . . 0.0 108.968 179.72 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.08 -47.44 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.677 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.98 -32.98 72.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.849 -0.532 . . . . 0.0 111.386 179.92 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -71.25 -42.95 68.15 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.9 mt -65.01 -42.58 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 p -65.25 -37.54 87.53 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.413 -0.804 . . . . 0.0 110.402 179.779 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.34 -46.43 64.17 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mm -65.79 -38.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.523 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -60.1 -39.61 86.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.545 -0.722 . . . . 0.0 109.822 179.592 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.74 -22.47 37.26 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.359 -0.838 . . . . 0.0 111.026 179.582 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.47 12.34 14.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.842 -0.536 . . . . 0.0 111.438 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mm . . . . . 0 N--CA 1.498 1.966 0 O-C-N 121.301 -0.874 . . . . 0.0 109.993 179.744 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.7 mt -54.74 -39.38 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.946 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -62.04 -42.62 99.37 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.308 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -66.63 -39.77 88.45 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.56 -39.15 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.623 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -42.37 82.92 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.698 -0.626 . . . . 0.0 109.509 179.488 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -68.84 -41.31 78.7 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -75.97 -23.69 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.739 -0.6 . . . . 0.0 110.081 179.589 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.28 -42.52 70.1 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.486 -0.759 . . . . 0.0 109.784 179.67 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.53 -11.46 60.94 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.885 -0.509 . . . . 0.0 110.935 179.146 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.38 13.0 30.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.456 179.192 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.4 mt . . . . . 0 N--CA 1.502 2.167 0 O-C-N 121.322 -0.861 . . . . 0.0 111.042 -179.983 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.403 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 8.4 mt -52.03 -41.87 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -42.8 99.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 0.0 110.068 179.628 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -66.85 -33.86 76.52 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.747 -0.596 . . . . 0.0 110.0 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 17' ' ' ILE . 86.9 mt -58.3 -43.39 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.253 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 m -69.09 -41.76 77.04 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.032 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -59.65 -46.03 90.25 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.514 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.9 mm -82.09 -15.56 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.712 -0.617 . . . . 0.0 110.249 179.611 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -54.33 -45.63 72.7 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 179.664 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.01 -21.91 66.91 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.387 179.237 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.41 0.45 56.22 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.056 -0.402 . . . . 0.0 111.188 179.215 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 24' ' ' LEU . 55.2 mt . . . . . 0 N--CA 1.5 2.032 0 O-C-N 121.46 -0.775 . . . . 0.0 109.898 179.543 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.5 mm -63.8 -40.26 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.204 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.6 -36.47 71.79 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.5 m -73.62 -39.9 64.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.201 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -41.34 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.853 -0.53 . . . . 0.0 110.364 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 p -65.54 -36.49 83.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.473 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -58.83 -42.76 89.99 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.405 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -74.88 -35.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.025 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.79 -44.57 82.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.427 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -14.61 62.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.788 -0.57 . . . . 0.0 111.423 179.431 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.73 5.17 52.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.782 -0.574 . . . . 0.0 110.637 179.18 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.0 mt . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 0.0 110.246 179.99 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.26 -36.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.805 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -63.12 -34.61 77.98 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.085 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 m -78.77 -27.52 44.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.681 -0.637 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.18 -45.18 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.69 -0.631 . . . . 0.0 110.198 179.975 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -67.02 -33.86 76.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.636 -0.665 . . . . 0.0 110.018 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -68.47 -50.83 49.5 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.6 -23.27 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.748 -0.595 . . . . 0.0 109.808 179.204 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -55.77 -42.65 75.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.511 -0.743 . . . . 0.0 110.014 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.09 -24.62 63.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.585 -0.697 . . . . 0.0 110.664 179.552 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.62 -24.8 28.97 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.773 -0.58 . . . . 0.0 111.183 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 121.201 0.524 . . . . 0.0 110.457 179.919 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.8 -32.56 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.16 -39.73 28.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.897 -0.502 . . . . 0.0 109.676 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -61.37 -47.57 85.25 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.854 -0.529 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.6 mt -58.5 -45.33 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 179.858 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -64.78 -33.3 75.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.825 -0.547 . . . . 0.0 110.541 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -68.46 -40.31 81.09 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.432 -0.793 . . . . 0.0 110.704 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.8 -36.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.786 -0.571 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.71 -44.27 93.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.522 -0.736 . . . . 0.0 109.727 179.644 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.31 -14.81 59.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.81 -0.556 . . . . 0.0 111.017 179.429 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.79 14.01 22.77 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.842 -0.536 . . . . 0.0 110.801 179.34 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.0 mm . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.631 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.4 mt -60.19 -42.15 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.502 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -63.64 -41.11 98.28 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.677 -0.64 . . . . 0.0 109.854 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.5 m -61.54 -42.94 99.57 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.471 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.09 -37.92 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.989 -0.444 . . . . 0.0 109.903 179.534 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.2 m -64.64 -39.57 93.94 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.208 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -61.93 -44.15 97.37 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.97 -41.59 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.7 tp -57.82 -41.21 81.77 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.279 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.98 -30.67 71.27 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.249 0.547 . . . . 0.0 109.994 179.099 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.95 -0.65 49.58 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.595 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.3 mt . . . . . 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.895 . . . . 0.0 110.002 179.908 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.48 -169.17 1.41 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.661 -0.906 . . . . 0.0 109.744 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.53 36.7 27.68 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.462 0.649 . . . . 0.0 111.206 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.62 -50.13 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.03 -42.35 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.437 HG22 HD12 ' A' ' 6' ' ' ILE . 36.0 mm -58.53 -41.42 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -66.8 -40.01 87.96 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.29 -27.92 61.82 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.727 -0.608 . . . . 0.0 111.462 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -66.71 -43.34 84.54 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.839 -0.538 . . . . 0.0 109.659 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 14' ' ' PRO . 19.4 p -84.13 -18.47 36.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.397 -0.814 . . . . 0.0 111.237 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.74 -33.49 12.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.228 -0.92 . . . . 0.0 111.577 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.4 mm -107.92 105.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.293 -0.879 . . . . 0.0 110.504 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.0 m80 53.6 61.4 10.63 Favored Pre-proline 0 N--CA 1.507 2.383 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 46.3 Cg_endo -70.31 -35.94 10.17 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 O-C-N 123.427 1.225 . . . . 0.0 111.354 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.03 -10.64 58.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.607 -0.683 . . . . 0.0 112.05 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.36 -43.78 5.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.376 -0.828 . . . . 0.0 109.712 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 20' ' ' ILE . 64.4 mt -61.76 -41.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.904 -0.498 . . . . 0.0 109.989 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.61 -42.61 88.58 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.2 m -62.35 -39.43 93.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 17' ' ' ILE . 68.0 mt -63.46 -43.35 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 m -58.91 -42.04 88.68 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -61.8 -47.28 85.85 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.89 -33.62 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 tp -56.06 -43.24 77.73 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.835 -0.541 . . . . 0.0 109.621 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.65 -30.62 68.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.732 -0.605 . . . . 0.0 110.12 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.19 -7.23 59.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.3 tt -76.48 -18.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.433 -0.792 . . . . 0.0 111.562 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -57.38 7.82 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.45 -0.781 . . . . 0.0 110.09 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.35 83.26 0.54 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -62.54 -37.18 60.5 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 O-C-N 123.858 1.452 . . . . 0.0 110.395 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mp -75.05 -42.22 57.5 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.1 mmt -56.83 -35.67 69.09 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.1 t -58.55 -30.98 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.55 13.09 10.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 0.0 111.267 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.5 ' HA ' HG21 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -137.79 25.74 2.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.198 -0.939 . . . . 0.0 110.441 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.13 103.63 16.23 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.065 -1.022 . . . . 0.0 109.011 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.12 48.77 37.56 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.5 HG21 ' HA ' ' A' ' 35' ' ' GLN . 1.6 pt -112.14 164.86 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 122.323 -0.516 . . . . 0.0 110.797 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 m 55.43 69.58 0.72 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.611 0.719 . . . . 0.0 110.433 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.687 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.514 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -110.54 23.72 13.88 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.667 -0.902 . . . . 0.0 111.739 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.58 -51.38 3.21 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.57 76.1 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.013 -0.429 . . . . 0.0 110.372 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -62.8 -43.55 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.99 -44.09 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.41 -33.83 76.78 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.763 -0.586 . . . . 0.0 109.655 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tp -81.3 8.53 8.89 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.723 -0.611 . . . . 0.0 111.521 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.4 m -105.1 -42.19 5.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.092 -1.005 . . . . 0.0 110.097 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.3 m -92.1 -34.82 14.21 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.65 -0.656 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.51 22.6 6.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.433 -0.792 . . . . 0.0 111.647 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.431 HD11 HG21 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -71.05 140.32 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.324 -0.86 . . . . 0.0 110.06 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.5 58.62 8.78 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 122.147 -0.345 . . . . 0.0 111.53 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.59 -41.07 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 O-C-N 123.175 1.092 . . . . 0.0 111.411 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.13 -40.63 98.16 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.726 -0.609 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.25 -44.54 97.08 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.6 -42.19 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -45.12 86.19 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.098 -0.376 . . . . 0.0 110.445 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 m -57.77 -42.09 83.32 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.69 -42.88 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.782 -0.574 . . . . 0.0 109.586 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -60.26 -41.46 93.29 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.732 -0.605 . . . . 0.0 110.088 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -58.65 -38.04 77.27 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -85.5 -29.06 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.85 -46.77 81.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.669 -0.645 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.86 -27.68 68.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.475 -0.766 . . . . 0.0 110.486 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.73 -31.69 57.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.309 0.576 . . . . 0.0 109.677 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.0 mt -114.42 56.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.17 -62.6 1.22 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.469 -0.77 . . . . 0.0 110.741 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.06 -56.42 0.45 Allowed Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.377 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -89.69 28.88 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.438 1.425 . . . . 0.0 112.33 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.02 -44.4 84.83 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.9 ttm -74.39 -34.77 63.4 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.51 -38.13 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.806 -0.559 . . . . 0.0 109.756 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.19 4.51 26.38 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.622 -0.674 . . . . 0.0 112.238 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.63 22.0 3.36 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.117 -0.99 . . . . 0.0 111.093 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.36 92.37 7.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.268 -0.895 . . . . 0.0 109.32 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.43 -42.38 1.93 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.4 mt -79.84 77.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.654 -0.909 . . . . 0.0 109.401 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -138.77 44.78 2.05 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.657 -0.652 . . . . 0.0 109.914 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.5 mptt . . . . . 0 N--CA 1.505 2.278 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.825 179.867 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.51 -176.91 3.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.794 -0.827 . . . . 0.0 110.068 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.59 33.26 23.03 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.273 0.559 . . . . 0.0 110.815 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.62 -53.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.2 t -60.2 -38.51 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 122.05 -0.406 . . . . 0.0 110.108 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 89.4 mt -60.56 -44.48 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.5 tp -67.65 -35.19 78.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.758 -0.589 . . . . 0.0 110.196 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 tp -75.31 1.44 13.69 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.279 -0.888 . . . . 0.0 112.216 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 m -101.88 -50.91 3.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.18 -0.95 . . . . 0.0 109.166 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.9 m -96.01 -35.67 11.31 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.681 -0.637 . . . . 0.0 111.106 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.05 43.74 1.05 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.342 -0.849 . . . . 0.0 110.817 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.8 tt -85.79 139.76 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.714 -0.616 . . . . 0.0 110.509 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -147.66 95.37 4.27 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.584 -0.697 . . . . 0.0 110.002 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.13 -25.97 36.97 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.39 1.393 . . . . 0.0 111.973 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.3 -28.52 42.77 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -42.01 62.77 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.735 -0.603 . . . . 0.0 109.581 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.91 -35.63 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.417 ' O ' HG23 ' A' ' 21' ' ' THR . 16.9 m-85 -71.68 -33.41 68.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.79 -0.569 . . . . 0.0 110.164 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.7 m -73.28 -42.13 62.81 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.0 110.412 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -64.53 -44.69 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.827 -0.545 . . . . 0.0 110.982 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 18' ' ' PHE . 9.3 t -64.5 -30.48 71.51 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.242 -0.911 . . . . 0.0 110.746 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.297 -0.877 . . . . 0.0 109.315 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.4 mt -98.17 10.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.788 -0.57 . . . . 0.0 110.597 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.18 -42.7 86.61 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.753 -1.217 . . . . 0.0 110.941 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.5 7.68 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.457 -0.777 . . . . 0.0 110.702 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.54 14.87 11.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.627 -0.671 . . . . 0.0 109.769 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.7 mt -118.29 -44.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.554 -0.717 . . . . 0.0 109.443 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mp -87.82 -69.02 0.72 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.663 -0.648 . . . . 0.0 109.586 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.03 -53.31 0.79 Allowed Glycine 0 N--CA 1.496 2.696 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.865 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -92.47 21.48 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 121.695 1.597 . . . . 0.0 113.073 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.7 tt -61.83 -43.4 98.93 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.289 -0.882 . . . . 0.0 109.977 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.7 ttm -73.91 -39.94 63.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.763 -0.586 . . . . 0.0 109.539 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.97 -28.4 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.79 -0.569 . . . . 0.0 110.551 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -92.93 10.4 31.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.382 -0.824 . . . . 0.0 112.069 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -147.46 26.69 1.04 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.246 -0.909 . . . . 0.0 111.425 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.48 -56.58 2.16 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.034 -1.041 . . . . 0.0 110.28 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.72 55.86 0.65 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.3 tp -87.22 67.96 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.797 -0.826 . . . . 0.0 111.148 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.7 p -108.06 -32.85 7.37 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.135 -0.978 . . . . 0.0 111.255 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.9 mttp . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.034 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptt85 -138.88 170.73 15.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.969 . . . . 0.0 110.612 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 t70 57.56 37.68 27.66 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.671 0.748 . . . . 0.0 110.668 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.71 -50.09 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.68 -42.42 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.17 -45.74 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.2 tp -63.5 -37.1 86.0 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -42.77 99.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.683 -0.635 . . . . 0.0 110.307 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.0 m -70.14 -34.46 73.07 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.564 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.2 m -62.71 -40.25 96.59 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.728 -0.607 . . . . 0.0 110.385 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.37 -45.63 9.33 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.709 -0.619 . . . . 0.0 110.264 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 tp 54.52 22.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 56.19 75.18 0.61 Allowed Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.481 -0.762 . . . . 0.0 110.766 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.53 -169.62 0.63 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 O-C-N 123.442 1.233 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 58.93 44.53 16.41 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 122.329 1.061 . . . . 0.0 110.384 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.51 -58.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -61.16 -31.28 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -70.03 -45.39 67.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.698 -0.626 . . . . 0.0 109.966 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.8 m -70.17 -42.99 71.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.705 -0.622 . . . . 0.0 109.756 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.2 mm -65.82 -48.28 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 0.0 110.219 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 t -63.5 -30.22 71.37 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.313 0.96 . . . . 0.0 110.878 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -40.24 93.01 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.867 0.758 . . . . 0.0 109.223 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -31.52 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.09 -49.32 74.16 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.833 -0.542 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 pp -70.23 -11.32 60.81 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.575 -0.703 . . . . 0.0 111.927 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.28 -1.07 48.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.32 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.2 mt -119.38 -47.53 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.03 -44.85 75.03 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.14 -0.35 . . . . 0.0 111.336 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.47 79.83 0.58 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -63.17 -33.35 72.6 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 O-C-N 123.919 1.484 . . . . 0.0 111.934 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 tp -61.9 -42.09 98.66 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.465 -0.772 . . . . 0.0 109.609 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 22.0 mtp -79.85 -41.73 25.71 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -59.66 -34.51 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.839 -0.538 . . . . 0.0 110.195 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tp -79.1 5.91 10.81 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.408 -0.808 . . . . 0.0 111.677 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -127.71 26.24 5.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.209 -0.932 . . . . 0.0 110.564 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.64 80.1 8.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.14 -0.975 . . . . 0.0 109.304 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.74 35.67 66.59 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.0 mm -111.13 111.85 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.469 -1.018 . . . . 0.0 109.842 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.6 p 41.31 59.14 2.44 Favored 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 123.284 0.633 . . . . 0.0 111.996 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.0 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.552 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.25 25.59 6.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.768 -0.843 . . . . 0.0 110.704 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.0 -54.1 2.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.398 -0.814 . . . . 0.0 109.259 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.91 52.66 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.919 -0.488 . . . . 0.0 110.992 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.3 -48.47 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.553 -0.717 . . . . 0.0 110.135 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -65.18 -35.69 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tp -69.38 -30.28 68.24 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.551 -0.718 . . . . 0.0 109.556 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.77 10.45 13.59 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.652 -0.655 . . . . 0.0 112.178 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 t -111.45 -31.09 7.14 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.908 -1.12 . . . . 0.0 111.238 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.2 m -61.55 -31.07 71.08 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.464 -0.773 . . . . 0.0 111.469 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.03 -32.42 66.16 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.825 -0.547 . . . . 0.0 111.003 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -80.17 122.83 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 56.41 59.81 8.35 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 122.228 -0.295 . . . . 0.0 110.813 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.53 -20.12 27.5 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 O-C-N 123.35 1.184 . . . . 0.0 112.072 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -57.12 -41.58 79.28 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.394 -0.816 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.83 -41.98 95.32 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.3 mt -72.41 -27.54 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.69 -39.61 70.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.953 . . . . 0.0 109.504 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.4 m -71.98 -39.2 69.47 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.72 -0.612 . . . . 0.0 110.252 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 17' ' ' ILE . 1.9 tp -60.32 -26.12 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.414 -0.803 . . . . 0.0 110.862 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -60.74 -41.69 95.89 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.492 -0.755 . . . . 0.0 109.339 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -63.61 -45.71 89.07 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 20' ' ' ILE . 6.2 mt -61.09 -40.73 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -61.45 -38.58 87.72 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 mt -76.96 -3.49 39.15 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.518 . . . . 0.0 111.365 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.28 -11.63 15.96 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.636 -0.665 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.3 mt -98.78 -45.13 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.612 -0.68 . . . . 0.0 109.568 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.1 -26.26 66.62 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.976 -0.453 . . . . 0.0 111.492 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.47 -63.32 5.23 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.02 0.01 9.43 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 O-C-N 123.663 1.349 . . . . 0.0 112.135 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -50.82 72.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.03 -1.044 . . . . 0.0 110.219 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.3 ttt -61.79 -37.47 84.5 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.703 -0.623 . . . . 0.0 110.151 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.7 t -61.99 -33.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.07 5.07 20.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.608 -0.683 . . . . 0.0 111.43 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -124.34 21.95 8.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.367 -0.833 . . . . 0.0 110.857 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.17 70.89 10.92 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.162 -0.961 . . . . 0.0 109.425 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.5 75.67 1.26 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.5 tp -78.55 61.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.004 0.907 . . . . 0.0 110.522 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.45 59.99 0.95 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.314 -0.866 . . . . 0.0 109.697 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.541 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.44 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -108.3 42.94 1.29 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.696 -0.885 . . . . 0.0 110.304 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -104.92 -45.59 4.52 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.481 -0.762 . . . . 0.0 110.167 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.34 -33.73 65.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.874 -0.516 . . . . 0.0 111.815 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -71.48 -46.75 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.243 -0.91 . . . . 0.0 110.715 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.32 -42.22 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.642 -0.661 . . . . 0.0 109.448 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 tp -64.32 -37.77 88.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.717 -0.614 . . . . 0.0 109.938 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.28 -6.82 45.84 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.732 -0.605 . . . . 0.0 111.872 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.8 m -88.69 -52.07 5.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.232 -0.918 . . . . 0.0 109.473 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 91.1 m -89.1 -41.91 12.02 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.75 -0.594 . . . . 0.0 110.515 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.23 44.86 1.01 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.56 -0.712 . . . . 0.0 110.134 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.548 HG13 ' HD3' ' A' ' 14' ' ' PRO . 6.8 tp -65.54 130.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-O 121.159 0.504 . . . . 0.0 110.823 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.59 66.24 3.15 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.651 -0.656 . . . . 0.0 110.421 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HD3' HG13 ' A' ' 12' ' ' ILE . 48.3 Cg_endo -72.06 -29.73 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 O-C-N 123.4 1.211 . . . . 0.0 111.267 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.51 -6.32 3.31 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.391 -0.818 . . . . 0.0 113.183 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -115.75 -49.93 2.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.052 -1.03 . . . . 0.0 109.656 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.06 -23.41 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.555 -0.715 . . . . 0.0 111.193 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -88.92 -42.69 11.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.963 -1.085 . . . . 0.0 108.748 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.8 m -64.81 -30.17 71.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.926 -0.484 . . . . 0.0 110.844 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 tp -55.08 -36.34 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.417 -0.802 . . . . 0.0 110.243 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -68.7 -41.55 78.99 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -42.57 99.36 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -62.24 -38.24 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -60.16 -40.74 90.98 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -4.18 46.63 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.731 -0.605 . . . . 0.0 110.876 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.42 5.1 14.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.451 -0.781 . . . . 0.0 111.036 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -103.78 -30.87 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.47 -0.768 . . . . 0.0 110.4 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.67 -30.59 70.16 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.325 -0.859 . . . . 0.0 110.288 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.92 69.11 0.47 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.54 -45.63 1.63 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 O-C-N 123.738 1.388 . . . . 0.0 111.029 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.76 -38.96 92.77 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.79 -0.569 . . . . 0.0 109.703 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -45.52 93.99 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.28 -36.66 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.725 -0.609 . . . . 0.0 109.481 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mt -68.4 -14.9 63.33 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.801 -0.562 . . . . 0.0 112.279 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -122.3 15.93 10.57 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.607 -0.683 . . . . 0.0 111.465 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.46 -64.05 1.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.261 -0.899 . . . . 0.0 109.05 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.93 -37.35 7.9 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 43.38 40.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 m -112.46 50.47 0.86 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.992 -1.068 . . . . 0.0 109.183 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 117.645 -1.169 . . . . 0.0 111.338 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.499 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -109.74 -161.55 0.76 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.649 -0.912 . . . . 0.0 109.803 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 50.22 31.16 4.87 Favored 'General case' 0 N--CA 1.507 2.412 0 CA-C-O 121.343 0.592 . . . . 0.0 111.66 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -171.32 -57.45 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.3 t -68.33 -50.73 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.18 -41.02 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -39.92 95.33 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.843 -0.536 . . . . 0.0 109.576 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tp -60.23 -26.4 66.39 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.714 -0.616 . . . . 0.0 111.374 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 m -97.1 -41.97 8.08 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.8 t -68.89 -29.41 67.68 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.68 -0.637 . . . . 0.0 111.291 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.72 -30.42 68.81 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.33 -0.856 . . . . 0.0 111.928 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -75.03 127.67 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.304 -0.872 . . . . 0.0 110.082 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 52.91 62.33 10.12 Favored Pre-proline 0 N--CA 1.506 2.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.656 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.38 -46.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.02 1.147 . . . . 0.0 111.706 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.79 -31.24 70.62 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.438 -0.789 . . . . 0.0 112.22 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -73.42 -46.63 47.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.812 -0.555 . . . . 0.0 110.03 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.14 -40.92 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.39 -23.43 62.6 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.013 -0.429 . . . . 0.0 111.056 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.0 m -100.48 -43.56 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.431 -0.793 . . . . 0.0 110.64 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.4 mm -73.42 -56.16 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.593 -0.692 . . . . 0.0 111.676 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -58.12 -35.42 71.45 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 119.203 0.911 . . . . 0.0 111.258 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -40.25 92.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.59 -0.694 . . . . 0.0 110.165 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.2 mt -81.0 -36.99 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -47.35 86.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.673 -0.642 . . . . 0.0 109.773 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HG ' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -68.0 -20.91 65.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.642 -0.661 . . . . 0.0 111.195 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.68 -17.94 39.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.686 -0.634 . . . . 0.0 111.492 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.5 mt -107.95 -50.27 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.768 -0.582 . . . . 0.0 109.778 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mt -97.94 -50.0 4.57 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.724 -0.61 . . . . 0.0 110.25 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.82 64.22 2.39 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.511 ' HD2' ' HG ' ' A' ' 25' ' ' LEU . 46.3 Cg_endo -68.72 -25.79 33.51 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 O-C-N 123.665 1.35 . . . . 0.0 112.287 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -59.08 -42.68 91.01 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.329 -0.857 . . . . 0.0 110.491 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.1 mmt -77.44 -39.49 46.61 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.57 -33.63 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.866 -0.521 . . . . 0.0 110.058 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.0 13.36 6.13 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.539 -0.726 . . . . 0.0 111.782 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -131.54 22.92 4.71 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.132 -0.98 . . . . 0.0 110.861 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.66 98.12 6.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.144 -0.973 . . . . 0.0 109.865 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.34 -28.56 14.23 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -74.7 78.64 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 118.374 1.087 . . . . 0.0 109.366 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.6 p -145.75 44.66 1.28 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.972 0 O-C-N 121.488 -0.758 . . . . 0.0 110.373 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -123.56 19.75 9.55 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 122.106 -0.643 . . . . 0.0 110.74 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -107.96 -46.26 3.81 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.315 -0.866 . . . . 0.0 110.369 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.66 -38.81 17.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.577 -0.702 . . . . 0.0 109.504 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.21 -43.84 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.763 -0.586 . . . . 0.0 109.645 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.47 -36.21 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.749 -0.595 . . . . 0.0 109.714 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.52 -33.06 66.63 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 109.877 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.37 -67.25 0.74 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.508 HG21 ' HB ' ' A' ' 12' ' ' ILE . 14.5 t 40.58 53.78 3.04 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.867 0.841 . . . . 0.0 110.997 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 58.06 37.18 26.5 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.667 -0.646 . . . . 0.0 109.294 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.59 38.94 29.38 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.508 ' HB ' HG21 ' A' ' 9' ' ' THR . 1.0 OUTLIER -71.27 159.52 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.692 -0.63 . . . . 0.0 110.418 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 44.8 m80 -100.59 102.56 19.5 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 45.9 Cg_endo -64.4 -167.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.311 2.007 . . . . 0.0 111.748 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 59.05 44.08 16.65 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.493 1.14 . . . . 0.0 109.454 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -171.64 -53.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.1 -37.87 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.58 -34.49 72.78 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -69.26 -45.75 68.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.76 -41.05 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.872 -0.517 . . . . 0.0 109.607 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 p -64.91 -30.3 71.29 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -64.29 -42.18 96.52 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.5 -39.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -64.34 -39.55 94.11 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.473 HD11 ' HA2' ' A' ' 29' ' ' GLY . 7.1 tp -69.06 -28.08 66.22 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.779 -0.575 . . . . 0.0 110.5 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.8 -16.71 60.7 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.746 0.308 . . . . 0.0 111.608 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.3 mt -111.78 -50.48 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.707 -0.621 . . . . 0.0 110.437 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.444 ' HB2' HD13 ' A' ' 24' ' ' LEU . 3.4 mm? -99.03 -57.66 2.12 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.579 -0.701 . . . . 0.0 110.405 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.473 ' HA2' HD11 ' A' ' 25' ' ' LEU . . . 94.09 59.31 1.18 Allowed Glycine 0 N--CA 1.499 2.837 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 25' ' ' LEU . 48.4 Cg_endo -74.32 -45.64 0.33 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.268 1.141 . . . . 0.0 111.686 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 tp -62.22 -35.42 78.83 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.526 -0.734 . . . . 0.0 110.992 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ttt -65.86 -44.93 83.96 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.88 -34.05 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.2 mt -83.63 10.13 9.92 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.529 -0.732 . . . . 0.0 111.628 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -126.78 22.35 6.84 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.377 -0.827 . . . . 0.0 110.266 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.24 -53.09 4.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.258 -0.901 . . . . 0.0 108.795 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 -17.71 52.46 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -101.12 121.34 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.101 -1.235 . . . . 0.0 109.351 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -121.75 37.35 4.38 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.35 0.595 . . . . 0.0 110.22 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.7 tttt . . . . . 0 N--CA 1.5 2.063 0 O-C-N 121.188 -0.945 . . . . 0.0 110.787 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.34 16.57 13.92 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.913 -0.757 . . . . 0.0 111.442 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -101.2 -52.3 3.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.591 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.07 -32.63 68.21 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.992 -0.442 . . . . 0.0 110.599 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.46 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.89 -41.68 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -63.32 -35.89 81.89 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.67 -0.644 . . . . 0.0 109.68 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 12' ' ' ILE . 4.4 tp -71.24 -16.82 62.51 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.51 -0.744 . . . . 0.0 111.401 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -40.17 69.43 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t -96.75 -34.25 11.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.816 -0.552 . . . . 0.0 109.68 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -117.19 58.5 0.78 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.018 0.913 . . . . 0.0 109.396 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.507 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 5.1 tt -62.61 145.44 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.802 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 55.85 64.81 4.92 Favored Pre-proline 0 N--CA 1.505 2.279 0 O-C-N 122.295 -0.253 . . . . 0.0 111.529 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.83 -30.66 17.01 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.24 1.293 . . . . 0.0 111.532 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.59 3.29 14.09 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.569 -0.707 . . . . 0.0 112.386 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.3 tp -113.91 -36.89 4.66 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.5 -48.7 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.621 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -44.25 69.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.632 -0.668 . . . . 0.0 110.763 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -58.45 -41.53 85.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.449 -0.782 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.54 -51.31 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.66 -0.65 . . . . 0.0 110.266 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -65.28 -33.12 75.23 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.377 -0.827 . . . . 0.0 110.52 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -66.08 -46.09 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.46 -40.69 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -36.4 79.26 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.724 -0.61 . . . . 0.0 109.439 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.27 -4.04 58.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.751 -0.593 . . . . 0.0 110.991 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.62 14.26 24.63 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 110.257 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.1 mm -125.52 -53.06 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.33 -0.856 . . . . 0.0 109.311 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.9 mt -79.87 -27.59 40.05 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.715 -0.616 . . . . 0.0 111.124 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.22 54.76 0.47 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.52 -25.46 62.73 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 O-C-N 123.735 1.387 . . . . 0.0 111.813 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 mt -51.11 -39.58 56.51 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 118.324 0.511 . . . . 0.0 110.903 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -45.46 39.45 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.607 -0.683 . . . . 0.0 109.366 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.62 -33.91 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.962 -0.461 . . . . 0.0 110.29 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.77 -2.62 21.18 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.544 -0.722 . . . . 0.0 112.169 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -124.58 21.13 8.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 110.266 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.85 70.69 1.02 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.299 -0.876 . . . . 0.0 109.747 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.49 51.95 1.09 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.03 144.84 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.635 -0.921 . . . . 0.0 109.492 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 t -153.03 72.1 0.94 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.895 0.855 . . . . 0.0 110.106 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.378 -0.826 . . . . 0.0 109.928 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -97.67 14.26 27.39 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.79 -0.83 . . . . 0.0 111.879 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.56 -44.94 89.14 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.05 74.37 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -69.28 -40.47 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.2 -43.51 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.5 -35.8 81.65 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.817 -0.552 . . . . 0.0 109.957 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.28 -7.84 51.63 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.404 -0.81 . . . . 0.0 111.413 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 m -111.66 -44.58 3.47 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.493 -0.754 . . . . 0.0 110.183 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.7 p -88.69 -27.39 21.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.623 -0.673 . . . . 0.0 111.944 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.33 10.61 41.08 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.201 -0.937 . . . . 0.0 112.205 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.2 tp -72.24 140.96 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 120.813 -1.18 . . . . 0.0 110.057 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -120.92 78.05 31.3 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.0 110.491 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.16 175.65 10.98 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.651 1.343 . . . . 0.0 109.953 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.21 6.53 4.86 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.585 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.41 -50.08 0.92 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 mm -61.23 -27.46 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -91.12 -36.06 14.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -76.67 -26.56 54.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.716 -0.615 . . . . 0.0 110.674 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.5 tp -52.17 -39.78 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.505 -0.747 . . . . 0.0 111.508 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.6 p -63.73 -44.22 94.2 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -66.82 -44.29 81.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.9 mm -62.87 -35.28 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.871 -0.518 . . . . 0.0 109.723 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.75 -42.93 84.97 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.696 -0.627 . . . . 0.0 110.119 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.97 -8.07 56.08 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.744 -0.598 . . . . 0.0 111.292 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.47 1.73 41.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.622 -0.673 . . . . 0.0 110.767 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.4 mt -114.07 -46.39 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.2 -67.85 0.31 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.013 -0.43 . . . . 0.0 110.057 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.41 83.24 0.27 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.33 -38.44 54.0 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 O-C-N 123.868 1.457 . . . . 0.0 110.888 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.41 -38.51 81.31 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.4 tpt -65.18 -42.07 94.02 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.936 -0.478 . . . . 0.0 109.742 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.0 t -64.85 -39.27 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.793 -0.567 . . . . 0.0 110.069 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.8 5.04 34.34 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.521 -0.737 . . . . 0.0 112.214 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.22 24.98 4.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.992 -1.067 . . . . 0.0 110.525 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.98 -58.5 1.87 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.42 -0.8 . . . . 0.0 109.758 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.43 46.7 1.13 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 tt -105.42 9.9 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.627 -0.925 . . . . 0.0 111.636 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -161.44 42.12 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.295 -0.878 . . . . 0.0 110.226 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.072 0 O-C-N 121.394 -0.816 . . . . 0.0 110.777 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.505 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -107.15 32.26 4.76 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.886 -0.773 . . . . 0.0 110.363 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -102.09 -57.7 2.02 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.93 -27.46 63.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 122.055 -0.403 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.6 t -59.21 -34.74 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.952 -0.467 . . . . 0.0 110.213 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.3 mm -67.43 -38.45 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.342 -0.849 . . . . 0.0 108.749 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.7 tp -75.82 -21.95 56.79 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.682 -0.636 . . . . 0.0 110.16 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.34 34.58 3.3 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.569 -0.707 . . . . 0.0 110.852 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -102.72 -43.78 5.49 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.277 -0.89 . . . . 0.0 110.059 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.6 m -68.54 -37.87 80.32 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.553 -0.717 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.98 -35.41 81.1 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.681 -0.637 . . . . 0.0 110.794 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.1 mm -94.51 165.33 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -105.82 94.58 9.14 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.525 -0.735 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.74 177.38 3.5 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.785 1.657 . . . . 0.0 111.3 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 52.19 38.92 25.79 Favored 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 122.26 1.028 . . . . 0.0 109.952 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -165.45 -55.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.25 -29.22 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.43 -36.12 63.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.99 -0.444 . . . . 0.0 110.436 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.7 m -73.57 -48.78 30.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.1 mm -54.89 -49.78 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.787 -0.571 . . . . 0.0 111.402 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -62.91 -34.7 78.0 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.627 -0.67 . . . . 0.0 110.54 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -68.0 -41.29 82.5 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.628 -0.67 . . . . 0.0 109.837 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.96 -38.63 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.78 -41.31 95.31 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.63 -17.02 60.76 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.071 -0.393 . . . . 0.0 111.072 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.0 12.62 29.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.841 -0.537 . . . . 0.0 111.204 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm -130.38 -57.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.774 . . . . 0.0 109.491 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 47.76 58.12 5.31 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.43 0.634 . . . . 0.0 110.685 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.97 82.23 1.65 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.42 -19.95 61.25 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 124.063 1.559 . . . . 0.0 112.628 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mt -53.49 -50.77 64.65 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.455 -0.778 . . . . 0.0 110.73 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 58.9 mtm -75.67 -33.27 60.39 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.863 -0.523 . . . . 0.0 110.135 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.6 t -59.09 -37.14 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.772 -0.58 . . . . 0.0 109.852 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.32 -31.51 67.61 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.837 -0.539 . . . . 0.0 111.25 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -113.06 23.56 13.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.216 -0.303 . . . . 0.0 110.856 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.74 76.58 3.69 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 36.99 11.0 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.0 tt -63.08 148.72 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.699 -0.883 . . . . 0.0 110.143 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.3 t -145.74 66.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.765 0.793 . . . . 0.0 109.814 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 117.784 -1.103 . . . . 0.0 110.517 -179.873 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.13 16.27 6.72 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.791 -0.829 . . . . 0.0 111.896 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -94.76 -46.41 6.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.433 -0.792 . . . . 0.0 109.644 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.56 17.53 4.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.836 -0.54 . . . . 0.0 111.416 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.55 -52.39 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.149 -0.969 . . . . 0.0 108.749 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.15 -45.76 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -62.09 -25.64 67.82 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.986 -0.446 . . . . 0.0 110.424 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -89.67 11.42 19.87 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.622 -0.674 . . . . 0.0 111.868 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 t -59.4 -36.97 76.83 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.049 -1.032 . . . . 0.0 110.617 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.4 t -78.61 -40.87 33.25 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . . . -63.72 -34.23 77.42 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 122.097 -0.377 . . . . 0.0 111.105 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.0 tt -90.33 16.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.578 -0.701 . . . . 0.0 111.603 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.463 ' CG ' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER 66.36 94.01 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.749 -0.595 . . . . 0.0 110.784 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 10' ' ' CYS . 47.7 Cg_endo -72.76 -40.77 1.79 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.17 1.247 . . . . 0.0 111.461 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -6.79 52.12 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.442 -0.786 . . . . 0.0 112.0 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -101.77 -47.62 4.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.467 -0.771 . . . . 0.0 110.007 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.459 ' HA ' HD13 ' A' ' 20' ' ' ILE . 17.1 mm -53.97 -41.79 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.983 -0.448 . . . . 0.0 110.395 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.72 -41.55 86.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.794 -0.566 . . . . 0.0 109.972 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.5 m -64.73 -43.84 92.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.78 -0.575 . . . . 0.0 109.578 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -58.41 -44.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.663 -0.648 . . . . 0.0 109.763 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.4 m -62.83 -42.83 99.89 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.739 -0.6 . . . . 0.0 109.802 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -44.14 97.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.836 -0.54 . . . . 0.0 110.007 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mm -62.1 -40.03 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.31 -43.21 88.06 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.3 -28.86 67.55 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.972 0.415 . . . . 0.0 110.171 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.34 60.77 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.0 mt -96.87 -69.18 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt 49.24 69.33 0.6 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.463 0.649 . . . . 0.0 110.931 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' N ' ' CD ' ' A' ' 30' ' ' PRO . . . -142.82 49.42 0.73 Allowed Glycine 0 N--CA 1.497 2.702 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.639 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 29' ' ' GLY . 43.0 Cg_endo -65.41 -40.98 16.86 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 O-C-N 123.272 1.143 . . . . 0.0 109.871 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.45 -37.12 82.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.8 mmt -60.95 -44.79 96.77 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.75 -34.97 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.786 -0.572 . . . . 0.0 109.622 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -81.35 -11.94 59.16 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.585 -0.697 . . . . 0.0 111.939 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -123.41 33.94 5.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.524 -0.735 . . . . 0.0 110.499 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.76 108.44 2.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.491 -0.756 . . . . 0.0 109.878 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.05 -43.48 1.7 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -86.55 127.63 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.571 -0.958 . . . . 0.0 109.793 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 t -154.37 53.66 0.68 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.716 0.769 . . . . 0.0 110.918 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.188 0 O-C-N 121.271 -0.893 . . . . 0.0 111.549 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.495 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.7 27.68 13.11 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 117.532 0.666 . . . . 0.0 111.832 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -115.95 -64.44 1.31 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.048 -1.033 . . . . 0.0 109.888 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.58 -29.87 71.07 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.052 -0.405 . . . . 0.0 111.488 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.16 -36.62 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.857 -0.527 . . . . 0.0 110.434 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.4 mt -65.69 -44.12 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.2 tp -67.83 -26.84 66.25 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.011 -0.431 . . . . 0.0 110.672 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.83 17.04 12.73 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.574 -0.704 . . . . 0.0 111.452 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -112.28 -45.58 3.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.862 -1.149 . . . . 0.0 109.941 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.5 m -58.81 -25.16 62.89 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.518 -0.739 . . . . 0.0 112.09 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.79 18.26 20.96 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.137 -0.977 . . . . 0.0 112.061 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.3 tp -117.48 12.93 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 120.984 -1.072 . . . . 0.0 112.058 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -132.11 78.49 68.93 Favored Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 120.962 -1.086 . . . . 0.0 110.867 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.7 -36.97 30.24 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.334 1.356 . . . . 0.0 111.598 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.39 -37.95 82.4 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.505 0.669 . . . . 0.0 109.502 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mp -69.23 -41.83 76.5 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.5 mm -59.5 -38.12 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -65.89 -36.81 84.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.113 -0.367 . . . . 0.0 110.636 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.53 -25.49 54.18 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.358 -0.839 . . . . 0.0 111.546 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.2 mt -58.3 -48.88 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.417 -0.802 . . . . 0.0 109.705 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.3 p -65.32 -36.5 84.24 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.749 -0.594 . . . . 0.0 109.898 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -45.37 93.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 90.1 mt -62.58 -37.06 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.96 -42.14 97.71 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.697 -0.627 . . . . 0.0 110.538 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.71 5.42 51.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.648 . . . . 0.0 111.305 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 27' ' ' ILE . 80.1 mt -132.79 5.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.135 -0.978 . . . . 0.0 111.279 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.66 1.55 34.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.561 -1.337 . . . . 0.0 112.686 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.09 -53.64 0.44 Allowed Glycine 0 N--CA 1.497 2.746 0 O-C-N 120.775 -1.203 . . . . 0.0 110.767 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -86.63 40.65 0.72 Allowed 'Trans proline' 0 N--CA 1.489 1.245 0 O-C-N 123.658 1.346 . . . . 0.0 110.98 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -30.23 71.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.617 -0.677 . . . . 0.0 110.744 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 21.4 ttm -90.21 -31.58 16.96 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.97 -38.24 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -27.85 67.62 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.651 -0.656 . . . . 0.0 111.021 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -106.74 24.31 12.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.002 -0.436 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.01 -39.31 72.45 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.002 -1.061 . . . . 0.0 110.474 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.66 -16.28 68.69 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.27 119.86 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 118.911 1.356 . . . . 0.0 109.88 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 m -105.73 47.63 0.87 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.675 -0.641 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 110.72 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.37 39.1 1.97 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.934 -0.745 . . . . 0.0 110.267 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.42 -54.85 2.83 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.76 65.21 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.024 -0.422 . . . . 0.0 110.151 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.7 t -59.27 -38.29 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.71 -0.618 . . . . 0.0 109.788 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.479 ' HA ' HG23 ' A' ' 9' ' ' THR . 21.6 mt -62.75 -40.72 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 tp -69.99 -28.25 65.36 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.621 -0.674 . . . . 0.0 109.933 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.56 15.25 27.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.61 -0.681 . . . . 0.0 112.152 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 6' ' ' ILE . 4.3 t -109.75 -25.35 10.42 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.971 -1.081 . . . . 0.0 111.75 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 90.8 m -63.53 -45.52 90.24 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.246 -0.909 . . . . 0.0 110.689 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.25 -44.2 47.33 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.716 -0.615 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.3 mm -78.26 118.18 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 59.08 61.54 4.53 Favored Pre-proline 0 N--CA 1.506 2.343 0 CA-C-O 120.721 0.296 . . . . 0.0 110.518 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.34 -21.87 25.97 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 O-C-N 123.506 1.266 . . . . 0.0 111.295 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.91 9.87 3.25 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.614 -0.679 . . . . 0.0 112.134 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.5 tp -109.48 -51.84 2.83 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.3 mt -59.11 -42.55 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.29 -39.13 85.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -61.27 -45.1 95.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.95 -0.469 . . . . 0.0 109.916 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.65 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.756 -0.59 . . . . 0.0 109.452 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.0 m -61.09 -40.53 94.08 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.592 -0.693 . . . . 0.0 109.41 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -63.21 -45.58 91.02 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.818 -0.551 . . . . 0.0 109.695 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.76 -39.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.4 -42.53 82.41 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.845 -0.535 . . . . 0.0 109.635 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.425 HD11 ' SD ' ' A' ' 32' ' ' MET . 8.5 tt -67.45 -35.65 79.63 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.235 0.541 . . . . 0.0 110.011 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.43 -8.51 54.29 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.4 mm -110.99 -46.78 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.536 -0.728 . . . . 0.0 109.668 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.77 -72.91 0.66 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.709 -0.62 . . . . 0.0 109.978 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.96 51.94 27.93 Favored Glycine 0 N--CA 1.502 3.049 0 CA-C-O 118.967 -0.907 . . . . 0.0 112.671 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -78.52 -57.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.098 1.052 . . . . 0.0 111.248 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.87 -35.38 78.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.375 -0.828 . . . . 0.0 109.607 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.425 ' SD ' HD11 ' A' ' 25' ' ' LEU . 12.2 mtp -63.36 -30.25 71.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.996 -0.44 . . . . 0.0 110.869 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -31.95 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.613 -0.68 . . . . 0.0 110.474 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 6.61 22.98 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.577 -0.702 . . . . 0.0 112.073 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.52 27.09 0.83 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.268 -0.895 . . . . 0.0 111.294 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.37 86.45 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.258 -0.901 . . . . 0.0 110.817 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.73 13.43 65.79 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mm -108.71 32.64 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 118.822 1.311 . . . . 0.0 108.996 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -157.23 32.06 0.29 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.325 -0.859 . . . . 0.0 111.005 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.218 0 CA-C-O 117.666 -1.159 . . . . 0.0 111.419 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -124.42 19.04 8.91 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.621 -0.929 . . . . 0.0 111.318 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.59 -57.1 2.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.796 . . . . 0.0 109.335 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.48 -26.61 66.45 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.952 -0.468 . . . . 0.0 110.936 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.1 -30.78 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.437 -0.79 . . . . 0.0 109.875 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.7 mt -67.85 -41.21 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.38 -47.93 31.02 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.0 -60.54 2.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.875 -0.516 . . . . 0.0 110.229 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.474 ' O ' ' HB ' ' A' ' 12' ' ' ILE . 3.4 t 40.01 56.92 2.44 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 122.119 0.962 . . . . 0.0 110.146 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 83.5 m 55.97 37.22 28.61 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.728 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB1' HG13 ' A' ' 17' ' ' ILE . . . 53.05 56.77 7.08 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.98 0.895 . . . . 0.0 109.841 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -85.16 13.76 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.787 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -117.02 93.34 41.84 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.988 -1.07 . . . . 0.0 110.0 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.49 175.45 5.11 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.816 1.678 . . . . 0.0 111.302 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 57.87 40.83 25.58 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 122.483 1.135 . . . . 0.0 109.507 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tt -169.65 -55.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.418 HG13 ' HB1' ' A' ' 11' ' ' ALA . 24.7 mm -60.16 -38.75 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.56 -32.15 73.53 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.697 -0.627 . . . . 0.0 110.678 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 m -85.4 -49.45 8.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.716 -0.615 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.99 -43.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -60.7 -39.05 87.05 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -44.62 88.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.698 -0.626 . . . . 0.0 109.58 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.93 -40.64 96.2 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.583 -0.698 . . . . 0.0 109.166 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.519 ' HA ' HD11 ' A' ' 28' ' ' LEU . 2.6 mm? -68.23 -22.56 64.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.838 -0.539 . . . . 0.0 110.496 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.02 -11.36 53.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.157 -0.339 . . . . 0.0 111.396 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.3 mt -118.05 30.64 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.572 -0.705 . . . . 0.0 110.051 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -70.83 -32.01 68.91 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.915 -1.116 . . . . 0.0 111.027 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.74 72.32 1.13 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.88 -37.12 3.91 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 O-C-N 123.706 1.371 . . . . 0.0 111.287 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.41 -45.48 84.51 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.601 -0.687 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.6 ttm -64.03 -44.27 93.03 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.644 -0.66 . . . . 0.0 110.849 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.1 -30.63 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.728 -0.608 . . . . 0.0 111.03 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 41.2 mt -92.29 -2.23 56.56 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.151 -0.968 . . . . 0.0 112.318 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -128.69 29.8 5.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.317 -0.864 . . . . 0.0 109.976 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.92 74.87 1.17 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.421 -0.799 . . . . 0.0 110.436 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.4 76.23 0.64 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.5 tp -81.19 58.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.843 -0.798 . . . . 0.0 110.622 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 m -150.07 66.94 0.97 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.206 -0.934 . . . . 0.0 109.175 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.293 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 54.35 26.42 6.93 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 117.31 0.555 . . . . 0.0 112.063 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.25 -37.12 6.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.611 -0.681 . . . . 0.0 109.812 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.78 -39.27 87.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.783 -0.573 . . . . 0.0 109.704 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.5 t -63.47 -37.78 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 6' ' ' ILE . 38.3 mm -66.23 -35.37 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 tp -78.7 -30.36 45.98 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.597 -0.69 . . . . 0.0 110.584 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.87 22.23 3.73 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.468 -0.77 . . . . 0.0 111.751 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.5 t -74.85 -25.62 59.11 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.089 -1.007 . . . . 0.0 110.926 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.514 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 55.9 m -67.68 -35.64 79.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.11 76.83 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.769 -0.582 . . . . 0.0 111.231 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -86.62 16.35 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.532 -0.73 . . . . 0.0 111.356 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 62.79 97.49 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.08 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 10' ' ' CYS . 50.5 Cg_endo -76.87 176.4 10.16 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.47 -1.396 . . . . 0.0 108.47 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 51.29 28.84 4.51 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 121.954 0.883 . . . . 0.0 110.661 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 tp -151.44 -53.88 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mm -57.09 -35.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -87.01 -33.81 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -71.23 -40.23 71.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.474 -0.766 . . . . 0.0 109.832 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 18.7 mm -65.59 -44.97 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.747 -0.595 . . . . 0.0 109.922 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 p -63.7 -39.37 94.15 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.811 -0.556 . . . . 0.0 110.691 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -59.18 -47.06 86.7 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.715 -0.616 . . . . 0.0 109.63 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.92 -29.1 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -57.71 -47.75 81.52 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.22 -33.39 73.41 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.298 0.571 . . . . 0.0 110.377 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.6 62.42 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.594 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.592 ' HA ' ' HB3' ' A' ' 31' ' ' LEU . 60.8 mt -112.84 26.78 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.851 -0.531 . . . . 0.0 109.724 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.96 18.18 10.92 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.937 -1.102 . . . . 0.0 112.021 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.53 -72.59 0.04 OUTLIER Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.99 28.67 0.39 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.562 1.508 . . . . 0.0 111.385 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.592 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 1.3 pp -58.46 -33.87 70.22 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.418 -0.801 . . . . 0.0 111.655 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 ttt -87.49 -38.58 15.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.357 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.48 -35.4 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.77 -0.581 . . . . 0.0 110.82 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 mt -87.43 -1.27 57.81 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.434 -0.791 . . . . 0.0 113.012 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -141.09 29.41 1.84 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.26 -0.9 . . . . 0.0 111.377 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.75 112.9 13.81 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.384 -0.823 . . . . 0.0 110.688 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.12 -43.4 1.68 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -84.71 132.92 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.418 -1.048 . . . . 0.0 110.847 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -108.39 41.77 1.51 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 tttp . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.102 -179.836 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.648 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -122.49 17.76 10.48 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.819 -0.812 . . . . 0.0 111.029 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -110.37 -43.73 3.85 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.568 -0.707 . . . . 0.0 109.852 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.06 -35.18 25.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.572 -0.705 . . . . 0.0 109.777 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.37 -42.95 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.811 -0.556 . . . . 0.0 109.802 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.16 -44.19 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.25 -33.36 75.8 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tp -81.62 -1.89 48.21 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.757 -0.59 . . . . 0.0 112.142 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 m -100.83 -50.06 3.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.171 -0.956 . . . . 0.0 109.238 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.8 m -64.51 -35.4 80.85 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.952 -0.468 . . . . 0.0 111.132 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.44 82.51 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.537 -0.727 . . . . 0.0 110.821 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.4 mt -68.88 143.13 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 59.31 66.94 2.06 Favored Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 122.178 -0.326 . . . . 0.0 110.779 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.52 -21.43 40.05 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.513 1.475 . . . . 0.0 111.62 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.76 -30.29 63.46 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.609 -0.682 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.8 -47.15 82.04 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 mt -62.03 -38.66 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -61.14 -28.52 69.17 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.819 -0.551 . . . . 0.0 110.686 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.3 m -88.98 -26.56 21.42 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.305 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.1 mt -60.48 -45.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.404 -0.81 . . . . 0.0 109.131 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -60.58 -33.54 72.86 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.805 -0.56 . . . . 0.0 109.812 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.69 -48.43 54.79 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.77 -34.18 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -40.28 78.13 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -12.28 59.97 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.973 -0.454 . . . . 0.0 111.276 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.01 8.63 28.42 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.784 -0.572 . . . . 0.0 110.942 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm -137.18 -51.41 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 0.0 109.75 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tp 57.8 57.75 4.03 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.439 0.638 . . . . 0.0 110.484 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.12 66.83 0.04 OUTLIER Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.49 -37.36 30.21 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.979 1.515 . . . . 0.0 111.657 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -58.2 -40.95 82.9 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.596 -0.69 . . . . 0.0 109.917 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.9 mmt -80.7 -41.4 23.73 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.886 -0.509 . . . . 0.0 109.887 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -29.73 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.571 -0.706 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 tp -79.51 -2.14 40.86 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.452 -0.78 . . . . 0.0 111.646 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -127.89 19.15 6.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.429 -0.795 . . . . 0.0 110.746 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.01 -56.74 3.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.197 -0.939 . . . . 0.0 109.441 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.23 41.41 2.0 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.42 140.4 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.621 -0.929 . . . . 0.0 110.456 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.8 m -125.77 56.8 1.38 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.605 0.717 . . . . 0.0 109.611 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 O-C-N 121.348 -0.845 . . . . 0.0 110.543 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.535 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.79 28.68 4.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.91 -0.759 . . . . 0.0 109.458 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -105.34 -57.57 2.01 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.15 -32.71 29.9 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 122.169 -0.332 . . . . 0.0 110.365 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.32 -47.57 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.716 -0.615 . . . . 0.0 110.443 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.3 mt -61.8 -38.98 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -23.19 60.79 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.74 -86.75 0.39 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m 42.08 56.33 3.59 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-O 121.973 0.892 . . . . 0.0 109.283 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.0 m 55.77 44.58 25.92 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.34 63.51 2.07 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.212 1.006 . . . . 0.0 109.491 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.4 tp -70.34 167.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.36 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 62.6 83.33 0.2 Allowed Pre-proline 0 N--CA 1.503 2.196 0 C-N-CA 123.19 0.596 . . . . 0.0 112.319 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.72 -19.43 7.35 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.515 1.477 . . . . 0.0 111.486 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -30.79 69.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.456 -0.777 . . . . 0.0 111.508 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.21 -46.72 79.56 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.502 ' HA ' HD13 ' A' ' 20' ' ' ILE . 42.4 mm -61.31 -39.18 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -45.42 93.1 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.808 -0.557 . . . . 0.0 110.223 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.8 m -60.81 -39.0 87.28 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.762 -0.586 . . . . 0.0 110.539 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.502 HD13 ' HA ' ' A' ' 17' ' ' ILE . 45.4 mt -65.35 -44.89 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.834 -0.541 . . . . 0.0 109.595 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.7 m -64.1 -39.11 93.35 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.717 -0.614 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -60.85 -45.66 93.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.721 -0.612 . . . . 0.0 109.429 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.19 -40.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -42.18 86.72 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.7 mt -78.53 -1.78 35.56 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.787 -0.571 . . . . 0.0 111.435 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.97 13.0 20.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.772 . . . . 0.0 110.3 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.4 mt -118.44 -48.43 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.356 -0.84 . . . . 0.0 109.596 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.57 -22.6 34.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.667 -0.645 . . . . 0.0 111.77 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.4 50.3 0.58 Allowed Glycine 0 N--CA 1.499 2.85 0 O-C-N 121.134 -0.979 . . . . 0.0 111.838 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.11 -35.58 32.88 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.342 1.18 . . . . 0.0 111.046 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mp -60.4 -41.89 94.81 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.798 -0.564 . . . . 0.0 109.686 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.9 ttm -65.0 -40.35 94.82 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.85 -32.96 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.925 -0.485 . . . . 0.0 110.179 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.21 4.56 53.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.43 -0.794 . . . . 0.0 111.801 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.15 25.48 4.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.311 -0.868 . . . . 0.0 110.568 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.74 89.7 7.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.281 -0.887 . . . . 0.0 110.199 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.47 50.59 3.13 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.9 tp -108.75 11.06 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 117.953 0.877 . . . . 0.0 111.457 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 m -132.05 55.35 1.88 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.096 -1.002 . . . . 0.0 108.721 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.704 -1.141 . . . . 0.0 110.625 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.565 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -122.87 26.44 8.17 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.76 -0.847 . . . . 0.0 111.38 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -115.26 -59.11 2.05 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.18 -30.18 66.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.907 -0.496 . . . . 0.0 111.288 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.2 -35.44 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.755 -0.591 . . . . 0.0 110.488 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.24 -45.36 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.02 -27.44 66.54 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.7 35.18 1.55 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.641 -0.662 . . . . 0.0 110.864 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -110.16 -32.1 7.11 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.006 -1.058 . . . . 0.0 110.957 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.9 t -69.13 -48.52 62.23 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.22 -0.925 . . . . 0.0 110.802 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.92 -25.58 61.96 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.577 -0.702 . . . . 0.0 111.472 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 tt -77.93 177.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.487 -0.758 . . . . 0.0 110.819 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -115.32 87.19 15.89 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.57 -0.706 . . . . 0.0 109.219 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.42 -44.6 11.13 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.695 1.366 . . . . 0.0 111.311 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.14 -38.46 89.08 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.732 -0.605 . . . . 0.0 110.189 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.87 -42.1 99.64 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 mm -63.73 -39.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.22 -38.82 84.53 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -65.62 -43.07 90.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.81 -42.46 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -59.81 -41.65 91.71 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.706 -0.621 . . . . 0.0 109.75 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -43.89 94.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.793 -0.567 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.1 -38.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 tp -61.34 -40.5 94.49 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.41 -36.02 81.78 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.3 68.68 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.197 0.522 . . . . 0.0 110.772 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.25 -23.09 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 122.051 -0.406 . . . . 0.0 110.367 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 2.1 mm? -97.71 47.48 1.02 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.243 -0.911 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' N ' ' HD2' ' A' ' 30' ' ' PRO . . . -53.96 -50.87 53.18 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.94 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 29' ' ' GLY . 43.9 Cg_endo -66.82 -33.94 32.28 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 O-C-N 123.151 1.079 . . . . 0.0 111.006 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 2.2 tt -63.27 -39.12 93.69 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.448 ' HA ' ' HE2' ' A' ' 32' ' ' MET . 0.2 OUTLIER -73.69 -39.08 64.65 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.858 -0.526 . . . . 0.0 109.924 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.43 -32.85 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 121.778 -0.576 . . . . 0.0 109.976 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.2 7.25 9.74 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.514 -0.741 . . . . 0.0 112.009 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -149.24 24.53 0.91 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.231 -0.918 . . . . 0.0 111.974 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.86 -55.46 2.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.965 -1.084 . . . . 0.0 110.057 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.11 37.75 3.44 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.5 tp -86.47 137.07 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.618 -0.931 . . . . 0.0 110.448 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 t -156.22 39.63 0.36 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.676 -0.64 . . . . 0.0 110.893 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.107 -0.996 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.611 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -123.07 19.41 9.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.76 -0.847 . . . . 0.0 110.997 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -121.25 -59.57 1.7 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.394 -0.816 . . . . 0.0 108.932 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.41 -36.7 78.76 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.982 -0.449 . . . . 0.0 109.795 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.18 -33.88 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.678 -0.638 . . . . 0.0 109.331 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.6 mm -70.65 -38.11 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.3 tp -72.82 -31.65 64.95 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.659 -0.65 . . . . 0.0 109.645 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tp -81.55 -62.03 1.76 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.535 HG23 ' HB ' ' A' ' 12' ' ' ILE . 12.3 t 41.21 54.5 3.41 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.941 0.877 . . . . 0.0 110.717 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 m 57.9 36.37 26.21 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 54.95 53.44 10.37 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.998 0.904 . . . . 0.0 110.305 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.535 ' HB ' HG23 ' A' ' 9' ' ' THR . 1.1 mp -99.69 129.63 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.455 0.645 . . . . 0.0 109.526 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 3.8 p80 -168.82 64.21 0.57 Allowed Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 122.086 -0.384 . . . . 0.0 111.168 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.52 -62.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.161 1.085 . . . . 0.0 110.631 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.81 -28.42 64.03 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.701 -0.624 . . . . 0.0 110.86 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 15.1 mt -65.95 -48.41 71.44 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.39 -41.2 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -60.58 -36.65 79.03 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.912 -0.492 . . . . 0.0 111.072 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -85.67 -44.35 12.65 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 110.555 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mt -60.06 -40.98 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.959 -0.463 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -65.52 -31.13 72.02 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 119.581 1.082 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.82 -36.38 59.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.39 -0.819 . . . . 0.0 109.612 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.441 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 46.2 mt -100.93 9.51 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 110.647 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 tp -58.16 -48.86 78.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.818 -1.176 . . . . 0.0 109.625 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -78.82 -14.03 59.48 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.907 -0.495 . . . . 0.0 110.906 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.55 21.96 15.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 111.571 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.18 -30.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.307 -0.871 . . . . 0.0 111.305 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.85 -37.32 30.27 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.768 -0.583 . . . . 0.0 112.391 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.12 60.92 0.09 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.541 ' HB2' ' HB2' ' A' ' 34' ' ' LEU . 47.4 Cg_endo -70.3 -83.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 O-C-N 124.014 1.534 . . . . 0.0 111.817 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 tp 50.02 33.22 6.53 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.936 0.874 . . . . 0.0 111.607 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.1 mtt -175.24 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -71.93 -21.78 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 3.0 tp -91.43 16.96 9.2 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.549 -0.72 . . . . 0.0 111.193 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.39 33.65 0.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.13 -0.981 . . . . 0.0 111.219 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.51 -48.05 3.64 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.226 -0.921 . . . . 0.0 110.799 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.92 45.03 1.37 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.8 mt -128.87 147.52 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.578 -0.954 . . . . 0.0 109.444 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -122.9 58.89 1.07 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.674 0.75 . . . . 0.0 109.191 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.629 -179.99 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -171.98 2.06 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.678 -0.895 . . . . 0.0 109.298 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.7 37.09 28.56 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 121.48 0.657 . . . . 0.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.18 -52.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.5 -36.74 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.922 -0.487 . . . . 0.0 109.79 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 mt -62.31 -37.43 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.7 tp -77.18 -33.58 56.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.787 -0.571 . . . . 0.0 110.129 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.95 26.58 3.13 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.692 -0.63 . . . . 0.0 111.564 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.5 t -63.0 -22.93 67.2 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.119 -0.988 . . . . 0.0 111.692 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 p -66.86 -26.82 67.08 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.429 -0.794 . . . . 0.0 111.328 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.44 -72.42 0.69 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.435 -0.791 . . . . 0.0 109.732 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.457 HD11 HG21 ' A' ' 12' ' ' ILE . 0.5 OUTLIER 56.71 18.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.857 -0.527 . . . . 0.0 112.311 179.908 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -144.66 63.25 10.44 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.852 -1.155 . . . . 0.0 110.638 179.769 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.26 -50.3 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.361 1.19 . . . . 0.0 111.004 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -29.64 70.36 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.791 -0.568 . . . . 0.0 110.563 179.44 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 1.6 mt -66.96 -46.49 74.51 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 ' HA ' HD11 ' A' ' 20' ' ' ILE . 63.1 mt -59.38 -37.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -65.26 -38.6 90.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.912 -0.493 . . . . 0.0 109.925 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.1 m -65.04 -43.12 93.4 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.75 -0.594 . . . . 0.0 109.503 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' A' ' 17' ' ' ILE . 14.4 mt -61.33 -41.94 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.957 -0.464 . . . . 0.0 109.749 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.6 m -65.08 -40.0 94.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.597 -0.689 . . . . 0.0 110.155 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -57.48 -45.02 85.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.962 -0.461 . . . . 0.0 109.89 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -38.19 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -49.6 77.23 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -17.03 62.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.82 -0.55 . . . . 0.0 111.31 179.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.03 2.18 56.51 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.807 -0.558 . . . . 0.0 111.184 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.4 mt -112.85 -55.66 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.8 mt -86.62 -32.54 20.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.85 -0.531 . . . . 0.0 110.468 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' N ' ' HD2' ' A' ' 30' ' ' PRO . . . -56.61 -54.33 37.08 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 29' ' ' GLY . 44.3 Cg_endo -68.16 -32.03 28.17 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 O-C-N 123.46 1.242 . . . . 0.0 110.89 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.66 -43.8 97.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.614 -0.679 . . . . 0.0 109.541 179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.7 ttm -62.59 -39.58 94.17 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.38 -30.23 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.2 mt -83.45 9.09 11.97 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.405 -0.809 . . . . 0.0 112.085 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.75 21.01 5.98 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.137 -0.977 . . . . 0.0 111.15 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.98 -54.86 3.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.234 -0.916 . . . . 0.0 109.53 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.92 -25.54 22.08 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.6 mm -82.25 121.03 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.481 -1.011 . . . . 0.0 109.791 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 m -137.89 60.28 1.63 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.097 0.475 . . . . 0.0 110.035 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 117.518 -1.229 . . . . 0.0 110.656 -179.926 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.481 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -82.55 89.15 6.65 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.184 0.992 . . . . 0.0 110.656 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -167.53 -61.58 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.37 -36.26 66.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.875 -0.515 . . . . 0.0 109.864 179.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.0 t -58.46 -40.35 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.6 mt -59.02 -47.02 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 tt -70.17 -28.93 65.71 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.043 -0.411 . . . . 0.0 109.977 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.67 8.84 18.13 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.6 -0.688 . . . . 0.0 112.223 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 t -63.41 -36.36 83.48 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.186 -0.946 . . . . 0.0 110.748 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -80.18 -29.8 38.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.414 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.77 -20.28 62.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.619 -0.675 . . . . 0.0 111.238 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -92.41 16.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.238 -0.914 . . . . 0.0 112.011 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.76 65.23 53.09 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.968 -1.082 . . . . 0.0 110.031 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.16 -40.42 11.42 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.336 1.357 . . . . 0.0 111.708 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -38.22 87.39 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.7 -0.625 . . . . 0.0 110.665 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -67.21 -45.65 76.19 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.344 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 37.1 mt -65.39 -38.65 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.67 -26.32 67.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.686 -0.634 . . . . 0.0 110.692 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -96.46 -41.96 8.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.689 -0.632 . . . . 0.0 109.963 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 tt -57.39 -33.37 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.717 -0.614 . . . . 0.0 111.254 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.8 p -63.49 -43.25 97.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.498 -0.751 . . . . 0.0 109.168 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -63.92 -35.68 81.47 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.3 mm -75.48 -40.9 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.59 -43.62 93.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.48 -32.99 74.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.797 -0.564 . . . . 0.0 110.44 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.84 -30.14 63.77 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.239 0.542 . . . . 0.0 110.533 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.484 HG21 ' HG3' ' A' ' 30' ' ' PRO . 47.7 mt -111.93 37.17 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tp -77.56 -30.95 52.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.94 -1.1 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.09 54.99 0.36 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HG3' HG21 ' A' ' 27' ' ' ILE . 45.4 Cg_endo -66.61 -36.02 27.02 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 O-C-N 123.619 1.326 . . . . 0.0 111.159 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.13 -46.39 89.81 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.504 -0.748 . . . . 0.0 109.678 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.4 mtm -66.71 -39.68 88.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.792 -0.568 . . . . 0.0 109.594 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.41 -39.51 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.646 -0.659 . . . . 0.0 109.886 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.32 7.84 27.0 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.609 -0.682 . . . . 0.0 111.929 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -126.72 16.16 7.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.183 -0.948 . . . . 0.0 110.78 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.85 73.28 7.51 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.79 65.05 1.57 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.12 57.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 122.009 0.909 . . . . 0.0 109.885 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.8 t -163.78 59.93 0.17 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.914 0.864 . . . . 0.0 109.655 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 O-C-N 121.3 -0.875 . . . . 0.0 111.363 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.543 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.51 -166.99 1.18 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.708 -0.878 . . . . 0.0 109.802 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.29 40.11 31.44 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.007 0.908 . . . . 0.0 109.839 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -178.35 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.69 -35.0 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.4 mm -63.78 -44.92 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.2 tp -60.69 -36.48 78.88 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.68 -44.34 96.5 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.819 -0.551 . . . . 0.0 109.853 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.564 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 10.5 m -63.15 -33.52 75.64 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.6 m -67.06 -35.2 79.34 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.88 -46.05 25.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.781 -0.575 . . . . 0.0 109.972 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.564 ' CG1' ' HA ' ' A' ' 9' ' ' THR . 1.1 pt -74.8 146.6 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.592 -0.693 . . . . 0.0 110.531 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 9.6 t-80 54.76 63.71 6.76 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 122.048 -0.408 . . . . 0.0 110.937 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.07 -21.62 36.45 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.225 1.283 . . . . 0.0 112.106 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -57.4 -37.78 73.27 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.308 -0.87 . . . . 0.0 110.781 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 13' ' ' HIS . 9.0 tp -65.05 -42.04 94.61 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mt -71.39 -36.36 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.6 -34.98 71.73 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.92 -0.488 . . . . 0.0 109.696 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.2 m -75.68 -41.13 54.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.4 mm -64.8 -40.31 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.995 -0.441 . . . . 0.0 110.271 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.8 p -64.73 -37.21 86.82 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.497 -0.752 . . . . 0.0 109.741 179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -45.02 93.99 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -65.13 -37.14 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.64 -40.85 89.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.205 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -68.26 -22.11 64.78 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.871 -0.518 . . . . 0.0 110.593 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.82 5.78 47.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.09 -0.382 . . . . 0.0 110.817 179.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -128.89 -50.77 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.496 -0.752 . . . . 0.0 109.902 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp 62.02 48.32 5.24 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.441 0.639 . . . . 0.0 110.686 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' CD ' ' A' ' 30' ' ' PRO . . . -154.84 51.41 0.46 Allowed Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 29' ' ' GLY . 47.7 Cg_endo -69.92 -33.26 16.34 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.567 1.298 . . . . 0.0 111.291 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.16 -47.36 85.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.614 -0.679 . . . . 0.0 110.515 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.5 tpt -63.37 -41.84 98.82 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.558 -0.714 . . . . 0.0 110.393 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -33.54 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.566 -0.709 . . . . 0.0 110.548 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.19 9.49 35.83 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.455 -0.778 . . . . 0.0 111.832 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.3 25.17 3.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.184 -0.948 . . . . 0.0 110.198 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.24 -49.03 7.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.423 -0.798 . . . . 0.0 109.289 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.01 46.79 1.12 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.6 mm -122.0 129.4 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.708 -0.878 . . . . 0.0 109.563 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -127.11 44.69 2.86 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.147 0.498 . . . . 0.0 110.362 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 N--CA 1.503 2.216 0 O-C-N 121.548 -0.72 . . . . 0.0 111.214 -179.943 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.483 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.3 mmt-85 54.84 22.02 3.98 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 122.338 -0.507 . . . . 0.0 112.051 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.14 -58.94 1.0 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.75 94.54 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.95 -41.82 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.2 mm -62.74 -43.44 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tt -61.43 -40.3 93.94 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.074 -0.391 . . . . 0.0 110.091 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tp -65.71 -19.55 65.94 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.93 -0.481 . . . . 0.0 111.792 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.5 m -101.82 -41.46 6.51 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.1 m -65.25 -37.56 87.6 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.823 -0.548 . . . . 0.0 110.971 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.56 -60.91 2.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.565 -0.71 . . . . 0.0 110.035 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 tp 55.47 -178.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 55.07 59.46 10.45 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.509 -0.744 . . . . 0.0 110.912 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.72 -24.54 13.36 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.367 1.193 . . . . 0.0 112.113 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.86 -50.36 68.88 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.369 -0.832 . . . . 0.0 111.061 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 tp -66.63 -41.52 88.19 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.83 -46.48 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -55.07 -38.24 67.8 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.834 -0.541 . . . . 0.0 111.009 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -78.57 -49.37 13.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.575 -0.703 . . . . 0.0 110.594 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.89 -45.63 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.733 -0.604 . . . . 0.0 110.005 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.7 m -59.55 -32.75 70.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.0 109.716 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.44 -35.64 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.038 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.97 -45.18 94.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -66.2 -29.54 69.83 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.919 -0.488 . . . . 0.0 110.943 179.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.81 -17.98 60.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.077 -0.39 . . . . 0.0 111.921 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.9 mt -103.31 -28.44 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.823 -0.548 . . . . 0.0 110.593 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.65 -42.2 71.12 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.163 -0.96 . . . . 0.0 111.01 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.7 71.65 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -62.99 -40.29 35.24 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 O-C-N 123.957 1.504 . . . . 0.0 111.332 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.68 -38.99 77.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.485 -0.759 . . . . 0.0 109.265 179.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -33.04 74.83 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 122.046 -0.409 . . . . 0.0 111.296 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.15 -29.95 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.478 -0.764 . . . . 0.0 110.209 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.57 17.41 5.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.645 -0.66 . . . . 0.0 110.666 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -144.53 25.22 1.51 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.561 -0.712 . . . . 0.0 109.999 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.44 -54.88 2.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.209 -0.932 . . . . 0.0 110.1 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.21 51.52 0.69 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 38' ' ' ILE . 51.1 mm -108.58 142.08 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.863 -0.787 . . . . 0.0 109.851 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m 56.62 58.03 4.41 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.205 0.526 . . . . 0.0 109.962 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 117.285 -1.341 . . . . 0.0 110.285 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -111.53 34.88 3.88 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.883 -0.774 . . . . 0.0 111.203 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.81 -51.06 2.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.397 -0.815 . . . . 0.0 109.789 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.32 96.97 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.894 -0.503 . . . . 0.0 110.515 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.55 -40.68 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.683 -0.635 . . . . 0.0 109.483 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.407 HG21 HD11 ' A' ' 6' ' ' ILE . 31.6 mm -61.05 -38.38 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.49 -30.21 59.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.73 -0.606 . . . . 0.0 109.865 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tp -89.25 12.32 16.34 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.654 -0.654 . . . . 0.0 111.924 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -58.6 -31.43 68.04 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.178 -0.951 . . . . 0.0 111.073 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -73.72 -36.72 65.23 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.547 -0.72 . . . . 0.0 109.816 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.77 43.69 1.9 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.505 0.669 . . . . 0.0 110.245 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.1 tp -87.37 136.46 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.588 -0.695 . . . . 0.0 109.876 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 94.7 m-70 -137.31 98.15 10.3 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.617 -0.677 . . . . 0.0 109.822 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.3 -45.19 10.1 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 O-C-N 123.885 1.466 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.24 -31.96 73.36 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.708 -0.62 . . . . 0.0 110.559 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 2.2 mm? -66.54 -39.66 88.7 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mm -64.82 -42.29 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -60.3 -33.37 72.26 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.6 m -68.67 -43.25 76.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HA ' HD11 ' A' ' 23' ' ' ILE . 37.1 mm -66.58 -42.31 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.079 -0.388 . . . . 0.0 110.037 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.3 p -63.54 -37.94 89.25 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.455 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.42 -40.92 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.738 -0.601 . . . . 0.0 109.546 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 20' ' ' ILE . 14.8 mt -74.01 -43.57 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -44.71 89.05 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.86 -0.525 . . . . 0.0 109.795 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.22 -5.08 45.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.808 -0.558 . . . . 0.0 111.298 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.52 9.27 21.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.613 -0.679 . . . . 0.0 110.53 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -107.56 -41.06 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.27 -45.42 11.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.328 -0.858 . . . . 0.0 108.968 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.91 75.49 0.57 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.82 -38.4 30.44 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.781 1.411 . . . . 0.0 110.737 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.66 -43.14 90.28 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.3 mtt -65.09 -36.42 84.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.11 -0.369 . . . . 0.0 110.439 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -58.85 -36.46 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.498 -0.751 . . . . 0.0 109.98 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.25 7.48 46.05 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.594 -0.691 . . . . 0.0 111.53 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.78 17.6 6.27 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.404 -0.81 . . . . 0.0 110.889 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.2 79.31 1.98 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.45 44.61 6.47 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 tp -95.67 34.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.717 -0.872 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.6 p -115.13 50.72 0.96 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.046 -1.034 . . . . 0.0 110.123 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 mttt . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.55 179.964 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.445 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -130.46 -174.66 3.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.735 -0.862 . . . . 0.0 109.742 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.83 35.96 24.49 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.416 0.627 . . . . 0.0 110.147 -179.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -174.66 -51.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.24 -38.18 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.958 -0.464 . . . . 0.0 109.817 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -62.83 -32.9 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -81.13 -25.57 36.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.537 -0.727 . . . . 0.0 110.521 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.28 21.14 9.36 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.416 -0.803 . . . . 0.0 111.967 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -87.95 -20.7 25.55 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.911 -1.118 . . . . 0.0 112.151 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.0 t -79.9 -53.61 6.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.348 -0.845 . . . . 0.0 111.027 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.25 42.35 1.1 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.585 -0.697 . . . . 0.0 111.451 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.7 tp -59.4 143.19 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.734 -0.604 . . . . 0.0 110.674 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 1.7 m-70 -145.87 84.54 8.13 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.487 -0.758 . . . . 0.0 110.433 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.68 -45.59 6.38 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 O-C-N 123.544 1.286 . . . . 0.0 111.078 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.21 -36.81 83.08 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.653 -0.654 . . . . 0.0 110.122 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -65.49 -42.93 91.61 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.372 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 20' ' ' ILE . 46.6 mt -57.49 -44.54 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.351 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.94 -42.93 99.67 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.131 -0.356 . . . . 0.0 110.119 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.7 m -59.04 -40.91 86.53 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 17' ' ' ILE . 49.2 mt -65.17 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 m -60.36 -41.13 93.04 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.633 -0.667 . . . . 0.0 109.783 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -63.62 -41.34 98.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -77.66 -26.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -45.46 86.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.498 -0.751 . . . . 0.0 109.566 179.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -16.53 63.96 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.782 -0.574 . . . . 0.0 111.365 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.27 5.71 50.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.827 -0.545 . . . . 0.0 111.073 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.8 mt -139.14 -51.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 0.0 109.319 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 59.39 35.9 23.17 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.426 0.632 . . . . 0.0 111.342 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.86 58.15 0.15 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.3 -34.72 26.41 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.755 1.397 . . . . 0.0 111.702 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.42 -48.05 83.13 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.731 -0.606 . . . . 0.0 110.163 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.8 ttt -64.96 -45.09 87.16 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.9 t -61.55 -39.81 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.84 -0.538 . . . . 0.0 110.479 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.14 5.17 23.53 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.473 -0.767 . . . . 0.0 112.292 179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.47 29.6 2.41 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.192 -0.943 . . . . 0.0 110.829 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.51 97.75 8.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.518 -0.739 . . . . 0.0 109.173 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.69 48.2 29.82 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.57 150.38 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.862 -0.787 . . . . 0.0 110.083 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m 56.84 60.38 3.07 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.462 0.648 . . . . 0.0 109.419 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.924 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.084 -179.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.462 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -174.53 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.333 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.84 40.86 32.03 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 121.6 0.714 . . . . 0.0 109.146 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.54 -55.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.62 -42.3 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.64 -39.75 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -40.0 94.93 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.994 -0.441 . . . . 0.0 109.823 179.388 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.32 -16.55 63.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.666 -0.646 . . . . 0.0 111.792 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.5 m -99.21 -43.28 6.68 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.4 m -66.75 -32.5 73.83 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.058 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.27 69.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.284 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 pt -63.65 -173.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.443 -179.395 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -142.96 129.85 10.74 Favored Pre-proline 0 N--CA 1.481 1.115 0 O-C-N 121.065 -1.022 . . . . 0.0 110.432 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.54 -160.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.548 2.166 . . . . 0.0 110.198 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 61.93 21.96 12.69 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 121.8 0.81 . . . . 0.0 110.228 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.1 tp -144.1 -53.87 0.34 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.03 -45.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.648 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.94 82.21 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -62.98 -42.68 99.91 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.402 ' HA ' HD11 ' A' ' 20' ' ' ILE . 19.5 mm -60.62 -42.25 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -63.47 -38.81 92.58 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.712 -0.618 . . . . 0.0 109.646 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -60.08 -35.91 76.23 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.497 . . . . 0.0 109.851 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.47 -31.18 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.79 -45.68 93.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.651 -0.655 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.6 -13.07 61.94 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.925 179.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.26 -8.24 33.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.73 -0.606 . . . . 0.0 111.056 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.3 mm -125.51 36.75 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.569 -0.707 . . . . 0.0 109.367 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -157.18 76.2 0.84 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.966 -1.084 . . . . 0.0 109.745 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' N ' ' CD ' ' A' ' 30' ' ' PRO . . . -145.63 51.57 0.6 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 29' ' ' GLY . 45.6 Cg_endo -65.83 -31.5 47.9 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.445 1.43 . . . . 0.0 111.521 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.7 -46.21 87.78 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.657 -0.652 . . . . 0.0 109.819 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.7 mmt -69.78 -40.75 75.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.99 -37.74 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.691 -0.631 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 16.49 3.56 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.527 -0.733 . . . . 0.0 112.433 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.45 26.0 0.77 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.16 -0.962 . . . . 0.0 111.215 179.664 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.43 -48.33 5.07 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.141 -0.974 . . . . 0.0 109.94 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.46 60.61 0.52 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 tp -80.12 133.02 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.794 -0.827 . . . . 0.0 110.44 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 p -144.4 -54.56 0.34 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.616 -0.678 . . . . 0.0 110.963 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 118.767 -0.635 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -108.33 23.97 13.71 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.82 -0.812 . . . . 0.0 111.155 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.6 -42.41 6.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.378 -0.826 . . . . 0.0 110.266 179.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.85 -27.46 62.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.706 -0.621 . . . . 0.0 110.583 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.79 -38.01 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.756 -0.59 . . . . 0.0 109.929 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.1 mt -62.75 -44.49 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.0 tp -69.35 -18.66 63.82 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.766 -0.584 . . . . 0.0 110.472 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.74 7.24 43.94 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.371 -0.831 . . . . 0.0 111.621 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -78.87 -40.82 31.42 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.179 -0.951 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.5 p -69.2 -13.8 62.62 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.543 -0.723 . . . . 0.0 112.161 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.29 46.83 0.92 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.172 -0.955 . . . . 0.0 110.227 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 tt -136.17 175.41 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.83 -0.544 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 67.21 106.86 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.307 0 C-N-CA 122.987 0.515 . . . . 0.0 111.257 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.96 -26.27 66.62 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.257 1.305 . . . . 0.0 112.041 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.77 -10.39 59.36 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.532 -0.73 . . . . 0.0 111.913 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -103.93 -39.81 6.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.514 -0.741 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.502 ' HA ' HD11 ' A' ' 20' ' ' ILE . 32.4 mm -54.37 -41.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 122.053 -0.405 . . . . 0.0 110.388 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -63.69 -38.65 91.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.713 -0.617 . . . . 0.0 110.171 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -65.41 -39.17 91.82 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.751 -0.593 . . . . 0.0 109.739 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 17' ' ' ILE . 7.6 mt -66.98 -43.96 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.8 m -58.75 -41.38 86.39 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.812 -0.555 . . . . 0.0 109.889 179.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.18 -35.8 74.19 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.931 -0.481 . . . . 0.0 110.456 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.78 -20.14 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.736 -0.603 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tp -57.98 -45.36 86.89 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.47 -29.32 70.36 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.846 -0.533 . . . . 0.0 110.037 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.62 -36.17 29.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.26 0.552 . . . . 0.0 110.208 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.2 mm -109.25 48.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.438 0.637 . . . . 0.0 109.726 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.74 -26.57 59.88 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.076 -1.015 . . . . 0.0 111.322 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.06 59.28 4.34 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.69 -29.77 15.44 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 123.606 1.319 . . . . 0.0 111.576 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 3.4 mm? -58.09 -34.81 70.57 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.594 -0.691 . . . . 0.0 111.287 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.6 -34.91 18.36 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.51 -0.744 . . . . 0.0 110.397 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -74.67 -39.52 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.497 -0.752 . . . . 0.0 110.689 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.39 16.97 5.67 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.423 -0.798 . . . . 0.0 112.147 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 29.4 mt-30 -146.49 24.88 1.23 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.243 -0.911 . . . . 0.0 110.435 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.96 -57.64 2.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.97 49.12 0.87 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.4 mm -114.87 50.4 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.723 -0.869 . . . . 0.0 109.118 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -154.55 49.82 0.61 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.63 0.728 . . . . 0.0 110.014 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.9 tptt . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.957 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -110.61 24.95 12.32 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.708 -0.877 . . . . 0.0 110.757 179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -100.2 -36.36 9.33 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.363 -0.835 . . . . 0.0 110.218 179.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.18 -37.92 8.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.847 -0.533 . . . . 0.0 110.177 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.94 -43.12 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.696 -0.628 . . . . 0.0 110.564 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 6' ' ' ILE . 35.2 mm -61.12 -36.07 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.424 -0.797 . . . . 0.0 109.342 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.9 tp -78.11 -33.53 50.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.783 -0.573 . . . . 0.0 110.536 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 13.24 13.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.515 -0.74 . . . . 0.0 112.132 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -66.21 -29.44 69.71 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.897 -1.127 . . . . 0.0 111.543 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.9 m -72.27 -35.27 68.69 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.445 -0.784 . . . . 0.0 112.004 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.73 11.86 24.34 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.255 -0.903 . . . . 0.0 112.848 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.3 tt -69.51 139.74 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.011 -1.055 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 56.28 68.6 2.18 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 122.259 -0.275 . . . . 0.0 111.098 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.0 -34.98 36.36 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.295 1.33 . . . . 0.0 111.605 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.02 -38.23 90.35 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.584 0.707 . . . . 0.0 109.613 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 tp -73.9 -33.24 63.93 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.616 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.6 mm -60.79 -35.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.674 -0.642 . . . . 0.0 109.597 179.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -75.85 -44.07 42.62 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m -66.24 -33.33 75.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.767 -0.583 . . . . 0.0 110.809 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.86 -34.24 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.13 -0.981 . . . . 0.0 110.098 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -65.62 -43.85 88.31 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -65.33 -44.15 88.73 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -63.61 -36.91 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.69 -38.84 79.12 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.612 -0.68 . . . . 0.0 110.121 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.95 -11.24 60.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.616 -0.678 . . . . 0.0 111.13 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.44 7.81 45.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.75 -0.594 . . . . 0.0 110.531 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm -126.93 -52.71 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.592 -0.693 . . . . 0.0 109.648 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 tp 57.83 71.58 0.57 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.717 0.77 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.95 55.42 0.4 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -66.21 -32.03 43.28 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 O-C-N 123.639 1.336 . . . . 0.0 111.223 179.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.07 -45.39 93.74 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.675 -0.641 . . . . 0.0 110.638 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.2 mtp -62.32 -38.62 90.15 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.861 -0.524 . . . . 0.0 110.101 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.9 t -75.83 -30.43 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.691 -0.63 . . . . 0.0 110.619 179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.0 mt -90.85 3.84 53.39 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.286 -0.883 . . . . 0.0 112.843 -179.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.401 ' HA ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -141.89 31.14 1.62 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 0.0 110.565 179.67 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.75 102.23 11.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 0.0 109.59 179.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.14 42.76 66.38 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 35' ' ' GLN . 86.9 mt -126.14 119.6 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.68 -0.894 . . . . 0.0 109.756 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.4 m -145.96 -72.51 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.519 -0.738 . . . . 0.0 110.637 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 117.339 -1.315 . . . . 0.0 110.941 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.556 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.57 18.19 21.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.923 -0.751 . . . . 0.0 110.36 179.517 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -114.98 -43.56 3.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.0 109.701 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.47 -39.02 62.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.786 -0.572 . . . . 0.0 109.739 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.2 t -62.65 -42.51 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mm -59.22 -46.35 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.12 -38.9 92.13 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.255 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.91 -31.87 70.23 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.926 0.394 . . . . 0.0 110.99 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.3 m -79.7 -38.77 32.75 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 t -74.45 -33.57 62.95 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.711 -0.618 . . . . 0.0 110.725 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.16 35.21 1.19 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.542 -0.724 . . . . 0.0 111.379 179.855 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 tp -90.26 143.45 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.398 -0.814 . . . . 0.0 109.552 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -154.59 101.08 2.38 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.452 -0.78 . . . . 0.0 111.149 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.58 167.0 25.46 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 O-C-N 123.581 1.306 . . . . 0.0 110.22 179.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 54.96 41.41 31.91 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 122.434 1.111 . . . . 0.0 109.504 -179.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 tt -167.75 -51.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.5 mt -58.14 -40.22 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -41.67 96.05 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.854 -0.529 . . . . 0.0 109.916 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -61.94 -41.7 98.26 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 17' ' ' ILE . 17.8 mt -63.68 -42.28 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.8 m -61.98 -33.95 75.25 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.487 -0.758 . . . . 0.0 110.022 179.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -69.12 -37.38 78.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 25.4 mt -102.63 6.03 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.786 -0.571 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -54.42 -50.12 68.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.852 -1.155 . . . . 0.0 110.626 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.0 mt -68.32 -19.22 64.66 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.243 178.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.34 10.45 39.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.109 -0.369 . . . . 0.0 111.166 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 2.7 tt -120.87 -8.04 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.249 -0.907 . . . . 0.0 111.905 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.3 -50.83 50.85 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.105 -0.997 . . . . 0.0 111.008 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.56 -52.56 0.83 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -93.36 53.56 0.41 Allowed 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 121.981 1.787 . . . . 0.0 110.038 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tt -49.42 -49.14 46.29 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.903 -0.498 . . . . 0.0 111.676 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -41.56 25.52 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.351 -0.843 . . . . 0.0 110.524 179.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.4 t -63.04 -41.61 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.718 -0.614 . . . . 0.0 110.271 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tp -85.22 7.38 22.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.618 -0.676 . . . . 0.0 111.682 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -122.86 13.83 9.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.254 -0.904 . . . . 0.0 110.5 179.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.49 -52.14 6.38 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.197 -0.939 . . . . 0.0 109.429 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.73 -42.83 8.74 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mt -80.78 129.85 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.666 -0.903 . . . . 0.0 108.925 179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -107.97 48.35 0.85 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.634 0.73 . . . . 0.0 110.577 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.4 tttt . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.47 179.9 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.463 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -123.59 8.28 8.92 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.753 -0.851 . . . . 0.0 112.264 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.79 -52.98 3.42 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.869 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.77 -27.95 69.54 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.992 -0.442 . . . . 0.0 110.644 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.84 -32.64 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.504 -0.747 . . . . 0.0 110.208 179.595 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.7 mm -67.0 -40.09 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.3 tp -74.37 -33.03 62.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.802 -0.562 . . . . 0.0 109.785 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.87 18.41 5.71 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.485 -0.759 . . . . 0.0 111.886 179.791 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.564 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 13.3 t -55.69 -28.8 57.54 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.397 -0.815 . . . . 0.0 110.682 179.58 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.0 m -70.44 -34.27 72.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.677 -0.64 . . . . 0.0 109.445 179.261 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.15 -39.29 19.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.55 -0.719 . . . . 0.0 110.358 179.635 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.564 ' CG1' ' HA ' ' A' ' 9' ' ' THR . 1.4 pt -80.65 126.34 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.529 -0.732 . . . . 0.0 110.492 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -144.16 98.21 5.14 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.444 -0.785 . . . . 0.0 109.993 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HA ' ' CD1' ' A' ' 17' ' ' ILE . 44.0 Cg_endo -66.68 -38.36 18.58 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.549 1.499 . . . . 0.0 111.746 179.925 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -57.95 -33.77 69.18 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.674 -0.641 . . . . 0.0 110.816 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -36.04 82.17 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.376 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 14' ' ' PRO . 7.7 mt -65.02 -30.54 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.751 -0.593 . . . . 0.0 109.706 179.462 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -88.43 -25.95 22.39 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.426 -0.796 . . . . 0.0 109.863 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.7 m -88.93 -21.57 23.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 0.0 110.503 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 tt -53.49 -37.66 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 121.315 -0.865 . . . . 0.0 110.581 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -71.01 -39.7 72.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -61.58 -36.12 79.76 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.294 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.9 mt -74.3 -30.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.66 -0.65 . . . . 0.0 109.35 179.25 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 tp -60.0 -41.21 91.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.701 -0.624 . . . . 0.0 110.297 179.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.68 2.59 28.94 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.503 -0.748 . . . . 0.0 110.701 179.034 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.2 10.89 13.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.515 -0.74 . . . . 0.0 110.355 179.294 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.1 tt -98.63 -29.01 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.605 -0.684 . . . . 0.0 109.987 179.848 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.57 -21.74 38.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.73 -0.606 . . . . 0.0 110.35 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.74 58.55 0.43 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 42.7 Cg_endo -62.35 -34.91 75.8 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.92 1.747 . . . . 0.0 111.493 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.65 -41.87 95.85 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.634 -0.667 . . . . 0.0 109.661 179.666 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ttp -80.93 -41.64 22.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.887 -0.508 . . . . 0.0 110.522 179.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.412 ' CG1' ' HA ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -60.4 -32.31 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.544 -0.722 . . . . 0.0 111.21 -179.897 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -30.81 70.61 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.456 -0.777 . . . . 0.0 111.332 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -97.25 21.47 9.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.165 -0.334 . . . . 0.0 111.084 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.26 57.76 0.63 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.332 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.25 58.06 0.24 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.573 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 tt -113.42 31.11 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 122.001 -0.705 . . . . 0.0 110.73 -179.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -135.86 53.6 1.94 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.293 -0.88 . . . . 0.0 109.873 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.0 tttm . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.197 179.877 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.517 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -122.24 18.35 10.69 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.736 -0.861 . . . . 0.0 111.174 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -101.87 -58.02 1.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.368 -0.832 . . . . 0.0 109.476 179.767 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.92 -28.59 69.05 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.956 -0.465 . . . . 0.0 110.876 179.596 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.84 -34.55 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.766 -0.584 . . . . 0.0 110.241 179.761 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.3 mt -63.34 -44.86 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.356 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.94 -37.2 81.33 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.185 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -27.95 69.52 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.9 -0.5 . . . . 0.0 111.302 179.698 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.5 m -68.86 -35.2 76.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.965 -0.46 . . . . 0.0 109.991 179.681 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 69.3 m -95.66 37.23 1.21 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.445 -0.784 . . . . 0.0 110.578 179.643 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.74 38.24 0.27 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.447 -0.783 . . . . 0.0 110.501 179.873 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.3 tt -135.55 148.24 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.572 -0.705 . . . . 0.0 110.797 -179.75 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 17.3 m170 -124.25 78.68 60.33 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.389 -0.819 . . . . 0.0 110.286 -179.929 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.21 -36.15 17.31 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.311 1.341 . . . . 0.0 111.047 179.996 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -79.79 4.41 16.53 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.664 -0.647 . . . . 0.0 111.026 179.396 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -112.38 -47.77 3.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.475 -0.766 . . . . 0.0 109.007 179.494 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.484 ' HA ' HD13 ' A' ' 20' ' ' ILE . 71.7 mt -56.96 -45.03 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -44.56 94.63 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.736 -0.603 . . . . 0.0 109.601 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.457 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 2.4 m -61.23 -33.95 74.32 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.818 -0.551 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 17' ' ' ILE . 64.1 mt -60.43 -40.25 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.44 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -58.75 -39.49 81.1 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.251 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -64.89 -43.48 92.74 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.187 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.2 mm -71.31 -33.28 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.313 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tp -55.56 -41.49 73.35 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.867 -0.521 . . . . 0.0 109.834 179.411 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 2.71 22.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.733 -0.604 . . . . 0.0 111.302 179.3 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.65 6.53 11.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.481 -0.762 . . . . 0.0 110.903 179.374 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.1 mt -99.22 -29.29 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 0.0 109.465 179.63 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mt -84.58 15.33 3.84 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.52 -0.738 . . . . 0.0 111.614 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.11 55.07 0.4 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.549 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.42 -30.77 43.85 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.473 1.449 . . . . 0.0 111.116 -179.946 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mp -55.22 -43.53 74.6 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.709 -0.62 . . . . 0.0 109.778 179.692 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 50.0 mtm -75.55 -41.72 54.17 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.284 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.58 -36.85 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.789 -0.569 . . . . 0.0 110.181 179.644 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.74 18.71 5.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.491 -0.755 . . . . 0.0 111.569 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -152.53 29.26 0.54 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.505 -0.747 . . . . 0.0 110.459 179.765 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.89 -37.97 28.84 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.296 -0.877 . . . . 0.0 111.348 -179.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.05 -31.49 42.86 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.875 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mm -99.3 118.35 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.516 -0.99 . . . . 0.0 110.044 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -110.83 20.11 17.89 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.84 -0.537 . . . . 0.0 111.607 179.77 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.509 2.481 0 O-C-N 121.62 -0.675 . . . . 0.0 112.038 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.09 -175.13 2.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.705 -0.879 . . . . 0.0 109.193 179.739 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 56.74 38.59 29.61 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.442 0.639 . . . . 0.0 110.38 -179.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.13 -52.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.874 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.2 t -60.5 -39.04 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.642 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.2 mt -62.14 -37.38 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.533 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.3 tp -78.61 -27.28 45.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.743 -0.598 . . . . 0.0 110.258 179.427 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tp -89.04 15.52 8.53 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.55 -0.718 . . . . 0.0 111.598 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 t -69.45 -25.71 64.23 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.162 -0.961 . . . . 0.0 111.346 179.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.21 -37.73 81.2 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.415 -0.803 . . . . 0.0 110.225 179.77 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.42 -48.17 57.31 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.646 -0.659 . . . . 0.0 110.146 179.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.6 tt -75.91 156.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.613 -0.679 . . . . 0.0 110.098 179.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -120.93 70.45 19.0 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.444 -0.785 . . . . 0.0 110.182 179.819 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.36 -18.88 22.76 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.431 1.227 . . . . 0.0 111.748 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -60.36 -48.42 81.82 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.582 -0.699 . . . . 0.0 111.419 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.8 tp -53.69 -44.85 70.1 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.258 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mt -64.07 -38.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.46 -34.83 77.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.825 -0.547 . . . . 0.0 109.952 179.276 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.1 m -59.4 -42.62 92.19 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.788 -0.57 . . . . 0.0 109.912 179.637 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.44 -43.43 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.524 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.5 m -61.69 -39.78 92.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.682 -0.636 . . . . 0.0 109.85 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -60.52 -51.83 67.77 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.9 mt -63.48 -35.74 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.12 -41.18 92.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 179.341 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.35 -18.61 62.37 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.951 -0.468 . . . . 0.0 110.952 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.11 -1.63 57.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.861 -0.524 . . . . 0.0 111.522 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -128.32 -53.35 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.589 -0.695 . . . . 0.0 109.667 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 58.4 51.6 8.05 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.356 0.598 . . . . 0.0 110.611 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.9 68.06 0.01 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.3 -39.82 3.58 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.647 1.341 . . . . 0.0 111.477 179.777 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.45 -51.03 71.63 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.424 -0.798 . . . . 0.0 111.318 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.9 ptm -64.16 -23.64 67.39 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.742 -0.599 . . . . 0.0 112.047 -179.819 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.5 t -89.62 -39.87 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 179.709 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mp -85.1 6.34 25.96 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.481 -0.762 . . . . 0.0 112.35 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -135.12 25.39 3.56 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.045 -1.035 . . . . 0.0 110.811 179.487 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.85 -44.48 13.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.411 -0.805 . . . . 0.0 109.859 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.24 56.62 0.62 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.0 tt -108.32 19.94 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 122.092 -0.652 . . . . 0.0 111.638 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 p -124.5 58.03 1.23 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.092 -1.005 . . . . 0.0 109.362 179.832 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 tptp . . . . . 0 N--CA 1.504 2.265 0 CA-C-O 117.247 -1.359 . . . . 0.0 111.04 -179.805 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -114.37 24.54 11.83 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.724 -0.868 . . . . 0.0 111.058 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -102.05 -54.05 2.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.479 -0.763 . . . . 0.0 109.839 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.92 -32.43 70.76 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.014 -0.429 . . . . 0.0 110.537 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.27 -40.07 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.653 -0.654 . . . . 0.0 109.605 179.678 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.7 mt -66.16 -41.47 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.729 -0.607 . . . . 0.0 109.535 179.67 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.3 tp -69.5 -31.69 70.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.389 -0.819 . . . . 0.0 110.968 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 tp -73.2 -14.75 61.41 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.508 -0.745 . . . . 0.0 112.105 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -50.89 -28.93 10.64 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.633 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.5 t -60.13 -33.93 72.82 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.423 -0.798 . . . . 0.0 111.742 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -117.45 -62.51 1.56 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.35 -0.844 . . . . 0.0 110.986 -179.892 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.6 mm 58.49 91.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-O 121.805 0.812 . . . . 0.0 110.847 -179.811 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 45.1 t-80 -132.51 99.06 16.02 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.771 -0.581 . . . . 0.0 109.799 179.798 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 45.0 Cg_endo -65.02 -177.34 0.57 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 O-C-N 123.83 1.437 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.6 28.05 17.74 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.796 0.808 . . . . 0.0 109.868 -179.13 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.1 -53.89 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.709 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.19 -32.54 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.801 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -87.8 -39.32 14.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.3 m -69.39 -22.95 63.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.752 -0.592 . . . . 0.0 110.87 179.641 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 tp -55.43 -36.0 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.044 0.838 . . . . 0.0 110.142 179.765 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.1 p -65.08 -42.91 93.67 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.081 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -67.54 -36.52 81.14 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 27' ' ' ILE . 71.1 mt -73.55 -36.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.56 -0.712 . . . . 0.0 109.827 179.605 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.6 tp -48.75 -49.8 36.7 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.619 -0.676 . . . . 0.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.49 -5.7 44.13 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.648 -0.658 . . . . 0.0 111.8 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -107.59 3.67 25.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.718 -0.614 . . . . 0.0 111.078 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 23' ' ' ILE . 22.6 mm -104.29 -44.73 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.443 -0.786 . . . . 0.0 108.968 179.72 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -67.73 -40.08 84.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.057 -0.402 . . . . 0.0 110.305 179.763 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.46 63.84 2.28 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.12 -26.59 57.51 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.609 1.32 . . . . 0.0 111.916 -179.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.56 -44.97 10.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.353 -0.842 . . . . 0.0 109.816 179.681 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.3 ttt -69.3 -46.78 66.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.669 -0.644 . . . . 0.0 110.654 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.91 -29.0 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.625 -0.672 . . . . 0.0 110.689 179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.04 -8.29 55.06 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.193 -0.942 . . . . 0.0 112.027 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -131.56 21.6 4.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.378 -0.826 . . . . 0.0 110.984 179.661 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.95 -53.68 4.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.743 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.09 46.59 1.15 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.433 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 tp -97.74 146.52 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.716 -0.873 . . . . 0.0 110.451 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -152.23 67.24 0.84 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.887 0.851 . . . . 0.0 109.902 179.943 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.376 -0.827 . . . . 0.0 110.207 179.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.538 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.86 19.24 8.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.723 -0.869 . . . . 0.0 111.906 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -104.2 -55.19 2.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.605 -0.685 . . . . 0.0 109.675 -179.864 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.52 -38.87 47.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.864 -0.523 . . . . 0.0 110.542 179.694 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -63.41 -45.07 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.95 -0.469 . . . . 0.0 110.172 179.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.2 mm -62.78 -40.26 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.722 -0.611 . . . . 0.0 109.38 179.712 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.88 -34.13 77.66 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.691 -0.63 . . . . 0.0 109.869 179.472 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 tp -73.7 -14.37 61.13 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.376 -0.827 . . . . 0.0 111.516 179.572 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.4 m -106.59 -41.57 5.23 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.666 -0.646 . . . . 0.0 110.548 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.4 m -92.77 -30.35 15.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.635 -0.666 . . . . 0.0 111.404 -179.789 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.72 50.58 0.77 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.293 -0.88 . . . . 0.0 110.029 179.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -99.25 -1.09 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.931 -0.481 . . . . 0.0 112.14 -179.823 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.08 66.23 7.13 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 120.852 -1.155 . . . . 0.0 110.538 179.687 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.89 -34.44 30.11 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.247 1.298 . . . . 0.0 111.489 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.51 -39.72 80.88 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.637 -0.665 . . . . 0.0 110.701 179.776 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.96 -38.14 53.88 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 122.148 -0.345 . . . . 0.0 110.32 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.08 -47.44 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.677 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.98 -32.98 72.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.849 -0.532 . . . . 0.0 111.386 179.92 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -71.25 -42.95 68.15 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.9 mt -65.01 -42.58 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 p -65.25 -37.54 87.53 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.413 -0.804 . . . . 0.0 110.402 179.779 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.34 -46.43 64.17 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mm -65.79 -38.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.523 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -60.1 -39.61 86.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.545 -0.722 . . . . 0.0 109.822 179.592 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.74 -22.47 37.26 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.359 -0.838 . . . . 0.0 111.026 179.582 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.47 12.34 14.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.842 -0.536 . . . . 0.0 111.438 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mm -117.24 -43.64 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.301 -0.874 . . . . 0.0 109.993 179.744 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mt -106.72 -74.61 0.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.54 -0.725 . . . . 0.0 110.412 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.57 70.79 1.01 Allowed Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.892 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.09 -34.5 13.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.534 1.281 . . . . 0.0 111.52 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.61 -48.87 79.98 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.66 -0.65 . . . . 0.0 110.669 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -71.06 -28.96 64.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.635 -0.666 . . . . 0.0 110.77 179.742 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.51 -33.78 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.236 -0.915 . . . . 0.0 110.473 179.681 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.08 -1.55 56.39 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.39 -0.819 . . . . 0.0 112.056 179.812 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.3 18.61 6.44 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.309 -0.869 . . . . 0.0 111.169 179.758 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.32 78.37 2.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.13 -0.981 . . . . 0.0 108.442 179.451 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.59 42.66 17.1 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.319 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.0 tp -81.46 145.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.599 -0.942 . . . . 0.0 110.237 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.8 m -110.07 51.5 0.76 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.729 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.657 -179.726 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.437 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 ttp-105 -128.57 31.35 5.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.754 -0.851 . . . . 0.0 110.218 179.874 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.61 -55.32 2.45 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.974 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.67 -36.37 32.5 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.261 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.75 -43.84 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.607 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 mm -64.1 -38.27 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.21 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.54 -30.11 64.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.611 -0.681 . . . . 0.0 109.877 179.295 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.75 7.14 18.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.58 -0.7 . . . . 0.0 111.72 179.712 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 6.3 t -59.3 -31.82 69.49 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.269 -0.894 . . . . 0.0 111.378 -179.997 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 m -64.68 -38.93 92.66 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.465 -0.772 . . . . 0.0 110.025 179.421 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.82 66.15 1.48 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.985 0.897 . . . . 0.0 108.685 179.557 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.51 ' CG2' ' HA ' ' A' ' 9' ' ' THR . 24.9 pt -64.21 167.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-O 121.631 0.729 . . . . 0.0 111.729 -179.421 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -118.58 -171.23 0.2 Allowed Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.822 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 13' ' ' HIS . 47.0 Cg_endo -80.26 -174.04 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.117 1.878 . . . . 0.0 110.612 -179.926 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 58.75 36.91 25.07 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.28 1.038 . . . . 0.0 110.233 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.67 -51.12 0.06 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.616 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.7 mt -54.74 -39.38 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.946 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -62.04 -42.62 99.37 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.308 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -66.63 -39.77 88.45 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.56 -39.15 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.623 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -42.37 82.92 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.698 -0.626 . . . . 0.0 109.509 179.488 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -68.84 -41.31 78.7 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -75.97 -23.69 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.739 -0.6 . . . . 0.0 110.081 179.589 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.28 -42.52 70.1 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.486 -0.759 . . . . 0.0 109.784 179.67 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.53 -11.46 60.94 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.885 -0.509 . . . . 0.0 110.935 179.146 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.38 13.0 30.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.456 179.192 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.73 -2.48 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.322 -0.861 . . . . 0.0 111.042 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.2 30.94 0.74 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.516 -1.365 . . . . 0.0 111.866 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.54 53.23 0.4 Allowed Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.695 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.54 -37.0 18.06 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.612 1.322 . . . . 0.0 110.505 179.806 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.83 -44.09 94.22 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.899 -0.5 . . . . 0.0 109.79 179.66 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.4 ttt -62.2 -45.06 95.07 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.35 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.5 -39.73 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.475 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.15 -22.51 65.77 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.809 -0.557 . . . . 0.0 111.928 179.963 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.61 21.25 17.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.73 -0.606 . . . . 0.0 110.687 179.554 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.9 74.48 8.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.234 -0.916 . . . . 0.0 109.35 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.11 40.15 10.67 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.749 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.84 98.75 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 118.251 1.025 . . . . 0.0 109.649 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 m 57.98 37.83 26.75 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.735 -0.603 . . . . 0.0 110.392 -179.617 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.6 mptt . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.153 179.984 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.506 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -78.06 86.29 4.23 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 122.191 0.996 . . . . 0.0 111.212 -179.875 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.88 -64.99 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.739 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.41 -29.73 27.9 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.935 -0.478 . . . . 0.0 110.636 179.741 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.91 -39.76 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.796 -0.565 . . . . 0.0 109.806 179.915 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mt -63.26 -38.6 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.291 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tt -73.29 -36.02 66.22 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.993 -0.442 . . . . 0.0 110.15 179.51 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.68 12.65 14.23 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.706 -0.621 . . . . 0.0 112.255 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 t -62.83 -32.38 73.58 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.232 -0.918 . . . . 0.0 111.622 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.2 t -70.92 -29.71 65.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.535 -0.728 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.06 -0.7 33.08 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.36 -0.837 . . . . 0.0 112.054 179.938 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.88 19.59 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.013 -1.054 . . . . 0.0 112.097 -179.854 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -121.15 77.45 32.73 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.034 -1.041 . . . . 0.0 110.85 179.788 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -80.26 -173.65 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.65 1.342 . . . . 0.0 110.128 179.572 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 67.05 3.08 2.98 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.731 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.02 -48.48 1.87 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.081 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.403 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 8.4 mt -52.03 -41.87 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -42.8 99.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 0.0 110.068 179.628 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -66.85 -33.86 76.52 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.747 -0.596 . . . . 0.0 110.0 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 17' ' ' ILE . 86.9 mt -58.3 -43.39 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.253 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 m -69.09 -41.76 77.04 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.032 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -59.65 -46.03 90.25 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.514 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.9 mm -82.09 -15.56 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.712 -0.617 . . . . 0.0 110.249 179.611 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -54.33 -45.63 72.7 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 179.664 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.01 -21.91 66.91 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.387 179.237 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.41 0.45 56.22 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.056 -0.402 . . . . 0.0 111.188 179.215 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 24' ' ' LEU . 55.2 mt -110.16 9.18 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.46 -0.775 . . . . 0.0 109.898 179.543 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -54.4 -51.28 65.35 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.082 -1.011 . . . . 0.0 110.923 -179.941 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.45 75.72 0.98 Allowed Glycine 0 N--CA 1.497 2.763 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.642 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.84 -34.23 9.03 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 123.579 1.304 . . . . 0.0 111.131 179.497 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.68 -50.74 71.27 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.685 -0.634 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.8 ptp -64.54 -35.18 80.15 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.649 -0.657 . . . . 0.0 110.76 179.971 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.41 -31.76 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.561 -0.712 . . . . 0.0 109.64 179.382 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.86 7.33 46.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.587 -0.696 . . . . 0.0 111.43 179.681 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -129.85 20.59 5.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.382 -0.824 . . . . 0.0 110.446 179.69 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.25 76.31 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.619 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.77 55.79 0.87 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.476 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tt -121.38 42.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.719 -0.871 . . . . 0.0 111.337 -179.991 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.7 p -114.39 42.71 2.04 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.981 -1.075 . . . . 0.0 109.756 179.453 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.199 0 O-C-N 122.053 -0.404 . . . . 0.0 110.628 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.7 ptt85 -121.85 5.64 9.92 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.957 -0.731 . . . . 0.0 111.834 179.852 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -108.53 -46.44 3.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.7 -0.625 . . . . 0.0 110.57 -179.662 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.04 -39.95 22.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.568 -0.708 . . . . 0.0 109.712 179.658 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.12 -41.91 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.747 -0.595 . . . . 0.0 109.673 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.4 mm -66.59 -37.12 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.309 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -30.4 62.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.757 -0.59 . . . . 0.0 110.04 179.41 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.44 25.02 3.61 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.615 -0.678 . . . . 0.0 111.174 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 t -67.16 -25.22 66.05 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.085 -1.009 . . . . 0.0 111.5 179.895 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.5 p -59.31 -28.76 67.09 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.387 -0.82 . . . . 0.0 110.989 179.606 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.94 -70.53 0.8 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.55 -0.719 . . . . 0.0 109.112 179.571 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.0 tt 40.29 29.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 60.6 92.18 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 122.049 -0.407 . . . . 0.0 110.329 179.947 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.04 -32.93 75.39 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.35 1.366 . . . . 0.0 112.107 -179.709 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -67.39 -37.06 82.53 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.449 -0.782 . . . . 0.0 109.033 179.205 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -66.82 -38.63 86.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.155 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.5 mm -63.8 -40.26 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.204 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.6 -36.47 71.79 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.5 m -73.62 -39.9 64.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.201 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -41.34 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.853 -0.53 . . . . 0.0 110.364 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 p -65.54 -36.49 83.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.473 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -58.83 -42.76 89.99 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.405 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -74.88 -35.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.025 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.79 -44.57 82.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.427 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -14.61 62.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.788 -0.57 . . . . 0.0 111.423 179.431 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.73 5.17 52.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.782 -0.574 . . . . 0.0 110.637 179.18 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.0 mt -126.81 -37.83 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 0.0 110.246 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.37 -36.81 74.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.393 -0.817 . . . . 0.0 111.768 -179.815 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.33 49.55 0.56 Allowed Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.288 -179.886 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.43 -32.11 20.62 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 O-C-N 123.414 1.218 . . . . 0.0 110.904 179.248 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -43.37 95.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.709 -0.619 . . . . 0.0 110.209 179.789 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.1 mtp -63.64 -43.23 97.38 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.685 -0.634 . . . . 0.0 109.476 179.385 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.99 -35.75 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.382 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.78 10.63 7.27 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.603 -0.686 . . . . 0.0 111.568 179.56 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -127.15 22.77 6.58 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.279 -0.888 . . . . 0.0 110.209 179.468 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.35 -55.37 3.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.256 -0.903 . . . . 0.0 109.016 179.731 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.42 41.92 1.88 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.325 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.1 tt -75.69 153.12 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.706 -0.879 . . . . 0.0 111.067 -179.78 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -108.74 42.76 1.35 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.636 -0.665 . . . . 0.0 109.967 179.738 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.13 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.408 -179.821 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.561 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.0 23.87 13.03 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.283 -0.54 . . . . 0.0 111.964 -179.951 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -99.37 -50.02 4.25 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.517 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.88 -27.74 68.44 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.179 179.569 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.8 t -63.35 -38.38 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 O-C-N 121.705 -0.622 . . . . 0.0 110.027 179.782 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.0 mm -60.57 -42.48 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.42 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.19 -32.39 73.79 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.124 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 7.53 13.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.477 -0.764 . . . . 0.0 111.844 179.585 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.0 m -93.7 -26.79 16.87 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.084 -1.01 . . . . 0.0 110.574 179.762 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.6 p -62.26 -31.16 71.7 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.154 -0.966 . . . . 0.0 111.411 179.893 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.81 -46.94 27.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.385 -0.822 . . . . 0.0 110.052 179.741 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 tp -68.79 156.89 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.595 -0.691 . . . . 0.0 109.619 179.71 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -112.0 86.05 7.17 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.564 -0.71 . . . . 0.0 110.2 -179.75 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -71.29 -172.47 0.75 Allowed 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.275 1.316 . . . . 0.0 110.442 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 56.1 44.98 24.38 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.258 1.028 . . . . 0.0 110.599 -179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.65 -51.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.26 -36.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.805 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -63.12 -34.61 77.98 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.085 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 m -78.77 -27.52 44.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.681 -0.637 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.18 -45.18 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.69 -0.631 . . . . 0.0 110.198 179.975 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -67.02 -33.86 76.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.636 -0.665 . . . . 0.0 110.018 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -68.47 -50.83 49.5 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.6 -23.27 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.748 -0.595 . . . . 0.0 109.808 179.204 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -55.77 -42.65 75.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.511 -0.743 . . . . 0.0 110.014 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.09 -24.62 63.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.585 -0.697 . . . . 0.0 110.664 179.552 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.62 -24.8 28.97 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.773 -0.58 . . . . 0.0 111.183 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.1 mm -103.35 33.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-O 121.201 0.524 . . . . 0.0 110.457 179.919 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mt -76.47 -27.6 56.2 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.735 -1.228 . . . . 0.0 110.537 179.49 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.23 70.37 0.02 OUTLIER Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.906 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.52 -49.11 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.774 1.407 . . . . 0.0 110.827 -179.923 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.16 -36.49 83.24 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.801 -0.562 . . . . 0.0 109.787 179.64 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 39.4 ttm -60.98 -45.32 95.29 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.562 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.12 -34.17 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.913 -0.492 . . . . 0.0 109.721 179.454 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mp -87.37 -1.74 58.13 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.632 -0.667 . . . . 0.0 111.964 179.708 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -123.66 22.87 8.96 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.394 -0.816 . . . . 0.0 110.709 179.73 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.65 76.11 1.37 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.338 -0.851 . . . . 0.0 109.064 179.702 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.04 51.37 2.27 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.56 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.98 125.16 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.606 -0.938 . . . . 0.0 110.77 -179.92 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -149.88 71.51 1.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.834 -1.079 . . . . 0.0 110.316 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -123.68 8.69 8.87 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.969 -0.724 . . . . 0.0 111.199 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -110.44 -51.2 2.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.897 -1.127 . . . . 0.0 109.608 179.911 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.51 74.41 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.896 -0.503 . . . . 0.0 110.839 179.697 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.44 -48.51 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.592 -0.693 . . . . 0.0 110.608 -179.887 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 mt -59.97 -42.97 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.751 -0.593 . . . . 0.0 109.462 179.656 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.68 -36.43 80.85 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.001 -0.437 . . . . 0.0 110.567 179.607 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.59 -43.38 80.66 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.733 -0.604 . . . . 0.0 111.014 179.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.2 m -64.15 -41.89 97.0 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.783 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.45 -39.61 93.93 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.483 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.17 -39.34 78.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.893 -0.505 . . . . 0.0 110.305 179.61 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.9 mt -92.7 81.77 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.76 0.79 . . . . 0.0 109.509 179.865 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 59.3 3.54 Favored Pre-proline 0 N--CA 1.499 2.02 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.052 179.816 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.46 -178.85 4.74 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 O-C-N 123.121 1.064 . . . . 0.0 111.173 -179.777 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 59.66 13.96 3.73 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-O 121.333 0.587 . . . . 0.0 111.997 -179.486 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 tp -143.04 -59.76 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.213 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.8 -32.56 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.16 -39.73 28.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.897 -0.502 . . . . 0.0 109.676 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -61.37 -47.57 85.25 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.854 -0.529 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.6 mt -58.5 -45.33 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 179.858 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -64.78 -33.3 75.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.825 -0.547 . . . . 0.0 110.541 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -68.46 -40.31 81.09 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.432 -0.793 . . . . 0.0 110.704 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.8 -36.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.786 -0.571 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.71 -44.27 93.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.522 -0.736 . . . . 0.0 109.727 179.644 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.31 -14.81 59.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.81 -0.556 . . . . 0.0 111.017 179.429 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.79 14.01 22.77 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.842 -0.536 . . . . 0.0 110.801 179.34 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.0 mm -120.97 -69.2 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.631 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt 49.47 67.04 0.95 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.592 0.71 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.07 70.56 0.03 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.23 -28.48 55.81 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 O-C-N 123.903 1.475 . . . . 0.0 111.493 179.571 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 tp -62.3 -40.73 97.24 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.553 -0.717 . . . . 0.0 110.143 179.708 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ttt -62.29 -36.48 82.22 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.916 -0.49 . . . . 0.0 109.73 179.511 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.6 t -62.33 -33.45 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.861 -0.524 . . . . 0.0 109.627 179.472 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.6 12.34 5.89 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.521 -0.737 . . . . 0.0 111.585 179.506 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.48 24.75 2.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.935 -1.103 . . . . 0.0 110.452 179.654 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.51 104.71 8.2 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.236 -0.915 . . . . 0.0 109.876 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.42 -0.89 22.15 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.678 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.0 tp -70.67 146.3 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 119.12 1.46 . . . . 0.0 110.378 179.997 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 15.1 p -112.94 54.28 0.73 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.738 -0.601 . . . . 0.0 109.75 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 39' ' ' THR . 7.0 mttm . . . . . 0 N--CA 1.509 2.492 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.723 -179.931 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -102.61 -165.98 1.23 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.793 -0.828 . . . . 0.0 110.315 179.783 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 31.45 21.37 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.131 0.491 . . . . 0.0 111.051 -179.592 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -170.72 -54.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.99 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.15 -47.4 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.61 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.03 -41.35 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.437 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -64.61 -34.63 78.73 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.077 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.72 11.78 8.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.602 -0.686 . . . . 0.0 111.694 179.501 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 m -102.51 -45.08 5.17 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.948 -1.095 . . . . 0.0 110.116 179.719 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 t -56.84 -38.77 73.13 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.807 -0.558 . . . . 0.0 111.712 -179.792 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.66 -20.97 66.61 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.637 -0.664 . . . . 0.0 111.886 -179.923 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.48 118.43 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.208 -0.932 . . . . 0.0 109.991 179.932 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.501 ' CD2' ' HB2' ' A' ' 16' ' ' LEU . 3.3 t60 -147.46 84.6 7.1 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.721 -0.612 . . . . 0.0 110.131 179.761 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.7 -27.24 68.51 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 O-C-N 123.824 1.434 . . . . 0.0 110.935 179.858 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.49 -44.81 95.47 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.494 0.664 . . . . 0.0 109.442 179.397 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.501 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -66.25 -41.27 90.22 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.294 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.4 mt -60.19 -42.15 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.502 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -63.64 -41.11 98.28 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.677 -0.64 . . . . 0.0 109.854 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.5 m -61.54 -42.94 99.57 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.471 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.09 -37.92 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.989 -0.444 . . . . 0.0 109.903 179.534 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.2 m -64.64 -39.57 93.94 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.208 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -61.93 -44.15 97.37 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.97 -41.59 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.7 tp -57.82 -41.21 81.77 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.279 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.98 -30.67 71.27 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.249 0.547 . . . . 0.0 109.994 179.099 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.95 -0.65 49.58 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.595 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.3 mt -105.11 -45.87 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.895 . . . . 0.0 110.002 179.908 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.0 mt -73.58 -38.37 65.18 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.743 -0.598 . . . . 0.0 111.581 -179.673 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.44 -65.98 3.13 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.845 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.14 38.19 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.407 1.404 . . . . 0.0 111.222 179.882 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.06 -45.41 67.14 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.387 -0.821 . . . . 0.0 110.016 179.822 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -80.66 -37.08 31.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.755 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.06 -34.26 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.718 -0.613 . . . . 0.0 109.962 179.682 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.99 14.12 4.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.663 -0.648 . . . . 0.0 111.232 179.396 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -134.13 26.64 3.87 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.304 -0.873 . . . . 0.0 110.612 179.847 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.17 101.54 12.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.297 -0.877 . . . . 0.0 109.783 179.779 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.97 52.94 25.51 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 15.8 tt -70.31 136.77 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.748 -0.854 . . . . 0.0 110.8 -179.97 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.0 p -132.58 32.72 3.85 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.07 0.462 . . . . 0.0 109.948 179.88 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 117.797 -1.097 . . . . 0.0 109.753 -179.746 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.599 ' HA ' HD12 ' A' ' 20' ' ' ILE . 64.4 mt -61.76 -41.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.904 -0.498 . . . . 0.0 109.989 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.61 -42.61 88.58 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.2 m -62.35 -39.43 93.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 17' ' ' ILE . 68.0 mt -63.46 -43.35 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 m -58.91 -42.04 88.68 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -61.8 -47.28 85.85 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.89 -33.62 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.597 ' O ' HG22 ' A' ' 27' ' ' ILE . 2.9 tp -56.06 -43.24 77.73 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.835 -0.541 . . . . 0.0 109.621 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.65 -30.62 68.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.732 -0.605 . . . . 0.0 110.12 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.19 -7.23 59.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 24' ' ' LEU . 7.3 tt . . . . . 0 N--CA 1.502 2.162 0 O-C-N 121.433 -0.792 . . . . 0.0 111.562 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.3 tp . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.6 -42.19 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -45.12 86.19 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.098 -0.376 . . . . 0.0 110.445 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 m -57.77 -42.09 83.32 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.69 -42.88 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.782 -0.574 . . . . 0.0 109.586 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -60.26 -41.46 93.29 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.732 -0.605 . . . . 0.0 110.088 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -58.65 -38.04 77.27 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.663 HG22 HD12 ' A' ' 27' ' ' ILE . 25.5 mm -85.5 -29.06 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.85 -46.77 81.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.669 -0.645 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.86 -27.68 68.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.475 -0.766 . . . . 0.0 110.486 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.73 -31.69 57.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.309 0.576 . . . . 0.0 109.677 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 23' ' ' ILE . 70.0 mt . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.91 -35.63 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -71.68 -33.41 68.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.79 -0.569 . . . . 0.0 110.164 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.7 m -73.28 -42.13 62.81 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.0 110.412 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -64.53 -44.69 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.827 -0.545 . . . . 0.0 110.982 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.3 t -64.5 -30.48 71.51 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.242 -0.911 . . . . 0.0 110.746 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.297 -0.877 . . . . 0.0 109.315 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.682 HG22 HG13 ' A' ' 27' ' ' ILE . 52.4 mt -98.17 10.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.788 -0.57 . . . . 0.0 110.597 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.18 -42.7 86.61 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.753 -1.217 . . . . 0.0 110.941 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.5 7.68 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.457 -0.777 . . . . 0.0 110.702 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.54 14.87 11.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.627 -0.671 . . . . 0.0 109.769 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.682 HG13 HG22 ' A' ' 23' ' ' ILE . 34.7 mt . . . . . 0 N--CA 1.497 1.921 0 O-C-N 121.554 -0.717 . . . . 0.0 109.443 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -61.16 -31.28 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -70.03 -45.39 67.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.698 -0.626 . . . . 0.0 109.966 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.8 m -70.17 -42.99 71.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.705 -0.622 . . . . 0.0 109.756 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.2 mm -65.82 -48.28 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 0.0 110.219 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.42 ' O ' HD23 ' A' ' 25' ' ' LEU . 2.9 t -63.5 -30.22 71.37 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.313 0.96 . . . . 0.0 110.878 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -40.24 93.01 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.867 0.758 . . . . 0.0 109.223 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -31.52 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.09 -49.32 74.16 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.833 -0.542 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 21' ' ' THR . 2.9 pp -70.23 -11.32 60.81 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.575 -0.703 . . . . 0.0 111.927 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.28 -1.07 48.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.32 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 179.926 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.3 mt -72.41 -27.54 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.69 -39.61 70.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.953 . . . . 0.0 109.504 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.4 m -71.98 -39.2 69.47 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.72 -0.612 . . . . 0.0 110.252 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 17' ' ' ILE . 1.9 tp -60.32 -26.12 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.414 -0.803 . . . . 0.0 110.862 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -60.74 -41.69 95.89 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.492 -0.755 . . . . 0.0 109.339 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -63.61 -45.71 89.07 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 20' ' ' ILE . 6.2 mt -61.09 -40.73 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -61.45 -38.58 87.72 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 mt -76.96 -3.49 39.15 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.518 . . . . 0.0 111.365 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.28 -11.63 15.96 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.636 -0.665 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.612 -0.68 . . . . 0.0 109.568 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.8 mp -74.06 -23.41 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.555 -0.715 . . . . 0.0 111.193 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -88.92 -42.69 11.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.963 -1.085 . . . . 0.0 108.748 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.8 m -64.81 -30.17 71.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.926 -0.484 . . . . 0.0 110.844 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 17' ' ' ILE . 9.0 tp -55.08 -36.34 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.417 -0.802 . . . . 0.0 110.243 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -68.7 -41.55 78.99 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -42.57 99.36 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -62.24 -38.24 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -60.16 -40.74 90.98 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -4.18 46.63 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.731 -0.605 . . . . 0.0 110.876 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.42 5.1 14.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.451 -0.781 . . . . 0.0 111.036 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.445 ' O ' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.47 -0.768 . . . . 0.0 110.4 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.14 -40.92 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.39 -23.43 62.6 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.013 -0.429 . . . . 0.0 111.056 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.0 m -100.48 -43.56 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.431 -0.793 . . . . 0.0 110.64 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 20' ' ' ILE . 20.4 mm -73.42 -56.16 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.593 -0.692 . . . . 0.0 111.676 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -58.12 -35.42 71.45 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 119.203 0.911 . . . . 0.0 111.258 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -40.25 92.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.59 -0.694 . . . . 0.0 110.165 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.2 mt -81.0 -36.99 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -61.49 -47.35 86.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.673 -0.642 . . . . 0.0 109.773 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -20.91 65.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.642 -0.661 . . . . 0.0 111.195 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.68 -17.94 39.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.686 -0.634 . . . . 0.0 111.492 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.499 1.978 0 O-C-N 121.768 -0.582 . . . . 0.0 109.778 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 21' ' ' THR . 1.6 mp -67.1 -37.87 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.58 -34.49 72.78 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -69.26 -45.75 68.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.76 -41.05 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.872 -0.517 . . . . 0.0 109.607 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 17' ' ' ILE . 72.9 p -64.91 -30.3 71.29 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -64.29 -42.18 96.52 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.5 -39.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -64.34 -39.55 94.11 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.316 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.06 -28.08 66.22 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.779 -0.575 . . . . 0.0 110.5 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.8 -16.71 60.7 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.746 0.308 . . . . 0.0 111.608 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.3 mt . . . . . 0 N--CA 1.498 1.949 0 O-C-N 121.707 -0.621 . . . . 0.0 110.437 -179.849 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' O ' HD13 ' A' ' 20' ' ' ILE . 28.3 tp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.5 -48.7 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.621 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -44.25 69.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.632 -0.668 . . . . 0.0 110.763 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -58.45 -41.53 85.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.449 -0.782 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 16' ' ' LEU . 1.3 mp -64.54 -51.31 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.66 -0.65 . . . . 0.0 110.266 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -65.28 -33.12 75.23 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.377 -0.827 . . . . 0.0 110.52 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -66.08 -46.09 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.46 -40.69 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -36.4 79.26 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.724 -0.61 . . . . 0.0 109.439 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.27 -4.04 58.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.751 -0.593 . . . . 0.0 110.991 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.62 14.26 24.63 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 110.257 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.1 mm . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.33 -0.856 . . . . 0.0 109.311 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 20' ' ' ILE . 9.0 mm -61.23 -27.46 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -91.12 -36.06 14.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 23' ' ' ILE . 7.3 m -76.67 -26.56 54.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.716 -0.615 . . . . 0.0 110.674 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 17' ' ' ILE . 9.5 tp -52.17 -39.78 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.505 -0.747 . . . . 0.0 111.508 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.6 p -63.73 -44.22 94.2 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -66.82 -44.29 81.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 19' ' ' THR . 27.9 mm -62.87 -35.28 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.871 -0.518 . . . . 0.0 109.723 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.75 -42.93 84.97 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.696 -0.627 . . . . 0.0 110.119 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.97 -8.07 56.08 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.744 -0.598 . . . . 0.0 111.292 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.47 1.73 41.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.622 -0.673 . . . . 0.0 110.767 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.704 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.25 -29.22 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.43 -36.12 63.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.99 -0.444 . . . . 0.0 110.436 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.7 m -73.57 -48.78 30.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.1 mm -54.89 -49.78 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.787 -0.571 . . . . 0.0 111.402 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -62.91 -34.7 78.0 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.627 -0.67 . . . . 0.0 110.54 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -68.0 -41.29 82.5 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.628 -0.67 . . . . 0.0 109.837 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.96 -38.63 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.78 -41.31 95.31 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.63 -17.02 60.76 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.071 -0.393 . . . . 0.0 111.072 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.0 12.62 29.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.841 -0.537 . . . . 0.0 111.204 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.774 . . . . 0.0 109.491 179.832 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.733 ' HA ' HD12 ' A' ' 20' ' ' ILE . 17.1 mm -53.97 -41.79 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.983 -0.448 . . . . 0.0 110.395 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.72 -41.55 86.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.794 -0.566 . . . . 0.0 109.972 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.5 m -64.73 -43.84 92.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.78 -0.575 . . . . 0.0 109.578 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -58.41 -44.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.663 -0.648 . . . . 0.0 109.763 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.4 m -62.83 -42.83 99.89 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.739 -0.6 . . . . 0.0 109.802 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -44.14 97.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.836 -0.54 . . . . 0.0 110.007 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mm -62.1 -40.03 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.31 -43.21 88.06 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.3 -28.86 67.55 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.972 0.415 . . . . 0.0 110.171 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.34 60.77 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.484 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 19' ' ' THR . 4.1 mp . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.792 ' HA ' HD12 ' A' ' 20' ' ' ILE . 25.5 mm -59.5 -38.12 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -65.89 -36.81 84.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.113 -0.367 . . . . 0.0 110.636 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -76.53 -25.49 54.18 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.358 -0.839 . . . . 0.0 111.546 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 17' ' ' ILE . 44.2 mt -58.3 -48.88 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.417 -0.802 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.3 p -65.32 -36.5 84.24 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.749 -0.594 . . . . 0.0 109.898 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -45.37 93.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 90.1 mt -62.58 -37.06 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.96 -42.14 97.71 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.697 -0.627 . . . . 0.0 110.538 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.71 5.42 51.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.648 . . . . 0.0 111.305 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 27' ' ' ILE . 80.1 mt . . . . . 0 N--CA 1.504 2.274 0 O-C-N 121.135 -0.978 . . . . 0.0 111.279 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.3 mt -59.11 -42.55 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.29 -39.13 85.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -61.27 -45.1 95.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.95 -0.469 . . . . 0.0 109.916 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.65 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.756 -0.59 . . . . 0.0 109.452 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.0 m -61.09 -40.53 94.08 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.592 -0.693 . . . . 0.0 109.41 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -63.21 -45.58 91.02 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.818 -0.551 . . . . 0.0 109.695 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.76 -39.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.4 -42.53 82.41 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.845 -0.535 . . . . 0.0 109.635 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 tt -67.45 -35.65 79.63 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.235 0.541 . . . . 0.0 110.011 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.43 -8.51 54.29 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.536 -0.728 . . . . 0.0 109.668 179.738 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 20' ' ' ILE . 2.8 tt . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.7 mm -60.16 -38.75 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.56 -32.15 73.53 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.697 -0.627 . . . . 0.0 110.678 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 m -85.4 -49.45 8.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.716 -0.615 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.404 HD13 HD23 ' A' ' 16' ' ' LEU . 1.2 mp -58.99 -43.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -60.7 -39.05 87.05 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -44.62 88.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.698 -0.626 . . . . 0.0 109.58 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.93 -40.64 96.2 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.583 -0.698 . . . . 0.0 109.166 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 25' ' ' LEU . 2.6 mm? -68.23 -22.56 64.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.838 -0.539 . . . . 0.0 110.496 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.02 -11.36 53.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.157 -0.339 . . . . 0.0 111.396 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 27' ' ' ILE . 63.3 mt . . . . . 0 N--CA 1.501 2.11 0 O-C-N 121.572 -0.705 . . . . 0.0 110.051 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 tp . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 17' ' ' ILE . 3.1 mm -57.09 -35.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -87.01 -33.81 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -71.23 -40.23 71.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.474 -0.766 . . . . 0.0 109.832 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 18.7 mm -65.59 -44.97 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.747 -0.595 . . . . 0.0 109.922 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 p -63.7 -39.37 94.15 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.811 -0.556 . . . . 0.0 110.691 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -59.18 -47.06 86.7 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.715 -0.616 . . . . 0.0 109.63 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.92 -29.1 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -57.71 -47.75 81.52 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.22 -33.39 73.41 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.298 0.571 . . . . 0.0 110.377 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.6 62.42 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.594 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 27' ' ' ILE . 60.8 mt . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.851 -0.531 . . . . 0.0 109.724 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.831 ' HA ' HD12 ' A' ' 20' ' ' ILE . 4.8 mt -62.03 -38.66 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -61.14 -28.52 69.17 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.819 -0.551 . . . . 0.0 110.686 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.3 m -88.98 -26.56 21.42 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.305 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.831 HD12 ' HA ' ' A' ' 17' ' ' ILE . 70.1 mt -60.48 -45.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.404 -0.81 . . . . 0.0 109.131 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.542 HG23 ' HD3' ' A' ' 22' ' ' LYS . 8.9 t -60.58 -33.54 72.86 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.805 -0.56 . . . . 0.0 109.812 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.542 ' HD3' HG23 ' A' ' 21' ' ' THR . 0.1 OUTLIER -70.69 -48.43 54.79 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.77 -34.18 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -40.28 78.13 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -12.28 59.97 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.973 -0.454 . . . . 0.0 111.276 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.01 8.63 28.42 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.784 -0.572 . . . . 0.0 110.942 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 0.0 109.75 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.538 ' HA ' HD12 ' A' ' 20' ' ' ILE . 42.4 mm -61.31 -39.18 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -45.42 93.1 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.808 -0.557 . . . . 0.0 110.223 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.8 m -60.81 -39.0 87.28 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.762 -0.586 . . . . 0.0 110.539 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 17' ' ' ILE . 45.4 mt -65.35 -44.89 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.834 -0.541 . . . . 0.0 109.595 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.7 m -64.1 -39.11 93.35 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.717 -0.614 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -60.85 -45.66 93.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.721 -0.612 . . . . 0.0 109.429 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.19 -40.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -42.18 86.72 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 25' ' ' LEU . 33.7 mt -78.53 -1.78 35.56 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.787 -0.571 . . . . 0.0 111.435 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.97 13.0 20.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.772 . . . . 0.0 110.3 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.4 mt . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.356 -0.84 . . . . 0.0 109.596 179.878 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 N--CA 1.501 2.075 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 mm -63.73 -39.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.22 -38.82 84.53 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -65.62 -43.07 90.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.81 -42.46 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -59.81 -41.65 91.71 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.706 -0.621 . . . . 0.0 109.75 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -43.89 94.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.793 -0.567 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 23' ' ' ILE . 30.4 mm -62.1 -38.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 tp -61.34 -40.5 94.49 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.436 ' HA ' HD13 ' A' ' 25' ' ' LEU . 3.3 mm? -66.41 -36.02 81.78 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.3 68.68 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.197 0.522 . . . . 0.0 110.772 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.501 2.081 0 O-C-N 122.051 -0.406 . . . . 0.0 110.367 179.632 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 N--CA 1.499 1.979 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.39 -41.2 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -60.58 -36.65 79.03 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.912 -0.492 . . . . 0.0 111.072 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -85.67 -44.35 12.65 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 110.555 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mt -60.06 -40.98 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.959 -0.463 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -65.52 -31.13 72.02 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 119.581 1.082 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.82 -36.38 59.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.39 -0.819 . . . . 0.0 109.612 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 23' ' ' ILE . 46.2 mt -100.93 9.51 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 110.647 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 tp -58.16 -48.86 78.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.818 -1.176 . . . . 0.0 109.625 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -78.82 -14.03 59.48 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.907 -0.495 . . . . 0.0 110.906 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.55 21.96 15.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 111.571 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.198 0 O-C-N 121.307 -0.871 . . . . 0.0 111.305 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 20' ' ' ILE . 63.1 mt -59.38 -37.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.161 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -65.26 -38.6 90.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.912 -0.493 . . . . 0.0 109.925 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.1 m -65.04 -43.12 93.4 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.75 -0.594 . . . . 0.0 109.503 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 17' ' ' ILE . 14.4 mt -61.33 -41.94 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.957 -0.464 . . . . 0.0 109.749 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.6 m -65.08 -40.0 94.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.597 -0.689 . . . . 0.0 110.155 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -57.48 -45.02 85.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.962 -0.461 . . . . 0.0 109.89 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -38.19 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -59.18 -49.6 77.23 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.442 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -17.03 62.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.82 -0.55 . . . . 0.0 111.31 179.422 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.03 2.18 56.51 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.807 -0.558 . . . . 0.0 111.184 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.4 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.449 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.506 ' HA ' HG22 ' A' ' 20' ' ' ILE . 37.1 mt -65.39 -38.65 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.67 -26.32 67.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.686 -0.634 . . . . 0.0 110.692 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -96.46 -41.96 8.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.689 -0.632 . . . . 0.0 109.963 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 17' ' ' ILE . 9.0 tt -57.39 -33.37 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.717 -0.614 . . . . 0.0 111.254 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.8 p -63.49 -43.25 97.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.498 -0.751 . . . . 0.0 109.168 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -63.92 -35.68 81.47 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.519 HG22 HD12 ' A' ' 27' ' ' ILE . 33.3 mm -75.48 -40.9 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.59 -43.62 93.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.48 -32.99 74.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.797 -0.564 . . . . 0.0 110.44 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.84 -30.14 63.77 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.239 0.542 . . . . 0.0 110.533 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 27' ' ' ILE . 47.7 mt . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mt -71.39 -36.36 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.226 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.6 -34.98 71.73 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.92 -0.488 . . . . 0.0 109.696 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.2 m -75.68 -41.13 54.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 20' ' ' ILE . 23.4 mm -64.8 -40.31 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.995 -0.441 . . . . 0.0 110.271 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.8 p -64.73 -37.21 86.82 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.497 -0.752 . . . . 0.0 109.741 179.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -45.02 93.99 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -65.13 -37.14 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.64 -40.85 89.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.205 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 25' ' ' LEU . 2.2 mm? -68.26 -22.11 64.78 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.871 -0.518 . . . . 0.0 110.593 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.82 5.78 47.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.09 -0.382 . . . . 0.0 110.817 179.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm . . . . . 0 N--CA 1.499 2.017 0 O-C-N 121.496 -0.752 . . . . 0.0 109.902 -179.884 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 N--CA 1.5 2.069 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.83 -46.48 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -55.07 -38.24 67.8 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.834 -0.541 . . . . 0.0 111.009 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -78.57 -49.37 13.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.575 -0.703 . . . . 0.0 110.594 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.89 -45.63 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.733 -0.604 . . . . 0.0 110.005 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.7 m -59.55 -32.75 70.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.0 109.716 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.44 -35.64 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.038 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -61.97 -45.18 94.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.369 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -66.2 -29.54 69.83 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.919 -0.488 . . . . 0.0 110.943 179.458 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.81 -17.98 60.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.077 -0.39 . . . . 0.0 111.921 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.9 mt . . . . . 0 N--CA 1.499 1.99 0 O-C-N 121.823 -0.548 . . . . 0.0 110.593 -179.977 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 16' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mm -64.82 -42.29 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -60.3 -33.37 72.26 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.6 m -68.67 -43.25 76.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.46 ' HA ' HD12 ' A' ' 23' ' ' ILE . 37.1 mm -66.58 -42.31 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.079 -0.388 . . . . 0.0 110.037 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.3 p -63.54 -37.94 89.25 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.455 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.42 -40.92 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.738 -0.601 . . . . 0.0 109.546 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 20' ' ' ILE . 14.8 mt -74.01 -43.57 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -44.71 89.05 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.86 -0.525 . . . . 0.0 109.795 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.22 -5.08 45.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.808 -0.558 . . . . 0.0 111.298 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.52 9.27 21.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.613 -0.679 . . . . 0.0 110.53 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 0.0 109.931 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.6 mt -57.49 -44.54 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.351 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.94 -42.93 99.67 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.131 -0.356 . . . . 0.0 110.119 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.7 m -59.04 -40.91 86.53 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.45 HG22 HD23 ' A' ' 24' ' ' LEU . 49.2 mt -65.17 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 m -60.36 -41.13 93.04 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.633 -0.667 . . . . 0.0 109.783 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -63.62 -41.34 98.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.457 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.454 HG22 HD12 ' A' ' 27' ' ' ILE . 32.5 mm -77.66 -26.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -57.91 -45.46 86.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.498 -0.751 . . . . 0.0 109.566 179.573 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -16.53 63.96 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.782 -0.574 . . . . 0.0 111.365 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.27 5.71 50.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.827 -0.545 . . . . 0.0 111.073 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.454 HD12 HG22 ' A' ' 23' ' ' ILE . 96.8 mt . . . . . 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 0.0 109.319 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.03 -45.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.648 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.94 82.21 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -62.98 -42.68 99.91 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.26 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.5 mm -60.62 -42.25 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -63.47 -38.81 92.58 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.712 -0.618 . . . . 0.0 109.646 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -60.08 -35.91 76.23 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.497 . . . . 0.0 109.851 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.47 -31.18 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.246 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.79 -45.68 93.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.651 -0.655 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.6 -13.07 61.94 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.925 179.356 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.26 -8.24 33.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.73 -0.606 . . . . 0.0 111.056 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 27' ' ' ILE . 39.3 mm . . . . . 0 N--CA 1.499 2.0 0 O-C-N 121.569 -0.707 . . . . 0.0 109.367 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.4 mm -54.37 -41.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 122.053 -0.405 . . . . 0.0 110.388 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -63.69 -38.65 91.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.713 -0.617 . . . . 0.0 110.171 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -65.41 -39.17 91.82 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.751 -0.593 . . . . 0.0 109.739 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.98 -43.96 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.602 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.8 m -58.75 -41.38 86.39 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.812 -0.555 . . . . 0.0 109.889 179.513 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.18 -35.8 74.19 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.931 -0.481 . . . . 0.0 110.456 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.78 -20.14 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.736 -0.603 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tp -57.98 -45.36 86.89 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.47 -29.32 70.36 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.846 -0.533 . . . . 0.0 110.037 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.62 -36.17 29.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.26 0.552 . . . . 0.0 110.208 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 27' ' ' ILE . 45.2 mm . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 121.438 0.637 . . . . 0.0 109.726 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.661 ' O ' HG22 ' A' ' 20' ' ' ILE . 12.6 mm -60.79 -35.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.674 -0.642 . . . . 0.0 109.597 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -75.85 -44.07 42.62 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m -66.24 -33.33 75.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.767 -0.583 . . . . 0.0 110.809 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 17' ' ' ILE . 2.5 tp -59.86 -34.24 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.13 -0.981 . . . . 0.0 110.098 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -65.62 -43.85 88.31 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -65.33 -44.15 88.73 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 23' ' ' ILE . 25.3 mm -63.61 -36.91 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.69 -38.84 79.12 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.612 -0.68 . . . . 0.0 110.121 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.95 -11.24 60.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.616 -0.678 . . . . 0.0 111.13 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.44 7.81 45.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.75 -0.594 . . . . 0.0 110.531 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.592 -0.693 . . . . 0.0 109.648 179.882 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.5 mt -58.14 -40.22 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -41.67 96.05 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.854 -0.529 . . . . 0.0 109.916 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -61.94 -41.7 98.26 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.532 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 17' ' ' ILE . 17.8 mt -63.68 -42.28 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.8 m -61.98 -33.95 75.25 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.487 -0.758 . . . . 0.0 110.022 179.483 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -69.12 -37.38 78.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 25.4 mt -102.63 6.03 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.786 -0.571 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -54.42 -50.12 68.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.852 -1.155 . . . . 0.0 110.626 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 25' ' ' LEU . 32.0 mt -68.32 -19.22 64.66 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.243 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.34 10.45 39.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.109 -0.369 . . . . 0.0 111.166 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 2.7 tt . . . . . 0 N--CA 1.501 2.09 0 O-C-N 121.249 -0.907 . . . . 0.0 111.905 -179.886 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 20' ' ' ILE . 7.7 mt -65.02 -30.54 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.751 -0.593 . . . . 0.0 109.706 179.462 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -88.43 -25.95 22.39 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.426 -0.796 . . . . 0.0 109.863 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.7 m -88.93 -21.57 23.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 0.0 110.503 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 17' ' ' ILE . 15.8 tt -53.49 -37.66 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 121.315 -0.865 . . . . 0.0 110.581 -179.994 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -71.01 -39.7 72.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -61.58 -36.12 79.76 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.294 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 20' ' ' ILE . 17.9 mt -74.3 -30.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.66 -0.65 . . . . 0.0 109.35 179.25 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 27' ' ' ILE . 11.0 tp -60.0 -41.21 91.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.701 -0.624 . . . . 0.0 110.297 179.739 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.68 2.59 28.94 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.503 -0.748 . . . . 0.0 110.701 179.034 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.2 10.89 13.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.515 -0.74 . . . . 0.0 110.355 179.294 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 24' ' ' LEU . 14.1 tt . . . . . 0 N--CA 1.499 1.977 0 O-C-N 121.605 -0.684 . . . . 0.0 109.987 179.848 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.832 ' HA ' HD12 ' A' ' 20' ' ' ILE . 71.7 mt -56.96 -45.03 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -44.56 94.63 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.736 -0.603 . . . . 0.0 109.601 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.484 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 2.4 m -61.23 -33.95 74.32 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.818 -0.551 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 17' ' ' ILE . 64.1 mt -60.43 -40.25 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.44 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -58.75 -39.49 81.1 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.251 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HD2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -64.89 -43.48 92.74 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.187 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 HD11 ' A' ' 27' ' ' ILE . 48.2 mm -71.31 -33.28 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.313 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.547 ' HA ' HD12 ' A' ' 27' ' ' ILE . 1.6 tp -55.56 -41.49 73.35 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.867 -0.521 . . . . 0.0 109.834 179.411 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 2.71 22.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.733 -0.604 . . . . 0.0 111.302 179.3 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.65 6.53 11.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.481 -0.762 . . . . 0.0 110.903 179.374 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 24' ' ' LEU . 28.1 mt . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 0.0 109.465 179.63 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mt -64.07 -38.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.321 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.46 -34.83 77.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.825 -0.547 . . . . 0.0 109.952 179.276 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.1 m -59.4 -42.62 92.19 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.788 -0.57 . . . . 0.0 109.912 179.637 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.44 -43.43 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.524 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.5 m -61.69 -39.78 92.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.682 -0.636 . . . . 0.0 109.85 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -60.52 -51.83 67.77 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.9 mt -63.48 -35.74 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.12 -41.18 92.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 179.341 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.35 -18.61 62.37 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.951 -0.468 . . . . 0.0 110.952 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.11 -1.63 57.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.861 -0.524 . . . . 0.0 111.522 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt . . . . . 0 N--CA 1.498 1.933 0 O-C-N 121.589 -0.695 . . . . 0.0 109.667 179.837 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 . . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.2 mp -62.19 -32.54 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.801 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -87.8 -39.32 14.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.3 m -69.39 -22.95 63.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.752 -0.592 . . . . 0.0 110.87 179.641 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 17' ' ' ILE . 2.1 tp -55.43 -36.0 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.044 0.838 . . . . 0.0 110.142 179.765 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.1 p -65.08 -42.91 93.67 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.081 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -67.54 -36.52 81.14 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.435 ' O ' HG12 ' A' ' 27' ' ' ILE . 71.1 mt -73.55 -36.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.56 -0.712 . . . . 0.0 109.827 179.605 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.6 tp -48.75 -49.8 36.7 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.619 -0.676 . . . . 0.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.49 -5.7 44.13 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.648 -0.658 . . . . 0.0 111.8 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -107.59 3.67 25.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.718 -0.614 . . . . 0.0 111.078 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 23' ' ' ILE . 22.6 mm . . . . . 0 N--CA 1.498 1.967 0 O-C-N 121.443 -0.786 . . . . 0.0 108.968 179.72 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.08 -47.44 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.677 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.98 -32.98 72.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.849 -0.532 . . . . 0.0 111.386 179.92 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -71.25 -42.95 68.15 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 80.9 mt -65.01 -42.58 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 179.913 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 p -65.25 -37.54 87.53 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.413 -0.804 . . . . 0.0 110.402 179.779 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.34 -46.43 64.17 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mm -65.79 -38.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.523 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 24' ' ' LEU . 1.8 tm? -60.1 -39.61 86.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.545 -0.722 . . . . 0.0 109.822 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.74 -22.47 37.26 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.359 -0.838 . . . . 0.0 111.026 179.582 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.47 12.34 14.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.842 -0.536 . . . . 0.0 111.438 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mm . . . . . 0 N--CA 1.498 1.966 0 O-C-N 121.301 -0.874 . . . . 0.0 109.993 179.744 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.7 mt -54.74 -39.38 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.946 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -62.04 -42.62 99.37 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.308 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -66.63 -39.77 88.45 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.789 HD12 ' HA ' ' A' ' 17' ' ' ILE . 81.4 mt -55.56 -39.15 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.623 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -42.37 82.92 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.698 -0.626 . . . . 0.0 109.509 179.488 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -68.84 -41.31 78.7 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.606 HG22 HD11 ' A' ' 27' ' ' ILE . 22.2 mm -75.97 -23.69 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.739 -0.6 . . . . 0.0 110.081 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.28 -42.52 70.1 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.486 -0.759 . . . . 0.0 109.784 179.67 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 25' ' ' LEU . 1.8 mm? -70.53 -11.46 60.94 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.885 -0.509 . . . . 0.0 110.935 179.146 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.38 13.0 30.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.456 179.192 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 23' ' ' ILE . 62.4 mt . . . . . 0 N--CA 1.502 2.167 0 O-C-N 121.322 -0.861 . . . . 0.0 111.042 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 16' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.904 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.4 mt -52.03 -41.87 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -42.8 99.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 0.0 110.068 179.628 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -66.85 -33.86 76.52 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.747 -0.596 . . . . 0.0 110.0 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 17' ' ' ILE . 86.9 mt -58.3 -43.39 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.253 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 m -69.09 -41.76 77.04 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.032 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -59.65 -46.03 90.25 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.514 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 27' ' ' ILE . 40.9 mm -82.09 -15.56 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.712 -0.617 . . . . 0.0 110.249 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HA ' HD12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -54.33 -45.63 72.7 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 179.664 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.01 -21.91 66.91 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.387 179.237 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.41 0.45 56.22 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.056 -0.402 . . . . 0.0 111.188 179.215 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 24' ' ' LEU . 55.2 mt . . . . . 0 N--CA 1.5 2.032 0 O-C-N 121.46 -0.775 . . . . 0.0 109.898 179.543 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.5 mm -63.8 -40.26 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.204 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.6 -36.47 71.79 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.5 m -73.62 -39.9 64.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.201 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -41.34 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.853 -0.53 . . . . 0.0 110.364 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 p -65.54 -36.49 83.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.473 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -58.83 -42.76 89.99 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.405 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -74.88 -35.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.025 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.79 -44.57 82.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.427 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -14.61 62.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.788 -0.57 . . . . 0.0 111.423 179.431 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.73 5.17 52.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.782 -0.574 . . . . 0.0 110.637 179.18 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.0 mt . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 0.0 110.246 179.99 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.26 -36.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.805 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -63.12 -34.61 77.98 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.085 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 m -78.77 -27.52 44.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.681 -0.637 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.18 -45.18 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.69 -0.631 . . . . 0.0 110.198 179.975 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -67.02 -33.86 76.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.636 -0.665 . . . . 0.0 110.018 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -68.47 -50.83 49.5 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.6 -23.27 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.748 -0.595 . . . . 0.0 109.808 179.204 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -55.77 -42.65 75.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.511 -0.743 . . . . 0.0 110.014 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.09 -24.62 63.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.585 -0.697 . . . . 0.0 110.664 179.552 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.62 -24.8 28.97 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.773 -0.58 . . . . 0.0 111.183 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 27' ' ' ILE . 50.1 mm . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 121.201 0.524 . . . . 0.0 110.457 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 20' ' ' ILE . 13.8 tp . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.8 -32.56 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.16 -39.73 28.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.897 -0.502 . . . . 0.0 109.676 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -61.37 -47.57 85.25 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.854 -0.529 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 16' ' ' LEU . 13.6 mt -58.5 -45.33 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -64.78 -33.3 75.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.825 -0.547 . . . . 0.0 110.541 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -68.46 -40.31 81.09 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.432 -0.793 . . . . 0.0 110.704 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.8 -36.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.786 -0.571 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.71 -44.27 93.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.522 -0.736 . . . . 0.0 109.727 179.644 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.31 -14.81 59.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.81 -0.556 . . . . 0.0 111.017 179.429 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.79 14.01 22.77 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.842 -0.536 . . . . 0.0 110.801 179.34 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 27' ' ' ILE . 12.0 mm . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.631 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.4 mt -60.19 -42.15 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.502 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -63.64 -41.11 98.28 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.677 -0.64 . . . . 0.0 109.854 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.5 m -61.54 -42.94 99.57 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.471 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.09 -37.92 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.989 -0.444 . . . . 0.0 109.903 179.534 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.2 m -64.64 -39.57 93.94 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.208 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -61.93 -44.15 97.37 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.97 -41.59 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 27' ' ' ILE . 9.7 tp -57.82 -41.21 81.77 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.279 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.98 -30.67 71.27 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.249 0.547 . . . . 0.0 109.994 179.099 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.95 -0.65 49.58 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.595 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 24' ' ' LEU . 48.3 mt . . . . . 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.895 . . . . 0.0 110.002 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.48 -169.17 1.41 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.661 -0.906 . . . . 0.0 109.744 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.53 36.7 27.68 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.462 0.649 . . . . 0.0 111.206 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.62 -50.13 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.03 -42.35 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.0 mm -58.53 -41.42 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 7' ' ' LEU . 1.8 tm? -66.8 -40.01 87.96 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.29 -27.92 61.82 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.727 -0.608 . . . . 0.0 111.462 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.708 HG23 HG21 ' A' ' 17' ' ' ILE . 2.3 m -66.71 -43.34 84.54 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.839 -0.538 . . . . 0.0 109.659 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 14' ' ' PRO . 19.4 p -84.13 -18.47 36.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.397 -0.814 . . . . 0.0 111.237 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.74 -33.49 12.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.228 -0.92 . . . . 0.0 111.577 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.4 mm -107.92 105.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.293 -0.879 . . . . 0.0 110.504 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 53.6 61.4 10.63 Favored Pre-proline 0 N--CA 1.507 2.383 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.507 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 46.3 Cg_endo -70.31 -35.94 10.17 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 O-C-N 123.427 1.225 . . . . 0.0 111.354 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.03 -10.64 58.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.607 -0.683 . . . . 0.0 112.05 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.36 -43.78 5.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.376 -0.828 . . . . 0.0 109.712 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.708 HG21 HG23 ' A' ' 9' ' ' THR . 64.4 mt -61.76 -41.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.904 -0.498 . . . . 0.0 109.989 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.61 -42.61 88.58 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.2 m -62.35 -39.43 93.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 17' ' ' ILE . 68.0 mt -63.46 -43.35 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 m -58.91 -42.04 88.68 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -61.8 -47.28 85.85 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.89 -33.62 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.597 ' O ' HG22 ' A' ' 27' ' ' ILE . 2.9 tp -56.06 -43.24 77.73 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.835 -0.541 . . . . 0.0 109.621 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.65 -30.62 68.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.732 -0.605 . . . . 0.0 110.12 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.19 -7.23 59.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 24' ' ' LEU . 7.3 tt -76.48 -18.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.433 -0.792 . . . . 0.0 111.562 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -57.38 7.82 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.45 -0.781 . . . . 0.0 110.09 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 33' ' ' VAL . . . 77.35 83.26 0.54 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -62.54 -37.18 60.5 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 O-C-N 123.858 1.452 . . . . 0.0 110.395 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mp -75.05 -42.22 57.5 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.1 mmt -56.83 -35.67 69.09 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' GLY . 56.1 t -58.55 -30.98 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.55 13.09 10.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 0.0 111.267 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.65 ' HA ' HG21 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -137.79 25.74 2.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.198 -0.939 . . . . 0.0 110.441 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.13 103.63 16.23 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.065 -1.022 . . . . 0.0 109.011 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.12 48.77 37.56 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.65 HG21 ' HA ' ' A' ' 35' ' ' GLN . 1.6 pt -112.14 164.86 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 122.323 -0.516 . . . . 0.0 110.797 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 m 55.43 69.58 0.72 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.611 0.719 . . . . 0.0 110.433 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.687 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.514 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -110.54 23.72 13.88 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.667 -0.902 . . . . 0.0 111.739 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.58 -51.38 3.21 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.57 76.1 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.013 -0.429 . . . . 0.0 110.372 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -62.8 -43.55 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.99 -44.09 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.41 -33.83 76.78 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.763 -0.586 . . . . 0.0 109.655 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tp -81.3 8.53 8.89 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.723 -0.611 . . . . 0.0 111.521 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.4 m -105.1 -42.19 5.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.092 -1.005 . . . . 0.0 110.097 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.3 m -92.1 -34.82 14.21 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.65 -0.656 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.51 22.6 6.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.433 -0.792 . . . . 0.0 111.647 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.562 HD13 ' N ' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -71.05 140.32 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.324 -0.86 . . . . 0.0 110.06 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.562 ' N ' HD13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER 56.5 58.62 8.78 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 122.147 -0.345 . . . . 0.0 111.53 -179.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.59 -41.07 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 O-C-N 123.175 1.092 . . . . 0.0 111.411 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.13 -40.63 98.16 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.726 -0.609 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.25 -44.54 97.08 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.6 -42.19 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -45.12 86.19 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.098 -0.376 . . . . 0.0 110.445 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 m -57.77 -42.09 83.32 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.69 -42.88 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.782 -0.574 . . . . 0.0 109.586 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -60.26 -41.46 93.29 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.732 -0.605 . . . . 0.0 110.088 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -58.65 -38.04 77.27 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.663 HG22 HD12 ' A' ' 27' ' ' ILE . 25.5 mm -85.5 -29.06 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.85 -46.77 81.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.669 -0.645 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.723 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.9 pp -65.86 -27.68 68.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.475 -0.766 . . . . 0.0 110.486 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.73 -31.69 57.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.309 0.576 . . . . 0.0 109.677 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 23' ' ' ILE . 70.0 mt -114.42 56.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.723 HD12 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -100.17 -62.6 1.22 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.469 -0.77 . . . . 0.0 110.741 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.06 -56.42 0.45 Allowed Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.377 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -89.69 28.88 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.438 1.425 . . . . 0.0 112.33 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.02 -44.4 84.83 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.9 ttm -74.39 -34.77 63.4 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.51 -38.13 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.806 -0.559 . . . . 0.0 109.756 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.19 4.51 26.38 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.622 -0.674 . . . . 0.0 112.238 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.63 22.0 3.36 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.117 -0.99 . . . . 0.0 111.093 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.36 92.37 7.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.268 -0.895 . . . . 0.0 109.32 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.43 -42.38 1.93 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.4 mt -79.84 77.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.654 -0.909 . . . . 0.0 109.401 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -138.77 44.78 2.05 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.657 -0.652 . . . . 0.0 109.914 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.5 mptt . . . . . 0 N--CA 1.505 2.278 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.825 179.867 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.51 -176.91 3.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.794 -0.827 . . . . 0.0 110.068 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.59 33.26 23.03 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.273 0.559 . . . . 0.0 110.815 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.62 -53.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.2 t -60.2 -38.51 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 122.05 -0.406 . . . . 0.0 110.108 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 89.4 mt -60.56 -44.48 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.5 tp -67.65 -35.19 78.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.758 -0.589 . . . . 0.0 110.196 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 12' ' ' ILE . 1.5 tp -75.31 1.44 13.69 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.279 -0.888 . . . . 0.0 112.216 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 m -101.88 -50.91 3.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.18 -0.95 . . . . 0.0 109.166 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.9 m -96.01 -35.67 11.31 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.681 -0.637 . . . . 0.0 111.106 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.05 43.74 1.05 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.342 -0.849 . . . . 0.0 110.817 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.447 HD12 ' O ' ' A' ' 8' ' ' LEU . 10.8 tt -85.79 139.76 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.714 -0.616 . . . . 0.0 110.509 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 19.7 p-80 -147.66 95.37 4.27 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.584 -0.697 . . . . 0.0 110.002 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 45.6 Cg_endo -68.13 -25.97 36.97 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.39 1.393 . . . . 0.0 111.973 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.3 -28.52 42.77 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -42.01 62.77 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.735 -0.603 . . . . 0.0 109.581 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 14' ' ' PRO . 2.5 mp -62.91 -35.63 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -71.68 -33.41 68.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.79 -0.569 . . . . 0.0 110.164 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.7 m -73.28 -42.13 62.81 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.0 110.412 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -64.53 -44.69 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.827 -0.545 . . . . 0.0 110.982 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.3 t -64.5 -30.48 71.51 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.242 -0.911 . . . . 0.0 110.746 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.297 -0.877 . . . . 0.0 109.315 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.682 HG22 HG13 ' A' ' 27' ' ' ILE . 52.4 mt -98.17 10.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.788 -0.57 . . . . 0.0 110.597 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.18 -42.7 86.61 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.753 -1.217 . . . . 0.0 110.941 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HG ' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -84.5 7.68 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.457 -0.777 . . . . 0.0 110.702 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.54 14.87 11.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.627 -0.671 . . . . 0.0 109.769 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.682 HG13 HG22 ' A' ' 23' ' ' ILE . 34.7 mt -118.29 -44.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.554 -0.717 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mp -87.82 -69.02 0.72 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.663 -0.648 . . . . 0.0 109.586 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.03 -53.31 0.79 Allowed Glycine 0 N--CA 1.496 2.696 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.865 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -92.47 21.48 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 121.695 1.597 . . . . 0.0 113.073 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.433 HD22 ' HG ' ' A' ' 25' ' ' LEU . 4.7 tt -61.83 -43.4 98.93 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.289 -0.882 . . . . 0.0 109.977 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.7 ttm -73.91 -39.94 63.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.763 -0.586 . . . . 0.0 109.539 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.97 -28.4 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.79 -0.569 . . . . 0.0 110.551 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -92.93 10.4 31.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.382 -0.824 . . . . 0.0 112.069 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -147.46 26.69 1.04 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.246 -0.909 . . . . 0.0 111.425 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.48 -56.58 2.16 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.034 -1.041 . . . . 0.0 110.28 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.72 55.86 0.65 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 38' ' ' ILE . 5.3 tp -87.22 67.96 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.797 -0.826 . . . . 0.0 111.148 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.7 p -108.06 -32.85 7.37 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.135 -0.978 . . . . 0.0 111.255 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.9 mttp . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.034 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptt85 -138.88 170.73 15.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.969 . . . . 0.0 110.612 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 t70 57.56 37.68 27.66 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.671 0.748 . . . . 0.0 110.668 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.71 -50.09 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.68 -42.42 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.17 -45.74 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.2 tp -63.5 -37.1 86.0 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -42.77 99.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.683 -0.635 . . . . 0.0 110.307 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.0 m -70.14 -34.46 73.07 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.564 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.2 m -62.71 -40.25 96.59 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.728 -0.607 . . . . 0.0 110.385 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.604 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -89.37 -45.63 9.33 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.709 -0.619 . . . . 0.0 110.264 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 11' ' ' ALA . 1.4 tp 54.52 22.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 56.19 75.18 0.61 Allowed Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.481 -0.762 . . . . 0.0 110.766 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.53 -169.62 0.63 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 O-C-N 123.442 1.233 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 58.93 44.53 16.41 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 122.329 1.061 . . . . 0.0 110.384 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.51 -58.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -61.16 -31.28 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -70.03 -45.39 67.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.698 -0.626 . . . . 0.0 109.966 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.8 m -70.17 -42.99 71.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.705 -0.622 . . . . 0.0 109.756 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.2 mm -65.82 -48.28 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 0.0 110.219 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.42 ' O ' HD23 ' A' ' 25' ' ' LEU . 2.9 t -63.5 -30.22 71.37 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.313 0.96 . . . . 0.0 110.878 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -40.24 93.01 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.867 0.758 . . . . 0.0 109.223 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -31.52 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.09 -49.32 74.16 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.833 -0.542 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 21' ' ' THR . 2.9 pp -70.23 -11.32 60.81 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.575 -0.703 . . . . 0.0 111.927 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.28 -1.07 48.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.32 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.2 mt -119.38 -47.53 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.03 -44.85 75.03 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.14 -0.35 . . . . 0.0 111.336 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.47 79.83 0.58 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -63.17 -33.35 72.6 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 O-C-N 123.919 1.484 . . . . 0.0 111.934 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 tp -61.9 -42.09 98.66 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.465 -0.772 . . . . 0.0 109.609 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 22.0 mtp -79.85 -41.73 25.71 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -59.66 -34.51 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.839 -0.538 . . . . 0.0 110.195 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tp -79.1 5.91 10.81 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.408 -0.808 . . . . 0.0 111.677 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -127.71 26.24 5.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.209 -0.932 . . . . 0.0 110.564 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.64 80.1 8.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.14 -0.975 . . . . 0.0 109.304 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.74 35.67 66.59 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.0 mm -111.13 111.85 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.469 -1.018 . . . . 0.0 109.842 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.6 p 41.31 59.14 2.44 Favored 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 123.284 0.633 . . . . 0.0 111.996 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.0 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.552 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.25 25.59 6.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.768 -0.843 . . . . 0.0 110.704 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.0 -54.1 2.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.398 -0.814 . . . . 0.0 109.259 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.91 52.66 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.919 -0.488 . . . . 0.0 110.992 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.3 -48.47 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.553 -0.717 . . . . 0.0 110.135 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.579 ' O ' HG22 ' A' ' 9' ' ' THR . 1.9 mp -65.18 -35.69 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tp -69.38 -30.28 68.24 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.551 -0.718 . . . . 0.0 109.556 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.77 10.45 13.59 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.652 -0.655 . . . . 0.0 112.178 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 6' ' ' ILE . 1.2 t -111.45 -31.09 7.14 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.908 -1.12 . . . . 0.0 111.238 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.2 m -61.55 -31.07 71.08 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.464 -0.773 . . . . 0.0 111.469 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.03 -32.42 66.16 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.825 -0.547 . . . . 0.0 111.003 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -80.17 122.83 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 56.41 59.81 8.35 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 122.228 -0.295 . . . . 0.0 110.813 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.53 -20.12 27.5 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 O-C-N 123.35 1.184 . . . . 0.0 112.072 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -57.12 -41.58 79.28 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.394 -0.816 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.83 -41.98 95.32 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.3 mt -72.41 -27.54 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.69 -39.61 70.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.953 . . . . 0.0 109.504 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.4 m -71.98 -39.2 69.47 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.72 -0.612 . . . . 0.0 110.252 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 17' ' ' ILE . 1.9 tp -60.32 -26.12 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.414 -0.803 . . . . 0.0 110.862 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -60.74 -41.69 95.89 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.492 -0.755 . . . . 0.0 109.339 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -63.61 -45.71 89.07 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 20' ' ' ILE . 6.2 mt -61.09 -40.73 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -61.45 -38.58 87.72 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 mt -76.96 -3.49 39.15 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.518 . . . . 0.0 111.365 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.28 -11.63 15.96 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.636 -0.665 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.3 mt -98.78 -45.13 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.612 -0.68 . . . . 0.0 109.568 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.1 -26.26 66.62 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.976 -0.453 . . . . 0.0 111.492 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.47 -63.32 5.23 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.02 0.01 9.43 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 O-C-N 123.663 1.349 . . . . 0.0 112.135 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -50.82 72.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.03 -1.044 . . . . 0.0 110.219 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.3 ttt -61.79 -37.47 84.5 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.703 -0.623 . . . . 0.0 110.151 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.7 t -61.99 -33.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 34' ' ' LEU . 3.1 mm? -82.07 5.07 20.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.608 -0.683 . . . . 0.0 111.43 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -124.34 21.95 8.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.367 -0.833 . . . . 0.0 110.857 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.17 70.89 10.92 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.162 -0.961 . . . . 0.0 109.425 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.5 75.67 1.26 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 38' ' ' ILE . 5.5 tp -78.55 61.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.004 0.907 . . . . 0.0 110.522 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.45 59.99 0.95 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.314 -0.866 . . . . 0.0 109.697 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.541 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.44 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -108.3 42.94 1.29 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.696 -0.885 . . . . 0.0 110.304 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -104.92 -45.59 4.52 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.481 -0.762 . . . . 0.0 110.167 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.34 -33.73 65.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.874 -0.516 . . . . 0.0 111.815 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -71.48 -46.75 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.243 -0.91 . . . . 0.0 110.715 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.32 -42.22 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.642 -0.661 . . . . 0.0 109.448 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 tp -64.32 -37.77 88.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.717 -0.614 . . . . 0.0 109.938 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.28 -6.82 45.84 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.732 -0.605 . . . . 0.0 111.872 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.8 m -88.69 -52.07 5.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.232 -0.918 . . . . 0.0 109.473 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 91.1 m -89.1 -41.91 12.02 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.75 -0.594 . . . . 0.0 110.515 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.23 44.86 1.01 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.56 -0.712 . . . . 0.0 110.134 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.592 HG13 ' HD3' ' A' ' 14' ' ' PRO . 6.8 tp -65.54 130.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-O 121.159 0.504 . . . . 0.0 110.823 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.59 66.24 3.15 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.651 -0.656 . . . . 0.0 110.421 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.592 ' HD3' HG13 ' A' ' 12' ' ' ILE . 48.3 Cg_endo -72.06 -29.73 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 O-C-N 123.4 1.211 . . . . 0.0 111.267 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.51 -6.32 3.31 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.391 -0.818 . . . . 0.0 113.183 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -115.75 -49.93 2.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.052 -1.03 . . . . 0.0 109.656 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.8 mp -74.06 -23.41 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.555 -0.715 . . . . 0.0 111.193 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -88.92 -42.69 11.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.963 -1.085 . . . . 0.0 108.748 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.8 m -64.81 -30.17 71.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.926 -0.484 . . . . 0.0 110.844 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 17' ' ' ILE . 9.0 tp -55.08 -36.34 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.417 -0.802 . . . . 0.0 110.243 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -68.7 -41.55 78.99 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -42.57 99.36 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -62.24 -38.24 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -60.16 -40.74 90.98 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -4.18 46.63 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.731 -0.605 . . . . 0.0 110.876 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.42 5.1 14.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.451 -0.781 . . . . 0.0 111.036 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.445 ' O ' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -103.78 -30.87 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.47 -0.768 . . . . 0.0 110.4 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.5 mm? -67.67 -30.59 70.16 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.325 -0.859 . . . . 0.0 110.288 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.92 69.11 0.47 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.41 ' HG2' HD12 ' A' ' 31' ' ' LEU . 46.2 Cg_endo -69.54 -45.63 1.63 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 O-C-N 123.738 1.388 . . . . 0.0 111.029 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.41 HD12 ' HG2' ' A' ' 30' ' ' PRO . 1.2 mp -64.76 -38.96 92.77 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.79 -0.569 . . . . 0.0 109.703 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -45.52 93.99 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.28 -36.66 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.725 -0.609 . . . . 0.0 109.481 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mt -68.4 -14.9 63.33 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.801 -0.562 . . . . 0.0 112.279 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -122.3 15.93 10.57 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.607 -0.683 . . . . 0.0 111.465 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.46 -64.05 1.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.261 -0.899 . . . . 0.0 109.05 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -87.93 -37.35 7.9 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER 43.38 40.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 m -112.46 50.47 0.86 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.992 -1.068 . . . . 0.0 109.183 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 117.645 -1.169 . . . . 0.0 111.338 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.499 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -109.74 -161.55 0.76 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.649 -0.912 . . . . 0.0 109.803 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 50.22 31.16 4.87 Favored 'General case' 0 N--CA 1.507 2.412 0 CA-C-O 121.343 0.592 . . . . 0.0 111.66 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -171.32 -57.45 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.3 t -68.33 -50.73 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.18 -41.02 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.467 ' HA ' HD22 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -63.87 -39.92 95.33 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.843 -0.536 . . . . 0.0 109.576 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tp -60.23 -26.4 66.39 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.714 -0.616 . . . . 0.0 111.374 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.585 ' O ' HG22 ' A' ' 12' ' ' ILE . 17.3 m -97.1 -41.97 8.08 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.8 t -68.89 -29.41 67.68 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.68 -0.637 . . . . 0.0 111.291 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.72 -30.42 68.81 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.33 -0.856 . . . . 0.0 111.928 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -75.03 127.67 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.304 -0.872 . . . . 0.0 110.082 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.529 ' N ' HD13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER 52.91 62.33 10.12 Favored Pre-proline 0 N--CA 1.506 2.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.656 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.38 -46.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.02 1.147 . . . . 0.0 111.706 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.79 -31.24 70.62 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.438 -0.789 . . . . 0.0 112.22 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -73.42 -46.63 47.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.812 -0.555 . . . . 0.0 110.03 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.14 -40.92 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.39 -23.43 62.6 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.013 -0.429 . . . . 0.0 111.056 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.0 m -100.48 -43.56 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.431 -0.793 . . . . 0.0 110.64 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 20' ' ' ILE . 20.4 mm -73.42 -56.16 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.593 -0.692 . . . . 0.0 111.676 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -58.12 -35.42 71.45 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 119.203 0.911 . . . . 0.0 111.258 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -40.25 92.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.59 -0.694 . . . . 0.0 110.165 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.2 mt -81.0 -36.99 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -61.49 -47.35 86.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.673 -0.642 . . . . 0.0 109.773 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.525 ' HG ' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -68.0 -20.91 65.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.642 -0.661 . . . . 0.0 111.195 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.68 -17.94 39.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.686 -0.634 . . . . 0.0 111.492 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.5 mt -107.95 -50.27 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.768 -0.582 . . . . 0.0 109.778 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mt -97.94 -50.0 4.57 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.724 -0.61 . . . . 0.0 110.25 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.82 64.22 2.39 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HD2' ' HG ' ' A' ' 25' ' ' LEU . 46.3 Cg_endo -68.72 -25.79 33.51 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 O-C-N 123.665 1.35 . . . . 0.0 112.287 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -59.08 -42.68 91.01 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.329 -0.857 . . . . 0.0 110.491 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.1 mmt -77.44 -39.49 46.61 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.57 -33.63 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.866 -0.521 . . . . 0.0 110.058 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.0 13.36 6.13 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.539 -0.726 . . . . 0.0 111.782 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -131.54 22.92 4.71 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.132 -0.98 . . . . 0.0 110.861 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.66 98.12 6.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.144 -0.973 . . . . 0.0 109.865 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.34 -28.56 14.23 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -74.7 78.64 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 118.374 1.087 . . . . 0.0 109.366 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.6 p -145.75 44.66 1.28 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.972 0 O-C-N 121.488 -0.758 . . . . 0.0 110.373 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -123.56 19.75 9.55 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 122.106 -0.643 . . . . 0.0 110.74 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -107.96 -46.26 3.81 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.315 -0.866 . . . . 0.0 110.369 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.66 -38.81 17.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.577 -0.702 . . . . 0.0 109.504 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.21 -43.84 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.763 -0.586 . . . . 0.0 109.645 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.47 -36.21 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.749 -0.595 . . . . 0.0 109.714 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.52 -33.06 66.63 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 109.877 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.37 -67.25 0.74 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.831 HG23 ' HB ' ' A' ' 12' ' ' ILE . 14.5 t 40.58 53.78 3.04 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.867 0.841 . . . . 0.0 110.997 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 58.06 37.18 26.5 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.667 -0.646 . . . . 0.0 109.294 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.59 38.94 29.38 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.831 ' HB ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -71.27 159.52 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.692 -0.63 . . . . 0.0 110.418 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 44.8 m80 -100.59 102.56 19.5 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 45.9 Cg_endo -64.4 -167.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.311 2.007 . . . . 0.0 111.748 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 59.05 44.08 16.65 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.493 1.14 . . . . 0.0 109.454 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -171.64 -53.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 21' ' ' THR . 1.6 mp -67.1 -37.87 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.58 -34.49 72.78 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -69.26 -45.75 68.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.76 -41.05 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.872 -0.517 . . . . 0.0 109.607 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 17' ' ' ILE . 72.9 p -64.91 -30.3 71.29 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -64.29 -42.18 96.52 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.5 -39.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.54 HD12 ' HG3' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -64.34 -39.55 94.11 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.316 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' HD2' ' A' ' 30' ' ' PRO . 7.1 tp -69.06 -28.08 66.22 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.779 -0.575 . . . . 0.0 110.5 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.8 -16.71 60.7 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.746 0.308 . . . . 0.0 111.608 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.469 HG22 HD22 ' A' ' 28' ' ' LEU . 71.3 mt -111.78 -50.48 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.707 -0.621 . . . . 0.0 110.437 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD22 HG22 ' A' ' 27' ' ' ILE . 3.4 mm? -99.03 -57.66 2.12 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.579 -0.701 . . . . 0.0 110.405 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.09 59.31 1.18 Allowed Glycine 0 N--CA 1.499 2.837 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HG3' HD12 ' A' ' 24' ' ' LEU . 48.4 Cg_endo -74.32 -45.64 0.33 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.268 1.141 . . . . 0.0 111.686 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 tp -62.22 -35.42 78.83 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.526 -0.734 . . . . 0.0 110.992 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ttt -65.86 -44.93 83.96 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.88 -34.05 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.2 mt -83.63 10.13 9.92 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.529 -0.732 . . . . 0.0 111.628 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -126.78 22.35 6.84 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.377 -0.827 . . . . 0.0 110.266 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.24 -53.09 4.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.258 -0.901 . . . . 0.0 108.795 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 -17.71 52.46 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -101.12 121.34 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.101 -1.235 . . . . 0.0 109.351 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -121.75 37.35 4.38 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.35 0.595 . . . . 0.0 110.22 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.7 tttt . . . . . 0 N--CA 1.5 2.063 0 O-C-N 121.188 -0.945 . . . . 0.0 110.787 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.34 16.57 13.92 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.913 -0.757 . . . . 0.0 111.442 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -101.2 -52.3 3.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.591 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.07 -32.63 68.21 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.992 -0.442 . . . . 0.0 110.599 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.46 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.89 -41.68 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -63.32 -35.89 81.89 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.67 -0.644 . . . . 0.0 109.68 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.519 ' HG ' ' HA ' ' A' ' 12' ' ' ILE . 4.4 tp -71.24 -16.82 62.51 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.51 -0.744 . . . . 0.0 111.401 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -40.17 69.43 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t -96.75 -34.25 11.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.816 -0.552 . . . . 0.0 109.68 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -117.19 58.5 0.78 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.018 0.913 . . . . 0.0 109.396 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.519 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 5.1 tt -62.61 145.44 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.802 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 55.85 64.81 4.92 Favored Pre-proline 0 N--CA 1.505 2.279 0 O-C-N 122.295 -0.253 . . . . 0.0 111.529 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 18' ' ' PHE . 47.8 Cg_endo -70.83 -30.66 17.01 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.24 1.293 . . . . 0.0 111.532 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.59 3.29 14.09 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.569 -0.707 . . . . 0.0 112.386 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' O ' HD13 ' A' ' 20' ' ' ILE . 28.3 tp -113.91 -36.89 4.66 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.5 -48.7 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.621 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -70.13 -44.25 69.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.632 -0.668 . . . . 0.0 110.763 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -58.45 -41.53 85.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.449 -0.782 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 16' ' ' LEU . 1.3 mp -64.54 -51.31 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.66 -0.65 . . . . 0.0 110.266 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -65.28 -33.12 75.23 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.377 -0.827 . . . . 0.0 110.52 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -66.08 -46.09 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.46 -40.69 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -36.4 79.26 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.724 -0.61 . . . . 0.0 109.439 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.27 -4.04 58.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.751 -0.593 . . . . 0.0 110.991 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.62 14.26 24.63 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 110.257 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.1 mm -125.52 -53.06 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.33 -0.856 . . . . 0.0 109.311 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.9 mt -79.87 -27.59 40.05 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.715 -0.616 . . . . 0.0 111.124 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.22 54.76 0.47 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.52 -25.46 62.73 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 O-C-N 123.735 1.387 . . . . 0.0 111.813 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 mt -51.11 -39.58 56.51 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 118.324 0.511 . . . . 0.0 110.903 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -45.46 39.45 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.607 -0.683 . . . . 0.0 109.366 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.62 -33.91 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.962 -0.461 . . . . 0.0 110.29 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.77 -2.62 21.18 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.544 -0.722 . . . . 0.0 112.169 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -124.58 21.13 8.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 110.266 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.85 70.69 1.02 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.299 -0.876 . . . . 0.0 109.747 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.49 51.95 1.09 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.03 144.84 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.635 -0.921 . . . . 0.0 109.492 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 t -153.03 72.1 0.94 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.895 0.855 . . . . 0.0 110.106 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.378 -0.826 . . . . 0.0 109.928 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -97.67 14.26 27.39 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.79 -0.83 . . . . 0.0 111.879 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' HA ' HD12 ' A' ' 6' ' ' ILE . 32.9 t70 -64.56 -44.94 89.14 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.05 74.37 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -69.28 -40.47 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 3' ' ' ASP . 56.8 mt -61.2 -43.51 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 11.5 tp -63.5 -35.8 81.65 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.817 -0.552 . . . . 0.0 109.957 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.28 -7.84 51.63 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.404 -0.81 . . . . 0.0 111.413 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 m -111.66 -44.58 3.47 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.493 -0.754 . . . . 0.0 110.183 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.7 p -88.69 -27.39 21.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.623 -0.673 . . . . 0.0 111.944 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 7' ' ' LEU . . . -99.33 10.61 41.08 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.201 -0.937 . . . . 0.0 112.205 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.2 tp -72.24 140.96 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 120.813 -1.18 . . . . 0.0 110.057 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.561 ' CD2' HD22 ' A' ' 16' ' ' LEU . 9.1 t60 -120.92 78.05 31.3 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.0 110.491 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.16 175.65 10.98 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.651 1.343 . . . . 0.0 109.953 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.21 6.53 4.86 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.585 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 13' ' ' HIS . 0.5 OUTLIER -132.41 -50.08 0.92 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 20' ' ' ILE . 9.0 mm -61.23 -27.46 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -91.12 -36.06 14.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 23' ' ' ILE . 7.3 m -76.67 -26.56 54.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.716 -0.615 . . . . 0.0 110.674 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 17' ' ' ILE . 9.5 tp -52.17 -39.78 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.505 -0.747 . . . . 0.0 111.508 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.6 p -63.73 -44.22 94.2 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -66.82 -44.29 81.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 19' ' ' THR . 27.9 mm -62.87 -35.28 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.871 -0.518 . . . . 0.0 109.723 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.75 -42.93 84.97 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.696 -0.627 . . . . 0.0 110.119 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.97 -8.07 56.08 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.744 -0.598 . . . . 0.0 111.292 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.47 1.73 41.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.622 -0.673 . . . . 0.0 110.767 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.4 mt -114.07 -46.39 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.2 -67.85 0.31 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.013 -0.43 . . . . 0.0 110.057 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.41 83.24 0.27 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.33 -38.44 54.0 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 O-C-N 123.868 1.457 . . . . 0.0 110.888 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.41 -38.51 81.31 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.4 tpt -65.18 -42.07 94.02 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.936 -0.478 . . . . 0.0 109.742 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.0 t -64.85 -39.27 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.793 -0.567 . . . . 0.0 110.069 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.8 5.04 34.34 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.521 -0.737 . . . . 0.0 112.214 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.22 24.98 4.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.992 -1.067 . . . . 0.0 110.525 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.98 -58.5 1.87 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.42 -0.8 . . . . 0.0 109.758 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.43 46.7 1.13 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 tt -105.42 9.9 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.627 -0.925 . . . . 0.0 111.636 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -161.44 42.12 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.295 -0.878 . . . . 0.0 110.226 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.072 0 O-C-N 121.394 -0.816 . . . . 0.0 110.777 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.505 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -107.15 32.26 4.76 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.886 -0.773 . . . . 0.0 110.363 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -102.09 -57.7 2.02 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.93 -27.46 63.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 122.055 -0.403 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.6 t -59.21 -34.74 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.952 -0.467 . . . . 0.0 110.213 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.3 mm -67.43 -38.45 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.342 -0.849 . . . . 0.0 108.749 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.7 tp -75.82 -21.95 56.79 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.682 -0.636 . . . . 0.0 110.16 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.34 34.58 3.3 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.569 -0.707 . . . . 0.0 110.852 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -102.72 -43.78 5.49 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.277 -0.89 . . . . 0.0 110.059 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.6 m -68.54 -37.87 80.32 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.553 -0.717 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.98 -35.41 81.1 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.681 -0.637 . . . . 0.0 110.794 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.1 mm -94.51 165.33 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 8.6 m-70 -105.82 94.58 9.14 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.525 -0.735 . . . . 0.0 109.44 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 48.8 Cg_endo -66.74 177.38 3.5 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.785 1.657 . . . . 0.0 111.3 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 52.19 38.92 25.79 Favored 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 122.26 1.028 . . . . 0.0 109.952 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -165.45 -55.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.25 -29.22 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.43 -36.12 63.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.99 -0.444 . . . . 0.0 110.436 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.7 m -73.57 -48.78 30.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.1 mm -54.89 -49.78 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.787 -0.571 . . . . 0.0 111.402 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -62.91 -34.7 78.0 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.627 -0.67 . . . . 0.0 110.54 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -68.0 -41.29 82.5 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.628 -0.67 . . . . 0.0 109.837 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.96 -38.63 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.78 -41.31 95.31 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.63 -17.02 60.76 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.071 -0.393 . . . . 0.0 111.072 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.0 12.62 29.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.841 -0.537 . . . . 0.0 111.204 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm -130.38 -57.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.774 . . . . 0.0 109.491 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 47.76 58.12 5.31 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.43 0.634 . . . . 0.0 110.685 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.97 82.23 1.65 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 44.0 Cg_endo -65.42 -19.95 61.25 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 124.063 1.559 . . . . 0.0 112.628 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mt -53.49 -50.77 64.65 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.455 -0.778 . . . . 0.0 110.73 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 58.9 mtm -75.67 -33.27 60.39 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.863 -0.523 . . . . 0.0 110.135 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 30' ' ' PRO . 75.6 t -59.09 -37.14 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.772 -0.58 . . . . 0.0 109.852 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' O ' HD12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -58.32 -31.51 67.61 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.837 -0.539 . . . . 0.0 111.25 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -113.06 23.56 13.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.216 -0.303 . . . . 0.0 110.856 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.74 76.58 3.69 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 36.99 11.0 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 34' ' ' LEU . 11.0 tt -63.08 148.72 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.699 -0.883 . . . . 0.0 110.143 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 39' ' ' THR . 11.3 t -145.74 66.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.765 0.793 . . . . 0.0 109.814 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 117.784 -1.103 . . . . 0.0 110.517 -179.873 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.13 16.27 6.72 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.791 -0.829 . . . . 0.0 111.896 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -94.76 -46.41 6.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.433 -0.792 . . . . 0.0 109.644 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.56 17.53 4.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.836 -0.54 . . . . 0.0 111.416 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.55 -52.39 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.149 -0.969 . . . . 0.0 108.749 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.15 -45.76 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -62.09 -25.64 67.82 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.986 -0.446 . . . . 0.0 110.424 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -89.67 11.42 19.87 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.622 -0.674 . . . . 0.0 111.868 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 t -59.4 -36.97 76.83 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.049 -1.032 . . . . 0.0 110.617 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.515 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.4 t -78.61 -40.87 33.25 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . . . -63.72 -34.23 77.42 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 122.097 -0.377 . . . . 0.0 111.105 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.406 ' HB ' HD23 ' A' ' 8' ' ' LEU . 13.0 tt -90.33 16.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.578 -0.701 . . . . 0.0 111.603 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.482 ' CG ' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER 66.36 94.01 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.749 -0.595 . . . . 0.0 110.784 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 10' ' ' CYS . 47.7 Cg_endo -72.76 -40.77 1.79 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.17 1.247 . . . . 0.0 111.461 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -6.79 52.12 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.442 -0.786 . . . . 0.0 112.0 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.482 ' HB2' ' CG ' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -101.77 -47.62 4.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.467 -0.771 . . . . 0.0 110.007 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.733 ' HA ' HD12 ' A' ' 20' ' ' ILE . 17.1 mm -53.97 -41.79 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.983 -0.448 . . . . 0.0 110.395 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.72 -41.55 86.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.794 -0.566 . . . . 0.0 109.972 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.5 m -64.73 -43.84 92.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.78 -0.575 . . . . 0.0 109.578 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -58.41 -44.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.663 -0.648 . . . . 0.0 109.763 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.4 m -62.83 -42.83 99.89 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.739 -0.6 . . . . 0.0 109.802 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -44.14 97.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.836 -0.54 . . . . 0.0 110.007 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mm -62.1 -40.03 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.31 -43.21 88.06 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.3 -28.86 67.55 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.972 0.415 . . . . 0.0 110.171 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.34 60.77 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.0 mt -96.87 -69.18 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt 49.24 69.33 0.6 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.463 0.649 . . . . 0.0 110.931 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' N ' ' CD ' ' A' ' 30' ' ' PRO . . . -142.82 49.42 0.73 Allowed Glycine 0 N--CA 1.497 2.702 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.639 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 29' ' ' GLY . 43.0 Cg_endo -65.41 -40.98 16.86 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 O-C-N 123.272 1.143 . . . . 0.0 109.871 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.45 -37.12 82.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.8 mmt -60.95 -44.79 96.77 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.75 -34.97 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.786 -0.572 . . . . 0.0 109.622 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -81.35 -11.94 59.16 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.585 -0.697 . . . . 0.0 111.939 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -123.41 33.94 5.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.524 -0.735 . . . . 0.0 110.499 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.76 108.44 2.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.491 -0.756 . . . . 0.0 109.878 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.05 -43.48 1.7 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -86.55 127.63 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.571 -0.958 . . . . 0.0 109.793 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 t -154.37 53.66 0.68 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.716 0.769 . . . . 0.0 110.918 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.188 0 O-C-N 121.271 -0.893 . . . . 0.0 111.549 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.495 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.7 27.68 13.11 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 117.532 0.666 . . . . 0.0 111.832 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -115.95 -64.44 1.31 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.048 -1.033 . . . . 0.0 109.888 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.58 -29.87 71.07 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.052 -0.405 . . . . 0.0 111.488 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.16 -36.62 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.857 -0.527 . . . . 0.0 110.434 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.4 mt -65.69 -44.12 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.2 tp -67.83 -26.84 66.25 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.011 -0.431 . . . . 0.0 110.672 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -93.83 17.04 12.73 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.574 -0.704 . . . . 0.0 111.452 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.0 m -112.28 -45.58 3.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.862 -1.149 . . . . 0.0 109.941 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.5 m -58.81 -25.16 62.89 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.518 -0.739 . . . . 0.0 112.09 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.79 18.26 20.96 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.137 -0.977 . . . . 0.0 112.061 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 9' ' ' THR . 5.3 tp -117.48 12.93 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 120.984 -1.072 . . . . 0.0 112.058 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -132.11 78.49 68.93 Favored Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 120.962 -1.086 . . . . 0.0 110.867 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.7 -36.97 30.24 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.334 1.356 . . . . 0.0 111.598 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.39 -37.95 82.4 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.505 0.669 . . . . 0.0 109.502 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 19' ' ' THR . 4.1 mp -69.23 -41.83 76.5 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.792 ' HA ' HD12 ' A' ' 20' ' ' ILE . 25.5 mm -59.5 -38.12 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -65.89 -36.81 84.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.113 -0.367 . . . . 0.0 110.636 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -76.53 -25.49 54.18 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.358 -0.839 . . . . 0.0 111.546 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 17' ' ' ILE . 44.2 mt -58.3 -48.88 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.417 -0.802 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.3 p -65.32 -36.5 84.24 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.749 -0.594 . . . . 0.0 109.898 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -45.37 93.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 90.1 mt -62.58 -37.06 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.96 -42.14 97.71 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.697 -0.627 . . . . 0.0 110.538 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.71 5.42 51.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.648 . . . . 0.0 111.305 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 27' ' ' ILE . 80.1 mt -132.79 5.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.135 -0.978 . . . . 0.0 111.279 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -102.66 1.55 34.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.561 -1.337 . . . . 0.0 112.686 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.09 -53.64 0.44 Allowed Glycine 0 N--CA 1.497 2.746 0 O-C-N 120.775 -1.203 . . . . 0.0 110.767 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -86.63 40.65 0.72 Allowed 'Trans proline' 0 N--CA 1.489 1.245 0 O-C-N 123.658 1.346 . . . . 0.0 110.98 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -30.23 71.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.617 -0.677 . . . . 0.0 110.744 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 21.4 ttm -90.21 -31.58 16.96 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.97 -38.24 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -27.85 67.62 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.651 -0.656 . . . . 0.0 111.021 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -106.74 24.31 12.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.002 -0.436 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.01 -39.31 72.45 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.002 -1.061 . . . . 0.0 110.474 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.66 -16.28 68.69 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.27 119.86 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 118.911 1.356 . . . . 0.0 109.88 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 m -105.73 47.63 0.87 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.675 -0.641 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 110.72 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.37 39.1 1.97 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.934 -0.745 . . . . 0.0 110.267 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.42 -54.85 2.83 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.76 65.21 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.024 -0.422 . . . . 0.0 110.151 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.7 t -59.27 -38.29 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.71 -0.618 . . . . 0.0 109.788 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.615 ' O ' HG22 ' A' ' 9' ' ' THR . 21.6 mt -62.75 -40.72 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 tp -69.99 -28.25 65.36 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.621 -0.674 . . . . 0.0 109.933 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.56 15.25 27.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.61 -0.681 . . . . 0.0 112.152 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 6' ' ' ILE . 4.3 t -109.75 -25.35 10.42 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.971 -1.081 . . . . 0.0 111.75 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 90.8 m -63.53 -45.52 90.24 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.246 -0.909 . . . . 0.0 110.689 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.25 -44.2 47.33 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.716 -0.615 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.3 mm -78.26 118.18 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 29.2 m170 59.08 61.54 4.53 Favored Pre-proline 0 N--CA 1.506 2.343 0 CA-C-O 120.721 0.296 . . . . 0.0 110.518 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.34 -21.87 25.97 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 O-C-N 123.506 1.266 . . . . 0.0 111.295 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.91 9.87 3.25 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.614 -0.679 . . . . 0.0 112.134 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.5 tp -109.48 -51.84 2.83 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.577 HD11 HG23 ' A' ' 9' ' ' THR . 44.3 mt -59.11 -42.55 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.29 -39.13 85.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -61.27 -45.1 95.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.95 -0.469 . . . . 0.0 109.916 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.65 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.756 -0.59 . . . . 0.0 109.452 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.0 m -61.09 -40.53 94.08 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.592 -0.693 . . . . 0.0 109.41 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -63.21 -45.58 91.02 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.818 -0.551 . . . . 0.0 109.695 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.76 -39.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.4 -42.53 82.41 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.845 -0.535 . . . . 0.0 109.635 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.664 HD12 ' SD ' ' A' ' 32' ' ' MET . 8.5 tt -67.45 -35.65 79.63 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.235 0.541 . . . . 0.0 110.011 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.43 -8.51 54.29 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.4 mm -110.99 -46.78 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.536 -0.728 . . . . 0.0 109.668 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.77 -72.91 0.66 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.709 -0.62 . . . . 0.0 109.978 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' HD3' ' A' ' 30' ' ' PRO . . . 49.96 51.94 27.93 Favored Glycine 0 N--CA 1.502 3.049 0 CA-C-O 118.967 -0.907 . . . . 0.0 112.671 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 29' ' ' GLY . 48.0 Cg_endo -78.52 -57.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.098 1.052 . . . . 0.0 111.248 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.87 -35.38 78.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.375 -0.828 . . . . 0.0 109.607 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.664 ' SD ' HD12 ' A' ' 25' ' ' LEU . 12.2 mtp -63.36 -30.25 71.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.996 -0.44 . . . . 0.0 110.869 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -31.95 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.613 -0.68 . . . . 0.0 110.474 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 6.61 22.98 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.577 -0.702 . . . . 0.0 112.073 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.52 27.09 0.83 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.268 -0.895 . . . . 0.0 111.294 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.37 86.45 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.258 -0.901 . . . . 0.0 110.817 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.73 13.43 65.79 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mm -108.71 32.64 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 118.822 1.311 . . . . 0.0 108.996 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -157.23 32.06 0.29 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.325 -0.859 . . . . 0.0 111.005 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.218 0 CA-C-O 117.666 -1.159 . . . . 0.0 111.419 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -124.42 19.04 8.91 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.621 -0.929 . . . . 0.0 111.318 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.59 -57.1 2.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.796 . . . . 0.0 109.335 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.48 -26.61 66.45 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.952 -0.468 . . . . 0.0 110.936 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.1 -30.78 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.437 -0.79 . . . . 0.0 109.875 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.7 mt -67.85 -41.21 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.38 -47.93 31.02 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.0 -60.54 2.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.875 -0.516 . . . . 0.0 110.229 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.551 HG23 ' HB ' ' A' ' 12' ' ' ILE . 3.4 t 40.01 56.92 2.44 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 122.119 0.962 . . . . 0.0 110.146 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 83.5 m 55.97 37.22 28.61 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.728 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.409 ' HB1' HG13 ' A' ' 17' ' ' ILE . . . 53.05 56.77 7.08 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.98 0.895 . . . . 0.0 109.841 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.551 ' HB ' HG23 ' A' ' 9' ' ' THR . 0.8 OUTLIER -85.16 13.76 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.787 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -117.02 93.34 41.84 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.988 -1.07 . . . . 0.0 110.0 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.49 175.45 5.11 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.816 1.678 . . . . 0.0 111.302 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 57.87 40.83 25.58 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 122.483 1.135 . . . . 0.0 109.507 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 20' ' ' ILE . 2.8 tt -169.65 -55.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.409 HG13 ' HB1' ' A' ' 11' ' ' ALA . 24.7 mm -60.16 -38.75 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.56 -32.15 73.53 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.697 -0.627 . . . . 0.0 110.678 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 m -85.4 -49.45 8.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.716 -0.615 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.404 HD13 HD23 ' A' ' 16' ' ' LEU . 1.2 mp -58.99 -43.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -60.7 -39.05 87.05 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -44.62 88.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.698 -0.626 . . . . 0.0 109.58 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.93 -40.64 96.2 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.583 -0.698 . . . . 0.0 109.166 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.6 mm? -68.23 -22.56 64.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.838 -0.539 . . . . 0.0 110.496 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.02 -11.36 53.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.157 -0.339 . . . . 0.0 111.396 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 27' ' ' ILE . 63.3 mt -118.05 30.64 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.572 -0.705 . . . . 0.0 110.051 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -70.83 -32.01 68.91 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.915 -1.116 . . . . 0.0 111.027 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.74 72.32 1.13 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.88 -37.12 3.91 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 O-C-N 123.706 1.371 . . . . 0.0 111.287 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.442 ' HA ' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -57.41 -45.48 84.51 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.601 -0.687 . . . . 0.0 111.015 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.6 ttm -64.03 -44.27 93.03 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.644 -0.66 . . . . 0.0 110.849 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.1 -30.63 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.728 -0.608 . . . . 0.0 111.03 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 41.2 mt -92.29 -2.23 56.56 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.151 -0.968 . . . . 0.0 112.318 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -128.69 29.8 5.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.317 -0.864 . . . . 0.0 109.976 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.92 74.87 1.17 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.421 -0.799 . . . . 0.0 110.436 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.4 76.23 0.64 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 38' ' ' ILE . 4.5 tp -81.19 58.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.843 -0.798 . . . . 0.0 110.622 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 m -150.07 66.94 0.97 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.206 -0.934 . . . . 0.0 109.175 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.293 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 54.35 26.42 6.93 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 117.31 0.555 . . . . 0.0 112.063 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.25 -37.12 6.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.611 -0.681 . . . . 0.0 109.812 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.78 -39.27 87.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.783 -0.573 . . . . 0.0 109.704 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.5 t -63.47 -37.78 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.3 mm -66.23 -35.37 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 tp -78.7 -30.36 45.98 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.597 -0.69 . . . . 0.0 110.584 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.87 22.23 3.73 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.468 -0.77 . . . . 0.0 111.751 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.465 ' O ' HG22 ' A' ' 12' ' ' ILE . 5.5 t -74.85 -25.62 59.11 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.089 -1.007 . . . . 0.0 110.926 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.569 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 55.9 m -67.68 -35.64 79.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.11 76.83 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.769 -0.582 . . . . 0.0 111.231 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -86.62 16.35 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.532 -0.73 . . . . 0.0 111.356 179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 62.79 97.49 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.08 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HD3' ' HA ' ' A' ' 10' ' ' CYS . 50.5 Cg_endo -76.87 176.4 10.16 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.47 -1.396 . . . . 0.0 108.47 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 51.29 28.84 4.51 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 121.954 0.883 . . . . 0.0 110.661 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 tp -151.44 -53.88 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 17' ' ' ILE . 3.1 mm -57.09 -35.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -87.01 -33.81 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -71.23 -40.23 71.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.474 -0.766 . . . . 0.0 109.832 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 18.7 mm -65.59 -44.97 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.747 -0.595 . . . . 0.0 109.922 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 p -63.7 -39.37 94.15 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.811 -0.556 . . . . 0.0 110.691 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -59.18 -47.06 86.7 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.715 -0.616 . . . . 0.0 109.63 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.92 -29.1 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -57.71 -47.75 81.52 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.22 -33.39 73.41 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.298 0.571 . . . . 0.0 110.377 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.6 62.42 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.594 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.661 ' HA ' ' HB3' ' A' ' 31' ' ' LEU . 60.8 mt -112.84 26.78 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.851 -0.531 . . . . 0.0 109.724 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.96 18.18 10.92 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.937 -1.102 . . . . 0.0 112.021 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.53 -72.59 0.04 OUTLIER Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.99 28.67 0.39 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.562 1.508 . . . . 0.0 111.385 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.661 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 1.3 pp -58.46 -33.87 70.22 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.418 -0.801 . . . . 0.0 111.655 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 ttt -87.49 -38.58 15.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.357 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.48 -35.4 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.77 -0.581 . . . . 0.0 110.82 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 mt -87.43 -1.27 57.81 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.434 -0.791 . . . . 0.0 113.012 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -141.09 29.41 1.84 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.26 -0.9 . . . . 0.0 111.377 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.75 112.9 13.81 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.384 -0.823 . . . . 0.0 110.688 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.12 -43.4 1.68 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 40' ' ' LYS . 2.8 mp -84.71 132.92 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.418 -1.048 . . . . 0.0 110.847 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -108.39 41.77 1.51 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' H ' HG22 ' A' ' 38' ' ' ILE . 22.3 tttp . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.102 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.648 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -122.49 17.76 10.48 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.819 -0.812 . . . . 0.0 111.029 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -110.37 -43.73 3.85 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.568 -0.707 . . . . 0.0 109.852 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.06 -35.18 25.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.572 -0.705 . . . . 0.0 109.777 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.37 -42.95 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.811 -0.556 . . . . 0.0 109.802 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.16 -44.19 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.25 -33.36 75.8 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 12' ' ' ILE . 1.7 tp -81.62 -1.89 48.21 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.757 -0.59 . . . . 0.0 112.142 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 m -100.83 -50.06 3.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.171 -0.956 . . . . 0.0 109.238 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.8 m -64.51 -35.4 80.85 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.952 -0.468 . . . . 0.0 111.132 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.44 82.51 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.537 -0.727 . . . . 0.0 110.821 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 8' ' ' LEU . 63.4 mt -68.88 143.13 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 59.31 66.94 2.06 Favored Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 122.178 -0.326 . . . . 0.0 110.779 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' HD12 ' A' ' 17' ' ' ILE . 47.6 Cg_endo -68.52 -21.43 40.05 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.513 1.475 . . . . 0.0 111.62 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.76 -30.29 63.46 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.609 -0.682 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.8 -47.15 82.04 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.831 ' HA ' HD12 ' A' ' 20' ' ' ILE . 4.8 mt -62.03 -38.66 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -61.14 -28.52 69.17 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.819 -0.551 . . . . 0.0 110.686 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.3 m -88.98 -26.56 21.42 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.305 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.831 HD12 ' HA ' ' A' ' 17' ' ' ILE . 70.1 mt -60.48 -45.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.404 -0.81 . . . . 0.0 109.131 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.542 HG23 ' HD3' ' A' ' 22' ' ' LYS . 8.9 t -60.58 -33.54 72.86 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.805 -0.56 . . . . 0.0 109.812 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.542 ' HD3' HG23 ' A' ' 21' ' ' THR . 0.1 OUTLIER -70.69 -48.43 54.79 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.77 -34.18 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -40.28 78.13 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -12.28 59.97 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.973 -0.454 . . . . 0.0 111.276 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.01 8.63 28.42 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.784 -0.572 . . . . 0.0 110.942 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm -137.18 -51.41 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 0.0 109.75 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tp 57.8 57.75 4.03 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.439 0.638 . . . . 0.0 110.484 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.12 66.83 0.04 OUTLIER Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 33' ' ' VAL . 43.7 Cg_endo -65.49 -37.36 30.21 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.979 1.515 . . . . 0.0 111.657 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -58.2 -40.95 82.9 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.596 -0.69 . . . . 0.0 109.917 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.9 mmt -80.7 -41.4 23.73 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.886 -0.509 . . . . 0.0 109.887 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -62.5 -29.73 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.571 -0.706 . . . . 0.0 110.485 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 tp -79.51 -2.14 40.86 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.452 -0.78 . . . . 0.0 111.646 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -127.89 19.15 6.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.429 -0.795 . . . . 0.0 110.746 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.01 -56.74 3.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.197 -0.939 . . . . 0.0 109.441 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.23 41.41 2.0 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.42 140.4 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.621 -0.929 . . . . 0.0 110.456 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.8 m -125.77 56.8 1.38 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.605 0.717 . . . . 0.0 109.611 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 O-C-N 121.348 -0.845 . . . . 0.0 110.543 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.535 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.602 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -130.79 28.68 4.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.91 -0.759 . . . . 0.0 109.458 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -105.34 -57.57 2.01 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.15 -32.71 29.9 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 122.169 -0.332 . . . . 0.0 110.365 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.32 -47.57 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.716 -0.615 . . . . 0.0 110.443 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 ' O ' ' A' ' 2' ' ' ARG . 55.3 mt -61.8 -38.98 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -58.89 -23.19 60.79 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.74 -86.75 0.39 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 9' ' ' THR . 13.9 m 42.08 56.33 3.59 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-O 121.973 0.892 . . . . 0.0 109.283 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.0 m 55.77 44.58 25.92 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.34 63.51 2.07 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.212 1.006 . . . . 0.0 109.491 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.425 ' HA ' HD12 ' A' ' 12' ' ' ILE . 8.4 tp -70.34 167.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.36 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 62.6 83.33 0.2 Allowed Pre-proline 0 N--CA 1.503 2.196 0 C-N-CA 123.19 0.596 . . . . 0.0 112.319 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.72 -19.43 7.35 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.515 1.477 . . . . 0.0 111.486 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -60.14 -30.79 69.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.456 -0.777 . . . . 0.0 111.508 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.409 ' N ' ' HG2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -65.21 -46.72 79.56 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.126 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.538 ' HA ' HD12 ' A' ' 20' ' ' ILE . 42.4 mm -61.31 -39.18 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -45.42 93.1 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.808 -0.557 . . . . 0.0 110.223 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.8 m -60.81 -39.0 87.28 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.762 -0.586 . . . . 0.0 110.539 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 17' ' ' ILE . 45.4 mt -65.35 -44.89 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.834 -0.541 . . . . 0.0 109.595 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.7 m -64.1 -39.11 93.35 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.717 -0.614 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -60.85 -45.66 93.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.721 -0.612 . . . . 0.0 109.429 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.19 -40.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -42.18 86.72 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 25' ' ' LEU . 33.7 mt -78.53 -1.78 35.56 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.787 -0.571 . . . . 0.0 111.435 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.97 13.0 20.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.772 . . . . 0.0 110.3 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.4 mt -118.44 -48.43 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.356 -0.84 . . . . 0.0 109.596 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.57 -22.6 34.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.667 -0.645 . . . . 0.0 111.77 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.4 50.3 0.58 Allowed Glycine 0 N--CA 1.499 2.85 0 O-C-N 121.134 -0.979 . . . . 0.0 111.838 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.11 -35.58 32.88 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.342 1.18 . . . . 0.0 111.046 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mp -60.4 -41.89 94.81 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.798 -0.564 . . . . 0.0 109.686 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.9 ttm -65.0 -40.35 94.82 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.85 -32.96 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.925 -0.485 . . . . 0.0 110.179 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.21 4.56 53.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.43 -0.794 . . . . 0.0 111.801 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.15 25.48 4.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.311 -0.868 . . . . 0.0 110.568 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.74 89.7 7.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.281 -0.887 . . . . 0.0 110.199 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.47 50.59 3.13 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.9 tp -108.75 11.06 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 117.953 0.877 . . . . 0.0 111.457 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 m -132.05 55.35 1.88 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.096 -1.002 . . . . 0.0 108.721 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.704 -1.141 . . . . 0.0 110.625 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.565 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -122.87 26.44 8.17 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.76 -0.847 . . . . 0.0 111.38 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -115.26 -59.11 2.05 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.18 -30.18 66.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.907 -0.496 . . . . 0.0 111.288 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.2 -35.44 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.755 -0.591 . . . . 0.0 110.488 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.24 -45.36 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.02 -27.44 66.54 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.7 35.18 1.55 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.641 -0.662 . . . . 0.0 110.864 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.8 m -110.16 -32.1 7.11 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.006 -1.058 . . . . 0.0 110.957 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.9 t -69.13 -48.52 62.23 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.22 -0.925 . . . . 0.0 110.802 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.92 -25.58 61.96 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.577 -0.702 . . . . 0.0 111.472 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 9' ' ' THR . 2.7 tt -77.93 177.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.487 -0.758 . . . . 0.0 110.819 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -115.32 87.19 15.89 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.57 -0.706 . . . . 0.0 109.219 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.42 -44.6 11.13 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.695 1.366 . . . . 0.0 111.311 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.14 -38.46 89.08 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.732 -0.605 . . . . 0.0 110.189 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.87 -42.1 99.64 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 mm -63.73 -39.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.22 -38.82 84.53 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -65.62 -43.07 90.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.81 -42.46 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -59.81 -41.65 91.71 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.706 -0.621 . . . . 0.0 109.75 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -43.89 94.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.793 -0.567 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 23' ' ' ILE . 30.4 mm -62.1 -38.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 tp -61.34 -40.5 94.49 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.436 ' HA ' HD13 ' A' ' 25' ' ' LEU . 3.3 mm? -66.41 -36.02 81.78 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.3 68.68 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.197 0.522 . . . . 0.0 110.772 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.25 -23.09 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 122.051 -0.406 . . . . 0.0 110.367 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 31' ' ' LEU . 2.1 mm? -97.71 47.48 1.02 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.243 -0.911 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.503 ' N ' ' HD2' ' A' ' 30' ' ' PRO . . . -53.96 -50.87 53.18 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.94 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 29' ' ' GLY . 43.9 Cg_endo -66.82 -33.94 32.28 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 O-C-N 123.151 1.079 . . . . 0.0 111.006 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.534 ' HB2' HD12 ' A' ' 28' ' ' LEU . 2.2 tt -63.27 -39.12 93.69 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -39.08 64.65 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.858 -0.526 . . . . 0.0 109.924 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 29' ' ' GLY . 53.1 t -58.43 -32.85 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 121.778 -0.576 . . . . 0.0 109.976 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.2 7.25 9.74 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.514 -0.741 . . . . 0.0 112.009 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -149.24 24.53 0.91 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.231 -0.918 . . . . 0.0 111.974 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.86 -55.46 2.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.965 -1.084 . . . . 0.0 110.057 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.11 37.75 3.44 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.5 tp -86.47 137.07 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.618 -0.931 . . . . 0.0 110.448 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 t -156.22 39.63 0.36 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.676 -0.64 . . . . 0.0 110.893 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.107 -0.996 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.611 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -123.07 19.41 9.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.76 -0.847 . . . . 0.0 110.997 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -121.25 -59.57 1.7 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.394 -0.816 . . . . 0.0 108.932 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.41 -36.7 78.76 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.982 -0.449 . . . . 0.0 109.795 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.18 -33.88 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.678 -0.638 . . . . 0.0 109.331 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.6 mm -70.65 -38.11 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.3 tp -72.82 -31.65 64.95 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.659 -0.65 . . . . 0.0 109.645 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tp -81.55 -62.03 1.76 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.806 HG23 ' HB ' ' A' ' 12' ' ' ILE . 12.3 t 41.21 54.5 3.41 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.941 0.877 . . . . 0.0 110.717 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 m 57.9 36.37 26.21 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 54.95 53.44 10.37 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.998 0.904 . . . . 0.0 110.305 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.806 ' HB ' HG23 ' A' ' 9' ' ' THR . 1.1 mp -99.69 129.63 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.455 0.645 . . . . 0.0 109.526 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 3.8 p80 -168.82 64.21 0.57 Allowed Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 122.086 -0.384 . . . . 0.0 111.168 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.52 -62.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.161 1.085 . . . . 0.0 110.631 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.81 -28.42 64.03 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.701 -0.624 . . . . 0.0 110.86 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 15.1 mt -65.95 -48.41 71.44 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.39 -41.2 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -60.58 -36.65 79.03 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.912 -0.492 . . . . 0.0 111.072 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -85.67 -44.35 12.65 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 110.555 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mt -60.06 -40.98 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.959 -0.463 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -65.52 -31.13 72.02 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 119.581 1.082 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.82 -36.38 59.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.39 -0.819 . . . . 0.0 109.612 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 23' ' ' ILE . 46.2 mt -100.93 9.51 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 110.647 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 tp -58.16 -48.86 78.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.818 -1.176 . . . . 0.0 109.625 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -78.82 -14.03 59.48 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.907 -0.495 . . . . 0.0 110.906 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.55 21.96 15.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 111.571 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.18 -30.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.307 -0.871 . . . . 0.0 111.305 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.85 -37.32 30.27 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.768 -0.583 . . . . 0.0 112.391 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.12 60.92 0.09 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HB2' ' HB2' ' A' ' 34' ' ' LEU . 47.4 Cg_endo -70.3 -83.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 O-C-N 124.014 1.534 . . . . 0.0 111.817 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 tp 50.02 33.22 6.53 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.936 0.874 . . . . 0.0 111.607 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.1 mtt -175.24 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -71.93 -21.78 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 3.0 tp -91.43 16.96 9.2 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.549 -0.72 . . . . 0.0 111.193 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.579 ' HA ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -161.39 33.65 0.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.13 -0.981 . . . . 0.0 111.219 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.51 -48.05 3.64 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.226 -0.921 . . . . 0.0 110.799 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.92 45.03 1.37 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 35' ' ' GLN . 41.8 mt -128.87 147.52 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.578 -0.954 . . . . 0.0 109.444 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -122.9 58.89 1.07 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.674 0.75 . . . . 0.0 109.191 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.629 -179.99 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -171.98 2.06 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.678 -0.895 . . . . 0.0 109.298 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.7 37.09 28.56 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 121.48 0.657 . . . . 0.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.18 -52.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.5 -36.74 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.922 -0.487 . . . . 0.0 109.79 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 mt -62.31 -37.43 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.7 tp -77.18 -33.58 56.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.787 -0.571 . . . . 0.0 110.129 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.95 26.58 3.13 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.692 -0.63 . . . . 0.0 111.564 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.5 t -63.0 -22.93 67.2 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.119 -0.988 . . . . 0.0 111.692 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 p -66.86 -26.82 67.08 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.429 -0.794 . . . . 0.0 111.328 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -118.44 -72.42 0.69 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.435 -0.791 . . . . 0.0 109.732 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.5 OUTLIER 56.71 18.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.857 -0.527 . . . . 0.0 112.311 179.908 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -144.66 63.25 10.44 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.852 -1.155 . . . . 0.0 110.638 179.769 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.26 -50.3 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.361 1.19 . . . . 0.0 111.004 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -29.64 70.36 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.791 -0.568 . . . . 0.0 110.563 179.44 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 1.6 mt -66.96 -46.49 74.51 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 20' ' ' ILE . 63.1 mt -59.38 -37.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.161 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -65.26 -38.6 90.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.912 -0.493 . . . . 0.0 109.925 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.1 m -65.04 -43.12 93.4 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.75 -0.594 . . . . 0.0 109.503 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 17' ' ' ILE . 14.4 mt -61.33 -41.94 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.957 -0.464 . . . . 0.0 109.749 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.6 m -65.08 -40.0 94.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.597 -0.689 . . . . 0.0 110.155 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -57.48 -45.02 85.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.962 -0.461 . . . . 0.0 109.89 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -38.19 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -59.18 -49.6 77.23 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.442 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -17.03 62.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.82 -0.55 . . . . 0.0 111.31 179.422 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.03 2.18 56.51 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.807 -0.558 . . . . 0.0 111.184 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.4 mt -112.85 -55.66 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.8 mt -86.62 -32.54 20.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.85 -0.531 . . . . 0.0 110.468 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' N ' ' HD2' ' A' ' 30' ' ' PRO . . . -56.61 -54.33 37.08 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 29' ' ' GLY . 44.3 Cg_endo -68.16 -32.03 28.17 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 O-C-N 123.46 1.242 . . . . 0.0 110.89 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.66 -43.8 97.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.614 -0.679 . . . . 0.0 109.541 179.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.7 ttm -62.59 -39.58 94.17 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.38 -30.23 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.2 mt -83.45 9.09 11.97 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.405 -0.809 . . . . 0.0 112.085 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.75 21.01 5.98 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.137 -0.977 . . . . 0.0 111.15 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.98 -54.86 3.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.234 -0.916 . . . . 0.0 109.53 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.92 -25.54 22.08 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.6 mm -82.25 121.03 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.481 -1.011 . . . . 0.0 109.791 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 m -137.89 60.28 1.63 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.097 0.475 . . . . 0.0 110.035 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 117.518 -1.229 . . . . 0.0 110.656 -179.926 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.481 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -82.55 89.15 6.65 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.184 0.992 . . . . 0.0 110.656 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -167.53 -61.58 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.37 -36.26 66.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.875 -0.515 . . . . 0.0 109.864 179.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.0 t -58.46 -40.35 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.6 mt -59.02 -47.02 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 tt -70.17 -28.93 65.71 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.043 -0.411 . . . . 0.0 109.977 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.67 8.84 18.13 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.6 -0.688 . . . . 0.0 112.223 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 12' ' ' ILE . 7.0 t -63.41 -36.36 83.48 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.186 -0.946 . . . . 0.0 110.748 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -80.18 -29.8 38.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.414 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.77 -20.28 62.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.619 -0.675 . . . . 0.0 111.238 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -92.41 16.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.238 -0.914 . . . . 0.0 112.011 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.76 65.23 53.09 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.968 -1.082 . . . . 0.0 110.031 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.16 -40.42 11.42 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.336 1.357 . . . . 0.0 111.708 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -38.22 87.39 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.7 -0.625 . . . . 0.0 110.665 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -45.65 76.19 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.506 ' HA ' HG22 ' A' ' 20' ' ' ILE . 37.1 mt -65.39 -38.65 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.67 -26.32 67.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.686 -0.634 . . . . 0.0 110.692 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -96.46 -41.96 8.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.689 -0.632 . . . . 0.0 109.963 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 17' ' ' ILE . 9.0 tt -57.39 -33.37 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.717 -0.614 . . . . 0.0 111.254 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.8 p -63.49 -43.25 97.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.498 -0.751 . . . . 0.0 109.168 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -63.92 -35.68 81.47 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.519 HG22 HD12 ' A' ' 27' ' ' ILE . 33.3 mm -75.48 -40.9 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.59 -43.62 93.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.48 -32.99 74.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.797 -0.564 . . . . 0.0 110.44 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.84 -30.14 63.77 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.239 0.542 . . . . 0.0 110.533 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 27' ' ' ILE . 47.7 mt -111.93 37.17 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.703 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tp -77.56 -30.95 52.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.94 -1.1 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.09 54.99 0.36 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.61 -36.02 27.02 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 O-C-N 123.619 1.326 . . . . 0.0 111.159 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 12.3 tp -60.13 -46.39 89.81 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.504 -0.748 . . . . 0.0 109.678 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.4 mtm -66.71 -39.68 88.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.792 -0.568 . . . . 0.0 109.594 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.41 -39.51 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.646 -0.659 . . . . 0.0 109.886 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.32 7.84 27.0 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.609 -0.682 . . . . 0.0 111.929 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 8.9 tt0 -126.72 16.16 7.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.183 -0.948 . . . . 0.0 110.78 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.85 73.28 7.51 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.79 65.05 1.57 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -102.12 57.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 122.009 0.909 . . . . 0.0 109.885 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 39' ' ' THR . 10.8 t -163.78 59.93 0.17 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.914 0.864 . . . . 0.0 109.655 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 O-C-N 121.3 -0.875 . . . . 0.0 111.363 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.543 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.51 -166.99 1.18 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.708 -0.878 . . . . 0.0 109.802 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.29 40.11 31.44 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.007 0.908 . . . . 0.0 109.839 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -178.35 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.69 -35.0 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.4 mm -63.78 -44.92 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.2 tp -60.69 -36.48 78.88 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.68 -44.34 96.5 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.819 -0.551 . . . . 0.0 109.853 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.592 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 10.5 m -63.15 -33.52 75.64 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.6 m -67.06 -35.2 79.34 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.88 -46.05 25.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.781 -0.575 . . . . 0.0 109.972 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' CG1' ' HA ' ' A' ' 9' ' ' THR . 1.1 pt -74.8 146.6 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.592 -0.693 . . . . 0.0 110.531 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.45 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 9.6 t-80 54.76 63.71 6.76 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 122.048 -0.408 . . . . 0.0 110.937 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.462 ' HA ' HD12 ' A' ' 17' ' ' ILE . 46.8 Cg_endo -69.07 -21.62 36.45 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.225 1.283 . . . . 0.0 112.106 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -57.4 -37.78 73.27 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.308 -0.87 . . . . 0.0 110.781 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 13' ' ' HIS . 9.0 tp -65.05 -42.04 94.61 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 14' ' ' PRO . 3.1 mt -71.39 -36.36 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.6 -34.98 71.73 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.92 -0.488 . . . . 0.0 109.696 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.2 m -75.68 -41.13 54.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 20' ' ' ILE . 23.4 mm -64.8 -40.31 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.995 -0.441 . . . . 0.0 110.271 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.8 p -64.73 -37.21 86.82 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.497 -0.752 . . . . 0.0 109.741 179.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -45.02 93.99 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -65.13 -37.14 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 30' ' ' PRO . 2.4 tp -59.64 -40.85 89.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.205 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 25' ' ' LEU . 2.2 mm? -68.26 -22.11 64.78 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.871 -0.518 . . . . 0.0 110.593 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.82 5.78 47.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.09 -0.382 . . . . 0.0 110.817 179.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -128.89 -50.77 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.496 -0.752 . . . . 0.0 109.902 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp 62.02 48.32 5.24 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.441 0.639 . . . . 0.0 110.686 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' CD ' ' A' ' 30' ' ' PRO . . . -154.84 51.41 0.46 Allowed Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HB3' HD11 ' A' ' 24' ' ' LEU . 47.7 Cg_endo -69.92 -33.26 16.34 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.567 1.298 . . . . 0.0 111.291 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.16 -47.36 85.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.614 -0.679 . . . . 0.0 110.515 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.5 tpt -63.37 -41.84 98.82 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.558 -0.714 . . . . 0.0 110.393 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -33.54 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.566 -0.709 . . . . 0.0 110.548 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.19 9.49 35.83 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.455 -0.778 . . . . 0.0 111.832 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.3 25.17 3.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.184 -0.948 . . . . 0.0 110.198 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.24 -49.03 7.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.423 -0.798 . . . . 0.0 109.289 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.01 46.79 1.12 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.6 mm -122.0 129.4 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.708 -0.878 . . . . 0.0 109.563 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -127.11 44.69 2.86 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.147 0.498 . . . . 0.0 110.362 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 N--CA 1.503 2.216 0 O-C-N 121.548 -0.72 . . . . 0.0 111.214 -179.943 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.483 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.3 mmt-85 54.84 22.02 3.98 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 122.338 -0.507 . . . . 0.0 112.051 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.14 -58.94 1.0 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.75 94.54 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.95 -41.82 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.2 mm -62.74 -43.44 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tt -61.43 -40.3 93.94 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.074 -0.391 . . . . 0.0 110.091 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tp -65.71 -19.55 65.94 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.93 -0.481 . . . . 0.0 111.792 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.5 m -101.82 -41.46 6.51 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.1 m -65.25 -37.56 87.6 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.823 -0.548 . . . . 0.0 110.971 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -68.56 -60.91 2.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.565 -0.71 . . . . 0.0 110.035 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 11' ' ' ALA . 1.4 tp 55.47 -178.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.424 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.5 OUTLIER 55.07 59.46 10.45 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.509 -0.744 . . . . 0.0 110.912 -179.636 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.72 -24.54 13.36 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.367 1.193 . . . . 0.0 112.113 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.86 -50.36 68.88 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.369 -0.832 . . . . 0.0 111.061 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 tp -66.63 -41.52 88.19 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.83 -46.48 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -55.07 -38.24 67.8 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.834 -0.541 . . . . 0.0 111.009 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -78.57 -49.37 13.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.575 -0.703 . . . . 0.0 110.594 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.89 -45.63 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.733 -0.604 . . . . 0.0 110.005 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.7 m -59.55 -32.75 70.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.0 109.716 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.44 -35.64 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.038 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -61.97 -45.18 94.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.369 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -66.2 -29.54 69.83 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.919 -0.488 . . . . 0.0 110.943 179.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.81 -17.98 60.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.077 -0.39 . . . . 0.0 111.921 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.9 mt -103.31 -28.44 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.823 -0.548 . . . . 0.0 110.593 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -70.65 -42.2 71.12 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.163 -0.96 . . . . 0.0 111.01 -179.973 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.7 71.65 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' HG12 ' A' ' 33' ' ' VAL . 42.8 Cg_endo -62.99 -40.29 35.24 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 O-C-N 123.957 1.504 . . . . 0.0 111.332 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.68 -38.99 77.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.485 -0.759 . . . . 0.0 109.265 179.343 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -33.04 74.83 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 122.046 -0.409 . . . . 0.0 111.296 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -59.15 -29.95 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.478 -0.764 . . . . 0.0 110.209 179.758 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.57 17.41 5.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.645 -0.66 . . . . 0.0 110.666 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -144.53 25.22 1.51 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.561 -0.712 . . . . 0.0 109.999 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.44 -54.88 2.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.209 -0.932 . . . . 0.0 110.1 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.21 51.52 0.69 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.1 mm -108.58 142.08 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.863 -0.787 . . . . 0.0 109.851 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m 56.62 58.03 4.41 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.205 0.526 . . . . 0.0 109.962 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 117.285 -1.341 . . . . 0.0 110.285 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -111.53 34.88 3.88 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.883 -0.774 . . . . 0.0 111.203 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.81 -51.06 2.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.397 -0.815 . . . . 0.0 109.789 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.32 96.97 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.894 -0.503 . . . . 0.0 110.515 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.55 -40.68 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.683 -0.635 . . . . 0.0 109.483 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.6 mm -61.05 -38.38 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.49 -30.21 59.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.73 -0.606 . . . . 0.0 109.865 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tp -89.25 12.32 16.34 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.654 -0.654 . . . . 0.0 111.924 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -58.6 -31.43 68.04 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.178 -0.951 . . . . 0.0 111.073 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -73.72 -36.72 65.23 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.547 -0.72 . . . . 0.0 109.816 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.77 43.69 1.9 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.505 0.669 . . . . 0.0 110.245 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.1 tp -87.37 136.46 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.588 -0.695 . . . . 0.0 109.876 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 94.7 m-70 -137.31 98.15 10.3 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.617 -0.677 . . . . 0.0 109.822 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 43.3 Cg_endo -64.3 -45.19 10.1 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 O-C-N 123.885 1.466 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.24 -31.96 73.36 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.708 -0.62 . . . . 0.0 110.559 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 2.2 mm? -66.54 -39.66 88.7 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.025 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mm -64.82 -42.29 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -60.3 -33.37 72.26 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.6 m -68.67 -43.25 76.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.46 ' HA ' HD12 ' A' ' 23' ' ' ILE . 37.1 mm -66.58 -42.31 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.079 -0.388 . . . . 0.0 110.037 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.3 p -63.54 -37.94 89.25 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.455 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.42 -40.92 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.738 -0.601 . . . . 0.0 109.546 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 20' ' ' ILE . 14.8 mt -74.01 -43.57 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -44.71 89.05 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.86 -0.525 . . . . 0.0 109.795 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.22 -5.08 45.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.808 -0.558 . . . . 0.0 111.298 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.52 9.27 21.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.613 -0.679 . . . . 0.0 110.53 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -107.56 -41.06 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.2 mm? -86.27 -45.42 11.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.328 -0.858 . . . . 0.0 108.968 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.582 ' O ' HG23 ' A' ' 33' ' ' VAL . . . 69.91 75.49 0.57 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.82 -38.4 30.44 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.781 1.411 . . . . 0.0 110.737 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.66 -43.14 90.28 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.3 mtt -65.09 -36.42 84.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.11 -0.369 . . . . 0.0 110.439 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 29' ' ' GLY . 56.9 t -58.85 -36.46 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.498 -0.751 . . . . 0.0 109.98 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.25 7.48 46.05 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.594 -0.691 . . . . 0.0 111.53 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.78 17.6 6.27 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.404 -0.81 . . . . 0.0 110.889 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.2 79.31 1.98 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.45 44.61 6.47 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 tp -95.67 34.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.717 -0.872 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.6 p -115.13 50.72 0.96 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.046 -1.034 . . . . 0.0 110.123 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 mttt . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.55 179.964 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.445 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -130.46 -174.66 3.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.735 -0.862 . . . . 0.0 109.742 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.83 35.96 24.49 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.416 0.627 . . . . 0.0 110.147 -179.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -174.66 -51.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.24 -38.18 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.958 -0.464 . . . . 0.0 109.817 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -62.83 -32.9 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -81.13 -25.57 36.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.537 -0.727 . . . . 0.0 110.521 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.28 21.14 9.36 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.416 -0.803 . . . . 0.0 111.967 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -87.95 -20.7 25.55 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.911 -1.118 . . . . 0.0 112.151 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.0 t -79.9 -53.61 6.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.348 -0.845 . . . . 0.0 111.027 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.25 42.35 1.1 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.585 -0.697 . . . . 0.0 111.451 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.7 tp -59.4 143.19 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.734 -0.604 . . . . 0.0 110.674 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.557 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 1.7 m-70 -145.87 84.54 8.13 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.487 -0.758 . . . . 0.0 110.433 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.669 ' HA ' HD12 ' A' ' 17' ' ' ILE . 43.0 Cg_endo -65.68 -45.59 6.38 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 O-C-N 123.544 1.286 . . . . 0.0 111.078 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.21 -36.81 83.08 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.653 -0.654 . . . . 0.0 110.122 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -65.49 -42.93 91.61 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.372 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 14' ' ' PRO . 46.6 mt -57.49 -44.54 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.351 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.94 -42.93 99.67 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.131 -0.356 . . . . 0.0 110.119 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.7 m -59.04 -40.91 86.53 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.45 HG22 HD23 ' A' ' 24' ' ' LEU . 49.2 mt -65.17 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 m -60.36 -41.13 93.04 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.633 -0.667 . . . . 0.0 109.783 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -63.62 -41.34 98.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.457 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.454 HG22 HD12 ' A' ' 27' ' ' ILE . 32.5 mm -77.66 -26.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -57.91 -45.46 86.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.498 -0.751 . . . . 0.0 109.566 179.573 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -16.53 63.96 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.782 -0.574 . . . . 0.0 111.365 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.27 5.71 50.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.827 -0.545 . . . . 0.0 111.073 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.454 HD12 HG22 ' A' ' 23' ' ' ILE . 96.8 mt -139.14 -51.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 0.0 109.319 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 59.39 35.9 23.17 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.426 0.632 . . . . 0.0 111.342 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.86 58.15 0.15 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.582 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.3 -34.72 26.41 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.755 1.397 . . . . 0.0 111.702 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 31' ' ' LEU . 2.9 mm? -59.42 -48.05 83.13 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.731 -0.606 . . . . 0.0 110.163 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.8 ttt -64.96 -45.09 87.16 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.9 t -61.55 -39.81 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.84 -0.538 . . . . 0.0 110.479 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.14 5.17 23.53 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.473 -0.767 . . . . 0.0 112.292 179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.47 29.6 2.41 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.192 -0.943 . . . . 0.0 110.829 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.51 97.75 8.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.518 -0.739 . . . . 0.0 109.173 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.69 48.2 29.82 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.57 150.38 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.862 -0.787 . . . . 0.0 110.083 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m 56.84 60.38 3.07 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.462 0.648 . . . . 0.0 109.419 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.924 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.084 -179.595 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.462 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -174.53 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.333 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.84 40.86 32.03 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 121.6 0.714 . . . . 0.0 109.146 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.54 -55.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.62 -42.3 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.64 -39.75 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -40.0 94.93 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.994 -0.441 . . . . 0.0 109.823 179.388 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.32 -16.55 63.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.666 -0.646 . . . . 0.0 111.792 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 12' ' ' ILE . 91.5 m -99.21 -43.28 6.68 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.4 m -66.75 -32.5 73.83 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.058 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.27 69.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.284 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 9' ' ' THR . 1.7 pt -63.65 -173.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.443 -179.395 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -142.96 129.85 10.74 Favored Pre-proline 0 N--CA 1.481 1.115 0 O-C-N 121.065 -1.022 . . . . 0.0 110.432 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.54 -160.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.548 2.166 . . . . 0.0 110.198 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 61.93 21.96 12.69 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 121.8 0.81 . . . . 0.0 110.228 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.1 tp -144.1 -53.87 0.34 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.03 -45.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.648 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.94 82.21 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -62.98 -42.68 99.91 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.26 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.5 mm -60.62 -42.25 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -63.47 -38.81 92.58 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.712 -0.618 . . . . 0.0 109.646 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -60.08 -35.91 76.23 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.497 . . . . 0.0 109.851 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.47 -31.18 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.246 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.79 -45.68 93.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.651 -0.655 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.6 -13.07 61.94 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.925 179.356 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.26 -8.24 33.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.73 -0.606 . . . . 0.0 111.056 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 27' ' ' ILE . 39.3 mm -125.51 36.75 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.569 -0.707 . . . . 0.0 109.367 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -157.18 76.2 0.84 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.966 -1.084 . . . . 0.0 109.745 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' N ' ' CD ' ' A' ' 30' ' ' PRO . . . -145.63 51.57 0.6 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 29' ' ' GLY . 45.6 Cg_endo -65.83 -31.5 47.9 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.445 1.43 . . . . 0.0 111.521 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 31' ' ' LEU . 3.2 mm? -58.7 -46.21 87.78 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.657 -0.652 . . . . 0.0 109.819 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.7 mmt -69.78 -40.75 75.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.99 -37.74 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.691 -0.631 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 16.49 3.56 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.527 -0.733 . . . . 0.0 112.433 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.45 26.0 0.77 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.16 -0.962 . . . . 0.0 111.215 179.664 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.43 -48.33 5.07 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.141 -0.974 . . . . 0.0 109.94 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.46 60.61 0.52 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 tp -80.12 133.02 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.794 -0.827 . . . . 0.0 110.44 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 p -144.4 -54.56 0.34 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.616 -0.678 . . . . 0.0 110.963 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 118.767 -0.635 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -108.33 23.97 13.71 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.82 -0.812 . . . . 0.0 111.155 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.404 ' HA ' HD12 ' A' ' 6' ' ' ILE . 9.1 p-10 -100.6 -42.41 6.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.378 -0.826 . . . . 0.0 110.266 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.85 -27.46 62.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.706 -0.621 . . . . 0.0 110.583 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.79 -38.01 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.756 -0.59 . . . . 0.0 109.929 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 3' ' ' ASP . 11.1 mt -62.75 -44.49 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.309 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.0 tp -69.35 -18.66 63.82 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.766 -0.584 . . . . 0.0 110.472 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.74 7.24 43.94 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.371 -0.831 . . . . 0.0 111.621 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -78.87 -40.82 31.42 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.179 -0.951 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.5 p -69.2 -13.8 62.62 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.543 -0.723 . . . . 0.0 112.161 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.29 46.83 0.92 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.172 -0.955 . . . . 0.0 110.227 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 tt -136.17 175.41 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.83 -0.544 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 67.21 106.86 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.307 0 C-N-CA 122.987 0.515 . . . . 0.0 111.257 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.96 -26.27 66.62 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.257 1.305 . . . . 0.0 112.041 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.77 -10.39 59.36 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.532 -0.73 . . . . 0.0 111.913 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -103.93 -39.81 6.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.514 -0.741 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.4 mm -54.37 -41.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 122.053 -0.405 . . . . 0.0 110.388 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -63.69 -38.65 91.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.713 -0.617 . . . . 0.0 110.171 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -65.41 -39.17 91.82 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.751 -0.593 . . . . 0.0 109.739 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.98 -43.96 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.602 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.8 m -58.75 -41.38 86.39 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.812 -0.555 . . . . 0.0 109.889 179.513 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.18 -35.8 74.19 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.931 -0.481 . . . . 0.0 110.456 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.78 -20.14 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.736 -0.603 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tp -57.98 -45.36 86.89 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.47 -29.32 70.36 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.846 -0.533 . . . . 0.0 110.037 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.62 -36.17 29.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.26 0.552 . . . . 0.0 110.208 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 27' ' ' ILE . 45.2 mm -109.25 48.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.438 0.637 . . . . 0.0 109.726 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.74 -26.57 59.88 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.076 -1.015 . . . . 0.0 111.322 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.06 59.28 4.34 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.69 -29.77 15.44 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 123.606 1.319 . . . . 0.0 111.576 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 3.4 mm? -58.09 -34.81 70.57 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.594 -0.691 . . . . 0.0 111.287 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.6 -34.91 18.36 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.51 -0.744 . . . . 0.0 110.397 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -74.67 -39.52 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.497 -0.752 . . . . 0.0 110.689 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.39 16.97 5.67 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.423 -0.798 . . . . 0.0 112.147 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 29.4 mt-30 -146.49 24.88 1.23 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.243 -0.911 . . . . 0.0 110.435 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.96 -57.64 2.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.97 49.12 0.87 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.4 mm -114.87 50.4 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.723 -0.869 . . . . 0.0 109.118 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -154.55 49.82 0.61 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.63 0.728 . . . . 0.0 110.014 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.9 tptt . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.957 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -110.61 24.95 12.32 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.708 -0.877 . . . . 0.0 110.757 179.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -100.2 -36.36 9.33 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.363 -0.835 . . . . 0.0 110.218 179.715 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.18 -37.92 8.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.847 -0.533 . . . . 0.0 110.177 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.94 -43.12 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.696 -0.628 . . . . 0.0 110.564 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.12 -36.07 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.424 -0.797 . . . . 0.0 109.342 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.9 tp -78.11 -33.53 50.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.783 -0.573 . . . . 0.0 110.536 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 13.24 13.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.515 -0.74 . . . . 0.0 112.132 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -66.21 -29.44 69.71 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.897 -1.127 . . . . 0.0 111.543 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.9 m -72.27 -35.27 68.69 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.445 -0.784 . . . . 0.0 112.004 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.73 11.86 24.34 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.255 -0.903 . . . . 0.0 112.848 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.3 tt -69.51 139.74 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.011 -1.055 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CD2' HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER 56.28 68.6 2.18 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 122.259 -0.275 . . . . 0.0 111.098 -179.986 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.0 -34.98 36.36 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.295 1.33 . . . . 0.0 111.605 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.02 -38.23 90.35 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.584 0.707 . . . . 0.0 109.613 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 13' ' ' HIS . 11.0 tp -73.9 -33.24 63.93 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.616 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.661 ' O ' HG22 ' A' ' 20' ' ' ILE . 12.6 mm -60.79 -35.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.674 -0.642 . . . . 0.0 109.597 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -75.85 -44.07 42.62 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m -66.24 -33.33 75.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.767 -0.583 . . . . 0.0 110.809 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 17' ' ' ILE . 2.5 tp -59.86 -34.24 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.13 -0.981 . . . . 0.0 110.098 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -65.62 -43.85 88.31 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -65.33 -44.15 88.73 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 23' ' ' ILE . 25.3 mm -63.61 -36.91 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.69 -38.84 79.12 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.612 -0.68 . . . . 0.0 110.121 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.95 -11.24 60.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.616 -0.678 . . . . 0.0 111.13 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.44 7.81 45.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.75 -0.594 . . . . 0.0 110.531 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm -126.93 -52.71 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.592 -0.693 . . . . 0.0 109.648 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 tp 57.83 71.58 0.57 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.717 0.77 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.95 55.42 0.4 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -66.21 -32.03 43.28 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 O-C-N 123.639 1.336 . . . . 0.0 111.223 179.666 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 31' ' ' LEU . 2.6 mm? -62.07 -45.39 93.74 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.675 -0.641 . . . . 0.0 110.638 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.2 mtp -62.32 -38.62 90.15 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.861 -0.524 . . . . 0.0 110.101 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.9 t -75.83 -30.43 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.691 -0.63 . . . . 0.0 110.619 179.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.0 mt -90.85 3.84 53.39 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.286 -0.883 . . . . 0.0 112.843 -179.712 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.598 ' HA ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -141.89 31.14 1.62 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 0.0 110.565 179.67 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.75 102.23 11.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 0.0 109.59 179.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.14 42.76 66.38 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 35' ' ' GLN . 86.9 mt -126.14 119.6 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.68 -0.894 . . . . 0.0 109.756 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.4 m -145.96 -72.51 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.519 -0.738 . . . . 0.0 110.637 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 117.339 -1.315 . . . . 0.0 110.941 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.556 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.57 18.19 21.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.923 -0.751 . . . . 0.0 110.36 179.517 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -114.98 -43.56 3.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.0 109.701 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.47 -39.02 62.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.786 -0.572 . . . . 0.0 109.739 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.2 t -62.65 -42.51 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mm -59.22 -46.35 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.339 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.12 -38.9 92.13 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.255 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.91 -31.87 70.23 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.926 0.394 . . . . 0.0 110.99 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.3 m -79.7 -38.77 32.75 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.511 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 t -74.45 -33.57 62.95 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.711 -0.618 . . . . 0.0 110.725 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.16 35.21 1.19 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.542 -0.724 . . . . 0.0 111.379 179.855 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 tp -90.26 143.45 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.398 -0.814 . . . . 0.0 109.552 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -154.59 101.08 2.38 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.452 -0.78 . . . . 0.0 111.149 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.58 167.0 25.46 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 O-C-N 123.581 1.306 . . . . 0.0 110.22 179.52 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 54.96 41.41 31.91 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 122.434 1.111 . . . . 0.0 109.504 -179.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 tt -167.75 -51.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.5 mt -58.14 -40.22 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -41.67 96.05 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.854 -0.529 . . . . 0.0 109.916 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -61.94 -41.7 98.26 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.532 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 17' ' ' ILE . 17.8 mt -63.68 -42.28 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.8 m -61.98 -33.95 75.25 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.487 -0.758 . . . . 0.0 110.022 179.483 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -69.12 -37.38 78.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 25.4 mt -102.63 6.03 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.786 -0.571 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -54.42 -50.12 68.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.852 -1.155 . . . . 0.0 110.626 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 31' ' ' LEU . 32.0 mt -68.32 -19.22 64.66 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.243 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.34 10.45 39.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.109 -0.369 . . . . 0.0 111.166 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 2.7 tt -120.87 -8.04 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.249 -0.907 . . . . 0.0 111.905 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.3 -50.83 50.85 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.105 -0.997 . . . . 0.0 111.008 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.56 -52.56 0.83 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -93.36 53.56 0.41 Allowed 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 121.981 1.787 . . . . 0.0 110.038 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 25' ' ' LEU . 1.3 tt -49.42 -49.14 46.29 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.903 -0.498 . . . . 0.0 111.676 -179.763 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -41.56 25.52 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.351 -0.843 . . . . 0.0 110.524 179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.4 t -63.04 -41.61 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.718 -0.614 . . . . 0.0 110.271 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tp -85.22 7.38 22.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.618 -0.676 . . . . 0.0 111.682 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -122.86 13.83 9.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.254 -0.904 . . . . 0.0 110.5 179.443 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.49 -52.14 6.38 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.197 -0.939 . . . . 0.0 109.429 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.73 -42.83 8.74 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mt -80.78 129.85 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.666 -0.903 . . . . 0.0 108.925 179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -107.97 48.35 0.85 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.634 0.73 . . . . 0.0 110.577 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.4 tttt . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.47 179.9 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.463 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -123.59 8.28 8.92 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.753 -0.851 . . . . 0.0 112.264 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.79 -52.98 3.42 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.869 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.77 -27.95 69.54 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.992 -0.442 . . . . 0.0 110.644 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.84 -32.64 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.504 -0.747 . . . . 0.0 110.208 179.595 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.7 mm -67.0 -40.09 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.448 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.3 tp -74.37 -33.03 62.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.802 -0.562 . . . . 0.0 109.785 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.87 18.41 5.71 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.485 -0.759 . . . . 0.0 111.886 179.791 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.589 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 13.3 t -55.69 -28.8 57.54 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.397 -0.815 . . . . 0.0 110.682 179.58 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.0 m -70.44 -34.27 72.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.677 -0.64 . . . . 0.0 109.445 179.261 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.15 -39.29 19.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.55 -0.719 . . . . 0.0 110.358 179.635 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.589 ' CG1' ' HA ' ' A' ' 9' ' ' THR . 1.4 pt -80.65 126.34 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.529 -0.732 . . . . 0.0 110.492 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 16.2 t-160 -144.16 98.21 5.14 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.444 -0.785 . . . . 0.0 109.993 -179.838 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.902 ' HA ' HD12 ' A' ' 17' ' ' ILE . 44.0 Cg_endo -66.68 -38.36 18.58 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.549 1.499 . . . . 0.0 111.746 179.925 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -57.95 -33.77 69.18 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.674 -0.641 . . . . 0.0 110.816 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -36.04 82.17 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.376 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 14' ' ' PRO . 7.7 mt -65.02 -30.54 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.751 -0.593 . . . . 0.0 109.706 179.462 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -88.43 -25.95 22.39 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.426 -0.796 . . . . 0.0 109.863 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.7 m -88.93 -21.57 23.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 0.0 110.503 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 17' ' ' ILE . 15.8 tt -53.49 -37.66 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 121.315 -0.865 . . . . 0.0 110.581 -179.994 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -71.01 -39.7 72.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -61.58 -36.12 79.76 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.294 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 20' ' ' ILE . 17.9 mt -74.3 -30.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.66 -0.65 . . . . 0.0 109.35 179.25 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 27' ' ' ILE . 11.0 tp -60.0 -41.21 91.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.701 -0.624 . . . . 0.0 110.297 179.739 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.68 2.59 28.94 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.503 -0.748 . . . . 0.0 110.701 179.034 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.634 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -117.2 10.89 13.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.515 -0.74 . . . . 0.0 110.355 179.294 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 24' ' ' LEU . 14.1 tt -98.63 -29.01 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.605 -0.684 . . . . 0.0 109.987 179.848 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.57 -21.74 38.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.73 -0.606 . . . . 0.0 110.35 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.74 58.55 0.43 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.609 ' HA ' HG12 ' A' ' 33' ' ' VAL . 42.7 Cg_endo -62.35 -34.91 75.8 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.92 1.747 . . . . 0.0 111.493 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 31' ' ' LEU . 3.1 mm? -60.65 -41.87 95.85 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.634 -0.667 . . . . 0.0 109.661 179.666 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ttp -80.93 -41.64 22.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.887 -0.508 . . . . 0.0 110.522 179.779 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.634 HG11 ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -60.4 -32.31 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.544 -0.722 . . . . 0.0 111.21 -179.897 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -30.81 70.61 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.456 -0.777 . . . . 0.0 111.332 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -97.25 21.47 9.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.165 -0.334 . . . . 0.0 111.084 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.26 57.76 0.63 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.332 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.25 58.06 0.24 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.573 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 tt -113.42 31.11 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 122.001 -0.705 . . . . 0.0 110.73 -179.826 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -135.86 53.6 1.94 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.293 -0.88 . . . . 0.0 109.873 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.0 tttm . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.197 179.877 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.517 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -122.24 18.35 10.69 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.736 -0.861 . . . . 0.0 111.174 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -101.87 -58.02 1.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.368 -0.832 . . . . 0.0 109.476 179.767 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.92 -28.59 69.05 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.956 -0.465 . . . . 0.0 110.876 179.596 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.84 -34.55 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.766 -0.584 . . . . 0.0 110.241 179.761 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.3 mt -63.34 -44.86 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.356 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.94 -37.2 81.33 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.185 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -27.95 69.52 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.9 -0.5 . . . . 0.0 111.302 179.698 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.5 m -68.86 -35.2 76.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.965 -0.46 . . . . 0.0 109.991 179.681 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 69.3 m -95.66 37.23 1.21 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.445 -0.784 . . . . 0.0 110.578 179.643 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.74 38.24 0.27 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.447 -0.783 . . . . 0.0 110.501 179.873 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.3 tt -135.55 148.24 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.572 -0.705 . . . . 0.0 110.797 -179.75 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 17.3 m170 -124.25 78.68 60.33 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.389 -0.819 . . . . 0.0 110.286 -179.929 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.21 -36.15 17.31 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.311 1.341 . . . . 0.0 111.047 179.996 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -79.79 4.41 16.53 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.664 -0.647 . . . . 0.0 111.026 179.396 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -112.38 -47.77 3.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.475 -0.766 . . . . 0.0 109.007 179.494 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.832 ' HA ' HD12 ' A' ' 20' ' ' ILE . 71.7 mt -56.96 -45.03 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -44.56 94.63 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.736 -0.603 . . . . 0.0 109.601 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.484 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 2.4 m -61.23 -33.95 74.32 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.818 -0.551 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 17' ' ' ILE . 64.1 mt -60.43 -40.25 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.44 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -58.75 -39.49 81.1 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.251 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HD2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -64.89 -43.48 92.74 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.187 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 HD11 ' A' ' 27' ' ' ILE . 48.2 mm -71.31 -33.28 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.313 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.547 ' HA ' HD12 ' A' ' 27' ' ' ILE . 1.6 tp -55.56 -41.49 73.35 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.867 -0.521 . . . . 0.0 109.834 179.411 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 2.71 22.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.733 -0.604 . . . . 0.0 111.302 179.3 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.65 6.53 11.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.481 -0.762 . . . . 0.0 110.903 179.374 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 24' ' ' LEU . 28.1 mt -99.22 -29.29 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 0.0 109.465 179.63 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mt -84.58 15.33 3.84 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.52 -0.738 . . . . 0.0 111.614 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.11 55.07 0.4 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.549 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.42 -30.77 43.85 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.473 1.449 . . . . 0.0 111.116 -179.946 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mp -55.22 -43.53 74.6 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.709 -0.62 . . . . 0.0 109.778 179.692 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 50.0 mtm -75.55 -41.72 54.17 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.284 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.58 -36.85 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.789 -0.569 . . . . 0.0 110.181 179.644 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.74 18.71 5.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.491 -0.755 . . . . 0.0 111.569 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -152.53 29.26 0.54 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.505 -0.747 . . . . 0.0 110.459 179.765 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.89 -37.97 28.84 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.296 -0.877 . . . . 0.0 111.348 -179.798 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.05 -31.49 42.86 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.875 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mm -99.3 118.35 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.516 -0.99 . . . . 0.0 110.044 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 15.0 t -110.83 20.11 17.89 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.84 -0.537 . . . . 0.0 111.607 179.77 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 39' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.509 2.481 0 O-C-N 121.62 -0.675 . . . . 0.0 112.038 -179.977 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.09 -175.13 2.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.705 -0.879 . . . . 0.0 109.193 179.739 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 56.74 38.59 29.61 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.442 0.639 . . . . 0.0 110.38 -179.892 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.13 -52.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.874 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.2 t -60.5 -39.04 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.642 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.2 mt -62.14 -37.38 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.533 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.3 tp -78.61 -27.28 45.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.743 -0.598 . . . . 0.0 110.258 179.427 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tp -89.04 15.52 8.53 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.55 -0.718 . . . . 0.0 111.598 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.422 ' HA ' HG22 ' A' ' 12' ' ' ILE . 5.4 t -69.45 -25.71 64.23 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.162 -0.961 . . . . 0.0 111.346 179.839 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.21 -37.73 81.2 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.415 -0.803 . . . . 0.0 110.225 179.77 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.42 -48.17 57.31 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.646 -0.659 . . . . 0.0 110.146 179.782 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.647 HG23 ' HD3' ' A' ' 14' ' ' PRO . 13.6 tt -75.91 156.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.613 -0.679 . . . . 0.0 110.098 179.694 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -120.93 70.45 19.0 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.444 -0.785 . . . . 0.0 110.182 179.819 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.647 ' HD3' HG23 ' A' ' 12' ' ' ILE . 49.6 Cg_endo -73.36 -18.88 22.76 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.431 1.227 . . . . 0.0 111.748 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -60.36 -48.42 81.82 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.582 -0.699 . . . . 0.0 111.419 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.8 tp -53.69 -44.85 70.1 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.258 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 14' ' ' PRO . 11.9 mt -64.07 -38.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.321 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.46 -34.83 77.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.825 -0.547 . . . . 0.0 109.952 179.276 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.1 m -59.4 -42.62 92.19 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.788 -0.57 . . . . 0.0 109.912 179.637 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.44 -43.43 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.524 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.5 m -61.69 -39.78 92.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.682 -0.636 . . . . 0.0 109.85 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -60.52 -51.83 67.77 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.9 mt -63.48 -35.74 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.12 -41.18 92.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 179.341 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.35 -18.61 62.37 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.951 -0.468 . . . . 0.0 110.952 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.11 -1.63 57.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.861 -0.524 . . . . 0.0 111.522 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -128.32 -53.35 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.589 -0.695 . . . . 0.0 109.667 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 58.4 51.6 8.05 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.356 0.598 . . . . 0.0 110.611 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.9 68.06 0.01 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.3 -39.82 3.58 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.647 1.341 . . . . 0.0 111.477 179.777 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.45 -51.03 71.63 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.424 -0.798 . . . . 0.0 111.318 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.9 ptm -64.16 -23.64 67.39 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.742 -0.599 . . . . 0.0 112.047 -179.819 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.5 t -89.62 -39.87 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 179.709 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mp -85.1 6.34 25.96 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.481 -0.762 . . . . 0.0 112.35 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -135.12 25.39 3.56 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.045 -1.035 . . . . 0.0 110.811 179.487 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.85 -44.48 13.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.411 -0.805 . . . . 0.0 109.859 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.24 56.62 0.62 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.0 tt -108.32 19.94 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 122.092 -0.652 . . . . 0.0 111.638 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 p -124.5 58.03 1.23 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.092 -1.005 . . . . 0.0 109.362 179.832 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 tptp . . . . . 0 N--CA 1.504 2.265 0 CA-C-O 117.247 -1.359 . . . . 0.0 111.04 -179.805 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -114.37 24.54 11.83 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.724 -0.868 . . . . 0.0 111.058 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -102.05 -54.05 2.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.479 -0.763 . . . . 0.0 109.839 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.92 -32.43 70.76 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.014 -0.429 . . . . 0.0 110.537 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.27 -40.07 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.653 -0.654 . . . . 0.0 109.605 179.678 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.7 mt -66.16 -41.47 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.729 -0.607 . . . . 0.0 109.535 179.67 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.3 tp -69.5 -31.69 70.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.389 -0.819 . . . . 0.0 110.968 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.486 HD23 HD13 ' A' ' 12' ' ' ILE . 1.5 tp -73.2 -14.75 61.41 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.508 -0.745 . . . . 0.0 112.105 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.44 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 1.4 t -50.89 -28.93 10.64 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.633 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.5 t -60.13 -33.93 72.82 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.423 -0.798 . . . . 0.0 111.742 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -117.45 -62.51 1.56 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.35 -0.844 . . . . 0.0 110.986 -179.892 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.486 HD13 HD23 ' A' ' 8' ' ' LEU . 47.6 mm 58.49 91.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-O 121.805 0.812 . . . . 0.0 110.847 -179.811 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 45.1 t-80 -132.51 99.06 16.02 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.771 -0.581 . . . . 0.0 109.799 179.798 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 45.0 Cg_endo -65.02 -177.34 0.57 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 O-C-N 123.83 1.437 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.6 28.05 17.74 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.796 0.808 . . . . 0.0 109.868 -179.13 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -152.1 -53.89 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.709 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.2 mp -62.19 -32.54 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.801 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -87.8 -39.32 14.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.3 m -69.39 -22.95 63.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.752 -0.592 . . . . 0.0 110.87 179.641 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 17' ' ' ILE . 2.1 tp -55.43 -36.0 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.044 0.838 . . . . 0.0 110.142 179.765 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.1 p -65.08 -42.91 93.67 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.081 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -67.54 -36.52 81.14 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.435 ' O ' HG12 ' A' ' 27' ' ' ILE . 71.1 mt -73.55 -36.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.56 -0.712 . . . . 0.0 109.827 179.605 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.6 tp -48.75 -49.8 36.7 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.619 -0.676 . . . . 0.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.49 -5.7 44.13 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.648 -0.658 . . . . 0.0 111.8 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -107.59 3.67 25.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.718 -0.614 . . . . 0.0 111.078 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 23' ' ' ILE . 22.6 mm -104.29 -44.73 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.443 -0.786 . . . . 0.0 108.968 179.72 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -67.73 -40.08 84.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.057 -0.402 . . . . 0.0 110.305 179.763 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.46 63.84 2.28 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' O ' HD23 ' A' ' 34' ' ' LEU . 44.1 Cg_endo -65.12 -26.59 57.51 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.609 1.32 . . . . 0.0 111.916 -179.849 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.56 -44.97 10.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.353 -0.842 . . . . 0.0 109.816 179.681 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.3 ttt -69.3 -46.78 66.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.669 -0.644 . . . . 0.0 110.654 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.91 -29.0 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.625 -0.672 . . . . 0.0 110.689 179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 30' ' ' PRO . 1.3 mm? -73.04 -8.29 55.06 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.193 -0.942 . . . . 0.0 112.027 179.583 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -131.56 21.6 4.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.378 -0.826 . . . . 0.0 110.984 179.661 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.95 -53.68 4.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.743 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.09 46.59 1.15 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.433 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 tp -97.74 146.52 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.716 -0.873 . . . . 0.0 110.451 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 39' ' ' THR . 9.6 t -152.23 67.24 0.84 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.887 0.851 . . . . 0.0 109.902 179.943 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.376 -0.827 . . . . 0.0 110.207 179.935 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.538 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.86 19.24 8.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.723 -0.869 . . . . 0.0 111.906 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -104.2 -55.19 2.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.605 -0.685 . . . . 0.0 109.675 -179.864 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.52 -38.87 47.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.864 -0.523 . . . . 0.0 110.542 179.694 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -63.41 -45.07 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.95 -0.469 . . . . 0.0 110.172 179.936 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.2 mm -62.78 -40.26 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.722 -0.611 . . . . 0.0 109.38 179.712 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 11' ' ' ALA . 10.3 tp -64.88 -34.13 77.66 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.691 -0.63 . . . . 0.0 109.869 179.472 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 tp -73.7 -14.37 61.13 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.376 -0.827 . . . . 0.0 111.516 179.572 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.4 m -106.59 -41.57 5.23 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.666 -0.646 . . . . 0.0 110.548 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.4 m -92.77 -30.35 15.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.635 -0.666 . . . . 0.0 111.404 -179.789 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.539 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -105.72 50.58 0.77 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.293 -0.88 . . . . 0.0 110.029 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.25 -1.09 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.931 -0.481 . . . . 0.0 112.14 -179.823 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.08 66.23 7.13 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 120.852 -1.155 . . . . 0.0 110.538 179.687 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.89 -34.44 30.11 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.247 1.298 . . . . 0.0 111.489 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.51 -39.72 80.88 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.637 -0.665 . . . . 0.0 110.701 179.776 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.96 -38.14 53.88 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 122.148 -0.345 . . . . 0.0 110.32 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.08 -47.44 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.677 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.98 -32.98 72.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.849 -0.532 . . . . 0.0 111.386 179.92 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -71.25 -42.95 68.15 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 80.9 mt -65.01 -42.58 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 179.913 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 p -65.25 -37.54 87.53 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.413 -0.804 . . . . 0.0 110.402 179.779 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.34 -46.43 64.17 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mm -65.79 -38.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.523 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 24' ' ' LEU . 1.8 tm? -60.1 -39.61 86.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.545 -0.722 . . . . 0.0 109.822 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.74 -22.47 37.26 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.359 -0.838 . . . . 0.0 111.026 179.582 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.47 12.34 14.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.842 -0.536 . . . . 0.0 111.438 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mm -117.24 -43.64 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.301 -0.874 . . . . 0.0 109.993 179.744 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mt -106.72 -74.61 0.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.54 -0.725 . . . . 0.0 110.412 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 33' ' ' VAL . . . 65.57 70.79 1.01 Allowed Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.892 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.09 -34.5 13.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.534 1.281 . . . . 0.0 111.52 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.61 -48.87 79.98 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.66 -0.65 . . . . 0.0 110.669 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 5.1 ptt? -71.06 -28.96 64.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.635 -0.666 . . . . 0.0 110.77 179.742 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 29' ' ' GLY . 38.7 t -64.51 -33.78 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.236 -0.915 . . . . 0.0 110.473 179.681 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.08 -1.55 56.39 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.39 -0.819 . . . . 0.0 112.056 179.812 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.3 18.61 6.44 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.309 -0.869 . . . . 0.0 111.169 179.758 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.32 78.37 2.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.13 -0.981 . . . . 0.0 108.442 179.451 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.59 42.66 17.1 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.319 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.0 tp -81.46 145.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.599 -0.942 . . . . 0.0 110.237 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.8 m -110.07 51.5 0.76 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.729 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.657 -179.726 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.437 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 ttp-105 -128.57 31.35 5.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.754 -0.851 . . . . 0.0 110.218 179.874 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.61 -55.32 2.45 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.974 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.67 -36.37 32.5 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.261 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.75 -43.84 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.607 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 mm -64.1 -38.27 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.21 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.54 -30.11 64.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.611 -0.681 . . . . 0.0 109.877 179.295 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.75 7.14 18.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.58 -0.7 . . . . 0.0 111.72 179.712 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.54 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 6.3 t -59.3 -31.82 69.49 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.269 -0.894 . . . . 0.0 111.378 -179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 m -64.68 -38.93 92.66 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.465 -0.772 . . . . 0.0 110.025 179.421 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.82 66.15 1.48 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.985 0.897 . . . . 0.0 108.685 179.557 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.54 ' CG2' ' HA ' ' A' ' 9' ' ' THR . 24.9 pt -64.21 167.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-O 121.631 0.729 . . . . 0.0 111.729 -179.421 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -118.58 -171.23 0.2 Allowed Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.822 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 13' ' ' HIS . 47.0 Cg_endo -80.26 -174.04 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.117 1.878 . . . . 0.0 110.612 -179.926 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 58.75 36.91 25.07 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.28 1.038 . . . . 0.0 110.233 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.67 -51.12 0.06 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.616 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.7 mt -54.74 -39.38 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.946 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -62.04 -42.62 99.37 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.308 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -66.63 -39.77 88.45 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.789 HD12 ' HA ' ' A' ' 17' ' ' ILE . 81.4 mt -55.56 -39.15 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.623 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -42.37 82.92 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.698 -0.626 . . . . 0.0 109.509 179.488 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -68.84 -41.31 78.7 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.606 HG22 HD11 ' A' ' 27' ' ' ILE . 22.2 mm -75.97 -23.69 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.739 -0.6 . . . . 0.0 110.081 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.28 -42.52 70.1 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.486 -0.759 . . . . 0.0 109.784 179.67 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 25' ' ' LEU . 1.8 mm? -70.53 -11.46 60.94 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.885 -0.509 . . . . 0.0 110.935 179.146 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.38 13.0 30.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.456 179.192 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 23' ' ' ILE . 62.4 mt -121.73 -2.48 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.322 -0.861 . . . . 0.0 111.042 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.2 30.94 0.74 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.516 -1.365 . . . . 0.0 111.866 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.54 53.23 0.4 Allowed Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.695 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.54 -37.0 18.06 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.612 1.322 . . . . 0.0 110.505 179.806 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.83 -44.09 94.22 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.899 -0.5 . . . . 0.0 109.79 179.66 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.4 ttt -62.2 -45.06 95.07 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.35 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.5 -39.73 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.475 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.15 -22.51 65.77 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.809 -0.557 . . . . 0.0 111.928 179.963 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.61 21.25 17.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.73 -0.606 . . . . 0.0 110.687 179.554 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.9 74.48 8.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.234 -0.916 . . . . 0.0 109.35 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.11 40.15 10.67 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.749 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 38' ' ' ILE . 8.4 tt -76.84 98.75 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 118.251 1.025 . . . . 0.0 109.649 179.886 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 m 57.98 37.83 26.75 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.735 -0.603 . . . . 0.0 110.392 -179.617 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.6 mptt . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.153 179.984 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.506 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -78.06 86.29 4.23 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 122.191 0.996 . . . . 0.0 111.212 -179.875 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.88 -64.99 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.739 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.41 -29.73 27.9 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.935 -0.478 . . . . 0.0 110.636 179.741 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.91 -39.76 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.796 -0.565 . . . . 0.0 109.806 179.915 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mt -63.26 -38.6 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.291 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tt -73.29 -36.02 66.22 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.993 -0.442 . . . . 0.0 110.15 179.51 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.68 12.65 14.23 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.706 -0.621 . . . . 0.0 112.255 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.571 ' HA ' HG22 ' A' ' 12' ' ' ILE . 7.6 t -62.83 -32.38 73.58 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.232 -0.918 . . . . 0.0 111.622 179.876 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.2 t -70.92 -29.71 65.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.535 -0.728 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.06 -0.7 33.08 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.36 -0.837 . . . . 0.0 112.054 179.938 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.571 HG22 ' HA ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -120.88 19.59 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.013 -1.054 . . . . 0.0 112.097 -179.854 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -121.15 77.45 32.73 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.034 -1.041 . . . . 0.0 110.85 179.788 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -80.26 -173.65 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.65 1.342 . . . . 0.0 110.128 179.572 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 67.05 3.08 2.98 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.731 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -124.02 -48.48 1.87 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.081 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.904 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.4 mt -52.03 -41.87 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -42.8 99.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 0.0 110.068 179.628 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -66.85 -33.86 76.52 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.747 -0.596 . . . . 0.0 110.0 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 17' ' ' ILE . 86.9 mt -58.3 -43.39 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.253 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 m -69.09 -41.76 77.04 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.032 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -59.65 -46.03 90.25 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.514 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 27' ' ' ILE . 40.9 mm -82.09 -15.56 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.712 -0.617 . . . . 0.0 110.249 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HA ' HD12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -54.33 -45.63 72.7 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 179.664 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.01 -21.91 66.91 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.387 179.237 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.41 0.45 56.22 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.056 -0.402 . . . . 0.0 111.188 179.215 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 24' ' ' LEU . 55.2 mt -110.16 9.18 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.46 -0.775 . . . . 0.0 109.898 179.543 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.7 mm? -54.4 -51.28 65.35 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.082 -1.011 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.45 75.72 0.98 Allowed Glycine 0 N--CA 1.497 2.763 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.642 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.84 -34.23 9.03 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 123.579 1.304 . . . . 0.0 111.131 179.497 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.68 -50.74 71.27 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.685 -0.634 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.8 ptp -64.54 -35.18 80.15 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.649 -0.657 . . . . 0.0 110.76 179.971 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.41 -31.76 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.561 -0.712 . . . . 0.0 109.64 179.382 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 34' ' ' LEU . 3.1 mm? -96.86 7.33 46.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.587 -0.696 . . . . 0.0 111.43 179.681 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -129.85 20.59 5.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.382 -0.824 . . . . 0.0 110.446 179.69 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.25 76.31 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.619 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.77 55.79 0.87 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.476 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tt -121.38 42.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.719 -0.871 . . . . 0.0 111.337 -179.991 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.7 p -114.39 42.71 2.04 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.981 -1.075 . . . . 0.0 109.756 179.453 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.199 0 O-C-N 122.053 -0.404 . . . . 0.0 110.628 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.7 ptt85 -121.85 5.64 9.92 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.957 -0.731 . . . . 0.0 111.834 179.852 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -108.53 -46.44 3.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.7 -0.625 . . . . 0.0 110.57 -179.662 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.04 -39.95 22.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.568 -0.708 . . . . 0.0 109.712 179.658 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.12 -41.91 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.747 -0.595 . . . . 0.0 109.673 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.4 mm -66.59 -37.12 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.309 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -30.4 62.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.757 -0.59 . . . . 0.0 110.04 179.41 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.44 25.02 3.61 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.615 -0.678 . . . . 0.0 111.174 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 t -67.16 -25.22 66.05 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.085 -1.009 . . . . 0.0 111.5 179.895 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.5 p -59.31 -28.76 67.09 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.387 -0.82 . . . . 0.0 110.989 179.606 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -113.94 -70.53 0.8 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.55 -0.719 . . . . 0.0 109.112 179.571 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 11' ' ' ALA . 3.0 tt 40.29 29.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 179.598 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.64 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 60.6 92.18 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 122.049 -0.407 . . . . 0.0 110.329 179.947 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 42.3 Cg_endo -63.04 -32.93 75.39 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.35 1.366 . . . . 0.0 112.107 -179.709 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -67.39 -37.06 82.53 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.449 -0.782 . . . . 0.0 109.033 179.205 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -66.82 -38.63 86.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.155 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.5 mm -63.8 -40.26 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.204 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.6 -36.47 71.79 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.5 m -73.62 -39.9 64.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.201 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -41.34 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.853 -0.53 . . . . 0.0 110.364 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 p -65.54 -36.49 83.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.473 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -58.83 -42.76 89.99 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.405 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -74.88 -35.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.025 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.79 -44.57 82.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.427 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -14.61 62.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.788 -0.57 . . . . 0.0 111.423 179.431 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.73 5.17 52.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.782 -0.574 . . . . 0.0 110.637 179.18 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.0 mt -126.81 -37.83 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 0.0 110.246 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.37 -36.81 74.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.393 -0.817 . . . . 0.0 111.768 -179.815 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.33 49.55 0.56 Allowed Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.288 -179.886 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.43 -32.11 20.62 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 O-C-N 123.414 1.218 . . . . 0.0 110.904 179.248 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.13 -43.37 95.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.709 -0.619 . . . . 0.0 110.209 179.789 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.1 mtp -63.64 -43.23 97.38 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.685 -0.634 . . . . 0.0 109.476 179.385 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.99 -35.75 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.382 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 34' ' ' LEU . 3.5 mm? -82.78 10.63 7.27 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.603 -0.686 . . . . 0.0 111.568 179.56 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -127.15 22.77 6.58 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.279 -0.888 . . . . 0.0 110.209 179.468 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.35 -55.37 3.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.256 -0.903 . . . . 0.0 109.016 179.731 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.42 41.92 1.88 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.325 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.1 tt -75.69 153.12 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.706 -0.879 . . . . 0.0 111.067 -179.78 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -108.74 42.76 1.35 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.636 -0.665 . . . . 0.0 109.967 179.738 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.13 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.408 -179.821 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.561 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.0 23.87 13.03 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.283 -0.54 . . . . 0.0 111.964 -179.951 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -99.37 -50.02 4.25 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.517 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.88 -27.74 68.44 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.179 179.569 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.8 t -63.35 -38.38 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 O-C-N 121.705 -0.622 . . . . 0.0 110.027 179.782 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.0 mm -60.57 -42.48 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.42 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.19 -32.39 73.79 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.124 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 7.53 13.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.477 -0.764 . . . . 0.0 111.844 179.585 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.0 m -93.7 -26.79 16.87 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.084 -1.01 . . . . 0.0 110.574 179.762 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.6 p -62.26 -31.16 71.7 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.154 -0.966 . . . . 0.0 111.411 179.893 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.81 -46.94 27.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.385 -0.822 . . . . 0.0 110.052 179.741 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.454 HG23 ' HD3' ' A' ' 14' ' ' PRO . 3.1 tp -68.79 156.89 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.595 -0.691 . . . . 0.0 109.619 179.71 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -112.0 86.05 7.17 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.564 -0.71 . . . . 0.0 110.2 -179.75 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD3' HG23 ' A' ' 12' ' ' ILE . 50.1 Cg_endo -71.29 -172.47 0.75 Allowed 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.275 1.316 . . . . 0.0 110.442 179.703 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 56.1 44.98 24.38 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.258 1.028 . . . . 0.0 110.599 -179.878 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.65 -51.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.26 -36.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.805 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -63.12 -34.61 77.98 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.085 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 m -78.77 -27.52 44.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.681 -0.637 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.18 -45.18 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.69 -0.631 . . . . 0.0 110.198 179.975 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -67.02 -33.86 76.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.636 -0.665 . . . . 0.0 110.018 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -68.47 -50.83 49.5 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.6 -23.27 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.748 -0.595 . . . . 0.0 109.808 179.204 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -55.77 -42.65 75.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.511 -0.743 . . . . 0.0 110.014 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -70.09 -24.62 63.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.585 -0.697 . . . . 0.0 110.664 179.552 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.62 -24.8 28.97 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.773 -0.58 . . . . 0.0 111.183 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 27' ' ' ILE . 50.1 mm -103.35 33.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-O 121.201 0.524 . . . . 0.0 110.457 179.919 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 25' ' ' LEU . 1.3 mt -76.47 -27.6 56.2 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.735 -1.228 . . . . 0.0 110.537 179.49 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.23 70.37 0.02 OUTLIER Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.906 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.52 -49.11 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.774 1.407 . . . . 0.0 110.827 -179.923 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.16 -36.49 83.24 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.801 -0.562 . . . . 0.0 109.787 179.64 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 39.4 ttm -60.98 -45.32 95.29 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.562 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.12 -34.17 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.913 -0.492 . . . . 0.0 109.721 179.454 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mp -87.37 -1.74 58.13 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.632 -0.667 . . . . 0.0 111.964 179.708 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -123.66 22.87 8.96 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.394 -0.816 . . . . 0.0 110.709 179.73 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.65 76.11 1.37 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.338 -0.851 . . . . 0.0 109.064 179.702 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.04 51.37 2.27 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.56 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.98 125.16 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.606 -0.938 . . . . 0.0 110.77 -179.92 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -149.88 71.51 1.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.834 -1.079 . . . . 0.0 110.316 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.442 ' O ' HD12 ' A' ' 6' ' ' ILE . 3.6 ttp180 -123.68 8.69 8.87 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.969 -0.724 . . . . 0.0 111.199 179.956 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -110.44 -51.2 2.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.897 -1.127 . . . . 0.0 109.608 179.911 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.51 74.41 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.896 -0.503 . . . . 0.0 110.839 179.697 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.44 -48.51 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.592 -0.693 . . . . 0.0 110.608 -179.887 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 2' ' ' ARG . 42.1 mt -59.97 -42.97 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.751 -0.593 . . . . 0.0 109.462 179.656 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.68 -36.43 80.85 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.001 -0.437 . . . . 0.0 110.567 179.607 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.59 -43.38 80.66 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.733 -0.604 . . . . 0.0 111.014 179.913 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.2 m -64.15 -41.89 97.0 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.783 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.45 -39.61 93.93 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.483 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.17 -39.34 78.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.893 -0.505 . . . . 0.0 110.305 179.61 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.9 mt -92.7 81.77 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.76 0.79 . . . . 0.0 109.509 179.865 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 59.3 3.54 Favored Pre-proline 0 N--CA 1.499 2.02 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.052 179.816 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.46 -178.85 4.74 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 O-C-N 123.121 1.064 . . . . 0.0 111.173 -179.777 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 59.66 13.96 3.73 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-O 121.333 0.587 . . . . 0.0 111.997 -179.486 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 20' ' ' ILE . 13.8 tp -143.04 -59.76 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.213 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.8 -32.56 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.16 -39.73 28.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.897 -0.502 . . . . 0.0 109.676 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -61.37 -47.57 85.25 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.854 -0.529 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 16' ' ' LEU . 13.6 mt -58.5 -45.33 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -64.78 -33.3 75.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.825 -0.547 . . . . 0.0 110.541 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -68.46 -40.31 81.09 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.432 -0.793 . . . . 0.0 110.704 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.8 -36.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.786 -0.571 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.71 -44.27 93.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.522 -0.736 . . . . 0.0 109.727 179.644 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.31 -14.81 59.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.81 -0.556 . . . . 0.0 111.017 179.429 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.79 14.01 22.77 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.842 -0.536 . . . . 0.0 110.801 179.34 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 27' ' ' ILE . 12.0 mm -120.97 -69.2 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.631 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt 49.47 67.04 0.95 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.592 0.71 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.07 70.56 0.03 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.23 -28.48 55.81 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 O-C-N 123.903 1.475 . . . . 0.0 111.493 179.571 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 tp -62.3 -40.73 97.24 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.553 -0.717 . . . . 0.0 110.143 179.708 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ttt -62.29 -36.48 82.22 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.916 -0.49 . . . . 0.0 109.73 179.511 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.6 t -62.33 -33.45 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.861 -0.524 . . . . 0.0 109.627 179.472 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.6 12.34 5.89 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.521 -0.737 . . . . 0.0 111.585 179.506 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.48 24.75 2.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.935 -1.103 . . . . 0.0 110.452 179.654 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.51 104.71 8.2 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.236 -0.915 . . . . 0.0 109.876 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.42 -0.89 22.15 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.678 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.0 tp -70.67 146.3 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 119.12 1.46 . . . . 0.0 110.378 179.997 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 15.1 p -112.94 54.28 0.73 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.738 -0.601 . . . . 0.0 109.75 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 39' ' ' THR . 7.0 mttm . . . . . 0 N--CA 1.509 2.492 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.723 -179.931 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -102.61 -165.98 1.23 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.793 -0.828 . . . . 0.0 110.315 179.783 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 31.45 21.37 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.131 0.491 . . . . 0.0 111.051 -179.592 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -170.72 -54.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.99 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.15 -47.4 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.61 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.03 -41.35 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.437 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 7' ' ' LEU . 1.5 tm? -64.61 -34.63 78.73 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.077 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.72 11.78 8.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.602 -0.686 . . . . 0.0 111.694 179.501 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 12' ' ' ILE . 18.6 m -102.51 -45.08 5.17 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.948 -1.095 . . . . 0.0 110.116 179.719 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 t -56.84 -38.77 73.13 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.807 -0.558 . . . . 0.0 111.712 -179.792 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.66 -20.97 66.61 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.637 -0.664 . . . . 0.0 111.886 -179.923 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 9' ' ' THR . 73.3 mt -76.48 118.43 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.208 -0.932 . . . . 0.0 109.991 179.932 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -147.46 84.6 7.1 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.721 -0.612 . . . . 0.0 110.131 179.761 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HA ' HD12 ' A' ' 17' ' ' ILE . 42.9 Cg_endo -63.7 -27.24 68.51 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 O-C-N 123.824 1.434 . . . . 0.0 110.935 179.858 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.49 -44.81 95.47 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.494 0.664 . . . . 0.0 109.442 179.397 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -41.27 90.22 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.294 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 14' ' ' PRO . 38.4 mt -60.19 -42.15 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.502 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -63.64 -41.11 98.28 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.677 -0.64 . . . . 0.0 109.854 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.5 m -61.54 -42.94 99.57 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.471 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.09 -37.92 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.989 -0.444 . . . . 0.0 109.903 179.534 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.2 m -64.64 -39.57 93.94 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.208 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -61.93 -44.15 97.37 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.97 -41.59 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 27' ' ' ILE . 9.7 tp -57.82 -41.21 81.77 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.279 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.98 -30.67 71.27 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.249 0.547 . . . . 0.0 109.994 179.099 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.95 -0.65 49.58 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.595 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 24' ' ' LEU . 48.3 mt -105.11 -45.87 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.895 . . . . 0.0 110.002 179.908 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.0 mt -73.58 -38.37 65.18 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.743 -0.598 . . . . 0.0 111.581 -179.673 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.44 -65.98 3.13 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.845 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.14 38.19 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.407 1.404 . . . . 0.0 111.222 179.882 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.06 -45.41 67.14 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.387 -0.821 . . . . 0.0 110.016 179.822 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -80.66 -37.08 31.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.755 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.06 -34.26 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.718 -0.613 . . . . 0.0 109.962 179.682 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.99 14.12 4.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.663 -0.648 . . . . 0.0 111.232 179.396 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -134.13 26.64 3.87 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.304 -0.873 . . . . 0.0 110.612 179.847 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.17 101.54 12.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.297 -0.877 . . . . 0.0 109.783 179.779 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.97 52.94 25.51 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 15.8 tt -70.31 136.77 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.748 -0.854 . . . . 0.0 110.8 -179.97 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.0 p -132.58 32.72 3.85 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.07 0.462 . . . . 0.0 109.948 179.88 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 117.797 -1.097 . . . . 0.0 109.753 -179.746 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.599 ' HA ' HD12 ' A' ' 20' ' ' ILE . 64.4 mt -61.76 -41.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.904 -0.498 . . . . 0.0 109.989 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.61 -42.61 88.58 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.2 m -62.35 -39.43 93.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 17' ' ' ILE . 68.0 mt -63.46 -43.35 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 m -58.91 -42.04 88.68 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -61.8 -47.28 85.85 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.89 -33.62 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.597 ' O ' HG22 ' A' ' 27' ' ' ILE . 2.9 tp -56.06 -43.24 77.73 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.835 -0.541 . . . . 0.0 109.621 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.65 -30.62 68.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.732 -0.605 . . . . 0.0 110.12 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.19 -7.23 59.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 24' ' ' LEU . 7.3 tt . . . . . 0 N--CA 1.502 2.162 0 O-C-N 121.433 -0.792 . . . . 0.0 111.562 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.3 tp . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.6 -42.19 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -45.12 86.19 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.098 -0.376 . . . . 0.0 110.445 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 m -57.77 -42.09 83.32 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.69 -42.88 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.782 -0.574 . . . . 0.0 109.586 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -60.26 -41.46 93.29 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.732 -0.605 . . . . 0.0 110.088 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -58.65 -38.04 77.27 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.663 HG22 HD12 ' A' ' 27' ' ' ILE . 25.5 mm -85.5 -29.06 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.85 -46.77 81.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.669 -0.645 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.86 -27.68 68.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.475 -0.766 . . . . 0.0 110.486 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.73 -31.69 57.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.309 0.576 . . . . 0.0 109.677 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 23' ' ' ILE . 70.0 mt . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.91 -35.63 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -71.68 -33.41 68.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.79 -0.569 . . . . 0.0 110.164 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.7 m -73.28 -42.13 62.81 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.0 110.412 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -64.53 -44.69 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.827 -0.545 . . . . 0.0 110.982 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.3 t -64.5 -30.48 71.51 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.242 -0.911 . . . . 0.0 110.746 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.297 -0.877 . . . . 0.0 109.315 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.682 HG22 HG13 ' A' ' 27' ' ' ILE . 52.4 mt -98.17 10.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.788 -0.57 . . . . 0.0 110.597 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.18 -42.7 86.61 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.753 -1.217 . . . . 0.0 110.941 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.5 7.68 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.457 -0.777 . . . . 0.0 110.702 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.54 14.87 11.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.627 -0.671 . . . . 0.0 109.769 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.682 HG13 HG22 ' A' ' 23' ' ' ILE . 34.7 mt . . . . . 0 N--CA 1.497 1.921 0 O-C-N 121.554 -0.717 . . . . 0.0 109.443 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -61.16 -31.28 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -70.03 -45.39 67.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.698 -0.626 . . . . 0.0 109.966 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.8 m -70.17 -42.99 71.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.705 -0.622 . . . . 0.0 109.756 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.2 mm -65.82 -48.28 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 0.0 110.219 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.42 ' O ' HD23 ' A' ' 25' ' ' LEU . 2.9 t -63.5 -30.22 71.37 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.313 0.96 . . . . 0.0 110.878 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -40.24 93.01 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.867 0.758 . . . . 0.0 109.223 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -31.52 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.09 -49.32 74.16 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.833 -0.542 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 21' ' ' THR . 2.9 pp -70.23 -11.32 60.81 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.575 -0.703 . . . . 0.0 111.927 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.28 -1.07 48.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.32 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 179.926 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.3 mt -72.41 -27.54 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.69 -39.61 70.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.953 . . . . 0.0 109.504 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.4 m -71.98 -39.2 69.47 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.72 -0.612 . . . . 0.0 110.252 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 17' ' ' ILE . 1.9 tp -60.32 -26.12 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.414 -0.803 . . . . 0.0 110.862 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -60.74 -41.69 95.89 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.492 -0.755 . . . . 0.0 109.339 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -63.61 -45.71 89.07 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 20' ' ' ILE . 6.2 mt -61.09 -40.73 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -61.45 -38.58 87.72 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 mt -76.96 -3.49 39.15 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.518 . . . . 0.0 111.365 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.28 -11.63 15.96 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.636 -0.665 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.612 -0.68 . . . . 0.0 109.568 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.8 mp -74.06 -23.41 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.555 -0.715 . . . . 0.0 111.193 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -88.92 -42.69 11.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.963 -1.085 . . . . 0.0 108.748 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.8 m -64.81 -30.17 71.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.926 -0.484 . . . . 0.0 110.844 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 17' ' ' ILE . 9.0 tp -55.08 -36.34 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.417 -0.802 . . . . 0.0 110.243 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -68.7 -41.55 78.99 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -42.57 99.36 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -62.24 -38.24 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -60.16 -40.74 90.98 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -4.18 46.63 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.731 -0.605 . . . . 0.0 110.876 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.42 5.1 14.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.451 -0.781 . . . . 0.0 111.036 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.445 ' O ' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.47 -0.768 . . . . 0.0 110.4 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.14 -40.92 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.39 -23.43 62.6 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.013 -0.429 . . . . 0.0 111.056 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.0 m -100.48 -43.56 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.431 -0.793 . . . . 0.0 110.64 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 20' ' ' ILE . 20.4 mm -73.42 -56.16 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.593 -0.692 . . . . 0.0 111.676 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -58.12 -35.42 71.45 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 119.203 0.911 . . . . 0.0 111.258 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -40.25 92.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.59 -0.694 . . . . 0.0 110.165 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.2 mt -81.0 -36.99 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -61.49 -47.35 86.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.673 -0.642 . . . . 0.0 109.773 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -20.91 65.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.642 -0.661 . . . . 0.0 111.195 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.68 -17.94 39.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.686 -0.634 . . . . 0.0 111.492 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.499 1.978 0 O-C-N 121.768 -0.582 . . . . 0.0 109.778 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 21' ' ' THR . 1.6 mp -67.1 -37.87 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.58 -34.49 72.78 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -69.26 -45.75 68.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.76 -41.05 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.872 -0.517 . . . . 0.0 109.607 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 17' ' ' ILE . 72.9 p -64.91 -30.3 71.29 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -64.29 -42.18 96.52 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.5 -39.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -64.34 -39.55 94.11 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.06 -28.08 66.22 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.779 -0.575 . . . . 0.0 110.5 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.8 -16.71 60.7 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.746 0.308 . . . . 0.0 111.608 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.3 mt . . . . . 0 N--CA 1.498 1.949 0 O-C-N 121.707 -0.621 . . . . 0.0 110.437 -179.849 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' O ' HD13 ' A' ' 20' ' ' ILE . 28.3 tp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.5 -48.7 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.621 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -44.25 69.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.632 -0.668 . . . . 0.0 110.763 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -58.45 -41.53 85.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.449 -0.782 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 16' ' ' LEU . 1.3 mp -64.54 -51.31 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.66 -0.65 . . . . 0.0 110.266 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -65.28 -33.12 75.23 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.377 -0.827 . . . . 0.0 110.52 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -66.08 -46.09 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.46 -40.69 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -36.4 79.26 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.724 -0.61 . . . . 0.0 109.439 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.27 -4.04 58.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.751 -0.593 . . . . 0.0 110.991 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.62 14.26 24.63 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 110.257 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.1 mm . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.33 -0.856 . . . . 0.0 109.311 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 20' ' ' ILE . 9.0 mm -61.23 -27.46 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -91.12 -36.06 14.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 23' ' ' ILE . 7.3 m -76.67 -26.56 54.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.716 -0.615 . . . . 0.0 110.674 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 17' ' ' ILE . 9.5 tp -52.17 -39.78 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.505 -0.747 . . . . 0.0 111.508 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.6 p -63.73 -44.22 94.2 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -66.82 -44.29 81.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 19' ' ' THR . 27.9 mm -62.87 -35.28 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.871 -0.518 . . . . 0.0 109.723 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.75 -42.93 84.97 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.696 -0.627 . . . . 0.0 110.119 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.97 -8.07 56.08 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.744 -0.598 . . . . 0.0 111.292 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.47 1.73 41.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.622 -0.673 . . . . 0.0 110.767 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.704 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.25 -29.22 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.43 -36.12 63.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.99 -0.444 . . . . 0.0 110.436 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.7 m -73.57 -48.78 30.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.1 mm -54.89 -49.78 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.787 -0.571 . . . . 0.0 111.402 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -62.91 -34.7 78.0 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.627 -0.67 . . . . 0.0 110.54 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -68.0 -41.29 82.5 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.628 -0.67 . . . . 0.0 109.837 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.96 -38.63 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.78 -41.31 95.31 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.63 -17.02 60.76 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.071 -0.393 . . . . 0.0 111.072 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.0 12.62 29.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.841 -0.537 . . . . 0.0 111.204 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.774 . . . . 0.0 109.491 179.832 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.733 ' HA ' HD12 ' A' ' 20' ' ' ILE . 17.1 mm -53.97 -41.79 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.983 -0.448 . . . . 0.0 110.395 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.72 -41.55 86.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.794 -0.566 . . . . 0.0 109.972 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.5 m -64.73 -43.84 92.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.78 -0.575 . . . . 0.0 109.578 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -58.41 -44.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.663 -0.648 . . . . 0.0 109.763 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.4 m -62.83 -42.83 99.89 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.739 -0.6 . . . . 0.0 109.802 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -44.14 97.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.836 -0.54 . . . . 0.0 110.007 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mm -62.1 -40.03 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.31 -43.21 88.06 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.3 -28.86 67.55 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.972 0.415 . . . . 0.0 110.171 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.34 60.77 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.484 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 19' ' ' THR . 4.1 mp . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.792 ' HA ' HD12 ' A' ' 20' ' ' ILE . 25.5 mm -59.5 -38.12 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -65.89 -36.81 84.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.113 -0.367 . . . . 0.0 110.636 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -76.53 -25.49 54.18 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.358 -0.839 . . . . 0.0 111.546 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 17' ' ' ILE . 44.2 mt -58.3 -48.88 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.417 -0.802 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.3 p -65.32 -36.5 84.24 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.749 -0.594 . . . . 0.0 109.898 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -45.37 93.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 90.1 mt -62.58 -37.06 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.96 -42.14 97.71 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.697 -0.627 . . . . 0.0 110.538 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.71 5.42 51.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.648 . . . . 0.0 111.305 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 27' ' ' ILE . 80.1 mt . . . . . 0 N--CA 1.504 2.274 0 O-C-N 121.135 -0.978 . . . . 0.0 111.279 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.3 mt -59.11 -42.55 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.29 -39.13 85.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -61.27 -45.1 95.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.95 -0.469 . . . . 0.0 109.916 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.65 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.756 -0.59 . . . . 0.0 109.452 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.0 m -61.09 -40.53 94.08 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.592 -0.693 . . . . 0.0 109.41 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -63.21 -45.58 91.02 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.818 -0.551 . . . . 0.0 109.695 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.76 -39.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.4 -42.53 82.41 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.845 -0.535 . . . . 0.0 109.635 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 tt -67.45 -35.65 79.63 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.235 0.541 . . . . 0.0 110.011 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.43 -8.51 54.29 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.536 -0.728 . . . . 0.0 109.668 179.738 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 20' ' ' ILE . 2.8 tt . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.7 mm -60.16 -38.75 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.56 -32.15 73.53 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.697 -0.627 . . . . 0.0 110.678 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 m -85.4 -49.45 8.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.716 -0.615 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.404 HD13 HD23 ' A' ' 16' ' ' LEU . 1.2 mp -58.99 -43.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -60.7 -39.05 87.05 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -44.62 88.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.698 -0.626 . . . . 0.0 109.58 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.93 -40.64 96.2 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.583 -0.698 . . . . 0.0 109.166 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 25' ' ' LEU . 2.6 mm? -68.23 -22.56 64.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.838 -0.539 . . . . 0.0 110.496 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.02 -11.36 53.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.157 -0.339 . . . . 0.0 111.396 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 27' ' ' ILE . 63.3 mt . . . . . 0 N--CA 1.501 2.11 0 O-C-N 121.572 -0.705 . . . . 0.0 110.051 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 tp . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 17' ' ' ILE . 3.1 mm -57.09 -35.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -87.01 -33.81 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -71.23 -40.23 71.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.474 -0.766 . . . . 0.0 109.832 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 18.7 mm -65.59 -44.97 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.747 -0.595 . . . . 0.0 109.922 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 p -63.7 -39.37 94.15 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.811 -0.556 . . . . 0.0 110.691 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -59.18 -47.06 86.7 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.715 -0.616 . . . . 0.0 109.63 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.92 -29.1 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -57.71 -47.75 81.52 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.22 -33.39 73.41 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.298 0.571 . . . . 0.0 110.377 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.6 62.42 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.594 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 27' ' ' ILE . 60.8 mt . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.851 -0.531 . . . . 0.0 109.724 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.831 ' HA ' HD12 ' A' ' 20' ' ' ILE . 4.8 mt -62.03 -38.66 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -61.14 -28.52 69.17 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.819 -0.551 . . . . 0.0 110.686 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.3 m -88.98 -26.56 21.42 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.305 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.831 HD12 ' HA ' ' A' ' 17' ' ' ILE . 70.1 mt -60.48 -45.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.404 -0.81 . . . . 0.0 109.131 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.542 HG23 ' HD3' ' A' ' 22' ' ' LYS . 8.9 t -60.58 -33.54 72.86 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.805 -0.56 . . . . 0.0 109.812 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.542 ' HD3' HG23 ' A' ' 21' ' ' THR . 0.1 OUTLIER -70.69 -48.43 54.79 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.77 -34.18 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -40.28 78.13 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -12.28 59.97 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.973 -0.454 . . . . 0.0 111.276 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.01 8.63 28.42 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.784 -0.572 . . . . 0.0 110.942 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 0.0 109.75 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.538 ' HA ' HD12 ' A' ' 20' ' ' ILE . 42.4 mm -61.31 -39.18 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -45.42 93.1 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.808 -0.557 . . . . 0.0 110.223 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.8 m -60.81 -39.0 87.28 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.762 -0.586 . . . . 0.0 110.539 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 17' ' ' ILE . 45.4 mt -65.35 -44.89 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.834 -0.541 . . . . 0.0 109.595 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.7 m -64.1 -39.11 93.35 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.717 -0.614 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -60.85 -45.66 93.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.721 -0.612 . . . . 0.0 109.429 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.19 -40.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -42.18 86.72 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 25' ' ' LEU . 33.7 mt -78.53 -1.78 35.56 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.787 -0.571 . . . . 0.0 111.435 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.97 13.0 20.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.772 . . . . 0.0 110.3 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.4 mt . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.356 -0.84 . . . . 0.0 109.596 179.878 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 N--CA 1.501 2.075 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 mm -63.73 -39.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.22 -38.82 84.53 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -65.62 -43.07 90.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.81 -42.46 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -59.81 -41.65 91.71 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.706 -0.621 . . . . 0.0 109.75 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -43.89 94.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.793 -0.567 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 23' ' ' ILE . 30.4 mm -62.1 -38.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 tp -61.34 -40.5 94.49 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.436 ' HA ' HD13 ' A' ' 25' ' ' LEU . 3.3 mm? -66.41 -36.02 81.78 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.3 68.68 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.197 0.522 . . . . 0.0 110.772 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.501 2.081 0 O-C-N 122.051 -0.406 . . . . 0.0 110.367 179.632 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 N--CA 1.499 1.979 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.39 -41.2 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -60.58 -36.65 79.03 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.912 -0.492 . . . . 0.0 111.072 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -85.67 -44.35 12.65 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 110.555 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mt -60.06 -40.98 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.959 -0.463 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -65.52 -31.13 72.02 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 119.581 1.082 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.82 -36.38 59.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.39 -0.819 . . . . 0.0 109.612 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 23' ' ' ILE . 46.2 mt -100.93 9.51 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 110.647 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 tp -58.16 -48.86 78.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.818 -1.176 . . . . 0.0 109.625 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -78.82 -14.03 59.48 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.907 -0.495 . . . . 0.0 110.906 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.55 21.96 15.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 111.571 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.198 0 O-C-N 121.307 -0.871 . . . . 0.0 111.305 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 20' ' ' ILE . 63.1 mt -59.38 -37.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -65.26 -38.6 90.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.912 -0.493 . . . . 0.0 109.925 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.1 m -65.04 -43.12 93.4 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.75 -0.594 . . . . 0.0 109.503 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 17' ' ' ILE . 14.4 mt -61.33 -41.94 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.957 -0.464 . . . . 0.0 109.749 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.6 m -65.08 -40.0 94.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.597 -0.689 . . . . 0.0 110.155 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -57.48 -45.02 85.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.962 -0.461 . . . . 0.0 109.89 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -38.19 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -59.18 -49.6 77.23 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.442 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -17.03 62.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.82 -0.55 . . . . 0.0 111.31 179.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.03 2.18 56.51 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.807 -0.558 . . . . 0.0 111.184 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.4 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.449 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.506 ' HA ' HG22 ' A' ' 20' ' ' ILE . 37.1 mt -65.39 -38.65 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.67 -26.32 67.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.686 -0.634 . . . . 0.0 110.692 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -96.46 -41.96 8.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.689 -0.632 . . . . 0.0 109.963 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 17' ' ' ILE . 9.0 tt -57.39 -33.37 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.717 -0.614 . . . . 0.0 111.254 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.8 p -63.49 -43.25 97.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.498 -0.751 . . . . 0.0 109.168 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -63.92 -35.68 81.47 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.519 HG22 HD12 ' A' ' 27' ' ' ILE . 33.3 mm -75.48 -40.9 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.59 -43.62 93.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.48 -32.99 74.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.797 -0.564 . . . . 0.0 110.44 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.84 -30.14 63.77 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.239 0.542 . . . . 0.0 110.533 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 27' ' ' ILE . 47.7 mt . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mt -71.39 -36.36 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.6 -34.98 71.73 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.92 -0.488 . . . . 0.0 109.696 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.2 m -75.68 -41.13 54.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 20' ' ' ILE . 23.4 mm -64.8 -40.31 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.995 -0.441 . . . . 0.0 110.271 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.8 p -64.73 -37.21 86.82 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.497 -0.752 . . . . 0.0 109.741 179.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -45.02 93.99 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -65.13 -37.14 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.64 -40.85 89.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.205 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 25' ' ' LEU . 2.2 mm? -68.26 -22.11 64.78 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.871 -0.518 . . . . 0.0 110.593 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.82 5.78 47.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.09 -0.382 . . . . 0.0 110.817 179.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm . . . . . 0 N--CA 1.499 2.017 0 O-C-N 121.496 -0.752 . . . . 0.0 109.902 -179.884 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 N--CA 1.5 2.069 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.83 -46.48 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -55.07 -38.24 67.8 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.834 -0.541 . . . . 0.0 111.009 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -78.57 -49.37 13.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.575 -0.703 . . . . 0.0 110.594 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.89 -45.63 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.733 -0.604 . . . . 0.0 110.005 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.7 m -59.55 -32.75 70.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.0 109.716 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.44 -35.64 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.038 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -61.97 -45.18 94.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -66.2 -29.54 69.83 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.919 -0.488 . . . . 0.0 110.943 179.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.81 -17.98 60.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.077 -0.39 . . . . 0.0 111.921 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.9 mt . . . . . 0 N--CA 1.499 1.99 0 O-C-N 121.823 -0.548 . . . . 0.0 110.593 -179.977 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 16' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mm -64.82 -42.29 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -60.3 -33.37 72.26 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.6 m -68.67 -43.25 76.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.46 ' HA ' HD12 ' A' ' 23' ' ' ILE . 37.1 mm -66.58 -42.31 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.079 -0.388 . . . . 0.0 110.037 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.3 p -63.54 -37.94 89.25 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.455 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.42 -40.92 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.738 -0.601 . . . . 0.0 109.546 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 20' ' ' ILE . 14.8 mt -74.01 -43.57 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -44.71 89.05 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.86 -0.525 . . . . 0.0 109.795 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.22 -5.08 45.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.808 -0.558 . . . . 0.0 111.298 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.52 9.27 21.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.613 -0.679 . . . . 0.0 110.53 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 0.0 109.931 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.6 mt -57.49 -44.54 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.94 -42.93 99.67 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.131 -0.356 . . . . 0.0 110.119 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.7 m -59.04 -40.91 86.53 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.45 HG22 HD23 ' A' ' 24' ' ' LEU . 49.2 mt -65.17 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 m -60.36 -41.13 93.04 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.633 -0.667 . . . . 0.0 109.783 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -63.62 -41.34 98.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.454 HG22 HD12 ' A' ' 27' ' ' ILE . 32.5 mm -77.66 -26.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -57.91 -45.46 86.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.498 -0.751 . . . . 0.0 109.566 179.573 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -16.53 63.96 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.782 -0.574 . . . . 0.0 111.365 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.27 5.71 50.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.827 -0.545 . . . . 0.0 111.073 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.454 HD12 HG22 ' A' ' 23' ' ' ILE . 96.8 mt . . . . . 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 0.0 109.319 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.03 -45.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.648 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.94 82.21 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -62.98 -42.68 99.91 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.5 mm -60.62 -42.25 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -63.47 -38.81 92.58 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.712 -0.618 . . . . 0.0 109.646 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -60.08 -35.91 76.23 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.497 . . . . 0.0 109.851 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.47 -31.18 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.79 -45.68 93.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.651 -0.655 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.6 -13.07 61.94 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.925 179.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.26 -8.24 33.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.73 -0.606 . . . . 0.0 111.056 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 27' ' ' ILE . 39.3 mm . . . . . 0 N--CA 1.499 2.0 0 O-C-N 121.569 -0.707 . . . . 0.0 109.367 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.4 mm -54.37 -41.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 122.053 -0.405 . . . . 0.0 110.388 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -63.69 -38.65 91.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.713 -0.617 . . . . 0.0 110.171 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -65.41 -39.17 91.82 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.751 -0.593 . . . . 0.0 109.739 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.98 -43.96 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.8 m -58.75 -41.38 86.39 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.812 -0.555 . . . . 0.0 109.889 179.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.18 -35.8 74.19 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.931 -0.481 . . . . 0.0 110.456 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.78 -20.14 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.736 -0.603 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tp -57.98 -45.36 86.89 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.47 -29.32 70.36 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.846 -0.533 . . . . 0.0 110.037 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.62 -36.17 29.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.26 0.552 . . . . 0.0 110.208 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 27' ' ' ILE . 45.2 mm . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 121.438 0.637 . . . . 0.0 109.726 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.661 ' O ' HG22 ' A' ' 20' ' ' ILE . 12.6 mm -60.79 -35.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.674 -0.642 . . . . 0.0 109.597 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -75.85 -44.07 42.62 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m -66.24 -33.33 75.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.767 -0.583 . . . . 0.0 110.809 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 17' ' ' ILE . 2.5 tp -59.86 -34.24 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.13 -0.981 . . . . 0.0 110.098 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -65.62 -43.85 88.31 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -65.33 -44.15 88.73 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 23' ' ' ILE . 25.3 mm -63.61 -36.91 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.69 -38.84 79.12 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.612 -0.68 . . . . 0.0 110.121 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.95 -11.24 60.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.616 -0.678 . . . . 0.0 111.13 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.44 7.81 45.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.75 -0.594 . . . . 0.0 110.531 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.592 -0.693 . . . . 0.0 109.648 179.882 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.5 mt -58.14 -40.22 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -41.67 96.05 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.854 -0.529 . . . . 0.0 109.916 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -61.94 -41.7 98.26 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 17' ' ' ILE . 17.8 mt -63.68 -42.28 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.8 m -61.98 -33.95 75.25 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.487 -0.758 . . . . 0.0 110.022 179.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -69.12 -37.38 78.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 25.4 mt -102.63 6.03 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.786 -0.571 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -54.42 -50.12 68.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.852 -1.155 . . . . 0.0 110.626 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 25' ' ' LEU . 32.0 mt -68.32 -19.22 64.66 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.243 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.34 10.45 39.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.109 -0.369 . . . . 0.0 111.166 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 2.7 tt . . . . . 0 N--CA 1.501 2.09 0 O-C-N 121.249 -0.907 . . . . 0.0 111.905 -179.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 20' ' ' ILE . 7.7 mt -65.02 -30.54 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.751 -0.593 . . . . 0.0 109.706 179.462 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -88.43 -25.95 22.39 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.426 -0.796 . . . . 0.0 109.863 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.7 m -88.93 -21.57 23.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 0.0 110.503 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 17' ' ' ILE . 15.8 tt -53.49 -37.66 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 121.315 -0.865 . . . . 0.0 110.581 -179.994 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -71.01 -39.7 72.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -61.58 -36.12 79.76 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.294 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 20' ' ' ILE . 17.9 mt -74.3 -30.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.66 -0.65 . . . . 0.0 109.35 179.25 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 27' ' ' ILE . 11.0 tp -60.0 -41.21 91.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.701 -0.624 . . . . 0.0 110.297 179.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.68 2.59 28.94 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.503 -0.748 . . . . 0.0 110.701 179.034 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.2 10.89 13.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.515 -0.74 . . . . 0.0 110.355 179.294 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 24' ' ' LEU . 14.1 tt . . . . . 0 N--CA 1.499 1.977 0 O-C-N 121.605 -0.684 . . . . 0.0 109.987 179.848 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.832 ' HA ' HD12 ' A' ' 20' ' ' ILE . 71.7 mt -56.96 -45.03 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -44.56 94.63 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.736 -0.603 . . . . 0.0 109.601 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.484 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 2.4 m -61.23 -33.95 74.32 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.818 -0.551 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 17' ' ' ILE . 64.1 mt -60.43 -40.25 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.44 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -58.75 -39.49 81.1 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.251 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HD2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -64.89 -43.48 92.74 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.187 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 HD11 ' A' ' 27' ' ' ILE . 48.2 mm -71.31 -33.28 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.313 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.547 ' HA ' HD12 ' A' ' 27' ' ' ILE . 1.6 tp -55.56 -41.49 73.35 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.867 -0.521 . . . . 0.0 109.834 179.411 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 2.71 22.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.733 -0.604 . . . . 0.0 111.302 179.3 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.65 6.53 11.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.481 -0.762 . . . . 0.0 110.903 179.374 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 24' ' ' LEU . 28.1 mt . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 0.0 109.465 179.63 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mt -64.07 -38.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.46 -34.83 77.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.825 -0.547 . . . . 0.0 109.952 179.276 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.1 m -59.4 -42.62 92.19 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.788 -0.57 . . . . 0.0 109.912 179.637 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.44 -43.43 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.524 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.5 m -61.69 -39.78 92.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.682 -0.636 . . . . 0.0 109.85 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -60.52 -51.83 67.77 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.9 mt -63.48 -35.74 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.12 -41.18 92.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 179.341 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.35 -18.61 62.37 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.951 -0.468 . . . . 0.0 110.952 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.11 -1.63 57.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.861 -0.524 . . . . 0.0 111.522 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt . . . . . 0 N--CA 1.498 1.933 0 O-C-N 121.589 -0.695 . . . . 0.0 109.667 179.837 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.2 mp -62.19 -32.54 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -87.8 -39.32 14.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.3 m -69.39 -22.95 63.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.752 -0.592 . . . . 0.0 110.87 179.641 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 17' ' ' ILE . 2.1 tp -55.43 -36.0 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.044 0.838 . . . . 0.0 110.142 179.765 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.1 p -65.08 -42.91 93.67 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.081 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -67.54 -36.52 81.14 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.435 ' O ' HG12 ' A' ' 27' ' ' ILE . 71.1 mt -73.55 -36.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.56 -0.712 . . . . 0.0 109.827 179.605 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.6 tp -48.75 -49.8 36.7 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.619 -0.676 . . . . 0.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.49 -5.7 44.13 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.648 -0.658 . . . . 0.0 111.8 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -107.59 3.67 25.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.718 -0.614 . . . . 0.0 111.078 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 23' ' ' ILE . 22.6 mm . . . . . 0 N--CA 1.498 1.967 0 O-C-N 121.443 -0.786 . . . . 0.0 108.968 179.72 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.08 -47.44 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.677 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.98 -32.98 72.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.849 -0.532 . . . . 0.0 111.386 179.92 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -71.25 -42.95 68.15 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 80.9 mt -65.01 -42.58 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 179.913 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 p -65.25 -37.54 87.53 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.413 -0.804 . . . . 0.0 110.402 179.779 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.34 -46.43 64.17 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mm -65.79 -38.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.523 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 24' ' ' LEU . 1.8 tm? -60.1 -39.61 86.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.545 -0.722 . . . . 0.0 109.822 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.74 -22.47 37.26 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.359 -0.838 . . . . 0.0 111.026 179.582 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.47 12.34 14.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.842 -0.536 . . . . 0.0 111.438 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mm . . . . . 0 N--CA 1.498 1.966 0 O-C-N 121.301 -0.874 . . . . 0.0 109.993 179.744 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.7 mt -54.74 -39.38 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.946 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -62.04 -42.62 99.37 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.308 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -66.63 -39.77 88.45 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.789 HD12 ' HA ' ' A' ' 17' ' ' ILE . 81.4 mt -55.56 -39.15 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.623 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -42.37 82.92 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.698 -0.626 . . . . 0.0 109.509 179.488 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -68.84 -41.31 78.7 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.606 HG22 HD11 ' A' ' 27' ' ' ILE . 22.2 mm -75.97 -23.69 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.739 -0.6 . . . . 0.0 110.081 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.28 -42.52 70.1 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.486 -0.759 . . . . 0.0 109.784 179.67 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 25' ' ' LEU . 1.8 mm? -70.53 -11.46 60.94 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.885 -0.509 . . . . 0.0 110.935 179.146 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.38 13.0 30.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.456 179.192 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 23' ' ' ILE . 62.4 mt . . . . . 0 N--CA 1.502 2.167 0 O-C-N 121.322 -0.861 . . . . 0.0 111.042 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 16' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.904 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.4 mt -52.03 -41.87 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -42.8 99.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 0.0 110.068 179.628 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -66.85 -33.86 76.52 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.747 -0.596 . . . . 0.0 110.0 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 17' ' ' ILE . 86.9 mt -58.3 -43.39 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.253 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 m -69.09 -41.76 77.04 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.032 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -59.65 -46.03 90.25 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.514 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 27' ' ' ILE . 40.9 mm -82.09 -15.56 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.712 -0.617 . . . . 0.0 110.249 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HA ' HD12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -54.33 -45.63 72.7 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 179.664 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.01 -21.91 66.91 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.387 179.237 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.41 0.45 56.22 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.056 -0.402 . . . . 0.0 111.188 179.215 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 24' ' ' LEU . 55.2 mt . . . . . 0 N--CA 1.5 2.032 0 O-C-N 121.46 -0.775 . . . . 0.0 109.898 179.543 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.5 mm -63.8 -40.26 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.204 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.6 -36.47 71.79 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.5 m -73.62 -39.9 64.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.201 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -41.34 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.853 -0.53 . . . . 0.0 110.364 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 p -65.54 -36.49 83.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.473 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -58.83 -42.76 89.99 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.405 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -74.88 -35.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.025 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.79 -44.57 82.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.427 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -14.61 62.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.788 -0.57 . . . . 0.0 111.423 179.431 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.73 5.17 52.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.782 -0.574 . . . . 0.0 110.637 179.18 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.0 mt . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 0.0 110.246 179.99 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.26 -36.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.805 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -63.12 -34.61 77.98 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.085 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 m -78.77 -27.52 44.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.681 -0.637 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.18 -45.18 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.69 -0.631 . . . . 0.0 110.198 179.975 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -67.02 -33.86 76.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.636 -0.665 . . . . 0.0 110.018 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -68.47 -50.83 49.5 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.6 -23.27 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.748 -0.595 . . . . 0.0 109.808 179.204 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -55.77 -42.65 75.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.511 -0.743 . . . . 0.0 110.014 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.09 -24.62 63.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.585 -0.697 . . . . 0.0 110.664 179.552 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.62 -24.8 28.97 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.773 -0.58 . . . . 0.0 111.183 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 27' ' ' ILE . 50.1 mm . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 121.201 0.524 . . . . 0.0 110.457 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 20' ' ' ILE . 13.8 tp . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.8 -32.56 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.16 -39.73 28.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.897 -0.502 . . . . 0.0 109.676 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -61.37 -47.57 85.25 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.854 -0.529 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 16' ' ' LEU . 13.6 mt -58.5 -45.33 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -64.78 -33.3 75.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.825 -0.547 . . . . 0.0 110.541 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -68.46 -40.31 81.09 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.432 -0.793 . . . . 0.0 110.704 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.8 -36.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.786 -0.571 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.71 -44.27 93.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.522 -0.736 . . . . 0.0 109.727 179.644 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.31 -14.81 59.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.81 -0.556 . . . . 0.0 111.017 179.429 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.79 14.01 22.77 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.842 -0.536 . . . . 0.0 110.801 179.34 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 27' ' ' ILE . 12.0 mm . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.631 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.4 mt -60.19 -42.15 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.502 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -63.64 -41.11 98.28 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.677 -0.64 . . . . 0.0 109.854 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.5 m -61.54 -42.94 99.57 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.471 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.09 -37.92 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.989 -0.444 . . . . 0.0 109.903 179.534 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.2 m -64.64 -39.57 93.94 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.208 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -61.93 -44.15 97.37 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.97 -41.59 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 27' ' ' ILE . 9.7 tp -57.82 -41.21 81.77 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.279 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.98 -30.67 71.27 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.249 0.547 . . . . 0.0 109.994 179.099 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.95 -0.65 49.58 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.595 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 24' ' ' LEU . 48.3 mt . . . . . 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.895 . . . . 0.0 110.002 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.48 -169.17 1.41 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.661 -0.906 . . . . 0.0 109.744 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.53 36.7 27.68 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.462 0.649 . . . . 0.0 111.206 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.62 -50.13 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.03 -42.35 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.0 mm -58.53 -41.42 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 7' ' ' LEU . 1.8 tm? -66.8 -40.01 87.96 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.29 -27.92 61.82 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.727 -0.608 . . . . 0.0 111.462 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.708 HG23 HG21 ' A' ' 17' ' ' ILE . 2.3 m -66.71 -43.34 84.54 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.839 -0.538 . . . . 0.0 109.659 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 14' ' ' PRO . 19.4 p -84.13 -18.47 36.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.397 -0.814 . . . . 0.0 111.237 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.74 -33.49 12.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.228 -0.92 . . . . 0.0 111.577 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.4 mm -107.92 105.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.293 -0.879 . . . . 0.0 110.504 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.0 m80 53.6 61.4 10.63 Favored Pre-proline 0 N--CA 1.507 2.383 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.507 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 46.3 Cg_endo -70.31 -35.94 10.17 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 O-C-N 123.427 1.225 . . . . 0.0 111.354 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.03 -10.64 58.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.607 -0.683 . . . . 0.0 112.05 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.36 -43.78 5.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.376 -0.828 . . . . 0.0 109.712 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.708 HG21 HG23 ' A' ' 9' ' ' THR . 64.4 mt -61.76 -41.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.904 -0.498 . . . . 0.0 109.989 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.61 -42.61 88.58 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.2 m -62.35 -39.43 93.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 17' ' ' ILE . 68.0 mt -63.46 -43.35 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 m -58.91 -42.04 88.68 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -61.8 -47.28 85.85 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.89 -33.62 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.597 ' O ' HG22 ' A' ' 27' ' ' ILE . 2.9 tp -56.06 -43.24 77.73 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.835 -0.541 . . . . 0.0 109.621 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.65 -30.62 68.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.732 -0.605 . . . . 0.0 110.12 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.19 -7.23 59.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 24' ' ' LEU . 7.3 tt -76.48 -18.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.433 -0.792 . . . . 0.0 111.562 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -57.38 7.82 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.45 -0.781 . . . . 0.0 110.09 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 33' ' ' VAL . . . 77.35 83.26 0.54 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -62.54 -37.18 60.5 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 O-C-N 123.858 1.452 . . . . 0.0 110.395 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mp -75.05 -42.22 57.5 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.1 mmt -56.83 -35.67 69.09 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' GLY . 56.1 t -58.55 -30.98 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.55 13.09 10.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 0.0 111.267 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.65 ' HA ' HG21 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -137.79 25.74 2.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.198 -0.939 . . . . 0.0 110.441 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.13 103.63 16.23 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.065 -1.022 . . . . 0.0 109.011 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.12 48.77 37.56 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.65 HG21 ' HA ' ' A' ' 35' ' ' GLN . 1.6 pt -112.14 164.86 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 122.323 -0.516 . . . . 0.0 110.797 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 m 55.43 69.58 0.72 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.611 0.719 . . . . 0.0 110.433 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.687 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.514 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -110.54 23.72 13.88 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.667 -0.902 . . . . 0.0 111.739 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.58 -51.38 3.21 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.57 76.1 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.013 -0.429 . . . . 0.0 110.372 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -62.8 -43.55 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.99 -44.09 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.41 -33.83 76.78 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.763 -0.586 . . . . 0.0 109.655 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tp -81.3 8.53 8.89 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.723 -0.611 . . . . 0.0 111.521 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.4 m -105.1 -42.19 5.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.092 -1.005 . . . . 0.0 110.097 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.3 m -92.1 -34.82 14.21 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.65 -0.656 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.51 22.6 6.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.433 -0.792 . . . . 0.0 111.647 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.562 HD13 ' N ' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -71.05 140.32 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.324 -0.86 . . . . 0.0 110.06 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.562 ' N ' HD13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER 56.5 58.62 8.78 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 122.147 -0.345 . . . . 0.0 111.53 -179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.59 -41.07 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 O-C-N 123.175 1.092 . . . . 0.0 111.411 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.13 -40.63 98.16 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.726 -0.609 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.25 -44.54 97.08 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.6 -42.19 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -45.12 86.19 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.098 -0.376 . . . . 0.0 110.445 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 m -57.77 -42.09 83.32 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.69 -42.88 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.782 -0.574 . . . . 0.0 109.586 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -60.26 -41.46 93.29 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.732 -0.605 . . . . 0.0 110.088 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -58.65 -38.04 77.27 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.663 HG22 HD12 ' A' ' 27' ' ' ILE . 25.5 mm -85.5 -29.06 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.85 -46.77 81.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.669 -0.645 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.723 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.9 pp -65.86 -27.68 68.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.475 -0.766 . . . . 0.0 110.486 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.73 -31.69 57.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.309 0.576 . . . . 0.0 109.677 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 23' ' ' ILE . 70.0 mt -114.42 56.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.723 HD12 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -100.17 -62.6 1.22 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.469 -0.77 . . . . 0.0 110.741 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.06 -56.42 0.45 Allowed Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.377 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -89.69 28.88 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.438 1.425 . . . . 0.0 112.33 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.02 -44.4 84.83 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.9 ttm -74.39 -34.77 63.4 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.51 -38.13 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.806 -0.559 . . . . 0.0 109.756 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.19 4.51 26.38 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.622 -0.674 . . . . 0.0 112.238 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.63 22.0 3.36 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.117 -0.99 . . . . 0.0 111.093 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.36 92.37 7.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.268 -0.895 . . . . 0.0 109.32 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.43 -42.38 1.93 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.4 mt -79.84 77.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.654 -0.909 . . . . 0.0 109.401 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -138.77 44.78 2.05 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.657 -0.652 . . . . 0.0 109.914 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.5 mptt . . . . . 0 N--CA 1.505 2.278 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.825 179.867 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.51 -176.91 3.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.794 -0.827 . . . . 0.0 110.068 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.59 33.26 23.03 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.273 0.559 . . . . 0.0 110.815 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.62 -53.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.2 t -60.2 -38.51 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 122.05 -0.406 . . . . 0.0 110.108 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 89.4 mt -60.56 -44.48 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.5 tp -67.65 -35.19 78.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.758 -0.589 . . . . 0.0 110.196 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 12' ' ' ILE . 1.5 tp -75.31 1.44 13.69 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.279 -0.888 . . . . 0.0 112.216 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 m -101.88 -50.91 3.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.18 -0.95 . . . . 0.0 109.166 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.9 m -96.01 -35.67 11.31 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.681 -0.637 . . . . 0.0 111.106 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.05 43.74 1.05 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.342 -0.849 . . . . 0.0 110.817 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.447 HD12 ' O ' ' A' ' 8' ' ' LEU . 10.8 tt -85.79 139.76 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.714 -0.616 . . . . 0.0 110.509 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 19.7 p-80 -147.66 95.37 4.27 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.584 -0.697 . . . . 0.0 110.002 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 45.6 Cg_endo -68.13 -25.97 36.97 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.39 1.393 . . . . 0.0 111.973 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.3 -28.52 42.77 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -42.01 62.77 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.735 -0.603 . . . . 0.0 109.581 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 14' ' ' PRO . 2.5 mp -62.91 -35.63 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -71.68 -33.41 68.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.79 -0.569 . . . . 0.0 110.164 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.7 m -73.28 -42.13 62.81 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.0 110.412 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -64.53 -44.69 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.827 -0.545 . . . . 0.0 110.982 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.3 t -64.5 -30.48 71.51 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.242 -0.911 . . . . 0.0 110.746 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.297 -0.877 . . . . 0.0 109.315 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.682 HG22 HG13 ' A' ' 27' ' ' ILE . 52.4 mt -98.17 10.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.788 -0.57 . . . . 0.0 110.597 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.18 -42.7 86.61 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.753 -1.217 . . . . 0.0 110.941 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HG ' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -84.5 7.68 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.457 -0.777 . . . . 0.0 110.702 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.54 14.87 11.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.627 -0.671 . . . . 0.0 109.769 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.682 HG13 HG22 ' A' ' 23' ' ' ILE . 34.7 mt -118.29 -44.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.554 -0.717 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mp -87.82 -69.02 0.72 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.663 -0.648 . . . . 0.0 109.586 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.03 -53.31 0.79 Allowed Glycine 0 N--CA 1.496 2.696 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.865 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -92.47 21.48 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 121.695 1.597 . . . . 0.0 113.073 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.433 HD22 ' HG ' ' A' ' 25' ' ' LEU . 4.7 tt -61.83 -43.4 98.93 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.289 -0.882 . . . . 0.0 109.977 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.7 ttm -73.91 -39.94 63.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.763 -0.586 . . . . 0.0 109.539 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.97 -28.4 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.79 -0.569 . . . . 0.0 110.551 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -92.93 10.4 31.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.382 -0.824 . . . . 0.0 112.069 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -147.46 26.69 1.04 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.246 -0.909 . . . . 0.0 111.425 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.48 -56.58 2.16 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.034 -1.041 . . . . 0.0 110.28 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.72 55.86 0.65 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 38' ' ' ILE . 5.3 tp -87.22 67.96 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.797 -0.826 . . . . 0.0 111.148 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.7 p -108.06 -32.85 7.37 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.135 -0.978 . . . . 0.0 111.255 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.9 mttp . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.034 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptt85 -138.88 170.73 15.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.969 . . . . 0.0 110.612 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 t70 57.56 37.68 27.66 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.671 0.748 . . . . 0.0 110.668 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.71 -50.09 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.68 -42.42 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.17 -45.74 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.2 tp -63.5 -37.1 86.0 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -42.77 99.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.683 -0.635 . . . . 0.0 110.307 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.0 m -70.14 -34.46 73.07 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.564 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.2 m -62.71 -40.25 96.59 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.728 -0.607 . . . . 0.0 110.385 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.604 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -89.37 -45.63 9.33 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.709 -0.619 . . . . 0.0 110.264 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 11' ' ' ALA . 1.4 tp 54.52 22.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 56.19 75.18 0.61 Allowed Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.481 -0.762 . . . . 0.0 110.766 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.53 -169.62 0.63 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 O-C-N 123.442 1.233 . . . . 0.0 111.279 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 58.93 44.53 16.41 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 122.329 1.061 . . . . 0.0 110.384 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.51 -58.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -61.16 -31.28 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -70.03 -45.39 67.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.698 -0.626 . . . . 0.0 109.966 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.8 m -70.17 -42.99 71.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.705 -0.622 . . . . 0.0 109.756 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.2 mm -65.82 -48.28 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.69 -0.631 . . . . 0.0 110.219 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.42 ' O ' HD23 ' A' ' 25' ' ' LEU . 2.9 t -63.5 -30.22 71.37 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.313 0.96 . . . . 0.0 110.878 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -40.24 93.01 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.867 0.758 . . . . 0.0 109.223 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -31.52 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.09 -49.32 74.16 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.833 -0.542 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 21' ' ' THR . 2.9 pp -70.23 -11.32 60.81 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.575 -0.703 . . . . 0.0 111.927 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.28 -1.07 48.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.652 -0.655 . . . . 0.0 111.32 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.2 mt -119.38 -47.53 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.03 -44.85 75.03 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.14 -0.35 . . . . 0.0 111.336 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.47 79.83 0.58 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -63.17 -33.35 72.6 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 O-C-N 123.919 1.484 . . . . 0.0 111.934 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 tp -61.9 -42.09 98.66 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.465 -0.772 . . . . 0.0 109.609 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 22.0 mtp -79.85 -41.73 25.71 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -59.66 -34.51 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.839 -0.538 . . . . 0.0 110.195 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tp -79.1 5.91 10.81 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.408 -0.808 . . . . 0.0 111.677 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -127.71 26.24 5.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.209 -0.932 . . . . 0.0 110.564 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.64 80.1 8.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.14 -0.975 . . . . 0.0 109.304 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.74 35.67 66.59 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.0 mm -111.13 111.85 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.469 -1.018 . . . . 0.0 109.842 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.6 p 41.31 59.14 2.44 Favored 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 123.284 0.633 . . . . 0.0 111.996 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.0 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.552 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.25 25.59 6.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.768 -0.843 . . . . 0.0 110.704 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.0 -54.1 2.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.398 -0.814 . . . . 0.0 109.259 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.91 52.66 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.919 -0.488 . . . . 0.0 110.992 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.3 -48.47 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.553 -0.717 . . . . 0.0 110.135 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.579 ' O ' HG22 ' A' ' 9' ' ' THR . 1.9 mp -65.18 -35.69 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tp -69.38 -30.28 68.24 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.551 -0.718 . . . . 0.0 109.556 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.77 10.45 13.59 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.652 -0.655 . . . . 0.0 112.178 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 6' ' ' ILE . 1.2 t -111.45 -31.09 7.14 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.908 -1.12 . . . . 0.0 111.238 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.2 m -61.55 -31.07 71.08 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.464 -0.773 . . . . 0.0 111.469 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.03 -32.42 66.16 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.825 -0.547 . . . . 0.0 111.003 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -80.17 122.83 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 56.41 59.81 8.35 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 122.228 -0.295 . . . . 0.0 110.813 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.53 -20.12 27.5 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 O-C-N 123.35 1.184 . . . . 0.0 112.072 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -57.12 -41.58 79.28 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.394 -0.816 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.83 -41.98 95.32 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.3 mt -72.41 -27.54 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.69 -39.61 70.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.953 . . . . 0.0 109.504 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.4 m -71.98 -39.2 69.47 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.72 -0.612 . . . . 0.0 110.252 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 17' ' ' ILE . 1.9 tp -60.32 -26.12 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.414 -0.803 . . . . 0.0 110.862 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -60.74 -41.69 95.89 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.492 -0.755 . . . . 0.0 109.339 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -63.61 -45.71 89.07 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 20' ' ' ILE . 6.2 mt -61.09 -40.73 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -61.45 -38.58 87.72 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 mt -76.96 -3.49 39.15 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.518 . . . . 0.0 111.365 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.28 -11.63 15.96 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.636 -0.665 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.3 mt -98.78 -45.13 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.612 -0.68 . . . . 0.0 109.568 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.1 -26.26 66.62 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.976 -0.453 . . . . 0.0 111.492 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.47 -63.32 5.23 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.02 0.01 9.43 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 O-C-N 123.663 1.349 . . . . 0.0 112.135 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -50.82 72.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.03 -1.044 . . . . 0.0 110.219 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.3 ttt -61.79 -37.47 84.5 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.703 -0.623 . . . . 0.0 110.151 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.7 t -61.99 -33.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 34' ' ' LEU . 3.1 mm? -82.07 5.07 20.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.608 -0.683 . . . . 0.0 111.43 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -124.34 21.95 8.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.367 -0.833 . . . . 0.0 110.857 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.17 70.89 10.92 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.162 -0.961 . . . . 0.0 109.425 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.5 75.67 1.26 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 38' ' ' ILE . 5.5 tp -78.55 61.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.004 0.907 . . . . 0.0 110.522 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.45 59.99 0.95 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.314 -0.866 . . . . 0.0 109.697 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.541 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.44 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -108.3 42.94 1.29 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.696 -0.885 . . . . 0.0 110.304 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -104.92 -45.59 4.52 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.481 -0.762 . . . . 0.0 110.167 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.34 -33.73 65.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.874 -0.516 . . . . 0.0 111.815 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -71.48 -46.75 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.243 -0.91 . . . . 0.0 110.715 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.32 -42.22 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.642 -0.661 . . . . 0.0 109.448 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 tp -64.32 -37.77 88.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.717 -0.614 . . . . 0.0 109.938 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.28 -6.82 45.84 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.732 -0.605 . . . . 0.0 111.872 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.8 m -88.69 -52.07 5.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.232 -0.918 . . . . 0.0 109.473 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 91.1 m -89.1 -41.91 12.02 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.75 -0.594 . . . . 0.0 110.515 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.23 44.86 1.01 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.56 -0.712 . . . . 0.0 110.134 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.592 HG13 ' HD3' ' A' ' 14' ' ' PRO . 6.8 tp -65.54 130.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-O 121.159 0.504 . . . . 0.0 110.823 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.59 66.24 3.15 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.651 -0.656 . . . . 0.0 110.421 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.592 ' HD3' HG13 ' A' ' 12' ' ' ILE . 48.3 Cg_endo -72.06 -29.73 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 O-C-N 123.4 1.211 . . . . 0.0 111.267 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.51 -6.32 3.31 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.391 -0.818 . . . . 0.0 113.183 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -115.75 -49.93 2.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.052 -1.03 . . . . 0.0 109.656 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.8 mp -74.06 -23.41 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.555 -0.715 . . . . 0.0 111.193 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -88.92 -42.69 11.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.963 -1.085 . . . . 0.0 108.748 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.8 m -64.81 -30.17 71.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.926 -0.484 . . . . 0.0 110.844 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 17' ' ' ILE . 9.0 tp -55.08 -36.34 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.417 -0.802 . . . . 0.0 110.243 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -68.7 -41.55 78.99 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -42.57 99.36 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 mm -62.24 -38.24 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -60.16 -40.74 90.98 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -4.18 46.63 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.731 -0.605 . . . . 0.0 110.876 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.42 5.1 14.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.451 -0.781 . . . . 0.0 111.036 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.445 ' O ' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -103.78 -30.87 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.47 -0.768 . . . . 0.0 110.4 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.5 mm? -67.67 -30.59 70.16 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.325 -0.859 . . . . 0.0 110.288 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.92 69.11 0.47 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.41 ' HG2' HD12 ' A' ' 31' ' ' LEU . 46.2 Cg_endo -69.54 -45.63 1.63 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 O-C-N 123.738 1.388 . . . . 0.0 111.029 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.41 HD12 ' HG2' ' A' ' 30' ' ' PRO . 1.2 mp -64.76 -38.96 92.77 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.79 -0.569 . . . . 0.0 109.703 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -45.52 93.99 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.28 -36.66 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.725 -0.609 . . . . 0.0 109.481 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mt -68.4 -14.9 63.33 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.801 -0.562 . . . . 0.0 112.279 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -122.3 15.93 10.57 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.607 -0.683 . . . . 0.0 111.465 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.46 -64.05 1.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.261 -0.899 . . . . 0.0 109.05 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -87.93 -37.35 7.9 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER 43.38 40.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 m -112.46 50.47 0.86 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.992 -1.068 . . . . 0.0 109.183 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 117.645 -1.169 . . . . 0.0 111.338 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.499 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -109.74 -161.55 0.76 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.649 -0.912 . . . . 0.0 109.803 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 50.22 31.16 4.87 Favored 'General case' 0 N--CA 1.507 2.412 0 CA-C-O 121.343 0.592 . . . . 0.0 111.66 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -171.32 -57.45 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.3 t -68.33 -50.73 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.18 -41.02 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.467 ' HA ' HD22 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -63.87 -39.92 95.33 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.843 -0.536 . . . . 0.0 109.576 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tp -60.23 -26.4 66.39 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.714 -0.616 . . . . 0.0 111.374 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.585 ' O ' HG22 ' A' ' 12' ' ' ILE . 17.3 m -97.1 -41.97 8.08 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.8 t -68.89 -29.41 67.68 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.68 -0.637 . . . . 0.0 111.291 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.72 -30.42 68.81 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.33 -0.856 . . . . 0.0 111.928 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -75.03 127.67 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.304 -0.872 . . . . 0.0 110.082 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.529 ' N ' HD13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER 52.91 62.33 10.12 Favored Pre-proline 0 N--CA 1.506 2.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.656 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.38 -46.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.02 1.147 . . . . 0.0 111.706 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.79 -31.24 70.62 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.438 -0.789 . . . . 0.0 112.22 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -73.42 -46.63 47.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.812 -0.555 . . . . 0.0 110.03 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.14 -40.92 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.39 -23.43 62.6 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.013 -0.429 . . . . 0.0 111.056 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.0 m -100.48 -43.56 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.431 -0.793 . . . . 0.0 110.64 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 20' ' ' ILE . 20.4 mm -73.42 -56.16 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.593 -0.692 . . . . 0.0 111.676 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -58.12 -35.42 71.45 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 119.203 0.911 . . . . 0.0 111.258 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -40.25 92.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.59 -0.694 . . . . 0.0 110.165 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.2 mt -81.0 -36.99 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -61.49 -47.35 86.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.673 -0.642 . . . . 0.0 109.773 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.525 ' HG ' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -68.0 -20.91 65.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.642 -0.661 . . . . 0.0 111.195 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.68 -17.94 39.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.686 -0.634 . . . . 0.0 111.492 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.5 mt -107.95 -50.27 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.768 -0.582 . . . . 0.0 109.778 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mt -97.94 -50.0 4.57 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.724 -0.61 . . . . 0.0 110.25 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.82 64.22 2.39 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HD2' ' HG ' ' A' ' 25' ' ' LEU . 46.3 Cg_endo -68.72 -25.79 33.51 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 O-C-N 123.665 1.35 . . . . 0.0 112.287 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -59.08 -42.68 91.01 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.329 -0.857 . . . . 0.0 110.491 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.1 mmt -77.44 -39.49 46.61 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.57 -33.63 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.866 -0.521 . . . . 0.0 110.058 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.0 13.36 6.13 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.539 -0.726 . . . . 0.0 111.782 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -131.54 22.92 4.71 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.132 -0.98 . . . . 0.0 110.861 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.66 98.12 6.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.144 -0.973 . . . . 0.0 109.865 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.34 -28.56 14.23 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -74.7 78.64 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 118.374 1.087 . . . . 0.0 109.366 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.6 p -145.75 44.66 1.28 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.972 0 O-C-N 121.488 -0.758 . . . . 0.0 110.373 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -123.56 19.75 9.55 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 122.106 -0.643 . . . . 0.0 110.74 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -107.96 -46.26 3.81 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.315 -0.866 . . . . 0.0 110.369 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.66 -38.81 17.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.577 -0.702 . . . . 0.0 109.504 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.21 -43.84 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.763 -0.586 . . . . 0.0 109.645 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.47 -36.21 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.749 -0.595 . . . . 0.0 109.714 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.52 -33.06 66.63 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 109.877 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.37 -67.25 0.74 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.831 HG23 ' HB ' ' A' ' 12' ' ' ILE . 14.5 t 40.58 53.78 3.04 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.867 0.841 . . . . 0.0 110.997 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 58.06 37.18 26.5 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.667 -0.646 . . . . 0.0 109.294 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.59 38.94 29.38 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.831 ' HB ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -71.27 159.52 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.692 -0.63 . . . . 0.0 110.418 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 44.8 m80 -100.59 102.56 19.5 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 45.9 Cg_endo -64.4 -167.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.311 2.007 . . . . 0.0 111.748 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 59.05 44.08 16.65 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.493 1.14 . . . . 0.0 109.454 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -171.64 -53.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 21' ' ' THR . 1.6 mp -67.1 -37.87 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.58 -34.49 72.78 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -69.26 -45.75 68.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.76 -41.05 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.872 -0.517 . . . . 0.0 109.607 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 17' ' ' ILE . 72.9 p -64.91 -30.3 71.29 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -64.29 -42.18 96.52 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.5 -39.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.54 HD12 ' HG3' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -64.34 -39.55 94.11 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' HD2' ' A' ' 30' ' ' PRO . 7.1 tp -69.06 -28.08 66.22 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.779 -0.575 . . . . 0.0 110.5 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.8 -16.71 60.7 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.746 0.308 . . . . 0.0 111.608 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.469 HG22 HD22 ' A' ' 28' ' ' LEU . 71.3 mt -111.78 -50.48 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.707 -0.621 . . . . 0.0 110.437 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD22 HG22 ' A' ' 27' ' ' ILE . 3.4 mm? -99.03 -57.66 2.12 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.579 -0.701 . . . . 0.0 110.405 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.09 59.31 1.18 Allowed Glycine 0 N--CA 1.499 2.837 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HG3' HD12 ' A' ' 24' ' ' LEU . 48.4 Cg_endo -74.32 -45.64 0.33 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.268 1.141 . . . . 0.0 111.686 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 tp -62.22 -35.42 78.83 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.526 -0.734 . . . . 0.0 110.992 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ttt -65.86 -44.93 83.96 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.88 -34.05 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.2 mt -83.63 10.13 9.92 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.529 -0.732 . . . . 0.0 111.628 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -126.78 22.35 6.84 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.377 -0.827 . . . . 0.0 110.266 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.24 -53.09 4.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.258 -0.901 . . . . 0.0 108.795 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 -17.71 52.46 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -101.12 121.34 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.101 -1.235 . . . . 0.0 109.351 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -121.75 37.35 4.38 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.35 0.595 . . . . 0.0 110.22 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.7 tttt . . . . . 0 N--CA 1.5 2.063 0 O-C-N 121.188 -0.945 . . . . 0.0 110.787 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.34 16.57 13.92 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.913 -0.757 . . . . 0.0 111.442 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -101.2 -52.3 3.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.591 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.07 -32.63 68.21 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.992 -0.442 . . . . 0.0 110.599 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.46 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.89 -41.68 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -63.32 -35.89 81.89 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.67 -0.644 . . . . 0.0 109.68 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.519 ' HG ' ' HA ' ' A' ' 12' ' ' ILE . 4.4 tp -71.24 -16.82 62.51 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.51 -0.744 . . . . 0.0 111.401 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -40.17 69.43 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t -96.75 -34.25 11.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.816 -0.552 . . . . 0.0 109.68 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -117.19 58.5 0.78 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.018 0.913 . . . . 0.0 109.396 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.519 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 5.1 tt -62.61 145.44 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.802 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 55.85 64.81 4.92 Favored Pre-proline 0 N--CA 1.505 2.279 0 O-C-N 122.295 -0.253 . . . . 0.0 111.529 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 18' ' ' PHE . 47.8 Cg_endo -70.83 -30.66 17.01 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.24 1.293 . . . . 0.0 111.532 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.59 3.29 14.09 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.569 -0.707 . . . . 0.0 112.386 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' O ' HD13 ' A' ' 20' ' ' ILE . 28.3 tp -113.91 -36.89 4.66 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.5 -48.7 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.621 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -70.13 -44.25 69.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.632 -0.668 . . . . 0.0 110.763 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -58.45 -41.53 85.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.449 -0.782 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 16' ' ' LEU . 1.3 mp -64.54 -51.31 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.66 -0.65 . . . . 0.0 110.266 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -65.28 -33.12 75.23 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.377 -0.827 . . . . 0.0 110.52 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -66.08 -46.09 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.46 -40.69 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -36.4 79.26 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.724 -0.61 . . . . 0.0 109.439 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.27 -4.04 58.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.751 -0.593 . . . . 0.0 110.991 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.62 14.26 24.63 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.565 -0.71 . . . . 0.0 110.257 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.1 mm -125.52 -53.06 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.33 -0.856 . . . . 0.0 109.311 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.9 mt -79.87 -27.59 40.05 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.715 -0.616 . . . . 0.0 111.124 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.22 54.76 0.47 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.52 -25.46 62.73 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 O-C-N 123.735 1.387 . . . . 0.0 111.813 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 mt -51.11 -39.58 56.51 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 118.324 0.511 . . . . 0.0 110.903 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -45.46 39.45 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.607 -0.683 . . . . 0.0 109.366 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.62 -33.91 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.962 -0.461 . . . . 0.0 110.29 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.77 -2.62 21.18 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.544 -0.722 . . . . 0.0 112.169 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -124.58 21.13 8.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 110.266 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.85 70.69 1.02 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.299 -0.876 . . . . 0.0 109.747 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.49 51.95 1.09 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.03 144.84 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.635 -0.921 . . . . 0.0 109.492 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 t -153.03 72.1 0.94 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.895 0.855 . . . . 0.0 110.106 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.378 -0.826 . . . . 0.0 109.928 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -97.67 14.26 27.39 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.79 -0.83 . . . . 0.0 111.879 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' HA ' HD12 ' A' ' 6' ' ' ILE . 32.9 t70 -64.56 -44.94 89.14 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.05 74.37 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -69.28 -40.47 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 3' ' ' ASP . 56.8 mt -61.2 -43.51 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 11.5 tp -63.5 -35.8 81.65 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.817 -0.552 . . . . 0.0 109.957 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.28 -7.84 51.63 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.404 -0.81 . . . . 0.0 111.413 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 m -111.66 -44.58 3.47 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.493 -0.754 . . . . 0.0 110.183 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.7 p -88.69 -27.39 21.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.623 -0.673 . . . . 0.0 111.944 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 7' ' ' LEU . . . -99.33 10.61 41.08 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.201 -0.937 . . . . 0.0 112.205 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.2 tp -72.24 140.96 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 120.813 -1.18 . . . . 0.0 110.057 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.561 ' CD2' HD22 ' A' ' 16' ' ' LEU . 9.1 t60 -120.92 78.05 31.3 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.0 110.491 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.16 175.65 10.98 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.651 1.343 . . . . 0.0 109.953 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.21 6.53 4.86 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.585 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 13' ' ' HIS . 0.5 OUTLIER -132.41 -50.08 0.92 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 20' ' ' ILE . 9.0 mm -61.23 -27.46 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -91.12 -36.06 14.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 23' ' ' ILE . 7.3 m -76.67 -26.56 54.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.716 -0.615 . . . . 0.0 110.674 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 17' ' ' ILE . 9.5 tp -52.17 -39.78 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.505 -0.747 . . . . 0.0 111.508 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.6 p -63.73 -44.22 94.2 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -66.82 -44.29 81.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 19' ' ' THR . 27.9 mm -62.87 -35.28 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.871 -0.518 . . . . 0.0 109.723 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.75 -42.93 84.97 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.696 -0.627 . . . . 0.0 110.119 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.97 -8.07 56.08 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.744 -0.598 . . . . 0.0 111.292 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.47 1.73 41.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.622 -0.673 . . . . 0.0 110.767 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.4 mt -114.07 -46.39 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.2 -67.85 0.31 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.013 -0.43 . . . . 0.0 110.057 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.41 83.24 0.27 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.33 -38.44 54.0 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 O-C-N 123.868 1.457 . . . . 0.0 110.888 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.41 -38.51 81.31 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.4 tpt -65.18 -42.07 94.02 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.936 -0.478 . . . . 0.0 109.742 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.0 t -64.85 -39.27 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.793 -0.567 . . . . 0.0 110.069 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.8 5.04 34.34 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.521 -0.737 . . . . 0.0 112.214 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.22 24.98 4.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.992 -1.067 . . . . 0.0 110.525 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.98 -58.5 1.87 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.42 -0.8 . . . . 0.0 109.758 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.43 46.7 1.13 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 tt -105.42 9.9 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.627 -0.925 . . . . 0.0 111.636 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -161.44 42.12 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.295 -0.878 . . . . 0.0 110.226 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.072 0 O-C-N 121.394 -0.816 . . . . 0.0 110.777 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.505 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -107.15 32.26 4.76 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.886 -0.773 . . . . 0.0 110.363 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -102.09 -57.7 2.02 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.93 -27.46 63.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 122.055 -0.403 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.6 t -59.21 -34.74 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.952 -0.467 . . . . 0.0 110.213 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.3 mm -67.43 -38.45 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.342 -0.849 . . . . 0.0 108.749 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.7 tp -75.82 -21.95 56.79 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.682 -0.636 . . . . 0.0 110.16 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.34 34.58 3.3 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.569 -0.707 . . . . 0.0 110.852 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -102.72 -43.78 5.49 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.277 -0.89 . . . . 0.0 110.059 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.6 m -68.54 -37.87 80.32 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.553 -0.717 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.98 -35.41 81.1 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.681 -0.637 . . . . 0.0 110.794 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.1 mm -94.51 165.33 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 8.6 m-70 -105.82 94.58 9.14 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.525 -0.735 . . . . 0.0 109.44 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 48.8 Cg_endo -66.74 177.38 3.5 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.785 1.657 . . . . 0.0 111.3 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 52.19 38.92 25.79 Favored 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 122.26 1.028 . . . . 0.0 109.952 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -165.45 -55.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.1 mm -62.25 -29.22 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.43 -36.12 63.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.99 -0.444 . . . . 0.0 110.436 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.7 m -73.57 -48.78 30.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.1 mm -54.89 -49.78 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.787 -0.571 . . . . 0.0 111.402 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -62.91 -34.7 78.0 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.627 -0.67 . . . . 0.0 110.54 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -68.0 -41.29 82.5 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.628 -0.67 . . . . 0.0 109.837 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.96 -38.63 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.78 -41.31 95.31 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.63 -17.02 60.76 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.071 -0.393 . . . . 0.0 111.072 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.0 12.62 29.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.841 -0.537 . . . . 0.0 111.204 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm -130.38 -57.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.774 . . . . 0.0 109.491 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 47.76 58.12 5.31 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.43 0.634 . . . . 0.0 110.685 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.97 82.23 1.65 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 44.0 Cg_endo -65.42 -19.95 61.25 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 124.063 1.559 . . . . 0.0 112.628 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mt -53.49 -50.77 64.65 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.455 -0.778 . . . . 0.0 110.73 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 58.9 mtm -75.67 -33.27 60.39 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.863 -0.523 . . . . 0.0 110.135 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 30' ' ' PRO . 75.6 t -59.09 -37.14 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.772 -0.58 . . . . 0.0 109.852 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' O ' HD12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -58.32 -31.51 67.61 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.837 -0.539 . . . . 0.0 111.25 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -113.06 23.56 13.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.216 -0.303 . . . . 0.0 110.856 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.74 76.58 3.69 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 36.99 11.0 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 34' ' ' LEU . 11.0 tt -63.08 148.72 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.699 -0.883 . . . . 0.0 110.143 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 39' ' ' THR . 11.3 t -145.74 66.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.765 0.793 . . . . 0.0 109.814 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 117.784 -1.103 . . . . 0.0 110.517 -179.873 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.13 16.27 6.72 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.791 -0.829 . . . . 0.0 111.896 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -94.76 -46.41 6.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.433 -0.792 . . . . 0.0 109.644 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.56 17.53 4.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.836 -0.54 . . . . 0.0 111.416 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.55 -52.39 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.149 -0.969 . . . . 0.0 108.749 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.15 -45.76 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -62.09 -25.64 67.82 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.986 -0.446 . . . . 0.0 110.424 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -89.67 11.42 19.87 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.622 -0.674 . . . . 0.0 111.868 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 t -59.4 -36.97 76.83 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.049 -1.032 . . . . 0.0 110.617 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.515 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.4 t -78.61 -40.87 33.25 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . . . -63.72 -34.23 77.42 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 122.097 -0.377 . . . . 0.0 111.105 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.406 ' HB ' HD23 ' A' ' 8' ' ' LEU . 13.0 tt -90.33 16.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.578 -0.701 . . . . 0.0 111.603 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.482 ' CG ' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER 66.36 94.01 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.749 -0.595 . . . . 0.0 110.784 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 10' ' ' CYS . 47.7 Cg_endo -72.76 -40.77 1.79 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.17 1.247 . . . . 0.0 111.461 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -6.79 52.12 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.442 -0.786 . . . . 0.0 112.0 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.482 ' HB2' ' CG ' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -101.77 -47.62 4.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.467 -0.771 . . . . 0.0 110.007 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.733 ' HA ' HD12 ' A' ' 20' ' ' ILE . 17.1 mm -53.97 -41.79 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.983 -0.448 . . . . 0.0 110.395 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.72 -41.55 86.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.794 -0.566 . . . . 0.0 109.972 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.5 m -64.73 -43.84 92.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.78 -0.575 . . . . 0.0 109.578 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -58.41 -44.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.663 -0.648 . . . . 0.0 109.763 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.4 m -62.83 -42.83 99.89 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.739 -0.6 . . . . 0.0 109.802 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -44.14 97.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.836 -0.54 . . . . 0.0 110.007 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mm -62.1 -40.03 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.31 -43.21 88.06 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.3 -28.86 67.55 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.972 0.415 . . . . 0.0 110.171 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.34 60.77 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.0 mt -96.87 -69.18 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt 49.24 69.33 0.6 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.463 0.649 . . . . 0.0 110.931 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' N ' ' CD ' ' A' ' 30' ' ' PRO . . . -142.82 49.42 0.73 Allowed Glycine 0 N--CA 1.497 2.702 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.639 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 29' ' ' GLY . 43.0 Cg_endo -65.41 -40.98 16.86 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 O-C-N 123.272 1.143 . . . . 0.0 109.871 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.45 -37.12 82.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.8 mmt -60.95 -44.79 96.77 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.75 -34.97 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.786 -0.572 . . . . 0.0 109.622 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -81.35 -11.94 59.16 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.585 -0.697 . . . . 0.0 111.939 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -123.41 33.94 5.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.524 -0.735 . . . . 0.0 110.499 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.76 108.44 2.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.491 -0.756 . . . . 0.0 109.878 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.05 -43.48 1.7 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -86.55 127.63 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.571 -0.958 . . . . 0.0 109.793 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 t -154.37 53.66 0.68 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.716 0.769 . . . . 0.0 110.918 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.188 0 O-C-N 121.271 -0.893 . . . . 0.0 111.549 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.495 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.7 27.68 13.11 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 117.532 0.666 . . . . 0.0 111.832 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -115.95 -64.44 1.31 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.048 -1.033 . . . . 0.0 109.888 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.58 -29.87 71.07 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.052 -0.405 . . . . 0.0 111.488 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.16 -36.62 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.857 -0.527 . . . . 0.0 110.434 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.4 mt -65.69 -44.12 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.2 tp -67.83 -26.84 66.25 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.011 -0.431 . . . . 0.0 110.672 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -93.83 17.04 12.73 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.574 -0.704 . . . . 0.0 111.452 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.0 m -112.28 -45.58 3.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.862 -1.149 . . . . 0.0 109.941 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.5 m -58.81 -25.16 62.89 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.518 -0.739 . . . . 0.0 112.09 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.79 18.26 20.96 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.137 -0.977 . . . . 0.0 112.061 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 9' ' ' THR . 5.3 tp -117.48 12.93 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 120.984 -1.072 . . . . 0.0 112.058 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -132.11 78.49 68.93 Favored Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 120.962 -1.086 . . . . 0.0 110.867 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.7 -36.97 30.24 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.334 1.356 . . . . 0.0 111.598 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.39 -37.95 82.4 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.505 0.669 . . . . 0.0 109.502 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 19' ' ' THR . 4.1 mp -69.23 -41.83 76.5 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.792 ' HA ' HD12 ' A' ' 20' ' ' ILE . 25.5 mm -59.5 -38.12 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -65.89 -36.81 84.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.113 -0.367 . . . . 0.0 110.636 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -76.53 -25.49 54.18 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.358 -0.839 . . . . 0.0 111.546 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 17' ' ' ILE . 44.2 mt -58.3 -48.88 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.417 -0.802 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.3 p -65.32 -36.5 84.24 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.749 -0.594 . . . . 0.0 109.898 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -45.37 93.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 90.1 mt -62.58 -37.06 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.96 -42.14 97.71 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.697 -0.627 . . . . 0.0 110.538 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.71 5.42 51.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.648 . . . . 0.0 111.305 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 27' ' ' ILE . 80.1 mt -132.79 5.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.135 -0.978 . . . . 0.0 111.279 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -102.66 1.55 34.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.561 -1.337 . . . . 0.0 112.686 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.09 -53.64 0.44 Allowed Glycine 0 N--CA 1.497 2.746 0 O-C-N 120.775 -1.203 . . . . 0.0 110.767 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -86.63 40.65 0.72 Allowed 'Trans proline' 0 N--CA 1.489 1.245 0 O-C-N 123.658 1.346 . . . . 0.0 110.98 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -30.23 71.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.617 -0.677 . . . . 0.0 110.744 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 21.4 ttm -90.21 -31.58 16.96 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.97 -38.24 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -27.85 67.62 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.651 -0.656 . . . . 0.0 111.021 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -106.74 24.31 12.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.002 -0.436 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.01 -39.31 72.45 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.002 -1.061 . . . . 0.0 110.474 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.66 -16.28 68.69 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.27 119.86 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 118.911 1.356 . . . . 0.0 109.88 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 m -105.73 47.63 0.87 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.675 -0.641 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 110.72 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.37 39.1 1.97 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.934 -0.745 . . . . 0.0 110.267 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.42 -54.85 2.83 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.76 65.21 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.024 -0.422 . . . . 0.0 110.151 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.7 t -59.27 -38.29 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.71 -0.618 . . . . 0.0 109.788 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.615 ' O ' HG22 ' A' ' 9' ' ' THR . 21.6 mt -62.75 -40.72 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 tp -69.99 -28.25 65.36 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.621 -0.674 . . . . 0.0 109.933 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.56 15.25 27.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.61 -0.681 . . . . 0.0 112.152 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 6' ' ' ILE . 4.3 t -109.75 -25.35 10.42 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.971 -1.081 . . . . 0.0 111.75 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 90.8 m -63.53 -45.52 90.24 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.246 -0.909 . . . . 0.0 110.689 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.25 -44.2 47.33 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.716 -0.615 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.491 HG22 ' CD2' ' A' ' 13' ' ' HIS . 50.3 mm -78.26 118.18 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.491 ' CD2' HG22 ' A' ' 12' ' ' ILE . 47.9 m-70 59.08 61.54 4.53 Favored Pre-proline 0 N--CA 1.506 2.343 0 CA-C-O 120.721 0.296 . . . . 0.0 110.518 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.34 -21.87 25.97 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 O-C-N 123.506 1.266 . . . . 0.0 111.295 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.91 9.87 3.25 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.614 -0.679 . . . . 0.0 112.134 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.5 tp -109.48 -51.84 2.83 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.577 HD11 HG23 ' A' ' 9' ' ' THR . 44.3 mt -59.11 -42.55 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.29 -39.13 85.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -61.27 -45.1 95.91 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.95 -0.469 . . . . 0.0 109.916 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.65 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.756 -0.59 . . . . 0.0 109.452 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.0 m -61.09 -40.53 94.08 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.592 -0.693 . . . . 0.0 109.41 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -63.21 -45.58 91.02 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.818 -0.551 . . . . 0.0 109.695 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.76 -39.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.4 -42.53 82.41 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.845 -0.535 . . . . 0.0 109.635 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.664 HD12 ' SD ' ' A' ' 32' ' ' MET . 8.5 tt -67.45 -35.65 79.63 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.235 0.541 . . . . 0.0 110.011 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.43 -8.51 54.29 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.4 mm -110.99 -46.78 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.536 -0.728 . . . . 0.0 109.668 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.77 -72.91 0.66 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.709 -0.62 . . . . 0.0 109.978 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' HD3' ' A' ' 30' ' ' PRO . . . 49.96 51.94 27.93 Favored Glycine 0 N--CA 1.502 3.049 0 CA-C-O 118.967 -0.907 . . . . 0.0 112.671 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 29' ' ' GLY . 48.0 Cg_endo -78.52 -57.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.098 1.052 . . . . 0.0 111.248 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.87 -35.38 78.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.375 -0.828 . . . . 0.0 109.607 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.664 ' SD ' HD12 ' A' ' 25' ' ' LEU . 12.2 mtp -63.36 -30.25 71.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.996 -0.44 . . . . 0.0 110.869 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -31.95 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.613 -0.68 . . . . 0.0 110.474 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 6.61 22.98 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.577 -0.702 . . . . 0.0 112.073 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.52 27.09 0.83 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.268 -0.895 . . . . 0.0 111.294 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.37 86.45 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.258 -0.901 . . . . 0.0 110.817 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.73 13.43 65.79 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mm -108.71 32.64 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 118.822 1.311 . . . . 0.0 108.996 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -157.23 32.06 0.29 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.325 -0.859 . . . . 0.0 111.005 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.218 0 CA-C-O 117.666 -1.159 . . . . 0.0 111.419 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -124.42 19.04 8.91 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.621 -0.929 . . . . 0.0 111.318 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.59 -57.1 2.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.796 . . . . 0.0 109.335 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.48 -26.61 66.45 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.952 -0.468 . . . . 0.0 110.936 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.1 -30.78 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.437 -0.79 . . . . 0.0 109.875 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.7 mt -67.85 -41.21 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.38 -47.93 31.02 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.0 -60.54 2.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.875 -0.516 . . . . 0.0 110.229 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.551 HG23 ' HB ' ' A' ' 12' ' ' ILE . 3.4 t 40.01 56.92 2.44 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 122.119 0.962 . . . . 0.0 110.146 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 83.5 m 55.97 37.22 28.61 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.728 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.409 ' HB1' HG13 ' A' ' 17' ' ' ILE . . . 53.05 56.77 7.08 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.98 0.895 . . . . 0.0 109.841 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.551 ' HB ' HG23 ' A' ' 9' ' ' THR . 0.8 OUTLIER -85.16 13.76 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.787 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -117.02 93.34 41.84 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.988 -1.07 . . . . 0.0 110.0 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.49 175.45 5.11 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.816 1.678 . . . . 0.0 111.302 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 57.87 40.83 25.58 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 122.483 1.135 . . . . 0.0 109.507 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 20' ' ' ILE . 2.8 tt -169.65 -55.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.409 HG13 ' HB1' ' A' ' 11' ' ' ALA . 24.7 mm -60.16 -38.75 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.56 -32.15 73.53 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.697 -0.627 . . . . 0.0 110.678 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 m -85.4 -49.45 8.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.716 -0.615 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.404 HD13 HD23 ' A' ' 16' ' ' LEU . 1.2 mp -58.99 -43.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -60.7 -39.05 87.05 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -44.62 88.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.698 -0.626 . . . . 0.0 109.58 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.93 -40.64 96.2 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.583 -0.698 . . . . 0.0 109.166 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.6 mm? -68.23 -22.56 64.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.838 -0.539 . . . . 0.0 110.496 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.02 -11.36 53.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.157 -0.339 . . . . 0.0 111.396 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 27' ' ' ILE . 63.3 mt -118.05 30.64 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.572 -0.705 . . . . 0.0 110.051 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -70.83 -32.01 68.91 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.915 -1.116 . . . . 0.0 111.027 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.74 72.32 1.13 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.88 -37.12 3.91 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 O-C-N 123.706 1.371 . . . . 0.0 111.287 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.442 ' HA ' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -57.41 -45.48 84.51 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.601 -0.687 . . . . 0.0 111.015 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.6 ttm -64.03 -44.27 93.03 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.644 -0.66 . . . . 0.0 110.849 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.1 -30.63 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.728 -0.608 . . . . 0.0 111.03 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 41.2 mt -92.29 -2.23 56.56 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.151 -0.968 . . . . 0.0 112.318 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -128.69 29.8 5.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.317 -0.864 . . . . 0.0 109.976 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.92 74.87 1.17 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.421 -0.799 . . . . 0.0 110.436 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.4 76.23 0.64 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 38' ' ' ILE . 4.5 tp -81.19 58.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.843 -0.798 . . . . 0.0 110.622 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 m -150.07 66.94 0.97 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.206 -0.934 . . . . 0.0 109.175 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.293 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 54.35 26.42 6.93 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 117.31 0.555 . . . . 0.0 112.063 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.25 -37.12 6.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.611 -0.681 . . . . 0.0 109.812 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.78 -39.27 87.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.783 -0.573 . . . . 0.0 109.704 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.5 t -63.47 -37.78 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.3 mm -66.23 -35.37 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 tp -78.7 -30.36 45.98 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.597 -0.69 . . . . 0.0 110.584 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.87 22.23 3.73 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.468 -0.77 . . . . 0.0 111.751 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.465 ' O ' HG22 ' A' ' 12' ' ' ILE . 5.5 t -74.85 -25.62 59.11 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.089 -1.007 . . . . 0.0 110.926 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.569 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 55.9 m -67.68 -35.64 79.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.11 76.83 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.769 -0.582 . . . . 0.0 111.231 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -86.62 16.35 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.532 -0.73 . . . . 0.0 111.356 179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 62.79 97.49 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.08 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HD3' ' HA ' ' A' ' 10' ' ' CYS . 50.5 Cg_endo -76.87 176.4 10.16 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.47 -1.396 . . . . 0.0 108.47 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 51.29 28.84 4.51 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 121.954 0.883 . . . . 0.0 110.661 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 tp -151.44 -53.88 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 17' ' ' ILE . 3.1 mm -57.09 -35.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -87.01 -33.81 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 m -71.23 -40.23 71.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.474 -0.766 . . . . 0.0 109.832 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 18.7 mm -65.59 -44.97 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.747 -0.595 . . . . 0.0 109.922 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 p -63.7 -39.37 94.15 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.811 -0.556 . . . . 0.0 110.691 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -59.18 -47.06 86.7 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.715 -0.616 . . . . 0.0 109.63 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.92 -29.1 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -57.71 -47.75 81.52 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.575 -0.703 . . . . 0.0 109.472 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.22 -33.39 73.41 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.298 0.571 . . . . 0.0 110.377 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.6 62.42 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.594 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.661 ' HA ' ' HB3' ' A' ' 31' ' ' LEU . 60.8 mt -112.84 26.78 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.851 -0.531 . . . . 0.0 109.724 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.96 18.18 10.92 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.937 -1.102 . . . . 0.0 112.021 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.53 -72.59 0.04 OUTLIER Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.99 28.67 0.39 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.562 1.508 . . . . 0.0 111.385 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.661 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 1.3 pp -58.46 -33.87 70.22 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.418 -0.801 . . . . 0.0 111.655 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 ttt -87.49 -38.58 15.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.357 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.48 -35.4 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.77 -0.581 . . . . 0.0 110.82 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 mt -87.43 -1.27 57.81 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.434 -0.791 . . . . 0.0 113.012 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -141.09 29.41 1.84 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.26 -0.9 . . . . 0.0 111.377 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.75 112.9 13.81 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.384 -0.823 . . . . 0.0 110.688 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.12 -43.4 1.68 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 40' ' ' LYS . 2.8 mp -84.71 132.92 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.418 -1.048 . . . . 0.0 110.847 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -108.39 41.77 1.51 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' H ' HG22 ' A' ' 38' ' ' ILE . 22.3 tttp . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.102 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.648 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -122.49 17.76 10.48 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.819 -0.812 . . . . 0.0 111.029 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -110.37 -43.73 3.85 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.568 -0.707 . . . . 0.0 109.852 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.06 -35.18 25.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.572 -0.705 . . . . 0.0 109.777 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.37 -42.95 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.811 -0.556 . . . . 0.0 109.802 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.16 -44.19 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.25 -33.36 75.8 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 12' ' ' ILE . 1.7 tp -81.62 -1.89 48.21 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.757 -0.59 . . . . 0.0 112.142 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 m -100.83 -50.06 3.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.171 -0.956 . . . . 0.0 109.238 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.8 m -64.51 -35.4 80.85 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.952 -0.468 . . . . 0.0 111.132 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.44 82.51 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.537 -0.727 . . . . 0.0 110.821 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 8' ' ' LEU . 63.4 mt -68.88 143.13 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 59.31 66.94 2.06 Favored Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 122.178 -0.326 . . . . 0.0 110.779 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' HD12 ' A' ' 17' ' ' ILE . 47.6 Cg_endo -68.52 -21.43 40.05 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.513 1.475 . . . . 0.0 111.62 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.76 -30.29 63.46 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.609 -0.682 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.8 -47.15 82.04 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.831 ' HA ' HD12 ' A' ' 20' ' ' ILE . 4.8 mt -62.03 -38.66 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -61.14 -28.52 69.17 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.819 -0.551 . . . . 0.0 110.686 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.3 m -88.98 -26.56 21.42 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.305 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.831 HD12 ' HA ' ' A' ' 17' ' ' ILE . 70.1 mt -60.48 -45.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.404 -0.81 . . . . 0.0 109.131 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.542 HG23 ' HD3' ' A' ' 22' ' ' LYS . 8.9 t -60.58 -33.54 72.86 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.805 -0.56 . . . . 0.0 109.812 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.542 ' HD3' HG23 ' A' ' 21' ' ' THR . 0.1 OUTLIER -70.69 -48.43 54.79 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.77 -34.18 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -40.28 78.13 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -12.28 59.97 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.973 -0.454 . . . . 0.0 111.276 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.01 8.63 28.42 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.784 -0.572 . . . . 0.0 110.942 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm -137.18 -51.41 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 0.0 109.75 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tp 57.8 57.75 4.03 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.439 0.638 . . . . 0.0 110.484 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.12 66.83 0.04 OUTLIER Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 33' ' ' VAL . 43.7 Cg_endo -65.49 -37.36 30.21 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.979 1.515 . . . . 0.0 111.657 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -58.2 -40.95 82.9 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.596 -0.69 . . . . 0.0 109.917 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.9 mmt -80.7 -41.4 23.73 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.886 -0.509 . . . . 0.0 109.887 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -62.5 -29.73 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.571 -0.706 . . . . 0.0 110.485 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 tp -79.51 -2.14 40.86 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.452 -0.78 . . . . 0.0 111.646 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -127.89 19.15 6.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.429 -0.795 . . . . 0.0 110.746 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.01 -56.74 3.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.197 -0.939 . . . . 0.0 109.441 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.23 41.41 2.0 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.42 140.4 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.621 -0.929 . . . . 0.0 110.456 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.8 m -125.77 56.8 1.38 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.605 0.717 . . . . 0.0 109.611 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 O-C-N 121.348 -0.845 . . . . 0.0 110.543 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.535 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.602 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -130.79 28.68 4.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.91 -0.759 . . . . 0.0 109.458 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -105.34 -57.57 2.01 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.15 -32.71 29.9 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 122.169 -0.332 . . . . 0.0 110.365 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.32 -47.57 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.716 -0.615 . . . . 0.0 110.443 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 ' O ' ' A' ' 2' ' ' ARG . 55.3 mt -61.8 -38.98 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -58.89 -23.19 60.79 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.74 -86.75 0.39 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 9' ' ' THR . 13.9 m 42.08 56.33 3.59 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-O 121.973 0.892 . . . . 0.0 109.283 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.0 m 55.77 44.58 25.92 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.34 63.51 2.07 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.212 1.006 . . . . 0.0 109.491 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.425 ' HA ' HD12 ' A' ' 12' ' ' ILE . 8.4 tp -70.34 167.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.36 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 62.6 83.33 0.2 Allowed Pre-proline 0 N--CA 1.503 2.196 0 C-N-CA 123.19 0.596 . . . . 0.0 112.319 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.72 -19.43 7.35 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.515 1.477 . . . . 0.0 111.486 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -60.14 -30.79 69.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.456 -0.777 . . . . 0.0 111.508 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.409 ' N ' ' HG2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -65.21 -46.72 79.56 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.126 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.538 ' HA ' HD12 ' A' ' 20' ' ' ILE . 42.4 mm -61.31 -39.18 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -45.42 93.1 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.808 -0.557 . . . . 0.0 110.223 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.8 m -60.81 -39.0 87.28 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.762 -0.586 . . . . 0.0 110.539 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 17' ' ' ILE . 45.4 mt -65.35 -44.89 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.834 -0.541 . . . . 0.0 109.595 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.7 m -64.1 -39.11 93.35 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.717 -0.614 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -60.85 -45.66 93.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.721 -0.612 . . . . 0.0 109.429 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.19 -40.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -42.18 86.72 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 25' ' ' LEU . 33.7 mt -78.53 -1.78 35.56 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.787 -0.571 . . . . 0.0 111.435 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.97 13.0 20.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.772 . . . . 0.0 110.3 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.4 mt -118.44 -48.43 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.356 -0.84 . . . . 0.0 109.596 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.57 -22.6 34.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.667 -0.645 . . . . 0.0 111.77 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.4 50.3 0.58 Allowed Glycine 0 N--CA 1.499 2.85 0 O-C-N 121.134 -0.979 . . . . 0.0 111.838 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.11 -35.58 32.88 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.342 1.18 . . . . 0.0 111.046 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mp -60.4 -41.89 94.81 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.798 -0.564 . . . . 0.0 109.686 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.9 ttm -65.0 -40.35 94.82 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.85 -32.96 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.925 -0.485 . . . . 0.0 110.179 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.21 4.56 53.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.43 -0.794 . . . . 0.0 111.801 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.15 25.48 4.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.311 -0.868 . . . . 0.0 110.568 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.74 89.7 7.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.281 -0.887 . . . . 0.0 110.199 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.47 50.59 3.13 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.9 tp -108.75 11.06 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 117.953 0.877 . . . . 0.0 111.457 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 m -132.05 55.35 1.88 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.096 -1.002 . . . . 0.0 108.721 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.704 -1.141 . . . . 0.0 110.625 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.565 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -122.87 26.44 8.17 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.76 -0.847 . . . . 0.0 111.38 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -115.26 -59.11 2.05 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.18 -30.18 66.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.907 -0.496 . . . . 0.0 111.288 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.2 -35.44 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.755 -0.591 . . . . 0.0 110.488 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.24 -45.36 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.02 -27.44 66.54 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.7 35.18 1.55 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.641 -0.662 . . . . 0.0 110.864 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.8 m -110.16 -32.1 7.11 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.006 -1.058 . . . . 0.0 110.957 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.9 t -69.13 -48.52 62.23 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.22 -0.925 . . . . 0.0 110.802 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.92 -25.58 61.96 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.577 -0.702 . . . . 0.0 111.472 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 9' ' ' THR . 2.7 tt -77.93 177.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.487 -0.758 . . . . 0.0 110.819 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -115.32 87.19 15.89 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.57 -0.706 . . . . 0.0 109.219 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.42 -44.6 11.13 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.695 1.366 . . . . 0.0 111.311 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.14 -38.46 89.08 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.732 -0.605 . . . . 0.0 110.189 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.87 -42.1 99.64 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 mm -63.73 -39.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.22 -38.82 84.53 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -65.62 -43.07 90.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.81 -42.46 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -59.81 -41.65 91.71 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.706 -0.621 . . . . 0.0 109.75 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -43.89 94.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.793 -0.567 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 23' ' ' ILE . 30.4 mm -62.1 -38.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 tp -61.34 -40.5 94.49 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.436 ' HA ' HD13 ' A' ' 25' ' ' LEU . 3.3 mm? -66.41 -36.02 81.78 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.3 68.68 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.197 0.522 . . . . 0.0 110.772 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.25 -23.09 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 122.051 -0.406 . . . . 0.0 110.367 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 31' ' ' LEU . 2.1 mm? -97.71 47.48 1.02 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.243 -0.911 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.503 ' N ' ' HD2' ' A' ' 30' ' ' PRO . . . -53.96 -50.87 53.18 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.94 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 29' ' ' GLY . 43.9 Cg_endo -66.82 -33.94 32.28 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 O-C-N 123.151 1.079 . . . . 0.0 111.006 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.534 ' HB2' HD12 ' A' ' 28' ' ' LEU . 2.2 tt -63.27 -39.12 93.69 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -39.08 64.65 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.858 -0.526 . . . . 0.0 109.924 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 29' ' ' GLY . 53.1 t -58.43 -32.85 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 121.778 -0.576 . . . . 0.0 109.976 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.2 7.25 9.74 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.514 -0.741 . . . . 0.0 112.009 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -149.24 24.53 0.91 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.231 -0.918 . . . . 0.0 111.974 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.86 -55.46 2.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.965 -1.084 . . . . 0.0 110.057 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.11 37.75 3.44 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.5 tp -86.47 137.07 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.618 -0.931 . . . . 0.0 110.448 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 t -156.22 39.63 0.36 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.676 -0.64 . . . . 0.0 110.893 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.107 -0.996 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.611 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -123.07 19.41 9.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.76 -0.847 . . . . 0.0 110.997 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -121.25 -59.57 1.7 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.394 -0.816 . . . . 0.0 108.932 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.41 -36.7 78.76 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.982 -0.449 . . . . 0.0 109.795 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.18 -33.88 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.678 -0.638 . . . . 0.0 109.331 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.6 mm -70.65 -38.11 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.3 tp -72.82 -31.65 64.95 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.659 -0.65 . . . . 0.0 109.645 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tp -81.55 -62.03 1.76 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.806 HG23 ' HB ' ' A' ' 12' ' ' ILE . 12.3 t 41.21 54.5 3.41 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.941 0.877 . . . . 0.0 110.717 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 m 57.9 36.37 26.21 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 54.95 53.44 10.37 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.998 0.904 . . . . 0.0 110.305 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.806 ' HB ' HG23 ' A' ' 9' ' ' THR . 1.1 mp -99.69 129.63 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.455 0.645 . . . . 0.0 109.526 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 3.8 p80 -168.82 64.21 0.57 Allowed Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 122.086 -0.384 . . . . 0.0 111.168 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.52 -62.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.161 1.085 . . . . 0.0 110.631 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.81 -28.42 64.03 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.701 -0.624 . . . . 0.0 110.86 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 15.1 mt -65.95 -48.41 71.44 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.39 -41.2 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -60.58 -36.65 79.03 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.912 -0.492 . . . . 0.0 111.072 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -85.67 -44.35 12.65 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 110.555 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mt -60.06 -40.98 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.959 -0.463 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -65.52 -31.13 72.02 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 119.581 1.082 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.82 -36.38 59.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.39 -0.819 . . . . 0.0 109.612 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 23' ' ' ILE . 46.2 mt -100.93 9.51 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 110.647 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 tp -58.16 -48.86 78.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.818 -1.176 . . . . 0.0 109.625 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -78.82 -14.03 59.48 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.907 -0.495 . . . . 0.0 110.906 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.55 21.96 15.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 111.571 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.18 -30.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.307 -0.871 . . . . 0.0 111.305 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.85 -37.32 30.27 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.768 -0.583 . . . . 0.0 112.391 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.12 60.92 0.09 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HB2' ' HB2' ' A' ' 34' ' ' LEU . 47.4 Cg_endo -70.3 -83.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 O-C-N 124.014 1.534 . . . . 0.0 111.817 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 tp 50.02 33.22 6.53 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.936 0.874 . . . . 0.0 111.607 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.1 mtt -175.24 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -71.93 -21.78 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 3.0 tp -91.43 16.96 9.2 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.549 -0.72 . . . . 0.0 111.193 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.579 ' HA ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -161.39 33.65 0.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.13 -0.981 . . . . 0.0 111.219 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.51 -48.05 3.64 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.226 -0.921 . . . . 0.0 110.799 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.92 45.03 1.37 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 35' ' ' GLN . 41.8 mt -128.87 147.52 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.578 -0.954 . . . . 0.0 109.444 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -122.9 58.89 1.07 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.674 0.75 . . . . 0.0 109.191 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.629 -179.99 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -171.98 2.06 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.678 -0.895 . . . . 0.0 109.298 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.7 37.09 28.56 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 121.48 0.657 . . . . 0.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.18 -52.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.5 -36.74 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.922 -0.487 . . . . 0.0 109.79 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 mt -62.31 -37.43 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.7 tp -77.18 -33.58 56.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.787 -0.571 . . . . 0.0 110.129 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.95 26.58 3.13 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.692 -0.63 . . . . 0.0 111.564 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.5 t -63.0 -22.93 67.2 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.119 -0.988 . . . . 0.0 111.692 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 p -66.86 -26.82 67.08 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.429 -0.794 . . . . 0.0 111.328 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -118.44 -72.42 0.69 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.435 -0.791 . . . . 0.0 109.732 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.5 OUTLIER 56.71 18.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.857 -0.527 . . . . 0.0 112.311 179.908 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -144.66 63.25 10.44 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.852 -1.155 . . . . 0.0 110.638 179.769 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.26 -50.3 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.361 1.19 . . . . 0.0 111.004 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -29.64 70.36 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.791 -0.568 . . . . 0.0 110.563 179.44 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 1.6 mt -66.96 -46.49 74.51 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 20' ' ' ILE . 63.1 mt -59.38 -37.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -65.26 -38.6 90.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.912 -0.493 . . . . 0.0 109.925 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.1 m -65.04 -43.12 93.4 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.75 -0.594 . . . . 0.0 109.503 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 17' ' ' ILE . 14.4 mt -61.33 -41.94 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.957 -0.464 . . . . 0.0 109.749 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.6 m -65.08 -40.0 94.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.597 -0.689 . . . . 0.0 110.155 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -57.48 -45.02 85.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.962 -0.461 . . . . 0.0 109.89 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -38.19 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -59.18 -49.6 77.23 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.442 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -17.03 62.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.82 -0.55 . . . . 0.0 111.31 179.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.03 2.18 56.51 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.807 -0.558 . . . . 0.0 111.184 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.4 mt -112.85 -55.66 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.8 mt -86.62 -32.54 20.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.85 -0.531 . . . . 0.0 110.468 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' N ' ' HD2' ' A' ' 30' ' ' PRO . . . -56.61 -54.33 37.08 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 29' ' ' GLY . 44.3 Cg_endo -68.16 -32.03 28.17 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 O-C-N 123.46 1.242 . . . . 0.0 110.89 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.66 -43.8 97.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.614 -0.679 . . . . 0.0 109.541 179.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.7 ttm -62.59 -39.58 94.17 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.38 -30.23 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.2 mt -83.45 9.09 11.97 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.405 -0.809 . . . . 0.0 112.085 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.75 21.01 5.98 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.137 -0.977 . . . . 0.0 111.15 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.98 -54.86 3.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.234 -0.916 . . . . 0.0 109.53 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.92 -25.54 22.08 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.6 mm -82.25 121.03 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.481 -1.011 . . . . 0.0 109.791 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 m -137.89 60.28 1.63 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.097 0.475 . . . . 0.0 110.035 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 117.518 -1.229 . . . . 0.0 110.656 -179.926 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.481 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -82.55 89.15 6.65 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.184 0.992 . . . . 0.0 110.656 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -167.53 -61.58 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.37 -36.26 66.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.875 -0.515 . . . . 0.0 109.864 179.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.0 t -58.46 -40.35 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.6 mt -59.02 -47.02 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 tt -70.17 -28.93 65.71 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.043 -0.411 . . . . 0.0 109.977 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.67 8.84 18.13 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.6 -0.688 . . . . 0.0 112.223 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 12' ' ' ILE . 7.0 t -63.41 -36.36 83.48 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.186 -0.946 . . . . 0.0 110.748 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -80.18 -29.8 38.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.414 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.77 -20.28 62.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.619 -0.675 . . . . 0.0 111.238 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -92.41 16.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.238 -0.914 . . . . 0.0 112.011 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.76 65.23 53.09 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.968 -1.082 . . . . 0.0 110.031 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.16 -40.42 11.42 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.336 1.357 . . . . 0.0 111.708 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -38.22 87.39 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.7 -0.625 . . . . 0.0 110.665 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -45.65 76.19 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.506 ' HA ' HG22 ' A' ' 20' ' ' ILE . 37.1 mt -65.39 -38.65 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.67 -26.32 67.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.686 -0.634 . . . . 0.0 110.692 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.4 m -96.46 -41.96 8.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.689 -0.632 . . . . 0.0 109.963 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 17' ' ' ILE . 9.0 tt -57.39 -33.37 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.717 -0.614 . . . . 0.0 111.254 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.8 p -63.49 -43.25 97.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.498 -0.751 . . . . 0.0 109.168 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -63.92 -35.68 81.47 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.519 HG22 HD12 ' A' ' 27' ' ' ILE . 33.3 mm -75.48 -40.9 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.59 -43.62 93.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.48 -32.99 74.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.797 -0.564 . . . . 0.0 110.44 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.84 -30.14 63.77 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.239 0.542 . . . . 0.0 110.533 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 27' ' ' ILE . 47.7 mt -111.93 37.17 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tp -77.56 -30.95 52.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.94 -1.1 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.09 54.99 0.36 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.61 -36.02 27.02 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 O-C-N 123.619 1.326 . . . . 0.0 111.159 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 12.3 tp -60.13 -46.39 89.81 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.504 -0.748 . . . . 0.0 109.678 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.4 mtm -66.71 -39.68 88.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.792 -0.568 . . . . 0.0 109.594 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.41 -39.51 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.646 -0.659 . . . . 0.0 109.886 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.32 7.84 27.0 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.609 -0.682 . . . . 0.0 111.929 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 8.9 tt0 -126.72 16.16 7.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.183 -0.948 . . . . 0.0 110.78 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.85 73.28 7.51 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.79 65.05 1.57 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -102.12 57.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 122.009 0.909 . . . . 0.0 109.885 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 39' ' ' THR . 10.8 t -163.78 59.93 0.17 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.914 0.864 . . . . 0.0 109.655 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 O-C-N 121.3 -0.875 . . . . 0.0 111.363 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.543 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.51 -166.99 1.18 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.708 -0.878 . . . . 0.0 109.802 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.29 40.11 31.44 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.007 0.908 . . . . 0.0 109.839 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -178.35 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.69 -35.0 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.4 mm -63.78 -44.92 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.2 tp -60.69 -36.48 78.88 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.68 -44.34 96.5 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.819 -0.551 . . . . 0.0 109.853 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.592 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 10.5 m -63.15 -33.52 75.64 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.6 m -67.06 -35.2 79.34 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.88 -46.05 25.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.781 -0.575 . . . . 0.0 109.972 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' CG1' ' HA ' ' A' ' 9' ' ' THR . 1.1 pt -74.8 146.6 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.592 -0.693 . . . . 0.0 110.531 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.45 ' CE1' ' HB2' ' A' ' 16' ' ' LEU . 9.6 t-80 54.76 63.71 6.76 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 122.048 -0.408 . . . . 0.0 110.937 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.462 ' HA ' HD12 ' A' ' 17' ' ' ILE . 46.8 Cg_endo -69.07 -21.62 36.45 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.225 1.283 . . . . 0.0 112.106 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -57.4 -37.78 73.27 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.308 -0.87 . . . . 0.0 110.781 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 13' ' ' HIS . 9.0 tp -65.05 -42.04 94.61 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 14' ' ' PRO . 3.1 mt -71.39 -36.36 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.6 -34.98 71.73 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.92 -0.488 . . . . 0.0 109.696 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.2 m -75.68 -41.13 54.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 20' ' ' ILE . 23.4 mm -64.8 -40.31 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.995 -0.441 . . . . 0.0 110.271 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.8 p -64.73 -37.21 86.82 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.497 -0.752 . . . . 0.0 109.741 179.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -45.02 93.99 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -65.13 -37.14 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 30' ' ' PRO . 2.4 tp -59.64 -40.85 89.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.205 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 25' ' ' LEU . 2.2 mm? -68.26 -22.11 64.78 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.871 -0.518 . . . . 0.0 110.593 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.82 5.78 47.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.09 -0.382 . . . . 0.0 110.817 179.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -128.89 -50.77 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.496 -0.752 . . . . 0.0 109.902 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp 62.02 48.32 5.24 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.441 0.639 . . . . 0.0 110.686 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' CD ' ' A' ' 30' ' ' PRO . . . -154.84 51.41 0.46 Allowed Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HB3' HD11 ' A' ' 24' ' ' LEU . 47.7 Cg_endo -69.92 -33.26 16.34 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.567 1.298 . . . . 0.0 111.291 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.16 -47.36 85.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.614 -0.679 . . . . 0.0 110.515 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.5 tpt -63.37 -41.84 98.82 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.558 -0.714 . . . . 0.0 110.393 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -33.54 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.566 -0.709 . . . . 0.0 110.548 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.19 9.49 35.83 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.455 -0.778 . . . . 0.0 111.832 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.3 25.17 3.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.184 -0.948 . . . . 0.0 110.198 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.24 -49.03 7.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.423 -0.798 . . . . 0.0 109.289 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.01 46.79 1.12 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.6 mm -122.0 129.4 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.708 -0.878 . . . . 0.0 109.563 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -127.11 44.69 2.86 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.147 0.498 . . . . 0.0 110.362 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 N--CA 1.503 2.216 0 O-C-N 121.548 -0.72 . . . . 0.0 111.214 -179.943 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.483 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.3 mmt-85 54.84 22.02 3.98 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 122.338 -0.507 . . . . 0.0 112.051 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.14 -58.94 1.0 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.75 94.54 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.95 -41.82 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.2 mm -62.74 -43.44 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tt -61.43 -40.3 93.94 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.074 -0.391 . . . . 0.0 110.091 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tp -65.71 -19.55 65.94 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.93 -0.481 . . . . 0.0 111.792 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.5 m -101.82 -41.46 6.51 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.1 m -65.25 -37.56 87.6 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.823 -0.548 . . . . 0.0 110.971 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -68.56 -60.91 2.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.565 -0.71 . . . . 0.0 110.035 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 11' ' ' ALA . 1.4 tp 55.47 -178.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.424 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.5 OUTLIER 55.07 59.46 10.45 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.509 -0.744 . . . . 0.0 110.912 -179.636 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.72 -24.54 13.36 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.367 1.193 . . . . 0.0 112.113 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.86 -50.36 68.88 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.369 -0.832 . . . . 0.0 111.061 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 tp -66.63 -41.52 88.19 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.83 -46.48 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -55.07 -38.24 67.8 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.834 -0.541 . . . . 0.0 111.009 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -78.57 -49.37 13.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.575 -0.703 . . . . 0.0 110.594 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.89 -45.63 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.733 -0.604 . . . . 0.0 110.005 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.7 m -59.55 -32.75 70.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.495 -0.753 . . . . 0.0 109.716 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.44 -35.64 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.038 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -61.97 -45.18 94.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -66.2 -29.54 69.83 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.919 -0.488 . . . . 0.0 110.943 179.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.81 -17.98 60.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.077 -0.39 . . . . 0.0 111.921 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.9 mt -103.31 -28.44 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.823 -0.548 . . . . 0.0 110.593 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -70.65 -42.2 71.12 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.163 -0.96 . . . . 0.0 111.01 -179.973 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.7 71.65 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' HG12 ' A' ' 33' ' ' VAL . 42.8 Cg_endo -62.99 -40.29 35.24 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 O-C-N 123.957 1.504 . . . . 0.0 111.332 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.68 -38.99 77.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.485 -0.759 . . . . 0.0 109.265 179.343 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -33.04 74.83 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 122.046 -0.409 . . . . 0.0 111.296 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -59.15 -29.95 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.478 -0.764 . . . . 0.0 110.209 179.758 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.57 17.41 5.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.645 -0.66 . . . . 0.0 110.666 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -144.53 25.22 1.51 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.561 -0.712 . . . . 0.0 109.999 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.44 -54.88 2.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.209 -0.932 . . . . 0.0 110.1 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.21 51.52 0.69 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.1 mm -108.58 142.08 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.863 -0.787 . . . . 0.0 109.851 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m 56.62 58.03 4.41 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.205 0.526 . . . . 0.0 109.962 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 117.285 -1.341 . . . . 0.0 110.285 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -111.53 34.88 3.88 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.883 -0.774 . . . . 0.0 111.203 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.81 -51.06 2.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.397 -0.815 . . . . 0.0 109.789 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.32 96.97 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.894 -0.503 . . . . 0.0 110.515 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.55 -40.68 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.683 -0.635 . . . . 0.0 109.483 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.6 mm -61.05 -38.38 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.49 -30.21 59.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.73 -0.606 . . . . 0.0 109.865 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tp -89.25 12.32 16.34 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.654 -0.654 . . . . 0.0 111.924 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -58.6 -31.43 68.04 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.178 -0.951 . . . . 0.0 111.073 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -73.72 -36.72 65.23 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.547 -0.72 . . . . 0.0 109.816 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.77 43.69 1.9 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.505 0.669 . . . . 0.0 110.245 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.1 tp -87.37 136.46 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.588 -0.695 . . . . 0.0 109.876 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 94.7 m-70 -137.31 98.15 10.3 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.617 -0.677 . . . . 0.0 109.822 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 43.3 Cg_endo -64.3 -45.19 10.1 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 O-C-N 123.885 1.466 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.24 -31.96 73.36 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.708 -0.62 . . . . 0.0 110.559 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 2.2 mm? -66.54 -39.66 88.7 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mm -64.82 -42.29 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -60.3 -33.37 72.26 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.6 m -68.67 -43.25 76.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.46 ' HA ' HD12 ' A' ' 23' ' ' ILE . 37.1 mm -66.58 -42.31 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.079 -0.388 . . . . 0.0 110.037 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.3 p -63.54 -37.94 89.25 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.455 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.42 -40.92 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.738 -0.601 . . . . 0.0 109.546 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 20' ' ' ILE . 14.8 mt -74.01 -43.57 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -44.71 89.05 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.86 -0.525 . . . . 0.0 109.795 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.22 -5.08 45.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.808 -0.558 . . . . 0.0 111.298 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.52 9.27 21.26 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.613 -0.679 . . . . 0.0 110.53 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -107.56 -41.06 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.2 mm? -86.27 -45.42 11.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.328 -0.858 . . . . 0.0 108.968 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.582 ' O ' HG23 ' A' ' 33' ' ' VAL . . . 69.91 75.49 0.57 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.82 -38.4 30.44 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.781 1.411 . . . . 0.0 110.737 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.66 -43.14 90.28 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.3 mtt -65.09 -36.42 84.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.11 -0.369 . . . . 0.0 110.439 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 29' ' ' GLY . 56.9 t -58.85 -36.46 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.498 -0.751 . . . . 0.0 109.98 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.25 7.48 46.05 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.594 -0.691 . . . . 0.0 111.53 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.78 17.6 6.27 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.404 -0.81 . . . . 0.0 110.889 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.2 79.31 1.98 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.45 44.61 6.47 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 tp -95.67 34.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.717 -0.872 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.6 p -115.13 50.72 0.96 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.046 -1.034 . . . . 0.0 110.123 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 mttt . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.55 179.964 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.445 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -130.46 -174.66 3.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.735 -0.862 . . . . 0.0 109.742 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.83 35.96 24.49 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.416 0.627 . . . . 0.0 110.147 -179.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -174.66 -51.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.24 -38.18 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.958 -0.464 . . . . 0.0 109.817 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -62.83 -32.9 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -81.13 -25.57 36.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.537 -0.727 . . . . 0.0 110.521 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.28 21.14 9.36 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.416 -0.803 . . . . 0.0 111.967 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -87.95 -20.7 25.55 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.911 -1.118 . . . . 0.0 112.151 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.0 t -79.9 -53.61 6.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.348 -0.845 . . . . 0.0 111.027 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.25 42.35 1.1 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.585 -0.697 . . . . 0.0 111.451 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.7 tp -59.4 143.19 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.734 -0.604 . . . . 0.0 110.674 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.557 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 1.7 m-70 -145.87 84.54 8.13 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.487 -0.758 . . . . 0.0 110.433 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.669 ' HA ' HD12 ' A' ' 17' ' ' ILE . 43.0 Cg_endo -65.68 -45.59 6.38 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 O-C-N 123.544 1.286 . . . . 0.0 111.078 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.21 -36.81 83.08 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.653 -0.654 . . . . 0.0 110.122 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -65.49 -42.93 91.61 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.372 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 14' ' ' PRO . 46.6 mt -57.49 -44.54 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.351 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.94 -42.93 99.67 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.131 -0.356 . . . . 0.0 110.119 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.7 m -59.04 -40.91 86.53 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.45 HG22 HD23 ' A' ' 24' ' ' LEU . 49.2 mt -65.17 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 m -60.36 -41.13 93.04 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.633 -0.667 . . . . 0.0 109.783 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -63.62 -41.34 98.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.454 HG22 HD12 ' A' ' 27' ' ' ILE . 32.5 mm -77.66 -26.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -57.91 -45.46 86.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.498 -0.751 . . . . 0.0 109.566 179.573 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -16.53 63.96 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.782 -0.574 . . . . 0.0 111.365 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.27 5.71 50.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.827 -0.545 . . . . 0.0 111.073 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.454 HD12 HG22 ' A' ' 23' ' ' ILE . 96.8 mt -139.14 -51.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 0.0 109.319 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 59.39 35.9 23.17 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.426 0.632 . . . . 0.0 111.342 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.86 58.15 0.15 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.582 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.3 -34.72 26.41 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.755 1.397 . . . . 0.0 111.702 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 31' ' ' LEU . 2.9 mm? -59.42 -48.05 83.13 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.731 -0.606 . . . . 0.0 110.163 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.8 ttt -64.96 -45.09 87.16 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.9 t -61.55 -39.81 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.84 -0.538 . . . . 0.0 110.479 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.14 5.17 23.53 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.473 -0.767 . . . . 0.0 112.292 179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.47 29.6 2.41 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.192 -0.943 . . . . 0.0 110.829 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.51 97.75 8.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.518 -0.739 . . . . 0.0 109.173 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.69 48.2 29.82 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.57 150.38 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.862 -0.787 . . . . 0.0 110.083 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m 56.84 60.38 3.07 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.462 0.648 . . . . 0.0 109.419 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.924 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.084 -179.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.462 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -174.53 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.333 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.84 40.86 32.03 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 121.6 0.714 . . . . 0.0 109.146 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.54 -55.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.62 -42.3 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.64 -39.75 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -40.0 94.93 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.994 -0.441 . . . . 0.0 109.823 179.388 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.32 -16.55 63.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.666 -0.646 . . . . 0.0 111.792 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 12' ' ' ILE . 91.5 m -99.21 -43.28 6.68 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.4 m -66.75 -32.5 73.83 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.058 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.27 69.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.284 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 9' ' ' THR . 1.7 pt -63.65 -173.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.443 -179.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -142.96 129.85 10.74 Favored Pre-proline 0 N--CA 1.481 1.115 0 O-C-N 121.065 -1.022 . . . . 0.0 110.432 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.54 -160.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.548 2.166 . . . . 0.0 110.198 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 61.93 21.96 12.69 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 121.8 0.81 . . . . 0.0 110.228 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.1 tp -144.1 -53.87 0.34 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.03 -45.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.648 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.94 82.21 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -62.98 -42.68 99.91 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.5 mm -60.62 -42.25 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -63.47 -38.81 92.58 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.712 -0.618 . . . . 0.0 109.646 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -60.08 -35.91 76.23 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.497 . . . . 0.0 109.851 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.47 -31.18 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.79 -45.68 93.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.651 -0.655 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.6 -13.07 61.94 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.925 179.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.26 -8.24 33.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.73 -0.606 . . . . 0.0 111.056 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 27' ' ' ILE . 39.3 mm -125.51 36.75 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.569 -0.707 . . . . 0.0 109.367 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -157.18 76.2 0.84 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.966 -1.084 . . . . 0.0 109.745 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' N ' ' CD ' ' A' ' 30' ' ' PRO . . . -145.63 51.57 0.6 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 29' ' ' GLY . 45.6 Cg_endo -65.83 -31.5 47.9 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.445 1.43 . . . . 0.0 111.521 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 31' ' ' LEU . 3.2 mm? -58.7 -46.21 87.78 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.657 -0.652 . . . . 0.0 109.819 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.7 mmt -69.78 -40.75 75.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.99 -37.74 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.691 -0.631 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 16.49 3.56 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.527 -0.733 . . . . 0.0 112.433 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.45 26.0 0.77 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.16 -0.962 . . . . 0.0 111.215 179.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.43 -48.33 5.07 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.141 -0.974 . . . . 0.0 109.94 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.46 60.61 0.52 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 tp -80.12 133.02 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.794 -0.827 . . . . 0.0 110.44 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 p -144.4 -54.56 0.34 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.616 -0.678 . . . . 0.0 110.963 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 118.767 -0.635 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -108.33 23.97 13.71 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.82 -0.812 . . . . 0.0 111.155 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.404 ' HA ' HD12 ' A' ' 6' ' ' ILE . 9.1 p-10 -100.6 -42.41 6.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.378 -0.826 . . . . 0.0 110.266 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.85 -27.46 62.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.706 -0.621 . . . . 0.0 110.583 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.79 -38.01 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.756 -0.59 . . . . 0.0 109.929 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 3' ' ' ASP . 11.1 mt -62.75 -44.49 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.309 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.0 tp -69.35 -18.66 63.82 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.766 -0.584 . . . . 0.0 110.472 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.74 7.24 43.94 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.371 -0.831 . . . . 0.0 111.621 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -78.87 -40.82 31.42 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.179 -0.951 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.5 p -69.2 -13.8 62.62 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.543 -0.723 . . . . 0.0 112.161 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.29 46.83 0.92 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.172 -0.955 . . . . 0.0 110.227 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 tt -136.17 175.41 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.83 -0.544 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 67.21 106.86 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.307 0 C-N-CA 122.987 0.515 . . . . 0.0 111.257 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.96 -26.27 66.62 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.257 1.305 . . . . 0.0 112.041 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.77 -10.39 59.36 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.532 -0.73 . . . . 0.0 111.913 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -103.93 -39.81 6.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.514 -0.741 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.4 mm -54.37 -41.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 122.053 -0.405 . . . . 0.0 110.388 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -63.69 -38.65 91.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.713 -0.617 . . . . 0.0 110.171 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -65.41 -39.17 91.82 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.751 -0.593 . . . . 0.0 109.739 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.98 -43.96 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.8 m -58.75 -41.38 86.39 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.812 -0.555 . . . . 0.0 109.889 179.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.18 -35.8 74.19 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.931 -0.481 . . . . 0.0 110.456 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -93.78 -20.14 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.736 -0.603 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tp -57.98 -45.36 86.89 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.47 -29.32 70.36 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.846 -0.533 . . . . 0.0 110.037 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.62 -36.17 29.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.26 0.552 . . . . 0.0 110.208 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 27' ' ' ILE . 45.2 mm -109.25 48.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.438 0.637 . . . . 0.0 109.726 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.74 -26.57 59.88 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.076 -1.015 . . . . 0.0 111.322 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.06 59.28 4.34 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.69 -29.77 15.44 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 123.606 1.319 . . . . 0.0 111.576 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 3.4 mm? -58.09 -34.81 70.57 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.594 -0.691 . . . . 0.0 111.287 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.6 -34.91 18.36 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.51 -0.744 . . . . 0.0 110.397 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -74.67 -39.52 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.497 -0.752 . . . . 0.0 110.689 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.39 16.97 5.67 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.423 -0.798 . . . . 0.0 112.147 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 29.4 mt-30 -146.49 24.88 1.23 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.243 -0.911 . . . . 0.0 110.435 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.96 -57.64 2.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.97 49.12 0.87 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.4 mm -114.87 50.4 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.723 -0.869 . . . . 0.0 109.118 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -154.55 49.82 0.61 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.63 0.728 . . . . 0.0 110.014 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.9 tptt . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.957 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -110.61 24.95 12.32 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.708 -0.877 . . . . 0.0 110.757 179.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -100.2 -36.36 9.33 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.363 -0.835 . . . . 0.0 110.218 179.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.18 -37.92 8.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.847 -0.533 . . . . 0.0 110.177 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.94 -43.12 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.696 -0.628 . . . . 0.0 110.564 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.12 -36.07 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.424 -0.797 . . . . 0.0 109.342 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.9 tp -78.11 -33.53 50.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.783 -0.573 . . . . 0.0 110.536 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 13.24 13.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.515 -0.74 . . . . 0.0 112.132 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -66.21 -29.44 69.71 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.897 -1.127 . . . . 0.0 111.543 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.9 m -72.27 -35.27 68.69 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.445 -0.784 . . . . 0.0 112.004 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.73 11.86 24.34 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.255 -0.903 . . . . 0.0 112.848 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.3 tt -69.51 139.74 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.011 -1.055 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CD2' HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER 56.28 68.6 2.18 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 122.259 -0.275 . . . . 0.0 111.098 -179.986 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.0 -34.98 36.36 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.295 1.33 . . . . 0.0 111.605 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.02 -38.23 90.35 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.584 0.707 . . . . 0.0 109.613 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 13' ' ' HIS . 11.0 tp -73.9 -33.24 63.93 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.616 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.661 ' O ' HG22 ' A' ' 20' ' ' ILE . 12.6 mm -60.79 -35.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.674 -0.642 . . . . 0.0 109.597 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -75.85 -44.07 42.62 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m -66.24 -33.33 75.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.767 -0.583 . . . . 0.0 110.809 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 17' ' ' ILE . 2.5 tp -59.86 -34.24 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.13 -0.981 . . . . 0.0 110.098 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -65.62 -43.85 88.31 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -65.33 -44.15 88.73 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 23' ' ' ILE . 25.3 mm -63.61 -36.91 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.69 -38.84 79.12 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.612 -0.68 . . . . 0.0 110.121 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.95 -11.24 60.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.616 -0.678 . . . . 0.0 111.13 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.44 7.81 45.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.75 -0.594 . . . . 0.0 110.531 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm -126.93 -52.71 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.592 -0.693 . . . . 0.0 109.648 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 tp 57.83 71.58 0.57 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.717 0.77 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.95 55.42 0.4 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -66.21 -32.03 43.28 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 O-C-N 123.639 1.336 . . . . 0.0 111.223 179.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 31' ' ' LEU . 2.6 mm? -62.07 -45.39 93.74 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.675 -0.641 . . . . 0.0 110.638 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.2 mtp -62.32 -38.62 90.15 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.861 -0.524 . . . . 0.0 110.101 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.9 t -75.83 -30.43 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.691 -0.63 . . . . 0.0 110.619 179.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.0 mt -90.85 3.84 53.39 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.286 -0.883 . . . . 0.0 112.843 -179.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.598 ' HA ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -141.89 31.14 1.62 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 0.0 110.565 179.67 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.75 102.23 11.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 0.0 109.59 179.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.14 42.76 66.38 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 35' ' ' GLN . 86.9 mt -126.14 119.6 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.68 -0.894 . . . . 0.0 109.756 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.4 m -145.96 -72.51 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.519 -0.738 . . . . 0.0 110.637 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 117.339 -1.315 . . . . 0.0 110.941 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.556 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.57 18.19 21.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.923 -0.751 . . . . 0.0 110.36 179.517 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -114.98 -43.56 3.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.0 109.701 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.47 -39.02 62.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.786 -0.572 . . . . 0.0 109.739 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.2 t -62.65 -42.51 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mm -59.22 -46.35 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.12 -38.9 92.13 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.255 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.91 -31.87 70.23 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.926 0.394 . . . . 0.0 110.99 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.3 m -79.7 -38.77 32.75 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 t -74.45 -33.57 62.95 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.711 -0.618 . . . . 0.0 110.725 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.16 35.21 1.19 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.542 -0.724 . . . . 0.0 111.379 179.855 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 tp -90.26 143.45 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.398 -0.814 . . . . 0.0 109.552 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.454 ' CD2' HD13 ' A' ' 16' ' ' LEU . 8.5 t60 -154.59 101.08 2.38 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.452 -0.78 . . . . 0.0 111.149 -179.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.58 167.0 25.46 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 O-C-N 123.581 1.306 . . . . 0.0 110.22 179.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 54.96 41.41 31.91 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 122.434 1.111 . . . . 0.0 109.504 -179.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 13' ' ' HIS . 2.2 tt -167.75 -51.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.5 mt -58.14 -40.22 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -41.67 96.05 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.854 -0.529 . . . . 0.0 109.916 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -61.94 -41.7 98.26 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 17' ' ' ILE . 17.8 mt -63.68 -42.28 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.8 m -61.98 -33.95 75.25 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.487 -0.758 . . . . 0.0 110.022 179.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -69.12 -37.38 78.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 25.4 mt -102.63 6.03 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.786 -0.571 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -54.42 -50.12 68.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.852 -1.155 . . . . 0.0 110.626 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 31' ' ' LEU . 32.0 mt -68.32 -19.22 64.66 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.243 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.34 10.45 39.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.109 -0.369 . . . . 0.0 111.166 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 2.7 tt -120.87 -8.04 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.249 -0.907 . . . . 0.0 111.905 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.3 -50.83 50.85 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.105 -0.997 . . . . 0.0 111.008 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.56 -52.56 0.83 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -93.36 53.56 0.41 Allowed 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 121.981 1.787 . . . . 0.0 110.038 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 25' ' ' LEU . 1.3 tt -49.42 -49.14 46.29 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.903 -0.498 . . . . 0.0 111.676 -179.763 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -41.56 25.52 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.351 -0.843 . . . . 0.0 110.524 179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.4 t -63.04 -41.61 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.718 -0.614 . . . . 0.0 110.271 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tp -85.22 7.38 22.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.618 -0.676 . . . . 0.0 111.682 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -122.86 13.83 9.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.254 -0.904 . . . . 0.0 110.5 179.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.49 -52.14 6.38 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.197 -0.939 . . . . 0.0 109.429 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.73 -42.83 8.74 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mt -80.78 129.85 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.666 -0.903 . . . . 0.0 108.925 179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -107.97 48.35 0.85 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.634 0.73 . . . . 0.0 110.577 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.4 tttt . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.47 179.9 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.463 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -123.59 8.28 8.92 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.753 -0.851 . . . . 0.0 112.264 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.79 -52.98 3.42 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.869 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.77 -27.95 69.54 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.992 -0.442 . . . . 0.0 110.644 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.84 -32.64 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.504 -0.747 . . . . 0.0 110.208 179.595 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.7 mm -67.0 -40.09 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.448 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.3 tp -74.37 -33.03 62.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.802 -0.562 . . . . 0.0 109.785 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.87 18.41 5.71 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.485 -0.759 . . . . 0.0 111.886 179.791 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.589 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 13.3 t -55.69 -28.8 57.54 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.397 -0.815 . . . . 0.0 110.682 179.58 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.0 m -70.44 -34.27 72.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.677 -0.64 . . . . 0.0 109.445 179.261 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.15 -39.29 19.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.55 -0.719 . . . . 0.0 110.358 179.635 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.589 ' CG1' ' HA ' ' A' ' 9' ' ' THR . 1.4 pt -80.65 126.34 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.529 -0.732 . . . . 0.0 110.492 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 16.2 t-160 -144.16 98.21 5.14 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.444 -0.785 . . . . 0.0 109.993 -179.838 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.902 ' HA ' HD12 ' A' ' 17' ' ' ILE . 44.0 Cg_endo -66.68 -38.36 18.58 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.549 1.499 . . . . 0.0 111.746 179.925 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -57.95 -33.77 69.18 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.674 -0.641 . . . . 0.0 110.816 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -36.04 82.17 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.376 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 14' ' ' PRO . 7.7 mt -65.02 -30.54 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.751 -0.593 . . . . 0.0 109.706 179.462 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -88.43 -25.95 22.39 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.426 -0.796 . . . . 0.0 109.863 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.7 m -88.93 -21.57 23.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 0.0 110.503 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 17' ' ' ILE . 15.8 tt -53.49 -37.66 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 121.315 -0.865 . . . . 0.0 110.581 -179.994 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -71.01 -39.7 72.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -61.58 -36.12 79.76 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.294 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 20' ' ' ILE . 17.9 mt -74.3 -30.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.66 -0.65 . . . . 0.0 109.35 179.25 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 27' ' ' ILE . 11.0 tp -60.0 -41.21 91.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.701 -0.624 . . . . 0.0 110.297 179.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.68 2.59 28.94 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.503 -0.748 . . . . 0.0 110.701 179.034 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.634 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -117.2 10.89 13.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.515 -0.74 . . . . 0.0 110.355 179.294 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 24' ' ' LEU . 14.1 tt -98.63 -29.01 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.605 -0.684 . . . . 0.0 109.987 179.848 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.57 -21.74 38.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.73 -0.606 . . . . 0.0 110.35 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.74 58.55 0.43 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.609 ' HA ' HG12 ' A' ' 33' ' ' VAL . 42.7 Cg_endo -62.35 -34.91 75.8 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.92 1.747 . . . . 0.0 111.493 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 31' ' ' LEU . 3.1 mm? -60.65 -41.87 95.85 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.634 -0.667 . . . . 0.0 109.661 179.666 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ttp -80.93 -41.64 22.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.887 -0.508 . . . . 0.0 110.522 179.779 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.634 HG11 ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -60.4 -32.31 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.544 -0.722 . . . . 0.0 111.21 -179.897 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -30.81 70.61 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.456 -0.777 . . . . 0.0 111.332 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -97.25 21.47 9.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.165 -0.334 . . . . 0.0 111.084 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.26 57.76 0.63 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.332 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.25 58.06 0.24 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.573 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 tt -113.42 31.11 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 122.001 -0.705 . . . . 0.0 110.73 -179.826 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -135.86 53.6 1.94 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.293 -0.88 . . . . 0.0 109.873 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.0 tttm . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.197 179.877 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.517 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -122.24 18.35 10.69 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.736 -0.861 . . . . 0.0 111.174 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -101.87 -58.02 1.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.368 -0.832 . . . . 0.0 109.476 179.767 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.92 -28.59 69.05 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.956 -0.465 . . . . 0.0 110.876 179.596 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.84 -34.55 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.766 -0.584 . . . . 0.0 110.241 179.761 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.3 mt -63.34 -44.86 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.356 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.94 -37.2 81.33 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.185 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -27.95 69.52 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.9 -0.5 . . . . 0.0 111.302 179.698 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.5 m -68.86 -35.2 76.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.965 -0.46 . . . . 0.0 109.991 179.681 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 69.3 m -95.66 37.23 1.21 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.445 -0.784 . . . . 0.0 110.578 179.643 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.74 38.24 0.27 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.447 -0.783 . . . . 0.0 110.501 179.873 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.3 tt -135.55 148.24 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.572 -0.705 . . . . 0.0 110.797 -179.75 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 17.3 m170 -124.25 78.68 60.33 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.389 -0.819 . . . . 0.0 110.286 -179.929 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.21 -36.15 17.31 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.311 1.341 . . . . 0.0 111.047 179.996 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -79.79 4.41 16.53 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.664 -0.647 . . . . 0.0 111.026 179.396 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -112.38 -47.77 3.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.475 -0.766 . . . . 0.0 109.007 179.494 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.832 ' HA ' HD12 ' A' ' 20' ' ' ILE . 71.7 mt -56.96 -45.03 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -44.56 94.63 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.736 -0.603 . . . . 0.0 109.601 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.484 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 2.4 m -61.23 -33.95 74.32 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.818 -0.551 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 17' ' ' ILE . 64.1 mt -60.43 -40.25 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.44 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -58.75 -39.49 81.1 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.251 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HD2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -64.89 -43.48 92.74 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.187 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 HD11 ' A' ' 27' ' ' ILE . 48.2 mm -71.31 -33.28 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.313 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.547 ' HA ' HD12 ' A' ' 27' ' ' ILE . 1.6 tp -55.56 -41.49 73.35 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.867 -0.521 . . . . 0.0 109.834 179.411 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 2.71 22.47 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.733 -0.604 . . . . 0.0 111.302 179.3 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.65 6.53 11.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.481 -0.762 . . . . 0.0 110.903 179.374 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 24' ' ' LEU . 28.1 mt -99.22 -29.29 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 0.0 109.465 179.63 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mt -84.58 15.33 3.84 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.52 -0.738 . . . . 0.0 111.614 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.11 55.07 0.4 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.549 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.42 -30.77 43.85 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.473 1.449 . . . . 0.0 111.116 -179.946 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mp -55.22 -43.53 74.6 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.709 -0.62 . . . . 0.0 109.778 179.692 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 50.0 mtm -75.55 -41.72 54.17 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.284 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.58 -36.85 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.789 -0.569 . . . . 0.0 110.181 179.644 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.74 18.71 5.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.491 -0.755 . . . . 0.0 111.569 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -152.53 29.26 0.54 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.505 -0.747 . . . . 0.0 110.459 179.765 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.89 -37.97 28.84 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.296 -0.877 . . . . 0.0 111.348 -179.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.05 -31.49 42.86 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.875 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mm -99.3 118.35 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.516 -0.99 . . . . 0.0 110.044 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 15.0 t -110.83 20.11 17.89 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.84 -0.537 . . . . 0.0 111.607 179.77 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 39' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.509 2.481 0 O-C-N 121.62 -0.675 . . . . 0.0 112.038 -179.977 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.09 -175.13 2.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.705 -0.879 . . . . 0.0 109.193 179.739 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 56.74 38.59 29.61 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.442 0.639 . . . . 0.0 110.38 -179.892 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.13 -52.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.874 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.2 t -60.5 -39.04 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.642 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.2 mt -62.14 -37.38 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.533 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.3 tp -78.61 -27.28 45.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.743 -0.598 . . . . 0.0 110.258 179.427 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tp -89.04 15.52 8.53 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.55 -0.718 . . . . 0.0 111.598 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.422 ' HA ' HG22 ' A' ' 12' ' ' ILE . 5.4 t -69.45 -25.71 64.23 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.162 -0.961 . . . . 0.0 111.346 179.839 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.21 -37.73 81.2 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.415 -0.803 . . . . 0.0 110.225 179.77 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.42 -48.17 57.31 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.646 -0.659 . . . . 0.0 110.146 179.782 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.647 HG23 ' HD3' ' A' ' 14' ' ' PRO . 13.6 tt -75.91 156.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.613 -0.679 . . . . 0.0 110.098 179.694 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -120.93 70.45 19.0 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.444 -0.785 . . . . 0.0 110.182 179.819 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.647 ' HD3' HG23 ' A' ' 12' ' ' ILE . 49.6 Cg_endo -73.36 -18.88 22.76 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.431 1.227 . . . . 0.0 111.748 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -60.36 -48.42 81.82 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.582 -0.699 . . . . 0.0 111.419 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.8 tp -53.69 -44.85 70.1 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.258 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 14' ' ' PRO . 11.9 mt -64.07 -38.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.321 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -62.46 -34.83 77.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.825 -0.547 . . . . 0.0 109.952 179.276 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.1 m -59.4 -42.62 92.19 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.788 -0.57 . . . . 0.0 109.912 179.637 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.44 -43.43 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.524 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.5 m -61.69 -39.78 92.66 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.682 -0.636 . . . . 0.0 109.85 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -60.52 -51.83 67.77 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.9 mt -63.48 -35.74 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.12 -41.18 92.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 179.341 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.35 -18.61 62.37 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.951 -0.468 . . . . 0.0 110.952 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.11 -1.63 57.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.861 -0.524 . . . . 0.0 111.522 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -128.32 -53.35 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.589 -0.695 . . . . 0.0 109.667 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 58.4 51.6 8.05 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.356 0.598 . . . . 0.0 110.611 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.9 68.06 0.01 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.3 -39.82 3.58 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.647 1.341 . . . . 0.0 111.477 179.777 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.45 -51.03 71.63 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.424 -0.798 . . . . 0.0 111.318 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.9 ptm -64.16 -23.64 67.39 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.742 -0.599 . . . . 0.0 112.047 -179.819 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.5 t -89.62 -39.87 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 179.709 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mp -85.1 6.34 25.96 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.481 -0.762 . . . . 0.0 112.35 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -135.12 25.39 3.56 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.045 -1.035 . . . . 0.0 110.811 179.487 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.85 -44.48 13.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.411 -0.805 . . . . 0.0 109.859 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.24 56.62 0.62 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.0 tt -108.32 19.94 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 122.092 -0.652 . . . . 0.0 111.638 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 p -124.5 58.03 1.23 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.092 -1.005 . . . . 0.0 109.362 179.832 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 tptp . . . . . 0 N--CA 1.504 2.265 0 CA-C-O 117.247 -1.359 . . . . 0.0 111.04 -179.805 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -114.37 24.54 11.83 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.724 -0.868 . . . . 0.0 111.058 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -102.05 -54.05 2.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.479 -0.763 . . . . 0.0 109.839 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.92 -32.43 70.76 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.014 -0.429 . . . . 0.0 110.537 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.27 -40.07 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.653 -0.654 . . . . 0.0 109.605 179.678 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.7 mt -66.16 -41.47 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.729 -0.607 . . . . 0.0 109.535 179.67 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.3 tp -69.5 -31.69 70.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.389 -0.819 . . . . 0.0 110.968 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.486 HD23 HD13 ' A' ' 12' ' ' ILE . 1.5 tp -73.2 -14.75 61.41 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.508 -0.745 . . . . 0.0 112.105 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.44 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 1.4 t -50.89 -28.93 10.64 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.633 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.5 t -60.13 -33.93 72.82 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.423 -0.798 . . . . 0.0 111.742 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -117.45 -62.51 1.56 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.35 -0.844 . . . . 0.0 110.986 -179.892 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.486 HD13 HD23 ' A' ' 8' ' ' LEU . 47.6 mm 58.49 91.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-O 121.805 0.812 . . . . 0.0 110.847 -179.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 45.1 t-80 -132.51 99.06 16.02 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.771 -0.581 . . . . 0.0 109.799 179.798 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 45.0 Cg_endo -65.02 -177.34 0.57 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 O-C-N 123.83 1.437 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.6 28.05 17.74 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.796 0.808 . . . . 0.0 109.868 -179.13 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -152.1 -53.89 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.709 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.2 mp -62.19 -32.54 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -87.8 -39.32 14.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.3 m -69.39 -22.95 63.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.752 -0.592 . . . . 0.0 110.87 179.641 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 17' ' ' ILE . 2.1 tp -55.43 -36.0 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.044 0.838 . . . . 0.0 110.142 179.765 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.1 p -65.08 -42.91 93.67 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.081 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -67.54 -36.52 81.14 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.435 ' O ' HG12 ' A' ' 27' ' ' ILE . 71.1 mt -73.55 -36.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.56 -0.712 . . . . 0.0 109.827 179.605 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.6 tp -48.75 -49.8 36.7 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.619 -0.676 . . . . 0.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.49 -5.7 44.13 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.648 -0.658 . . . . 0.0 111.8 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -107.59 3.67 25.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.718 -0.614 . . . . 0.0 111.078 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 23' ' ' ILE . 22.6 mm -104.29 -44.73 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.443 -0.786 . . . . 0.0 108.968 179.72 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -67.73 -40.08 84.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.057 -0.402 . . . . 0.0 110.305 179.763 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.46 63.84 2.28 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' O ' HD23 ' A' ' 34' ' ' LEU . 44.1 Cg_endo -65.12 -26.59 57.51 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.609 1.32 . . . . 0.0 111.916 -179.849 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.56 -44.97 10.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.353 -0.842 . . . . 0.0 109.816 179.681 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.3 ttt -69.3 -46.78 66.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.669 -0.644 . . . . 0.0 110.654 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.91 -29.0 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.625 -0.672 . . . . 0.0 110.689 179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 30' ' ' PRO . 1.3 mm? -73.04 -8.29 55.06 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.193 -0.942 . . . . 0.0 112.027 179.583 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -131.56 21.6 4.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.378 -0.826 . . . . 0.0 110.984 179.661 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.95 -53.68 4.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.743 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.09 46.59 1.15 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.433 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 tp -97.74 146.52 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.716 -0.873 . . . . 0.0 110.451 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 39' ' ' THR . 9.6 t -152.23 67.24 0.84 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.887 0.851 . . . . 0.0 109.902 179.943 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.376 -0.827 . . . . 0.0 110.207 179.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.538 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.86 19.24 8.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.723 -0.869 . . . . 0.0 111.906 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -104.2 -55.19 2.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.605 -0.685 . . . . 0.0 109.675 -179.864 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.52 -38.87 47.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.864 -0.523 . . . . 0.0 110.542 179.694 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -63.41 -45.07 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.95 -0.469 . . . . 0.0 110.172 179.936 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.2 mm -62.78 -40.26 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.722 -0.611 . . . . 0.0 109.38 179.712 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 11' ' ' ALA . 10.3 tp -64.88 -34.13 77.66 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.691 -0.63 . . . . 0.0 109.869 179.472 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 tp -73.7 -14.37 61.13 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.376 -0.827 . . . . 0.0 111.516 179.572 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.4 m -106.59 -41.57 5.23 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.666 -0.646 . . . . 0.0 110.548 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.4 m -92.77 -30.35 15.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.635 -0.666 . . . . 0.0 111.404 -179.789 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.539 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -105.72 50.58 0.77 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.293 -0.88 . . . . 0.0 110.029 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.25 -1.09 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.931 -0.481 . . . . 0.0 112.14 -179.823 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.405 ' CD2' HD12 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -151.08 66.23 7.13 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 120.852 -1.155 . . . . 0.0 110.538 179.687 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.89 -34.44 30.11 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.247 1.298 . . . . 0.0 111.489 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.51 -39.72 80.88 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.637 -0.665 . . . . 0.0 110.701 179.776 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.405 HD12 ' CD2' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -76.96 -38.14 53.88 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 122.148 -0.345 . . . . 0.0 110.32 179.595 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.08 -47.44 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.677 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.98 -32.98 72.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.849 -0.532 . . . . 0.0 111.386 179.92 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -71.25 -42.95 68.15 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 80.9 mt -65.01 -42.58 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 179.913 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 p -65.25 -37.54 87.53 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.413 -0.804 . . . . 0.0 110.402 179.779 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.34 -46.43 64.17 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mm -65.79 -38.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.523 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 24' ' ' LEU . 1.8 tm? -60.1 -39.61 86.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.545 -0.722 . . . . 0.0 109.822 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.74 -22.47 37.26 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.359 -0.838 . . . . 0.0 111.026 179.582 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.47 12.34 14.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.842 -0.536 . . . . 0.0 111.438 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mm -117.24 -43.64 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.301 -0.874 . . . . 0.0 109.993 179.744 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mt -106.72 -74.61 0.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.54 -0.725 . . . . 0.0 110.412 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 33' ' ' VAL . . . 65.57 70.79 1.01 Allowed Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.892 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.09 -34.5 13.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.534 1.281 . . . . 0.0 111.52 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.61 -48.87 79.98 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.66 -0.65 . . . . 0.0 110.669 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 5.1 ptt? -71.06 -28.96 64.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.635 -0.666 . . . . 0.0 110.77 179.742 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 29' ' ' GLY . 38.7 t -64.51 -33.78 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.236 -0.915 . . . . 0.0 110.473 179.681 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.08 -1.55 56.39 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.39 -0.819 . . . . 0.0 112.056 179.812 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.3 18.61 6.44 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.309 -0.869 . . . . 0.0 111.169 179.758 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.32 78.37 2.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.13 -0.981 . . . . 0.0 108.442 179.451 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.59 42.66 17.1 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.319 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.0 tp -81.46 145.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.599 -0.942 . . . . 0.0 110.237 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.8 m -110.07 51.5 0.76 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.729 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.657 -179.726 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.437 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 ttp-105 -128.57 31.35 5.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.754 -0.851 . . . . 0.0 110.218 179.874 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.61 -55.32 2.45 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.974 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.67 -36.37 32.5 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.261 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.75 -43.84 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.607 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 mm -64.1 -38.27 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.21 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.54 -30.11 64.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.611 -0.681 . . . . 0.0 109.877 179.295 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.75 7.14 18.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.58 -0.7 . . . . 0.0 111.72 179.712 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.54 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 6.3 t -59.3 -31.82 69.49 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.269 -0.894 . . . . 0.0 111.378 -179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 m -64.68 -38.93 92.66 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.465 -0.772 . . . . 0.0 110.025 179.421 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.82 66.15 1.48 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.985 0.897 . . . . 0.0 108.685 179.557 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.54 ' CG2' ' HA ' ' A' ' 9' ' ' THR . 24.9 pt -64.21 167.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-O 121.631 0.729 . . . . 0.0 111.729 -179.421 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -118.58 -171.23 0.2 Allowed Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.822 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 13' ' ' HIS . 47.0 Cg_endo -80.26 -174.04 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.117 1.878 . . . . 0.0 110.612 -179.926 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 58.75 36.91 25.07 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.28 1.038 . . . . 0.0 110.233 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.67 -51.12 0.06 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.616 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.7 mt -54.74 -39.38 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.946 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -62.04 -42.62 99.37 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.308 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -66.63 -39.77 88.45 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.789 HD12 ' HA ' ' A' ' 17' ' ' ILE . 81.4 mt -55.56 -39.15 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.623 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -42.37 82.92 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.698 -0.626 . . . . 0.0 109.509 179.488 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -68.84 -41.31 78.7 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.606 HG22 HD11 ' A' ' 27' ' ' ILE . 22.2 mm -75.97 -23.69 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.739 -0.6 . . . . 0.0 110.081 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.28 -42.52 70.1 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.486 -0.759 . . . . 0.0 109.784 179.67 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 25' ' ' LEU . 1.8 mm? -70.53 -11.46 60.94 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.885 -0.509 . . . . 0.0 110.935 179.146 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.38 13.0 30.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.738 -0.601 . . . . 0.0 110.456 179.192 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 23' ' ' ILE . 62.4 mt -121.73 -2.48 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.322 -0.861 . . . . 0.0 111.042 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.2 30.94 0.74 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.516 -1.365 . . . . 0.0 111.866 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.54 53.23 0.4 Allowed Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.695 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.54 -37.0 18.06 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.612 1.322 . . . . 0.0 110.505 179.806 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.83 -44.09 94.22 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.899 -0.5 . . . . 0.0 109.79 179.66 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.4 ttt -62.2 -45.06 95.07 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.35 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.5 -39.73 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.475 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.15 -22.51 65.77 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.809 -0.557 . . . . 0.0 111.928 179.963 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.61 21.25 17.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.73 -0.606 . . . . 0.0 110.687 179.554 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.9 74.48 8.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.234 -0.916 . . . . 0.0 109.35 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.11 40.15 10.67 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.749 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 38' ' ' ILE . 8.4 tt -76.84 98.75 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 118.251 1.025 . . . . 0.0 109.649 179.886 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 m 57.98 37.83 26.75 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.735 -0.603 . . . . 0.0 110.392 -179.617 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.6 mptt . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.153 179.984 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.506 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -78.06 86.29 4.23 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 122.191 0.996 . . . . 0.0 111.212 -179.875 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.88 -64.99 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.739 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.41 -29.73 27.9 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.935 -0.478 . . . . 0.0 110.636 179.741 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.91 -39.76 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.796 -0.565 . . . . 0.0 109.806 179.915 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mt -63.26 -38.6 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.291 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tt -73.29 -36.02 66.22 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.993 -0.442 . . . . 0.0 110.15 179.51 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.68 12.65 14.23 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.706 -0.621 . . . . 0.0 112.255 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.571 ' HA ' HG22 ' A' ' 12' ' ' ILE . 7.6 t -62.83 -32.38 73.58 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.232 -0.918 . . . . 0.0 111.622 179.876 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.2 t -70.92 -29.71 65.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.535 -0.728 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.06 -0.7 33.08 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.36 -0.837 . . . . 0.0 112.054 179.938 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.571 HG22 ' HA ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -120.88 19.59 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.013 -1.054 . . . . 0.0 112.097 -179.854 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -121.15 77.45 32.73 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.034 -1.041 . . . . 0.0 110.85 179.788 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -80.26 -173.65 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.65 1.342 . . . . 0.0 110.128 179.572 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 67.05 3.08 2.98 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.731 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -124.02 -48.48 1.87 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.081 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.904 ' HA ' HD12 ' A' ' 20' ' ' ILE . 8.4 mt -52.03 -41.87 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -42.8 99.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 0.0 110.068 179.628 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -66.85 -33.86 76.52 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.747 -0.596 . . . . 0.0 110.0 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 17' ' ' ILE . 86.9 mt -58.3 -43.39 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.253 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 m -69.09 -41.76 77.04 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.032 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -59.65 -46.03 90.25 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.514 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 27' ' ' ILE . 40.9 mm -82.09 -15.56 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.712 -0.617 . . . . 0.0 110.249 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HA ' HD12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -54.33 -45.63 72.7 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 179.664 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.01 -21.91 66.91 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.387 179.237 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.41 0.45 56.22 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.056 -0.402 . . . . 0.0 111.188 179.215 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 24' ' ' LEU . 55.2 mt -110.16 9.18 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.46 -0.775 . . . . 0.0 109.898 179.543 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.7 mm? -54.4 -51.28 65.35 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.082 -1.011 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.45 75.72 0.98 Allowed Glycine 0 N--CA 1.497 2.763 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.642 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.84 -34.23 9.03 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 123.579 1.304 . . . . 0.0 111.131 179.497 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.68 -50.74 71.27 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.685 -0.634 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.8 ptp -64.54 -35.18 80.15 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.649 -0.657 . . . . 0.0 110.76 179.971 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.41 -31.76 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.561 -0.712 . . . . 0.0 109.64 179.382 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 34' ' ' LEU . 3.1 mm? -96.86 7.33 46.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.587 -0.696 . . . . 0.0 111.43 179.681 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -129.85 20.59 5.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.382 -0.824 . . . . 0.0 110.446 179.69 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.25 76.31 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.619 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.77 55.79 0.87 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.476 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tt -121.38 42.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.719 -0.871 . . . . 0.0 111.337 -179.991 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.7 p -114.39 42.71 2.04 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.981 -1.075 . . . . 0.0 109.756 179.453 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.199 0 O-C-N 122.053 -0.404 . . . . 0.0 110.628 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.7 ptt85 -121.85 5.64 9.92 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.957 -0.731 . . . . 0.0 111.834 179.852 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -108.53 -46.44 3.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.7 -0.625 . . . . 0.0 110.57 -179.662 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.04 -39.95 22.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.568 -0.708 . . . . 0.0 109.712 179.658 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.12 -41.91 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.747 -0.595 . . . . 0.0 109.673 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.4 mm -66.59 -37.12 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.309 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -30.4 62.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.757 -0.59 . . . . 0.0 110.04 179.41 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.44 25.02 3.61 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.615 -0.678 . . . . 0.0 111.174 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 t -67.16 -25.22 66.05 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.085 -1.009 . . . . 0.0 111.5 179.895 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.5 p -59.31 -28.76 67.09 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.387 -0.82 . . . . 0.0 110.989 179.606 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -113.94 -70.53 0.8 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.55 -0.719 . . . . 0.0 109.112 179.571 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 11' ' ' ALA . 3.0 tt 40.29 29.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 179.598 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.64 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 60.6 92.18 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 122.049 -0.407 . . . . 0.0 110.329 179.947 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 13' ' ' HIS . 42.3 Cg_endo -63.04 -32.93 75.39 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.35 1.366 . . . . 0.0 112.107 -179.709 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -67.39 -37.06 82.53 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.449 -0.782 . . . . 0.0 109.033 179.205 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -66.82 -38.63 86.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.155 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.5 mm -63.8 -40.26 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.204 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.6 -36.47 71.79 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.5 m -73.62 -39.9 64.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.201 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -41.34 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.853 -0.53 . . . . 0.0 110.364 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 p -65.54 -36.49 83.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.473 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -58.83 -42.76 89.99 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.405 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -74.88 -35.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.025 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.79 -44.57 82.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.427 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -14.61 62.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.788 -0.57 . . . . 0.0 111.423 179.431 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.73 5.17 52.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.782 -0.574 . . . . 0.0 110.637 179.18 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.0 mt -126.81 -37.83 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 0.0 110.246 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.37 -36.81 74.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.393 -0.817 . . . . 0.0 111.768 -179.815 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.33 49.55 0.56 Allowed Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.288 -179.886 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.43 -32.11 20.62 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 O-C-N 123.414 1.218 . . . . 0.0 110.904 179.248 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.13 -43.37 95.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.709 -0.619 . . . . 0.0 110.209 179.789 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.1 mtp -63.64 -43.23 97.38 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.685 -0.634 . . . . 0.0 109.476 179.385 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.99 -35.75 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.382 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 34' ' ' LEU . 3.5 mm? -82.78 10.63 7.27 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.603 -0.686 . . . . 0.0 111.568 179.56 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -127.15 22.77 6.58 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.279 -0.888 . . . . 0.0 110.209 179.468 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.35 -55.37 3.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.256 -0.903 . . . . 0.0 109.016 179.731 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.42 41.92 1.88 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.325 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.1 tt -75.69 153.12 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.706 -0.879 . . . . 0.0 111.067 -179.78 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -108.74 42.76 1.35 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.636 -0.665 . . . . 0.0 109.967 179.738 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.13 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.408 -179.821 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.561 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.0 23.87 13.03 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.283 -0.54 . . . . 0.0 111.964 -179.951 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -99.37 -50.02 4.25 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.517 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.88 -27.74 68.44 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.179 179.569 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.8 t -63.35 -38.38 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 O-C-N 121.705 -0.622 . . . . 0.0 110.027 179.782 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.0 mm -60.57 -42.48 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.42 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.19 -32.39 73.79 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.124 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 7.53 13.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.477 -0.764 . . . . 0.0 111.844 179.585 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.0 m -93.7 -26.79 16.87 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.084 -1.01 . . . . 0.0 110.574 179.762 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.6 p -62.26 -31.16 71.7 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.154 -0.966 . . . . 0.0 111.411 179.893 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.81 -46.94 27.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.385 -0.822 . . . . 0.0 110.052 179.741 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.454 HG23 ' HD3' ' A' ' 14' ' ' PRO . 3.1 tp -68.79 156.89 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.595 -0.691 . . . . 0.0 109.619 179.71 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -112.0 86.05 7.17 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.564 -0.71 . . . . 0.0 110.2 -179.75 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD3' HG23 ' A' ' 12' ' ' ILE . 50.1 Cg_endo -71.29 -172.47 0.75 Allowed 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.275 1.316 . . . . 0.0 110.442 179.703 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 56.1 44.98 24.38 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.258 1.028 . . . . 0.0 110.599 -179.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.65 -51.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.26 -36.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.805 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -63.12 -34.61 77.98 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.085 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 m -78.77 -27.52 44.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.681 -0.637 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.18 -45.18 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.69 -0.631 . . . . 0.0 110.198 179.975 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -67.02 -33.86 76.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.636 -0.665 . . . . 0.0 110.018 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -68.47 -50.83 49.5 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.6 -23.27 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.748 -0.595 . . . . 0.0 109.808 179.204 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -55.77 -42.65 75.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.511 -0.743 . . . . 0.0 110.014 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -70.09 -24.62 63.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.585 -0.697 . . . . 0.0 110.664 179.552 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.62 -24.8 28.97 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.773 -0.58 . . . . 0.0 111.183 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 27' ' ' ILE . 50.1 mm -103.35 33.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-O 121.201 0.524 . . . . 0.0 110.457 179.919 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 25' ' ' LEU . 1.3 mt -76.47 -27.6 56.2 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.735 -1.228 . . . . 0.0 110.537 179.49 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.23 70.37 0.02 OUTLIER Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.906 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.52 -49.11 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 O-C-N 123.774 1.407 . . . . 0.0 110.827 -179.923 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.16 -36.49 83.24 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.801 -0.562 . . . . 0.0 109.787 179.64 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 39.4 ttm -60.98 -45.32 95.29 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.562 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.12 -34.17 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.913 -0.492 . . . . 0.0 109.721 179.454 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mp -87.37 -1.74 58.13 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.632 -0.667 . . . . 0.0 111.964 179.708 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -123.66 22.87 8.96 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.394 -0.816 . . . . 0.0 110.709 179.73 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.65 76.11 1.37 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.338 -0.851 . . . . 0.0 109.064 179.702 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.04 51.37 2.27 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.56 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.98 125.16 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.606 -0.938 . . . . 0.0 110.77 -179.92 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -149.88 71.51 1.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.834 -1.079 . . . . 0.0 110.316 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.442 ' O ' HD12 ' A' ' 6' ' ' ILE . 3.6 ttp180 -123.68 8.69 8.87 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.969 -0.724 . . . . 0.0 111.199 179.956 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -110.44 -51.2 2.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.897 -1.127 . . . . 0.0 109.608 179.911 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.51 74.41 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.896 -0.503 . . . . 0.0 110.839 179.697 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.44 -48.51 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.592 -0.693 . . . . 0.0 110.608 -179.887 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 2' ' ' ARG . 42.1 mt -59.97 -42.97 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.751 -0.593 . . . . 0.0 109.462 179.656 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.68 -36.43 80.85 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.001 -0.437 . . . . 0.0 110.567 179.607 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.59 -43.38 80.66 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.733 -0.604 . . . . 0.0 111.014 179.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.2 m -64.15 -41.89 97.0 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.783 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.45 -39.61 93.93 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.483 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.17 -39.34 78.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.893 -0.505 . . . . 0.0 110.305 179.61 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.9 mt -92.7 81.77 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.76 0.79 . . . . 0.0 109.509 179.865 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 59.3 3.54 Favored Pre-proline 0 N--CA 1.499 2.02 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.052 179.816 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.46 -178.85 4.74 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 O-C-N 123.121 1.064 . . . . 0.0 111.173 -179.777 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 59.66 13.96 3.73 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-O 121.333 0.587 . . . . 0.0 111.997 -179.486 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 20' ' ' ILE . 13.8 tp -143.04 -59.76 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.213 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.8 -32.56 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.16 -39.73 28.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.897 -0.502 . . . . 0.0 109.676 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -61.37 -47.57 85.25 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.854 -0.529 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 16' ' ' LEU . 13.6 mt -58.5 -45.33 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -64.78 -33.3 75.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.825 -0.547 . . . . 0.0 110.541 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -68.46 -40.31 81.09 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.432 -0.793 . . . . 0.0 110.704 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.8 -36.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.786 -0.571 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.71 -44.27 93.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.522 -0.736 . . . . 0.0 109.727 179.644 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.31 -14.81 59.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.81 -0.556 . . . . 0.0 111.017 179.429 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.79 14.01 22.77 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.842 -0.536 . . . . 0.0 110.801 179.34 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 27' ' ' ILE . 12.0 mm -120.97 -69.2 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.631 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt 49.47 67.04 0.95 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.592 0.71 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.07 70.56 0.03 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.23 -28.48 55.81 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 O-C-N 123.903 1.475 . . . . 0.0 111.493 179.571 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 tp -62.3 -40.73 97.24 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.553 -0.717 . . . . 0.0 110.143 179.708 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ttt -62.29 -36.48 82.22 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.916 -0.49 . . . . 0.0 109.73 179.511 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.6 t -62.33 -33.45 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.861 -0.524 . . . . 0.0 109.627 179.472 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.6 12.34 5.89 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.521 -0.737 . . . . 0.0 111.585 179.506 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.48 24.75 2.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.935 -1.103 . . . . 0.0 110.452 179.654 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.51 104.71 8.2 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.236 -0.915 . . . . 0.0 109.876 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.42 -0.89 22.15 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.678 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.0 tp -70.67 146.3 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 119.12 1.46 . . . . 0.0 110.378 179.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 15.1 p -112.94 54.28 0.73 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.738 -0.601 . . . . 0.0 109.75 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 39' ' ' THR . 7.0 mttm . . . . . 0 N--CA 1.509 2.492 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.723 -179.931 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -102.61 -165.98 1.23 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.793 -0.828 . . . . 0.0 110.315 179.783 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 31.45 21.37 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.131 0.491 . . . . 0.0 111.051 -179.592 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -170.72 -54.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.99 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.15 -47.4 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.61 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.03 -41.35 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.437 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 7' ' ' LEU . 1.5 tm? -64.61 -34.63 78.73 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.077 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.72 11.78 8.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.602 -0.686 . . . . 0.0 111.694 179.501 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 12' ' ' ILE . 18.6 m -102.51 -45.08 5.17 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.948 -1.095 . . . . 0.0 110.116 179.719 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 t -56.84 -38.77 73.13 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.807 -0.558 . . . . 0.0 111.712 -179.792 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.66 -20.97 66.61 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.637 -0.664 . . . . 0.0 111.886 -179.923 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 9' ' ' THR . 73.3 mt -76.48 118.43 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.208 -0.932 . . . . 0.0 109.991 179.932 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.507 ' CD2' ' HB2' ' A' ' 16' ' ' LEU . 3.3 t60 -147.46 84.6 7.1 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.721 -0.612 . . . . 0.0 110.131 179.761 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HA ' HD12 ' A' ' 17' ' ' ILE . 42.9 Cg_endo -63.7 -27.24 68.51 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 O-C-N 123.824 1.434 . . . . 0.0 110.935 179.858 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.49 -44.81 95.47 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.494 0.664 . . . . 0.0 109.442 179.397 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.507 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -66.25 -41.27 90.22 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.294 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 14' ' ' PRO . 38.4 mt -60.19 -42.15 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.502 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -63.64 -41.11 98.28 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.677 -0.64 . . . . 0.0 109.854 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.5 m -61.54 -42.94 99.57 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.471 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.09 -37.92 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.989 -0.444 . . . . 0.0 109.903 179.534 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.2 m -64.64 -39.57 93.94 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.208 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -61.93 -44.15 97.37 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.97 -41.59 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 27' ' ' ILE . 9.7 tp -57.82 -41.21 81.77 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.279 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.98 -30.67 71.27 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.249 0.547 . . . . 0.0 109.994 179.099 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.95 -0.65 49.58 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.595 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 24' ' ' LEU . 48.3 mt -105.11 -45.87 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.895 . . . . 0.0 110.002 179.908 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.0 mt -73.58 -38.37 65.18 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.743 -0.598 . . . . 0.0 111.581 -179.673 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.44 -65.98 3.13 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.845 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.14 38.19 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.407 1.404 . . . . 0.0 111.222 179.882 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.06 -45.41 67.14 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.387 -0.821 . . . . 0.0 110.016 179.822 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -80.66 -37.08 31.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.755 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.06 -34.26 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.718 -0.613 . . . . 0.0 109.962 179.682 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.99 14.12 4.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.663 -0.648 . . . . 0.0 111.232 179.396 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -134.13 26.64 3.87 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.304 -0.873 . . . . 0.0 110.612 179.847 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.17 101.54 12.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.297 -0.877 . . . . 0.0 109.783 179.779 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.97 52.94 25.51 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 15.8 tt -70.31 136.77 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.748 -0.854 . . . . 0.0 110.8 -179.97 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.0 p -132.58 32.72 3.85 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.07 0.462 . . . . 0.0 109.948 179.88 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 117.797 -1.097 . . . . 0.0 109.753 -179.746 . . . . . . . . 0 0 . 1 stop_ save_